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Summary 
Background 
Classification systems for use in the diagnosis of mental disorders have been 
developed based on a categorical model of psychopathology. Although current 
categorical diagnostic classification systems have been found to have good utility 
and reliability, studies have questioned whether these systems have adequate 
validity. Dimensional models of psychopathology have been examined as an 
alternative to categorical diagnostic classification systems and found to be more 
strongly related to clinical parameters, such as the severity and outcome of mental 
disorders. 
 
A literature review found a small evidence base on dimensional models of 
psychopathology experienced by adults with intellectual disabilities. However, the 
findings were limited by small sample sizes, biased samples and inclusion of only a 
limited range of items of psychopathology. Furthermore, the methods of exploratory 
factor analysis used do not meet established best practice guidelines. 
 
Informed by the existing literature, this thesis aimed to; 
1. identify a dimensional model of psychopathology experienced by adults with 
intellectual disabilities 
2. examine the associations of a dimensional model of psychopathology with 
measures of the severity and outcome of mental disorders 
3. compare the predictive validity of dimensional and categorical models of 
psychopathology. 
 
Methods 
The Psychiatric Present State- Learning Disabilities (PPS-LD) was used as a 
structured instrument to collect psychopathology data. Exploratory factor analysis 
(EFA) following best practice guidelines was used to identify dimensions of 
psychopathology. Continuous measures representing the dimensions of 
psychopathology were calculated. Meeting criteria for the diagnosis of a mental 
disorder from the Diagnostic Criteria for Psychiatric Disorders for use with Adults 
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with Learning Disabilities (DC-LD) was used as the variable representing the 
categorical model of psychopathology. 
 
Baseline data was collected on four measures of severity; the Health of the Nation 
Outcome Scales- Learning Disabilities (HoNOS-LD), Global Assessment of 
Functioning (GAF), Clinical Global Impression (CGI), and the Camberwell 
Assessment of Needs for Adults with Developmental and Intellectual Disabilities- 
Research version (CANDID-R) unmet needs. These measures were completed again 
at follow up 4-5 years later and change over time used as a measure of longitudinal 
outcome.  
 
Bivariate statistics and multivariate linear regression were used to examine the 
associations of the dimensions of psychopathology, and DC-LD diagnosis, with the 
measures of the severity of and longitudinal outcome of mental disorders. Relevant 
socio-clinical variables, associated with psychopathology in previous population-
based intellectual disabilities studies were included in the analyses: ; gender, age, 
living circumstances, level of intellectual disabilities, autism, Down syndrome, 
epilepsy, sensory impairments, mobility problems and incontinence. 
 
 
Key results 
A model of psychopathology with four dimensions was extracted from the EFA. This 
model was stable in two additional EFA using random samples. There were no 
significant correlations between the four dimensions which were labeled depressive, 
organic, behaviour-affective and anxiety. 
 
Only the anxiety dimension of psychopathology was not associated with any of the 
measures of severity of mental disorders. The depression dimension was 
independently associated with severity on the HoNOS-LD (β=.413, p<.001), GAF 
(β=-.402, p<.001) and the CGI (β=.457, p<.001). The organic dimension was 
independently associated with severity on the HoNOS-LD (β=.205, p=.004), GAF 
(β=-.326 p<.001) and CGI (β=.266, p<.001). The behaviour-affective dimension was 
 xxii
independently associated with severity on the HoNOS-LD (β=.332, p<.001), GAF 
(β=-.286, p<.001), CGI (β=.253, p<.001) and CANDID-R unmet needs (β=.178, 
p=.018). Level of intellectual disabilities was independently associated with severity 
on the HoNOS-LD and CANDID-R unmet needs. Finally, younger age (β=-.208, 
p=.010), living independently (β=-.599, p<.001) and not having a visual impairment 
(β=-.191, p=.009) were associated with greater CANDID-R unmet needs. 
 
None of the baseline measures of psychopathology were associated with longitudinal 
outcome on the CANDID-R unmet needs. Baseline scores on the depressive 
dimension were significantly associated with longitudinal outcome on the HoNOS-
LD (β=.297, p=.034), GAF (β=.342, p=.002) and CGI (β=.373, p=.001). Similarly, 
the behaviour-affective dimension was significantly associated with longitudinal 
outcome on the HoNOS-LD (β=.292, p=.033), GAF (β=.244, p=.036) and CGI 
(β=.298, p=.009). The organic dimension was only associated with longitudinal 
outcome on the HoNOS-LD (β=-.382, p=.006). Individuals with mild intellectual 
disabilities had poorer outcomes on all four measures of longitudinal outcome. 
Hearing impairment was associated with poorer outcome on the GAF (β=-.483, 
p=.000) and CGI (β=-.331, p=.004), and poorly controlled seizures with poorer 
outcome on the CGI (β=-1.638, p=.004). 
 
The variable representing the categorical model of psychopathology was only 
independently associated with severity on the HoNOS-LD (β=.178, p=.026), and 
longitudinal outcome on the GAF (β=.259, p=.045) and CGI (β=.257, p=.044). 
However, when categorical and dimensional models were both included in the 
regression analyses only the dimensional model of psychopathology was retained as 
independently associated with these measures of severity and outcome.  
 
Conclusions 
The description of a stable dimensional model demonstrates the value of using 
multivariate statistical methods to examine psychopathology experienced by adults 
with intellectual disabilities. Since the findings suggest that dimensional models have 
better validity than categorical models of psychopathology, the use of EFA, and other 
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multivariate methods, could contribute to the development of valid categorical 
diagnostic classification systems.  
 
The presence of affective items of psychopathology across the depressive, behaviour-
affective and anxiety dimensions highlights the possible relevance of a global 
affective model of psychopathology. Findings reported in this thesis support the 
potential relevance of models of affect regulation and affective arousal to developing 
an understanding of psychopathology experienced by persons with intellectual 
disabilities.  
 
There are similarities between the dimensional model in this thesis and the tripartite 
model of depression and anxiety psychopathology, described in the literature- which 
has depressive, anxiety and general distress dimensions. Overlaps between the 
behaviour-affective dimension, and general distress dimension within the tripartite 
model, suggest that there may be an association between affective psychopathology 
and problem behaviours. However, it could be that this association is with affective 
psychopathology in the general distress dimension, rather than with depressive 
psychopathology, as examined in previous studies. 
 
Confirmatory factor analyses should be considered to examine the four dimension 
model of psychopathology. Future studies involving individuals with intellectual 
disabilities should examine the relevance and validity of the tripartite model of 
depression and anxiety psychopathology. 
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Chapter 1 Background 
1.1 Classification in medicine 
Classification and diagnosis are closely related and central to the contemporary practice 
of medicine. 
 
Classification is the “activity of ordering or arrangement of objects into groups or sets 
on the basis of their relationships”, and nosology is the application of classification in 
medicine (Parshall & Priest 1993). Taxonomy- is the theoretical study of classification, 
which is described as an attempt to move from the question of, “how we classify?” to 
“how should we classify?” (Frances et al. 1994). 
 
Most branches of science have established systems of classification. In medicine, the 
first attempts at classification are traced back to the ancient Greeks, and the 
philosophical schools of Plato and Aristotle (Parshall & Priest 1993). Central to 
classification in medicine (nosology) is the process of diagnosis.  
 
Medical diagnosis is described as “organising unorganised illness” (Balint 1964). There 
are multiple stages involved and one end-point of the process is assigning an 
individual’s symptoms and signs to a named categorical diagnosis (Elstein & Schwartz 
2002). Therefore, at one level, the process of diagnosis is a form of classification. 
Throughout this thesis the term categorical diagnostic classification systems will be 
used to refer to the current classification systems used in medicine, and more 
particularly in the study of mental disorders, and psychiatry. 
 
Based on a historical view of the development of classification, a model of the 
classification of health and disease applicable to all branches of medicine was 
proposed, illustrated in figure 1.1 (Scadding 1988). In Scadding’s model (Scadding 
1988), the development of a classification system begins with the clinical description of 
symptoms and signs, gradually integrating the more robust/ scientific characteristics- 
disorder of structure, disorder of function, and aetiological description. This model 
illustrates that, as knowledge of health and disease move forward, classification 
systems become increasingly sophisticated.  
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Figure 1.1. Scadding’s hierarchical model of the characteristics of classification 
systems for disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.1 Approaches to developing systems of classification  
The classification of intellectual disabilities is used to illustrate two different 
approaches to classification. 
 
Intellectual disabilities is the internationally accepted term used to describe the needs of 
individuals with significant limitations both in intellectual functioning and adaptive 
behavior as expressed in conceptual, social, and practical skills- originating before age 
 
4. Discovery of the aetiology/ causation of a disease 
 
3. Recognition of a functional abnormality- pathophysiology 
 
2. Recognition of a structural abnormality- anatomy 
 
1. Clinical description of signs and symptoms 
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18 (American Association on Intellectual and Developmental Disabilities 2010). Such 
needs necessitate additional support from an individual's family, community and/ or 
services.  
 
1.1.1.1 A “top-down” consensus approach to classification 
Historical conceptualisations of intellectual disabilities used socially derived definitions 
to classify individuals as belonging to a distinct category. Eminent theorists, and social 
commentators of the day presented their opinions, influenced by broader social systems 
and ideas (Berrios 1999). This is an example of a “top down” approach to classification 
which results in categorical definitions. The 13th century legal system provided one of 
the earliest proposals to separate intellectual disabilities (termed idiocy) from mental 
disorders (lunacy). Such categories were defined on the basis of unifying 
characteristics; for example, individuals with intellectual disabilities were seen as 
having a permanent disability, present from birth; whilst mental disorders were 
believed to be acquired after birth, with some possibility of change over time (Digby 
1996). Further sub-categorisation emerged in the 18th and 19th century- using the terms 
such as feeble-minded, idiocy and imbecility - based largely on an individual’s ability 
to carry out work (Berrios & Porter 1998).  
 
1.1.1.2 A “bottom-up” statistical approach 
An alternative to categorisation in classification is the study and description of 
individual human traits, or dimensions, which is considered to provide a more detailed 
representation of the complex pattern of similarities and differences between 
individuals (Sternberg & Kaufman 1998). 
 
In the late 19th and early 20th century, researchers with an interest in understanding the 
construct of intelligence began the development of “bottom- up” empirical methods 
used in the study of traits and dimensions (Brody 2000). These statistical methods, such 
as factor analysis, have subsequently provided evidence comparing dimensional models 
with categorical diagnostic classification systems for mental disorders (Krueger 1999; 
Brown & Barlow 2005). 
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One of the earliest individuals interested in examining dimensions underlying 
intelligence was Charles Spearman. As part of his work, Spearman developed factor 
analytic methods to examine whether a single underlying intelligence factor could 
explain correlations between separate dimensions of intellectual functioning- such as 
sensory perception, memory, attention etc.  Spearman’s work, alongside that of Jensen, 
Eysenck and others contributed to a theory of general intelligence- the g factor, with an 
alternative theory of multiple intelligences proposed by Thurstone, Gardner and 
Sternberg (Deary 2001). This early work on general intelligence made a clear 
contribution to ideas around the normal distribution of intelligence, and intelligent 
quotient (IQ) testing - both of which are integral to current definitions of intellectual 
disabilities.  
 
1.1.2 Intellectual disabilities in current classification systems  
Both the “top-down” and “bottom-up” approaches have had an influence on the criteria 
for intellectual disabilities in contemporary classification systems. These criteria 
comprise three parts: 
• a measure of intellectual functioning- usually IQ 
• a measure of adaptive functioning 
• a time/ duration criterion. 
 
These parts from the definition used in the Diagnostic Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR; (American Psychiatric 
Association 2000) categorical diagnostic classification system (which uses the term 
mental retardation) are presented in table 1.1.  
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Table 1.1 Diagnostic criteria for intellectual disabilities from DSM-IV-TR 
 
 DSM-IV-TR 
Intellectual 
functioning 
Significantly sub-average intellectual functioning: An IQ 
of approximately 70 or below on an individually 
administered IQ test.  
Adaptive behaviour Concurrent deficits or impairments in present adaptive 
functioning (i.e., the person's effectiveness in meeting the 
standards expected for his or her age by his or her cultural 
group) in at least two of the following areas: 
communication, self-care and home living, social skills, 
use of community resources, self-direction, functional 
academic skills, work, leisure, health issues, safety 
Age of onset The age of onset is before 18 years old 
 
 
The other commonly used categorical diagnostic classification system in medicine is 
the International Statistical Classification of Diseases, Tenth Edition (ICD-10; (World 
Health Organisation 1993). The description of the ICD-10 term mental retardation 
below is provided, 
 
“A condition of arrested or incomplete development of the mind, which is 
especially characterized by impairment of skills manifested during the 
developmental period, skills which contribute to the overall level of intelligence, 
i.e. cognitive, language, motor, and social abilities. Retardation can occur with or 
without any other mental or physical condition.” 
 
This is followed by the use of IQ as the basis to further categorise individuals with mild 
(approximate IQ range 50-69), moderate (approximate IQ range 35-49), severe 
(approximate IQ range 20-34) and profound (IQ under 20) intellectual disabilities.  
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The inclusion of IQ measurements within the criteria for intellectual disabilities shows 
that a categorical diagnosis can make use of the “top-down” consensus and “bottom-
up” statistical processes.   
 
1.2 Classification systems for mental disorders 
Psychopathology is defined as the study of abnormal experience, cognition and 
behaviour (Sims 2003). It is, both, a core skill in psychiatry and the basis for the 
classification of mental disorders (Wallace 1994). A categorical model of 
psychopathology is used in current categorical diagnostic classification systems. 
 
The two main, generic classification systems for mental disorders, ICD and DSM, have 
acted as the basis for the development of categorical diagnostic classification systems 
for the classification of mental disorders experienced by adults with intellectual 
disabilities- the ICD-10 Guide to Mental Retardation (ICD-10-MR; World Health 
Organisation 1996); the Diagnostic Criteria for Psychiatric Disorders for use with 
Adults with Learning Disabilities (DC-LD: Royal College of Psychiatrists 2001) and 
the Diagnostic Manual-Intellectual Disability: a textbook of diagnosis of mental 
disorders in persons with intellectual disability (DM-ID: Fletcher et al. 2007). 
Therefore, examining ICD and DSM is necessary before a more detailed description of 
these categorical diagnostic classification systems specific to intellectual disabilities.  
  
1.2.1 The requirements for a good classification system of mental disorders. 
Any classification system for mental disorders will be used for multiple purposes, 
simultaneously (Johnstone 1998): 
• communication with service users, carers and professionals 
• clinical decision making 
• strategic development of services 
• research 
• teaching and training 
• legal purposes 
• service commissioning and reimbursement. 
 
 7 
Although each of these purposes has different requirements, there is a degree of 
consensus about the core characteristics which a classification system should have; 
utility- defined in terms of comprehensiveness and ease of use- reliability and validity 
(Kendler 1990; Kendell & Jablensky 2003).  
 
Reliability refers to the consistency, or repeatability, with which a decision, or 
statement, is made. Although there are many types of reliability, the key one in the 
diagnosis and classification of mental disorders is inter-rater reliability (Helzer et al. 
1977).  Inter-rater reliability refers to the level of agreement in the diagnoses 
independently reached by two, or more, clinicians or researchers.  
 
As well as reliability, the validity of categorical diagnostic classification systems has 
also been examined. Validity is defined as the, “…best available approximation to the 
truth or falsity of a given inference, proposition or conclusion…”  (Cook & Campbell 
1979). There are many types of validity, the use of which are determined by the 
context. The three types of validity relevant to diagnosis in mental disorders are each 
given below with a short description: 
• face validity- the criteria and diagnostic category seem to represent the experiences 
of individuals with mental disorders, and clinicians 
• discriminant validity- the criteria used to define a specific diagnostic categories 
adequately distinguish it from neighbouring, related categories 
• predictive validity- a diagnostic category makes it possible to predict outcome or 
prognosis. 
 
1.2.2 A history of the classification of mental disorders 
During the classical Greek era, a system of classification based on psychopathology 
described five categories of mental disorder; phrenitis (delirium), mania, melancholia, 
hysteria and epilepsy. Galen adopted the first aetiologically based model for the 
classification of mental disorders comprising the vesanias, which were caused by 
poisons, the lunacies caused by phases of the moon, and the hereditary insanities 
(Everitt & Landau 1998). As medical knowledge developed, Galen’s early shift towards 
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the higher levels of classification on Scadding’s hierarchical model (figure 1; Scadding 
1988) was not sustained.  
 
In the 19th, and early 20th, centuries the process of developing a classification system 
for mental disorders was dominated by the “famous professor principle” (Kendler 
1990). Similar to the “top-down” approach to the definition of intellectual disabilities, 
described in section 1.1.1.1, European professors of psychiatry put forth their own ideas 
on classification. Amongst the many eminent names that contributed to thinking on 
classification, Kraepelin is most often cited as significantly influencing the 
development of ideas on classification (Moller 2008). Postulating that all psychotic 
disorders converge in “natural disease entities” he produced his basic idea that 
psychotic disorders can be dichotomized into “dementia praecox” and “manic 
depressive insanity” (Kraepelin 1921). This idea of distinct categories of mental 
disorders informed the development of current categorical diagnostic classification 
systems- ICD and DSM.   
 
1.2.3 International Classification of Disease (ICD) 
In 1853, two medical statisticians presented a list of causes of death which became 
known as Bertillon’s Classification of the Cause of Death. Subsequent revisions lead to 
the International List of Causes of Death. This was used by the World Health 
Organisation (WHO) as the basis for the publication of the International Classification 
of Diseases, Injuries and Causes of Death (ICD-6) in 1948. Published in revised form 
approximately every 10 years, the most recent edition was published as ICD-10 in 
1993.  
 
ICD-10 aims to provide comprehensive coverage of all causes of morbidity across all 
the major body systems across. Organised into separate chapters for diseases with 
shared aetiology, chapter V is for the classification of Mental and behavioural 
disorders. Although ICD-10 is viewed as the main classification system in use 
internationally, the majority of the developments in the classification of mental 
disorders have been taken forward by the American Psychiatric Association, in 
subsequent editions of the DSM. Since these innovations in DSM have generally been 
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incorporated into the ICD Mental and behavioural disorders chapter, a fuller 
description of DSM is given here, and reference made to ICD where appropriate. 
 
1.2.4 Diagnostic and Statistical Manual of Mental Disorders (DSM) 
In 1952, the American Psychiatric Association published DSM-I. Both DSM-I, and also 
DSM-II published in 1968, were designed primarily for the specific purpose of 
counting the number of cases of individuals with specific diagnoses (Kraemer 2007). 
To meet this requirement, the early versions of DSM clearly had a focus on ensuring 
adequate face validity i.e. the descriptions of clinical syndromes matched the views of 
experts (Kendler 1990).  
 
An influential paper by Robins and Guze (1970), extended the focus on face validity to 
a more research based approach to validity- suggesting five criteria for diagnostic 
validity, added to by Kendell (1989) to comprise: 
• identification and description of a syndrome- face validity 
• demonstration of boundaries between syndromes- discriminant validity 
• follow up studies and course of illness- predictive validity 
• outcome of therapeutic trials- predictive validity 
• family studies- pathophysiology and aetiology 
• association with a biological or psychological abnormality- pathophysiology and 
aetiology. 
 
This shift to a research-based development process created a clear break point in the 
revision of classification systems. Studies had shown that DSM-III had poor inter-rater 
reliability (Kreitman et al. 1961; Sandifer et al. 1968). The International Pilot Study of 
Schizophrenia examined diagnosis in nine countries (Carpenter. et al. 1973) and found 
that schizophrenia was diagnosed significantly more frequently at the centre in the 
United States of America (U.S.A.) and the Union of Soviet Socialist republics 
(U.S.S.R.), than in other countries. As a consequence of these findings attempts were 
made to improve the reliability of categorical diagnoses through the introduction of 
operationalised criteria in classification systems.  
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Via the specific description of operationalised criteria, including items of 
psychopathology, DSM-III provided a classification system that could be more readily 
observed and replicated across settings, and between observers. This was shown to 
improve upon the poor reliability DSM-II (Kreitman et al. 1961; Sandifer et al. 1968) 
in the DSM-III field trials (Spitzer et al. 1979), and subsequent studies (Mellsop et al. 
1991). The operationally defined criteria were further refined in DSM-IV, and ICD-10 
and have been shown to have good reliability (Klin et al. 2000; Brown et al. 2001). As 
a consequence, it has been suggested that the major improvements in reliability have 
been achieved (Kendell 2002). 
 
DSM-IV was published in 1994, with a text revision, DSM-IV-TR, following in 2000. 
For these, there was considerable time and resource spent in examining any evidence 
that could inform the diagnostic criteria in DSM-IV. Prior to publication, extensive 
field trials were carried out with the draft criteria, again largely focusing on the inter-
rater reliability and face validity of the classification system. DSM-IV-TR has been 
used as the basis for the development of DM-ID. 
 
There has been a recent focus on a more evidence-based approach to developing 
classification systems for mental disorders. However, overall the “top-down” consensus 
approach has had the biggest influence. 
 
1.3 Mental disorders and intellectual disabilities 
As described in section 1.1.1, mental disorders and intellectual disabilities have been 
conceptualised as separate categories for several centuries. Interest in the study of 
mental disorders experienced by individuals with intellectual disabilities has developed 
gradually since early case reports in the 19th century (Clouston 1883). This gathered 
pace in the mid 20th century, with the recognition that individuals with intellectual 
disabilities experience higher rates of mental disorders than individuals who do not 
have intellectual disabilities. 
 
In 1936, a study of the 2134 individuals in the Severalls Mental Hospital categorised 
the mental disorders of the inpatient sample as schizophrenia, organic insanities, manic 
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depressive insanity, epileptic psychosis, and cases without definite psychotic symptoms 
(explained as neurosis, psychoneurosis, emotional instability, and mental defect 
uncomplicated by mental disorder). These categories were in keeping with the use of 
terminology to describe mental disorders at that time. The level of abilities of 
participants was also assessed, and intellectual disabilities classified using the 
historical terms dull, feebleminded, imbecile and idiot (Duncan et al. 1936). Within the 
40.8% of the sample assessed as having intellectual disabilities (defined as having an 
equivalent mental age of less than 10), there were high rates of schizophrenia, manic 
depressive insanity and epileptic psychosis. The authors concluded that there may be a 
shared aetiological factor between manic-depression and intellectual disabilities 
(Duncan 1936). Subsequent studies confirmed the increased rates of mental ill health in 
adults with intellectual disabilities- using a similar inpatient sample in a large 
institution and the available categorical diagnostic system of the time (Penrose 1938; 
Pollock 1945; Heaton-Ward 1977; Reid 1972; Corbett 1979; Wright 1982). Even in the 
earliest of these studies the limitations, of the available classification systems for 
mental disorders, based on categorical models of psychopathology, when used with 
persons with intellectual disabilities were recognised (Duncan et al. 1936).  
 
1.3.1 The classification of mental disorders experienced by individuals with 
intellectual disabilities  
The use of generic classification systems, such as ICD and DSM, for the diagnosis of 
mental disorders in persons with intellectual disabilities is recognised to be problematic 
(Reid 1983; Sovner 1986; Sturmey 1993; Clarke et al. 1994; Einfeld & Aman 1995; 
Einfeld & Tonge 1999; Cooper et al. 2003). Since they were designed for the diagnosis 
of mental disorders in the general population, they: 
• are reliant on verbal communication 
• require an understanding of abstract and complex concepts beyond the cognitive 
abilities of many individuals with intellectual disabilities  
• do not include problem behaviours and other psychopathology relevant to 
intellectual disabilities. 
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Therefore, ICD and DSM are less reliable and valid for the assessment and diagnosis of 
mental disorders in individuals with intellectual disabilities (Cooper et al. 2003). 
Various authors have debated whether to amend existing systems of classification, 
particularly for use with individuals with mild intellectual disabilities (Sovner & Hurley 
1983; Reid 1983; Sovner 1986; Bruininks 1991; Sturmey 1993; Clarke et al. 1994; 
Einfeld & Tonge 1999; Clarke & Gomez 1999; Cooper & Bailey 2001) or to publish 
classification systems specific to intellectual disabilities. Ultimately, a combined 
approach has been adopted, with the publication of three classification systems, based 
upon ICD and DSM, designed for specific use in the diagnosis of mental disorders, 
experienced by individuals with intellectual disabilities- ICD-10-MR (World Health 
Organisation 1996); DC-LD (Royal College of Psychiatrists, 2001) and the DM-ID 
(Fletcher et al. 2007).   The publication of these specific systems may act as an 
important stimulus to take forward developments in research and clinical practice; 
aiming to improve the outcomes and quality of life of individuals with intellectual 
disabilities experiencing mental disorders.  
 
1.3.1.1 ICD-10 Guide to Mental Retardation (ICD-10-MR) 
The World Health Organisation published the ICD-10 Guide to Mental Retardation in 
1996 (World Health Organisation 1996). Although it has never been adopted as part of 
routine clinical practice, or used extensively in research, it represented the first attempt 
to tackle the challenges inherent in the classification of mental disorders experienced by 
persons with intellectual disabilities. 
 
Similar to ICD-10 and DSM-IV-TR, ICD-10-MR proposed a multi-axial classification 
system, with five axes: 
• axis I -severity of intellectual disabilities and problem behaviours 
• axis II-associated medical conditions not causative of intellectual disabilities 
• axis III-associated psychiatric disorders 
• axis IV-global assessment of psychosocial disability 
• axis V-abnormal psychosocial conditions. 
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With regards to the classification of mental disorders using axis III, ICD-10-MR did not 
change any of the psychopathology, duration or impairment criteria compared to the 
generic ICD-10. Rather, the guide makes comment where there are specific issues 
relevant to a particular diagnosis in individuals with intellectual disabilities. For 
example, a comment is made on the association of Down syndrome with Alzheimer's 
disease, and the need to rule out hypothyroidism as a differential diagnosis for 
depressive symptoms in persons with Down syndrome. Given that ICD-10-MR did not 
really address any of the issues relevant to assessing and diagnosing mental disorders in 
individuals with intellectual disabilities, it is not surprising that it has never been taken 
up and used by professionals working in clinical practice, or research. One study that 
trialed its use in the diagnosis of mental disorders experienced by young people with 
intellectual disabilities highlighted some of the inconsistencies and discrepancies 
(Einfeld & Tonge 1999). It was concluded that there was a need to establish working 
groups to further develop a reliable and valid classification system. 
 
1.3.1.2 Diagnostic Criteria for Psychiatric Disorders for use with Adults with 
Learning Disabilities (DC-LD) 
An expert working group, of specialists in intellectual disabilities psychiatry, developed 
the DC-LD on behalf of the Royal College of Psychiatrists (Royal College of 
Psychiatrists 2001). Using ICD-10 and DSM-IV as a basis, the working group set out 
with the aim of developing a classification system that would be reliable and valid for 
use in research and clinical settings (Cooper et al. 2003). Similar to the development of 
DSM-IV, the working group used a consensus process, informed by comprehensive 
literature searches and a field trial of the draft criteria. This lead to the publication of 
DC-LD, in 2001.  
 
Although DC-LD has a multiaxial system of classification, it is quite distinct from that 
in ICD-10-MR: 
• axis I-severity of learning disabilities 
• axis II-cause of intellectual disabilities 
• axis III-psychiatric disorders 
− DC-LD level A: developmental disorders 
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− DC-LD level B: psychiatric illness 
− DC-LD level C: personality disorders 
− DC-LD level D: problem behaviours 
− DC-LD level E: other disorders. 
 
 
The introduction to DC-LD emphasises the importance of using a hierarchical 
approach to classification. When an item of psychopathology is identified, it is 
recommended that the person making the diagnosis moves systematically down the 
axes, and five levels in axis III- considering, at each stage, the appropriate axis, or 
level, to consider the item of psychopathology as part of classification. It is relevant to 
note that an item of psychopathology can be attributed, and used as part of 
classification, in several axes, or levels, in the hierarchical system. However, the 
introduction to DC-LD emphasises the need to give careful consideration before 
counting psychopathology twice within the hierarchical model of classification. 
 
The format and content of DC-LD addresses many of the previously expressed 
concerns over the use of ICD-10 and DSM-IV, when diagnosing mental disorders 
experienced by persons with intellectual disabilities. Furthermore, DC-LD specifically 
addresses some of the criticisms of ICD-MR made by Einfeld and Tonge (Einfeld & 
Tonge 1999). For example, whereas ICD-10-MR included problem behaviours in the 
same axis as severity of intellectual disabilities (Einfeld & Tonge 1999), DC-LD 
conceptualises problem behaviours as a separate level within psychiatric disorders in 
axis III.  
 
In contrast to ICD-10-MR, DC-LD has altered some of the ICD-10 criteria for certain 
categorical diagnoses of mental disorders. For example, a DC-LD diagnosis of 
depressive episode can be made if one key depressive symptom, from a choice of two-
either depressed mood or loss of interest or pleasure in activities-is identified; whereas 
in ICD-10, two key depressive symptoms, from a choice of three -depressed mood, loss 
of interest or pleasure in activities, and loss of energy-are required. Overall, only minor 
modifications to ICD-10 criteria were made on the basis that there was evidence to 
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support the changes, and it is stated that further research is needed to examine the 
reliability and validity of the modifications that have been made (Royal College of 
Psychiatrists 2001).  
 
Some initial work examining the utility of DC-LD has been published. A retrospective 
case note study, carried out in an institution in Ireland, looked at the utility of DC-LD 
to classify mental disorders in 113 adults with intellectual disabilities. The majority of 
participants (87.6%) had severe or profound intellectual disabilities. This study reported 
improved utility of DC-LD to diagnose problem behaviours and eating disorders, 
compared to ICD-10 and DSM IV. However, a significant number of “residual 
category” or “not otherwise specified” diagnoses were recorded, as DC-LD or ICD-10 
criteria were not fully met.  
 
Cooper et al (2007a) applied DC-LD, ICD-10 and DSM-IV-TR diagnostic criteria to a 
large sample of adults with intellectual disabilities, who had been assessed using a 
comprehensive, standardised process. The prevalence of mental disorders using DC-LD 
criteria was more than double the prevalence when ICD-10 and DSM-IV-TR criteria 
were used. Furthermore, DC- LD diagnoses showed a greater level of agreement with 
the gold standard consensus clinicians’ diagnoses, than ICD-10 and DSM-IV-TR. This 
provides evidence for the utility and face validity of DC-LD.  
 
Finally, Hove and Havik (2008) used the operationalised DC-LD criteria to develop 10 
psychopathology and eight problem behaviour checklists. Informants working with 
adults with intellectual disabilities, comprising paid carers and health care staff, 
completed the checklists for 583 individuals. The checklists were found to have 
acceptable internal, and inter-rater reliability, and specificity-although sensitivity was 
found to be poor. 
 
Further research examining the reliability, validity and utility of DC-LD is required. 
However, these initial studies suggest that it is an important initial step in tackling some 
of the problems associated with the use of ICD and DSM categorical diagnostic 
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classification systems for mental disorders experienced by individuals with intellectual 
disabilities. 
 
1.3.1.3 Diagnostic Manual-Intellectual Disability (DM-ID) 
DM-ID can be used to make diagnoses in children and adults with intellectual 
disabilities. Similar to DC-LD, an expert consensus process was used to produce the 
DM-ID. For each section in DSM-IV-TR, a detailed literature review was carried out to 
examine the evidence on the diagnosis of particular categories of disorders, and this 
was used to inform the adaptation of DSM-IV-TR criteria. 
 
In a general DM-ID chapter on assessment and diagnosis (Hurley et al. 2007), it is 
suggested that all five axes of DSM-IV-TR can be used with individuals with 
intellectual disabilities: 
• axis I- mental disorders, other than personality disorders and intellectual disabilities 
• axis II- for coding level of intellectual disabilities and personality disorders 
• axis III- medical disorders relevant to any medical disorders, or the cause of 
intellectual disabilities 
• axis IV- allows coding of relevant psychosocial and environmental stressors 
• axis V- the Global Assessment of Functioning (GAF), is a rating scale to allow 
clinicians to rate an  individual’s overall level of functioning. 
 
DM-ID states that axes I-V should be used as part of a multi-axial diagnosis for adults 
with intellectual disabilities. The majority of DM-ID reviews the use of criteria for axis 
I and axis II diagnostic categories for persons with intellectual disabilities. It is 
suggested that axis III should be used as it stands in DSM-IV-TR, and modified 
versions of axes IV and V can be used. 
 
There are potential problems in using axis V, the GAF, to rate the overall functioning of 
individuals with intellectual disabilities (Hurley 2001; Shedlack et al. 2005). One issue 
arises because clinicians are asked to rate overall functioning based on the impairments 
due to mental disorders, which in DSM-IV-TR would include intellectual disabilities. 
This could lead to persons with severe intellectual disabilities, but with no mental 
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disorders such as depression or schizophrenia, being rated with very low scores, despite 
leading happy, fulfilling lives. Since the impact on functioning of impairments due to 
physical disabilities is excluded from the axis V rating, it has been suggested that 
intellectual disabilities be viewed similarly (Hurley 2001). As individuals would not be 
starting with artificially low scores this would make it more likely that changes in 
functioning due to mental disorders could be reliably rated.  
 
Examining DM-ID, there are very few adaptations to the DSM-IV-TR criteria for 
individual diagnostic categories. More commonly, qualifying statements are made 
about individual criteria, often separately for individuals with mild/ moderate and 
severe/ profound intellectual disabilities. Thus, DM-ID is largely identical to DSM-IV-
TR with suggestions to clinicians on how best to apply criteria.  
 
A field trial was carried out to examine the clinical usefulness of the DM-ID (Fletcher 
et al. 2009). Sixty three clinicians in 11 countries were asked to make use of the DM-
ID with individuals on their existing clinical caseloads and to provide a DSM-IV-TR 
and DM-ID diagnoses for each case. The clinicians were also asked to complete a short 
questionnaire, with six specific items rating the usefulness of the DM-ID. Although no 
data on the reliability or validity of the DM-ID was presented, overall, DM-ID was 
rated as clinically useful in reaching a diagnosis in 51.7% of the 845 cases, and easy or 
very easy to use in 67.9% of cases. Importantly, clinicians rated it as useful in 
diagnosing clinical disorders across the full range of abilities and the authors tentatively 
suggest DM-ID may have advantages over DSM-IV-TR experienced by individuals 
with intellectual disabilities (Fletcher et al. 2009). 
 
To date, only one study examining the reliability, validity or utility of DM-ID has been 
published. A retrospective case note review of clinic attendees with intellectual 
disabilities concluded that many individuals with depression would not meet the 
adapted DM-ID criteria for depressive disorder (Hurley 2008). This was attributed to 
the communication skills of people with intellectual disabilities making self-report of 
symptoms difficult, and the limitations around informant report of symptoms. 
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1.3.2 Summary of the classification of mental disorders in intellectual disabilities 
The general requirements for a good classification system of mental disorders have 
been described. Specific categorical diagnostic classification systems for mental 
disorders experienced by persons with intellectual disabilities have been published. 
However, few published studies have examined whether DC-LD and DM-ID meet the 
requirements for a good classification system. Since the generic ICD-10 and DSM-IV 
categorical diagnostic classification systems were used to develop DC-LD and DM-ID, 
the next section reviews the evidence on generic ICD and DSM classification systems.  
 
1.4 The advantages and disadvantages of categorical diagnostic 
classification systems  
1.4.1 Advantages of categorical diagnostic classification systems  
ICD and DSM are able to fulfill many of the purposes, and characteristics of an 
adequate system described in section 1.2.1. They have lead to enhanced communication 
with service users and amongst professionals, improved reliability, and have been 
widely utilized in research and teaching (Kendell & Jablensky 2003). Categorical 
diagnoses act as a short hand description of an individual’s experiences, symptoms and 
presentation to clinical services. The improved reliability of communication between 
professionals, associated with existing categorical classification systems is reported as 
the most valued feature of DSM and ICD (Mellsop et al. 2007; Bell et al. 2008). 
 
With respect to communication with service users, using a diagnostic term that is 
familiar to an individual can have a positive impact. Although, more often categorical 
diagnoses are linked to the stigmatization of individuals with mental disorders, research 
has also described the positive effects that some individuals experience when they are 
told of a recognizable diagnosis (Dinos et al. 2004; Holm-Denoma et al. 2008). 
Moreover, at a population level the use of categorical diagnoses provide a shared 
language essential for anti-stigma (Crisp et al. 2005; Mehta et al. 2009) and public 
mental health campaigns (Jorm et al. 1999). 
 
The improved reliability of the diagnostic process through the use of categorical 
diagnostic classification systems was discussed previously whilst describing the 
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changes in DSM. This has encouraged the development of semi-structured diagnostic 
interviews. Beginning with the development of the Diagnostic Interview Schedule 
(Robins et al. 1981), which produced diagnoses based on DSM-III, the major 
diagnostic interview schedules identify disorders described in the ICD and DSM 
diagnostic classification systems: 
• Schedules for Clinical Assessment in Neuropsychiatry (SCAN; (Wing et al. 1990)- 
ICD-10 and DSM-IV 
• Structured Clinical Interview for DSM IV (SCID; First et al. 1994)- DSM-IV 
• Composite International Diagnostic Interview (CIDI; (Kessler & Ustun 2004) 
• Clinical Interview Schedule- Revised (CIS-R; (Lewis et al. 1992). 
 
This link between classification systems and diagnostic interviews is useful for certain 
types of research, such as epidemiological studies. 
 
 ICD-10 and DSM have also been used as the framework to design outcome measures 
used in clinical and research settings. The clearest example of this is the Patient Health 
Questionnaire (PHQ-9), widely used as an outcome measure for depression. The PHQ-
9 comprises the nine DSM-IV criteria for depression, self- scored on a scale of 0 (not at 
all) to 3 (nearly every day), and has been shown to be reliable and valid (Lowe et al. 
2004).  
 
This relationship between ICD, DSM, diagnostic interviews and outcome measures has 
encouraged the consistent use of methods in clinical practice and research, 
internationally. 
 
1.4.2 Disadvantages of categorical diagnostic classification systems 
1.4.2.1 Evidence on the validity of categorical diagnostic classification systems 
The discriminant validity of a categorical diagnosis depends upon being able to clearly 
demonstrate a boundary between the category in question, and alternative categories. 
For example, Kraepelin’s dichotomous boundary between schizophrenia and bipolar 
disorder is widely utilised in clinical practice and research. In “carving nature at the 
joints” (Pickles & Angold 2003), categorical diagnostic classification systems seek to 
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delineate categories from one another, and also to establish a discontinuity between 
normality and pathology, defined as a category, or syndrome.  
 
One approach to examining the validity of a categorical system of diagnosis is to 
consider the distribution of psychopathology. If diagnostic categories are valid, we 
might expect to identify a natural breakpoint, or “point of rarity“(Sneath 1957), 
between neighbouring categories, or find that psychopathology has a bimodal 
distribution (Murphy 1964; Everitt 1981; Meehl 1995). A commonly cited example of a 
bimodal distribution is the frequency peak at the tail of the normally distributed IQ 
distribution curve. This is believed to represent individuals with intellectual disabilities 
associated with genetic, and other biological, syndromes or causes.  
 
In the case of psychopathology, researchers have sought to examine points of rarity, or 
a bimodal distribution, to discriminate between: 
• normality and caseness  
• neighbouring, categorically defined diagnoses. 
 
To examine if there is a categorical breakpoint between normality and caseness, a study 
examined non-psychotic psychopathology, in a nationally representative sample of 
9556 UK adults from the National Household Psychiatric Morbidity study (Melzer et 
al. 2002). The CIS-R (Lewis et al. 1992) was used to collect the data on 
psychopathology and analysis carried out to identify the best fitting theoretical 
distribution curve. The best fit for the distribution was a single exponential curve with 
no points of rarity or frequency peaks to distinguish between normality from caseness. 
No evidence to support a bimodal distribution of psychopathology was  found (Melzer 
et al. 2002). Although the study had a large sample size and used a structured method 
to identify psychopathology, the exclusion of individuals with psychopathology 
suggestive of psychosis could have impacted on the findings. In particular, the finding 
that psychopathology has a continuous distribution cannot be generalized to diagnostic 
categories of schizophrenia, schizoaffective and bipolar disorders. 
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Large studies, of non-clinical populations, have been used to explore the distribution of 
specific types of psychopathology in order to identify whether a bimodal distribution 
can identify a cut-off point for a diagnostic category. Studies focused on psychotic 
symptoms (Allardyce et al. 2007b), depressive symptoms (Flett et al. 1997; Solomon et 
al. 2001) and anxiety symptoms (Anderson et al. 1993) all seem to conclude that there 
is a continuous distribution of these types of psychopathology in the population. Similar 
findings have been reported for the distribution of psychopathology in representative 
samples of children and adolescents (Levy et al. 1997; van den Oord et al. 2003). 
Although more readily accepted for anxiety and depressive symptoms, which have long 
been conceptualised as variations on normal human emotional experience, the 
suggestion that psychotic psychopathology exists on a continuum that extends into 
normal experience is perhaps more surprising. However, multiple studies support this 
continuous distribution of positive psychotic symptoms in non-clinical populations 
(Allardyce et al. 2007b), with rates between 4% (Eaton et al. 1991) and 17.5% (van Os 
et al. 2000). 
 
Further evidence in support of a continuous distribution of psychopathology emerges 
from studies examining sub-threshold clinical syndromes, in non-clinical samples. In 
the case of affective disorders, high rates of sub-threshold depressive (Angst et al. 
1997; Wagner et al. 2000; Cuijpers et al. 2004; Chuan et al. 2008) and hypomanic 
symptoms (Angst et al. 2003; Kessler et al. 2006; Merikangas et al. 2007) are 
described. These studies used established structured methods to assess psychopathology 
but have not all used representative, population-based samples (Wagner et al. 2000) 
and not all the studies found that these sub-threshold syndrome were associated with 
impairment (Angst & Merikangas 1997). Despite these limitations in some studies, the 
concept of depressive (Angst & Merikangas 1997) and bipolar spectrum disorders 
(Judd & Akiskal 2003) have emerged, with similar arguments being made for 
schizophrenia (Siever & Davis 2004), and obsessional (Bienvenu et al. 2000) 
spectrums.  
 
A second method used to examine the discriminant validity of categorical models of 
psychopathology is to study categories with a postulated overlap, or some shared 
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features. With regard to such neighbouring categorical diagnoses, most studies have 
focused on psychopathology in the psychoses. Krapelin’s original dichotomisation 
continues to influence work attempting to delineate psychosis associated with 
schizophrenia and affective disorders; although it is interesting to note that Kraepelin 
recognized the problems discriminating between the two when he wrote, ’. . . it is 
becoming increasingly clear that we cannot distinguish satisfactorily between these two 
illnesses . . .’ (Taylor 1992). Early studies, examining psychopathology, failed to 
identify points of rarity, or a bimodal distribution, that could distinguish between 
schizophrenia and the affective psychoses (Kendell & Gourlay 1970; Kendell & 
Brockington 1980). Nor has more recent work found that psychopathology 
discriminates between the categories of psychoses described in ICD and DSM.  
 
Two studies used factor analysis to examine the psychopathology experienced by adults 
meeting the criteria for schizophrenia, schizoaffective disorder and affective psychoses- 
using DSM-III-R in a study with 314 participants (Peralta et al. 1997) and ICD-10 with 
387 participants (Murray et al. 2005). Factors extracted, that included positive, negative 
and disorganization psychopathology, were scored highly in participants with and 
without schizophrenia, and depressive and mania/ hypomania factors scored highly in 
individuals diagnosed with schizophrenia. Although these findings require further 
validation, particularly using categorical diagnostic classification systems using 
operationalised criteria, such as DSM-IV-TR, they suggest an overlap between 
diagnostic categories. This area of work has moved beyond just psychopathology with 
detailed reviews reaching the conclusion that the overlapping psychopathology, risk 
factors and outcomes of schizophrenia and psychotic bipolar disorder argue against the 
existence of separate diagnostic categories (Maier et al. 2006).  
 
A further challenge to the categorical classification of psychopathology has come from 
the evidence that individuals with mental disorders have very high levels of 
comorbidity. The suggestion is that the high levels of comorbidity in epidemiological 
studies are due to the poor discriminant validity of diagnostic categories, such that the 
boundaries between categories are not valid, and so individuals end up meeting criteria 
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for more than one diagnosis. This issue has raised concerns that current categories are 
not representative of distinct clinical entitities (Mineka et al. 1998). 
 
The extent of comorbidity experienced by persons with mental disorders first became 
clear during the Epidemiological Catchment Area (ECA) study (Bourdon et al. 1992). 
Of the 28.1% of participants with one diagnosis, over 60% had two or more diagnoses. 
Similarly, the National Comorbidity Survey (Kessler et al. 1994) reported that of 29.5% 
of participants with one diagnosis in the prior 12 month period, 56% had two or more 
diagnoses. In the follow up National Comorbidity Survey- replication study (Kessler et 
al. 2005) of 26.2% of participants meeting criteria for at least one diagnosis over the 
prior 12 month period, 45% met criteria for two or more diagnoses. Such consistently 
high rates of comorbidity raised concerns about the validity of the categories defined 
within the classification systems, which in these studies was DSM. 
 
There are cases where an individual meeting criteria for more than one diagnosis 
represents the presence of distinct, yet comorbid, psychopathology. However, the more 
common finding is that the multiple diagnoses are similar enough to one another to 
suggest a shared pathophysiology, or aetiology. For example, one study reported high 
rates of comorbid depressive and anxiety diagnoses (Brown et al. 2001). The Anxiety 
Disorder Interview Schedule for DSM-IV: Lifetime Version (ADIS-IV-L;  (Di Nardo et 
al. 1993) was used to assess psychopathology in 1, 127 individuals attending two 
specialist centres for the management of anxiety disorders in the U.S.A. Fifty seven 
per-cent of participants had current co-morbid mood and anxiety disorders, and the rate 
of lifetime comorbidity was 81% (Brown et al. 2001). Given that the recruiting sites 
were specialist treatment centres for anxiety disorders it could be that the sample is 
biased towards inclusion of individuals with severe, treatment resistant disorders. This 
may have influenced the high rates of comorbidity. 
 
The predictive validity of a diagnostic classification system is considered by some to be 
the single most important requirement (Kendell 1989; Kendell & Jablensky 2003). 
However, less research has focused on this aspect of the validity of categorical 
diagnostic classification systems, than discriminant validity. Early studies reported that 
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the criteria for a categorical diagnosis of schizophrenia were not associated to an 
individual’s prognosis (Hawk et al. 1975; Brockington et al. 1978). This raised 
concerns that categorical diagnostic classification systems had poor predictive validity. 
However, more recent studies have suggested that the inclusion of operationalised 
criteria within the categorical diagnosis of schizophrenia has improved predictive 
validity (Mason et al. 1997). However, other studies have found that ICD-10 and DSM-
IV categorical diagnostic classification systems may lack predictive validity when used 
to classify a broader range of mental disorders (Jager et al. 2004). Overall, the evidence 
base on the predictive validity of categorical diagnostic classification systems in at an 
early stage. There is a recognized need to study this further (Kendell & Jablensky 2003; 
Vieta & Phillips 2007). 
 
1.4.2.2 The use of categorical models of psychopathology in research 
The evidence suggesting that categorical diagnostic classification systems may lack 
discriminant and predictive validity raises concerns about their utility in research.  
 
It is recognised that the use of a categorical variable to describe what is actually a 
continuous variable, will affect the power and precision of research (Cohen 1983; 
MacCallum et al. 2002; Altman & Royston 2006). The evidence described above 
suggests that psychopathology appears to have a continuous distribution in the 
population. Although it is a common practice, the two general criticisms of 
dichotomizing a continuous variable are that it is leads to a loss of data - affecting the 
power of studies - and distorts the understanding of the relationship between variables. 
A calculation of the extent of the loss of power, estimated that three times the sample 
size is needed for equivalent power, compared to use of a continuous variable (Neale et 
al. 1994).  
 
These issues are highly pertinent to psychopathology research, for example as 
described affecting the results in a randomised controlled trial of CBT for eating 
disorders (Kraemer 2007). An initial analysis using a categorical outcome measure 
found no evidence for the efficacy of the intervention. Reanalysis using a dimensional 
outcome measure suggested that the effects of the intervention are statistically 
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significant, and potentially clinically relevant. It was argued that the loss of power 
associated with the use of categorical outcome measures, creates a need for 
unnecessarily large sample sizes and then misinterpretation of clinically relevant 
findings.  
 
As has already been stated, the DSM-I and DSM-II categorical systems of classification 
were originally devised for use in epidemiological research (Kraemer 2007). Whilst 
existing systems appear to meet criteria for use in this type of work, a case is emerging 
around the limitations of the use of categorical diagnostic classification systems in 
biological research in the field of mental disorders, such as genetics, and neuroscience 
(van Praag 1997; Verhoeven & Tuinier 2001). Whilst the methods in research in 
genetics and neuroscience have developed considerably, further developments are held 
back by the diagnostic categories in use.  
 
Studies have shown an overlap in the genetics of separate diagnostic categories. The 
genetic overlap between bipolar disorder and schizophrenia (Craddock et al. 2006; 
Maier 2008) and between anxiety and mood disorders (Kendler et al. 2008) adds 
weight to the argument above. This apparent lack of validity of the diagnostic 
categories hinders genetic aetiological research. In light of this, and other problems that 
have emerged in the interface between genetics and diagnoses, researchers have begun 
to examine associations between genetics and more detailed phenotypes, to allow a 
degree of separation from the limitations imposed by diagnostic categories. 
 
Research in psychosis has begun to identify endophenotypes that it is hoped will be of 
greater relevance to genetic studies than categorical diagnoses (Craddock et al. 2006; 
Cardno et al. 2008). Endophenotypes are identifiable, quantitative clinical features, or 
functional impairments. These tend to be continuous, or dimensional, in nature and are 
often measurable using objective, laboratory tests-for example, neuropsychological 
batteries of assessment (Gottesman & Gould 2003; Braff et al. 2007). Examples of 
endophenotypes studied include, measures of verbal memory, and neurophysiological 
measures such as the P50 event related suppression. Of course, this approach still 
involves challenges to successfully identify the relevant components of the adult  
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phenotype to study. However, initial findings linking endophenotypes to genetic factors 
in schizophrenia (Greenwood et al. 2007) and depression (Nash et al. 2004) are of 
interest. 
 
As well as considering the impact on genetic research, it is also relevant to consider the 
use of categorical diagnostic classification systems of psychopathology in neuro-
scientific research. Similar to genetic research, scientists working in neuro-imaging, 
and related fields, have begun to identify neuro-endophenotypes (Glahn et al. 2007) 
and link these to models of psychopathology distinct from diagnostic categories (Pan et 
al. 2009). Furthermore, the opportunity to combine work on neuro- imaging, genetics 
and endophenotypes offers promise to the understanding of the development of the 
normally developing human brain (Lenroot & Giedd 2008), as well as the 
pathophysiology of mental disorders (Potkin et al. 2009).  
 
Although the relationship between ICD, DSM, diagnostic interviews and outcome 
measures is a potential advantage, this is also a potential limitation to developing the 
evidence base. The clearest example of this has been described in relation to the 
inclusion of the clinical significance criterion in DSM-IV (Spitzer & Wakefield 1999). 
Some authors have argued that this additional criterion improves the validity of the 
classification system because individuals diagnosed with a disorder have higher levels 
of suicidality, disability and service utilization (Narrow et al. 2002). However, this 
would seem to be a tautology, since the disorder is defined in terms of “clinically 
significant distress or impairment in social, occupational, or other important areas of 
functioning” (American Psychiatric Association 2000). 
 
Similar problems arise in relation to outcome measures developed from ICD and DSM. 
There is evidence to support the use of the PHQ-9 as an outcome measure (Kroenke et 
al. 2001). However, given that the nine DSM-IV criteria for depressive disorder were 
the basis for it’s original development, the findings are again potentially subject to a 
tautology (Lowe et al. 2004), similar to the one described for the significance criterion. 
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In summary, although the improved reliability of categorical diagnostic classification 
systems was an important step forward, the concerns over validity raises questions 
about the need for alternative, or complementary approaches. The lack of evidence to 
support the validity of categories suggests this may be impacting upon research to 
elucidate the aetiology of mental disorders (Hyman 2002), and preventing any move 
towards the higher levels of Scadding’s hierarchical model of diagnosis (figure 1.1). 
Although the publication of DSM-III in 1980 has had a positive effect on classification, 
the groups working on DSM-V recognize that very little progress has been made on 
developing an understanding of the aetiology and pathophysiology of mental disorders 
(First 2009).  
 
1.4.3 Summary of the advantages and disadvantages of categorical diagnostic 
classification systems 
Existing categorical diagnostic classification systems are based on a categorical model 
of psychopathology. These systems fulfill many of the requirements for a good 
classification system in 1.2.1 and are valued, and widely used in clinical practice. 
However, research has highlighted limitations surrounding the validity of these 
systems, which may be a particular issue for research. Given these limitations there is a 
need to further consider categorical and other models of psychopathology. 
 
1.5 Dimensional models of psychopathology 
The main alternative to classification systems of mental disorders that are based on 
categorical models of psychopathology are based on dimensional models of 
psychopathology. Before reviewing the intellectual disabilities literature on 
dimensional models of psychopathology, an overview is provided of relevant findings 
from studies that did not include adults with intellectual disabilities. 
 
1.5.1 Research on dimensions of psychopathology 
In contrast to the “top-down” development of existing categorical diagnostic 
classification systems, via the consensus of experts process, dimensional models of 
psychopathology have been derived from studies that used statistical methods to 
examine the underlying structure of psychopathology. 
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Much of this work has developed from the factor analytic methods used by Spearman 
in the study of intelligence. Early studies used factor analysis to study psychopathology 
in an attempt to identify broad dimensions of psychopathology, and examine the 
tendency of symptoms to cluster together (Wittenborn 1951; Lorr 1957). A review of 
the early work using exploratory factor analysis, identified 12 dimensions of 
psychopathology from observer psychopathology ratings of inpatients, listed below 
with the key characteristic symptoms cited in the review (Bolton 1973): 
• Paranoid Delusions (feels systematically persecuted; believes others influence him; 
believes people talk about him) 
• Thinking Disorganization (irrelevant speech; disoriented; emotional disharmony) 
• Anxiety-Depression (doubts he can be helped; feelings of impending doom; 
unrealistic self-blame) 
• Excitement- Hostility (initiates physical assaults; destructive; obscene)  
• Excitement-Depression (shouts, sings, and talks loudly; irritable; temper tantrums) 
• Withdrawal-Retardation (speech is slowed or deliberate; shut-in personality; lacks 
motivation) 
• Perceptual Distortions (visual hallucinations; auditory hallucinations; tactile 
hallucinations) 
• Phobic-Compulsive Reaction (behavior disrupted by phobias; compulsive acts 
occur daily; obsessional thinking) 
• Paranoid (grandiose convictions; dramatically attention-demanding; voices praise or 
extol him)  
• Motor Disturbances (manneristic movements; giggling; assumes bizarre postures)  
• Deterioration (incontinent because of own negligence; foreign objects in mouth; 
unaware of the feelings of others) 
• Conversion Hysteria (no organic basis for complaints; organic pathology with 
emotional basis; use made of physical disease symptoms). 
 
From these early broad dimensions, research on adult psychopathology has examined 
dimensions related to specific domains of psychopathology, such as psychosis. As 
discussed in section 1.4.2.1, studies included individuals meeting criteria for 
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schizophrenia, schizo-affective disorder and affective psychoses on the basis of 
categorical diagnostic classification systems (Peralta et al. 1997; Murray et al. 2005). 
Since categorical models are used to define potential participants, the dimensions 
identified are not generalisable beyond individuals with these specific mental disorders.  
 
The studies examining dimensions of psychopathology with relevance to a broader 
range of individuals has used common forms of psychopathology in large, population-
based, non-clinical samples (Krueger 1999; Vollebergh et al. 2001; Slade & Watson 
2006; Slade 2007). These studies have tended to focus on affective, neurotic, 
interpersonal and substance misuse psychopathology. This is because the non-clinical 
nature of the samples used in these studies, means that psychotic psychopathology does 
not occur at a high enough frequency for inclusion in the factor analyses. Once again 
these studies examined dimensions of psychopathology using categorical models of 
psychopathology as an integral part of the research methodology. In each of the four 
studies, the psychopathology experienced by participants was classified based on 
criteria within ICD-10 (Slade & Watson 2006; Slade 2007), DSM-III-R (Krueger 1999; 
Vollebergh et al. 2001) and DSM-IV (Slade & Watson 2006) categorical diagnostic 
classification systems. Multivariate statistical methods were then used to examine how 
the categorical diagnoses correlate. The findings seem relatively consistent across 
studies, with dimensions of psychopathology mapping onto two higher order 
dimensions- labeled internalizing and externalizing (Slade & Watson 2006; Slade 
2007). This consistent description of two higher order, internalizing and externalizing, 
dimensions of psychopathology is proposed as a way of conceptualising the high levels 
of comorbidity (i.e. the poor discriminant validity described in section 1.4.2.1) of 
categorical diagnostic classification systems (Krueger & Markon 2006; Slade 2007). 
However, given that the categorical diagnostic classification systems were used to 
diagnose participants’ mental disorders it does not appear that these studies are 
identifying the underlying dimensional structure of psychopathology. 
 
Internalising and externalizing dimensions of psychopathology were originally 
described from studies involving children and adolescents as participants. In contrast to 
adult studies, the methods used did not use categorical models of psychopathology.  
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These studies used factor analysis, and other multivariate methods, to examine the 
structure underlying psychopathology assessed with a instruments that included 
individual items of psychopathology. For example, the Child and Adolescent 
Psychopathology Scale (CAPS; Lahey et al. 2004) includes all non-psychosis DSM-IV 
and ICD-10 items of psychopathology relevant to mental disorders experienced by 
children and adolescents. Principal components analysis was used to examine 1, 382 
informant ratings of psychopathology experienced by a representative sample of 4-17 
year olds in Georgia, U.S.A. Six stable dimensions of psychopathology were identified 
labeled as hyperactivity-impulsivity, depression, inattention, conduct disorder, 
separation anxiety/ fears and social anxiety (Lahey et al. 2004). The significant 
correlations between the six dimensions agreed with earlier conceptions of two higher–
order, internalizing (depression, separation anxiety/ fears and social anxiety) and 
externalising (hyperactivity-impulsivity, inattention, conduct disorder) dimensions of 
psychopathology (Achenbach 1966; Achenbach & Edelbrock 1978; Cantwell 1996). 
These studies included children and adolescents who did not have intellectual 
disabilities. Therefore, the findings may not be generalisable to psychopathology 
experienced by individuals with intellectual disabilities. However, the results highlight 
the value of using factor analysis to identify dimensions underlying items of 
psychopathology, rather than the methods in adult studies that used categorical models 
of psychopathology (Krueger 1999; Vollebergh et al. 2001; Slade & Watson 2006; 
Slade 2007). An important aspect of the conceptualization of internalizing and 
externalizing dimensions of psychopathology is these have consistently been shown to 
apply in studies that have included participants from early childhood (Achenbach et al. 
1987; van den Oord et al. 1995) through adolescence (Leung & Wong 1998; Seiffge-
Krenke & Kollmar 1998). This is potentially of interest to the field of intellectual 
disabilities where there is a need to study psychopathology in individuals with widely 
varying developmental levels.   
 
1.5.2 Comparing dimensional and categorical models of psychopathology 
As well as research to identify the structure of dimensional models of psychopathology, 
studies have begun to examine the potential relevance of the models. Since they are less 
well established than categorical diagnostic classification systems, less research has 
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looked specifically at the advantages and disadvantages of dimensional models of 
psychopathology. Rather, there has been a focus on examining whether dimensional 
models are of value in relation to questions over the validity of classification systems 
using a categorical model of psychopathology. As discussed above, the research on 
adult psychopathology has focused on a narrower range of psychopathology, than 
studies including children and adolescents as participants. However, these serve to 
illustrate potential uses of dimensional models of psychopathology. 
 
1.5.2.1 Models of psychopathology and the severity of mental disorders 
Two cross-sectional studies examining the association of a multi-dimensional model of 
psychopathology and the severity of mental disorders were identified. 
 
A study of 706 participants recruited to a randomized controlled trial of case 
management in individuals with psychosis, compared the associations of dimensional 
and categorical models of psychopathology with measures of the severity of mental 
disorders (van Os et al. 1999). To identify the dimensional model, principal component 
analysis (PCA) was used to identify dimensions of psychopathology from the 
Operational Criteria Checklist for Psychotic Illness (OCCPI; McGuffin et al. 1991). 
The categorical diagnoses from ICD-10 and DSM-III-R were generated using the 
Operational Criteria for Psychotic Illness (OPCRIT; McGuffin et al. 1991). Clinical 
measures, including measures of the severity of mental disorders were used in the 
analysis: quality of life (Lancashire Quality of Life Profile, Oliver et al. 1997), 
satisfaction with services, movement disorders (Abmormal Involuntary Movement 
Scale, AIMS; Guy et al. 1986), social disability (Disability Assessment Schedule, DAS; 
Jablensky et al. 1980), unmet and met needs (Camberwell Assessment of Need, CAN; 
Phelan et al. 1995), living independently, occupational status, suicidality, misuse of 
drugs and alcohol; neuropsychological functioning [National Adult reading Test, 
NART; (Nelson 1982); Trail Making Test b, TRAILS B; (Reitan 1958)], course of 
illness WHO Life Chart (World Health Organisation 1992), service use in the previous 
two years (days in hospital, psychotherapy use), and psychotropic medication use in the 
previous two years (antidepressants, anitpsychotics & lithium). The measures of 
severity were used as the dependant variables in regression analyses including the 
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measures of psychopathology as the independent variables, and adjusting for gender, 
age, occupational status, and ethnicity.  Four dimensions were identified and labeled 
depressive, manic, negative and positive psychopathology. The multi-dimensional 
model of psychopathology was more strongly associated with 15 of 18 measures of 
severity; categorical diagnosis was more strongly associated with employment status, 
use of antipsychotics and use of lithium. When both models were included in an 
analysis, the dimensional and categorical models were both associated with social 
disability, employment status, suicidality and use of antidepressants and lithium; the 
dimensional model was significantly associated with 12 of the remaining 13 measures 
of severity and neither model was associated with antipsychotic use. Therefore, it was 
concluded that the multi-dimensional model of psychopathology was more strongly 
associated with measures of severity than the categorical model (van Os et al. 1999a). 
 
The second study looked only at depressive psychopathology (Prisciandaro & Roberts 
2009), collected using the Composite International Diagnostic Interview (CIDI; Robins 
et al. 1988) from 8098 participants in the National Comorbidity Study (NCS; Kessler et 
al. 1994). Since the psychopathology data was binary, weighted least squares 
estimation was used in the exploratory factor analysis. The categorical diagnoses from 
the DSM-III-R were generated using the NCS diagnostic algorithm (Kessler et al. 
1994). The variables representing the severity of mental disorders were: 
• Interference with activities- interference with life and activities; work impairment & 
social impairment 
• Treatment seeking- contact with mental health professionals; psychiatric 
hospitalization and use of psychotropic medications. 
 
These measures of severity were used as the dependant variables in regression analyses 
with the measures of psychopathology as independent variables, unadjusted for socio-
clinical variables. Two dimensions were identified and labelled cognitive-affective and 
somatic. The dimensional model of depressive psychopathology, and categorical 
diagnoses were both significantly associated with both measures of severity. However, 
when the analyses including both dimensional measures and categorical diagnoses were 
carried out, categorical diagnoses were not independently associated with the measures 
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of severity. The authors concluded that the dimensional model of depression was more 
strongly associated with the measures of severity (Prisciandaro & Roberts 2009). 
 
Therefore, from these two studies it appears that dimensional models are more strongly 
associated than categorical models of psychopathology to measures of the severity of 
mental disorders. 
 
1.5.2.2 Models of psychopathology and the longitudinal outcome of mental 
disorders 
Three studies comparing the associations of dimensional and categorical models of 
psychopathology with measures of the outcome of mental disorders were identified. 
 
 A cohort of 337 admissions, with at least one psychotic symptom, to two London 
hospitals were assessed using the Present State Examination (PSE; (Wing et al. 1974) 
and the data used to complete the Operational Criteria Checklist for Psychotic Illness 
(OCCPI; McGuffin et al. 1991). ICD-10 and DSM-III-R categorical diagnoses were 
generated with the OPCRIT computer program (McGuffin et al. 1991). PCA was used 
to identify dimensions of psychopathology from the baseline OCCPI and factor scores 
calculated. Follow-up interviews after four years were carried out with 166 (49%) of 
participants and nine outcome measures completed- the DAS (Jablensky et al. 1980), 
Lager negative symptom scale (Lager et al. 1985; van Os et al. 1996), usual negative 
symptoms, usual symptom severity, course of illness, time in hospital, time living 
independently, unemployment and employment status at follow-up. The nine outcome 
measures were used as the dependent variables in regression anlyses, adjusted for 
gender, catchment area and duration of illness. Seven factors were identified from the 
PCA and labeled inappropriate-catatonia, delusions-hallucinations, mania, insidious-
blunting, depressions, lack of insight and paranoid delusions. The multi-dimensional 
model was found to be significantly associated with all nine measures of outcome. The 
categorical diagnoses were only associated with the score on the DAS (Jablensky et al. 
1980) and employment status at follow up. When the dimensional model and 
categorical diagnoses were both included in a regression analyses, the dimensional 
model was a consistently better predictor of outcome and course of illness. One aspect 
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of the study that may have impacted on the results is a sampling bias towards including 
individuals with more severe disorders. The initial sample included inpatients and the 
loss to follow-up of 51% of the initial participants may have biased the sample further. 
Individuals with more severe disorders are more likely to remain in contact with 
services, and are therefore more readily identified at the time of follow up. As well as 
affecting the generalisability of the findings, inclusion of more severe disorders may 
have impacted differently on the multi-dimensional and categorical models of 
psychopathology (van Os et al. 1996). 
 
In a study of a sub-sample of the 694 participants in the Maudsley Family Study, 
psychopathology on the OPCRIT from 191 individuals with psychotic or mood 
disorders was used in PCA to identify a multi-dimensional model of psychopathology 
(Dikeos et al. 2006). OPCRIT categorical diagnoses from DSM-IV were included in 
the analyses. The associations of the dimensional and categorical models were 
compared to measures of longitudinal outcome - employment, social adjustment, 
personality disorder, potential stressor triggering episode, age of onset, impairment 
during episodes, quality of remisson between episodes, deterioration from pre-morbid 
functioning, response to anti-psychotics and overall course of illness. Five dimensions 
of psychopathology were identified- described as mania, reality distortion, depression, 
disorganization and negative symptomatology- and regression factor scores calculated 
for each dimensions. In regression analyses, adjusted for gender, age, occupational 
status, and ethnicity, the categorical diagnoses were associated with pre-morbid social 
adjustment, mode of onset, no remission between episodes, no response to anti-
psychotics and bad overall course of illness. The multi-dimensional model of 
psychopathology was associated with these same parameters and stressors. When both 
models were included in the analyses, the dimensional and categorical models were 
both retained as independently associated with the measures of outcome. 
 
The final study identified, used a different methodology, examining the correlations 
between change in dimensional measures of of psychopathology and outcome. 
Psychopathology data was used from 708 participants recruited to a randomized 
controlled trial of case management in individuals with psychosis and followed up for 
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two years (van Os et al. 1999b). PCA was used to identify dimensions of 
psychopathology from the OCCPI data (McGuffin et al. 1991).   Categorical diagnoses 
were also generated OPCRIT (McGuffin et al. 1991).  Using twenty measures of 
outcome, change over time in the multi-dimensional model of psychopathology was 
found to be strongly associated with the measures of outcome, than categorical 
diagnoses.  
 
The findings comparing the associations of dimensional and categorical models of 
psychosis are inconsistent; one study reporting that the dimensional models of 
psychopathology were more strongly associated with measures of longitudinal outcome 
of mental disorders (van Os et al. 1996; van Os et al. 1999b) and one concluded that 
they were similar and complementary (Dikeos et al. 2006). 
 
1.5.3 Summary of research on dimensional models of psychopathology 
There is evidence that dimensional models are a useful alternative to categorical models 
of psychopathology incorporated in current categorical diagnostic classification 
systems. The evidence suggests that: 
• identified dimensions of psychopathology may be correlated to form higher order 
dimensions of psychopathology 
• dimensional models appear more strongly associated than categorical models of 
psychopathology with the severity of mental disorders  
• since the findings on predictive validity to date are inconsistent, further work is 
required to examine the associations of dimensional and categorical models of 
psychopathology with longitudinal outcome. 
 
1.6 Dimensional models of psychopathology and intellectual 
disabilities 
This section examines previous studies that have used multivariate statistical methods 
to identify dimensional models of psychopathology experienced by adults with 
intellectual disabilities. As discussed above, general research has compared the 
associations of dimensional and categorical models with the severity and outcome of 
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mental disorders. Thus, research is reviewed that could inform studies to examine the 
utility of dimensional models of psychopathology in adults with intellectual disabilities. 
 
1.6.1 Studies using exploratory factor analysis to identify dimensional models of 
psychopathology in intellectual disabilities 
There is less published evidence on dimensional models of psychopathology in adults 
with intellectual disabilities. Work to date has mainly been by research groups 
examining the psychometric properties of rating scales, or interview schedules, for the 
identification and measurement of psychopathology in individuals with intellectual 
disabilities.  
 
Table 1.2 outlines the results from studies that have used empirical methods to examine 
dimensions of psychopathology in adults with intellectual disabilities. Over and above 
the small number of studies in table 1.2, there are some limitations in the evidence 
which makes interpretation of the results from these studies difficult.  
 
Several factors relating to the samples used in the studies cited in table 1.2 are relevant. 
General guidelines on the sample size required for factor analysis is that a ratio of cases 
to variables should be at least 5:1 (Costello & Osborne 2005), with a total sample size 
of 300 (Tabachnik & Fidell 2001). The only studies meeting these criteria are one of 
the five using the Psychopathology Instrument for Mentally Retarded Adults (PIMRA; 
Balboni et al. 2000), the three studies using the Psychiatric Assessment Schedule for 
Adults with Developmental Disabilities Checklist (PAS-ADD checklist; Moss et al. 
1998; Sturmey et al. 2005; Hatton & Taylor 2008) and the studies using the Diagnostic 
Assessment of the Severely Handicapped, version II (DASH-II; Sturmey et al. 2004) 
and the Brief Symptom Inventory (BSI; Kellett et al. 2004). Although these guidelines 
are not absolute, they have been demonstrated to affect the power and reliability of the 
results of factor analyses (Costello & Osborne 2005).  
 37 
Table 1.2. Studies of the dimensions of psychopathology in adults with intellectual disabilities 
 
 
Authors Sample Measure of 
psychopathology 
Methods Number of factors 
retained  
(% variance) 
Dimension names  
(eigenvalue, % variance, 
number of items) 
Matson et 
al. 1984 
N= 110 clinic 
sample, 
borderline= 
8.1%, mild= 
47.3%, 
moderate= 
40.9%, severe= 
3.7%; Mean 
age= 45.9 (18-
71, SD N/A1) 
PIMRA- 56 
psychopathology 
items derived from 
DSM-III criteria for 
schizophrenia, 
affective, 
psychosexual, 
adjustment, anxiety, 
somatoform and 
personality 
disorders. Self-
report and informant 
versions available. 
PCA2, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35. Only factors 
with at least five 
items are reported. 
Self- report version 2 
(N/A)  
Informant version 3 
(N/A) 
Self-report: Anxiety (N/A, N/A, 
8 items), Social adjustment (N/A, 
N/A, 5 items); Informant: 
Affective (N/A, N/A, 14 items), 
Somatoform (N/A, N/A, 5 items), 
Psychosis (N/A, N/A, 5 items)  
Linaker 
1991 
N= 169 
inpatients; mild= 
3.6%, moderate= 
20.1%, severe= 
50.9%, 
profound= 
15.2%, 
unknown= 9.7%. 
Mean age= 40.4 
(16-65, SD N/A) 
PIMRA- informant 
version 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35.  
9 (49.3%) Somatoform (5.06, 10.3%, 8), 
gender identity (3.68, 7.5%, 3), 
hostility (3.11 6.3%, 4), 
psychosis (2.66, 5.4%, 5), self-
consciousness (2.29, 4.7%, 4), 
adjustment problem (2.25, 4.6%, 
4), anxiety (1.88, 3.8%, 3), 
autistic traits (1.69, 3.4%’ 3), 
avoidant/ anxious (1.53 3.1%, 3) 
Balboni et 
al. 2000 
N=652 mixed 
sample- 
community (411) 
institution (241); 
mild= 34%, 
PIMRA- informant 
version 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
7 (34.5%) Anxiety (6.03, 10.8%, 11), 
Adjustment problem (3.28, 5.9%, 
7), Somatoform (2.74, 4.9%, 9), 
Schizophrenic isolation (2.01, 
3.6%, 5), Schizophrenic 
 38 
moderate= 39%, 
severe/profound= 
27%. Mean age= 
33.6 (17-74, SD 
N/A) 
0.35 bizarreness (1.96, 3.5%, 5), 
Soundness (1.75, 3.1%, 6), 
gender identity (1.50, 2.7%, 5) 
Gustafsson 
& 
Sonnander 
2005 
N= 101, mixed 
sample- 
community (30), 
institution (71); 
mild= 25.7%, 
moderate= 
32.9%, 
severe/profound= 
41.4%. Mean 
age= 50.2 (24-
94, SD= 14.3) 
PIMRA- informant 
version 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, ≥ 
3 items/ factor 
with loading ≥ 0.4 
5 (51%) Somatoform (4.29, 16.5%, 5), 
Psychosis (3.17, 12.2%, 7), 
Psychosexual (2.37, 9.1%, 4), 
Adjustment problem (1.85, 7.1%, 
5), Anxiety (1.56, 6.0%, 5) 
Watson et 
al. 1988 
N= 160 mixed 
sample living in 
community (95) 
& institutuional 
(65) settings; 
borderline= 
19.4%, mild= 
47.5%, 
moderate= 
33.1%. 
Mean age= 29.4 
(18-67, SD= 
11.4) 
PIMRA Self & informant 
version; PCA, 
varimax rotation, 
factor extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35 
4 (N/A) Self- report: Anxiety ; Social 
adjustment; Identity/ reality 
concern; Unlabelled 
Informant: Affective concerns; 
Social adjustment; Somatoform; 
Unlabelled (Problem behaviours) 
Moss et al. 
1998 
N= 201 
community 
sample; Mean 
age= 44 (18-83, 
SD N/A)  
PAS-ADD 
checklist- 29 item 
screening 
instrument, 
completed by 
PCA, quartimax 
rotation, item 
loading ≥ 0.5 
8 (N/A) Depression (N/A, N/A, 6), 
Restlessness (N/A, N/A, 4), 
Phobic anxiety (N/A, N/A, 5), 
Psychosis (N/A, N/A, 3), 
Hypomania (N/A, N/A, 3), 
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informant to identify 
possible mental ill-
health 
Autistic spectrum (N/A, N/A, 3), 
Depression (N/A, N/A, 2), Non-
specific (N/A, N/A, 2) 
Sturmey et 
al. 2005 
N=226 clinic 
attendees; mild= 
68%, moderate= 
20%, 
severe/profound= 
12%. Mean age= 
34 (Range N/A, 
SD= 13.5) 
PAS-ADD checklist PCA, quartimax 
rotation, factor 
extraction 
eigenvalue ≥ 1, 
item loading ≥ 0.5 
9 initially but only 3 
factors interpretable 
(34.6%) 
Mood (5.33, 19.7%, 8); Sleep 
(2.20, 8.1%, 3); Psychosis (1.83, 
6.3%, 3) 
Hatton & 
Taylor 
2008 
N= 1, 115 
administrative 
sample (98% 
response rate); 
Mean age= 44.0 
(17-92, SD= 
15.19) 
PAS-ADD checklist PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
rotated factors 
account > 5% 
variance, 
sufficient factors 
included to 
account > 60% 
variance  
7 (61.25%) Depression 1 (4.19, 15.50%, 7); 
Sleep problems (2.46, 9.10, 3); 
Organic problem (2.35, 8.70%, 
4); Panic (2.11, 7.80%, 3); 
Psychosis (2.09, 7.72%, 4); 
Hypomania (1.72, 6.37%, 3); 
Depression 2 (1.64, 6.06%, 2) 
 
 
Hove & 
Havik 
2008 
N= 593 
administrative 
sample (66% 
response rate); 
mild= 23%, 
moderate= 44%, 
severe= 19%, 
profound= 14%. 
Mean age= 42 
(18-97, SD= 
14.5) 
P-AID3- 18 
checklists of 
psychpathology and 
problem behaviours, 
derived from DC-
LD - 260 items rated 
by informant, scores 
psychpathology and 
problem behaviours 
PCA of checklist 
sum scores, 
varimax rotation, 
factor extraction 
eigenvalue ≥ 1, 
item loading ≥ 0.3 
4 (54.9%) Problem behaviour I -includes 
OCD (4.56, 17.5%, 7), Anxiety 
(2.21, 14.5%, 5), Severe 
psychopathology- depression, 
dementia, mania, psychosis (1.91, 
14.5%, 4), Wandering/ sexual 
problem behaviours (1.21, 8.2%, 
2) 
Sturmey et Three samples: RSMB4- 38 item PCA, varimax Sample 1= 1 factor Sample 1: General factor (6.55, 
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al. 1996 Sample 1 n= 180 
community 
sample, Sample 
2 n= 102 college 
sample, Sample 
3 n= 71 
institutional 
sample. Age and 
ability level N/A 
screening instrument 
for identification of 
emotional and 
behaviour problems 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 0.3 
(25.2%); Sample 2 & 
3= 3 factors (Sample 
2 44.2%; Sample 3 
41.5%) 
25.2%, 26); Sample 2: 
Extrapersonal maladaptive 
behaviour (6.24, 24%, 9), 
Psychosis (2.94, 11.3%, 8), 
Intrapersonal maladaptive 
behaviour (2.31, 8.9%, 6); 
Sample 3: Extrapersonal 
maladaptive behaviour (5.62, 
21.6%, 11), Psychosis (2.91, 
11.2%, 10), Intrapersonal 
maladaptive behaviour (2.26, 
8.7%, 8) 
Sturmey et 
al. 2003 
N= 163 clinic 
sample; 
borderline= 3%, 
mild= 22%, 
moderate= 28%, 
severe= 38%, 
profound= 9%. 
Mean age= 54 
(30-84, SD= 
10.7) 
MOSES5- 40 items 
of psychopathology 
& behaviour, 
interviewer rated 
based on informant 
report and 
observation  
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 0.3 
3 (42.2%) Self- care (8.0, 20.6%, 6), 
Irritability/ depression (5.6, 
14.6%, 11), Withdrawal (2.7, 
7.0%, 8) 
Sturmey et 
al. 2004 
N= 451 
institutional 
sample; severe= 
11%, profound= 
89%. Mean age= 
48 years (Range 
N/A, SD=15) 
DASH-II- 84 items 
of psychopathology 
and behaviour 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35 
5 (26%) Emotional lability/ antisocial 
(9.1, 11.1%, 9), Langauge 
disorder (3.9, 4.8%, 4), 
Dementia/ anxiety (2.9, 3.6%, 7), 
Sleep disorder (2.8, 3.4%, 3), 
Psychosis (2.5, 3.1%, 3) 
Tsiouris et 
al. 2003 
N=92; mild= 
24%, moderate= 
30.4%, severe= 
26%, profound= 
10.9%, 
CBCPID6- 30 items, 
psychopathology 
and problem 
behaviour over past 
two weeks 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 0.3 
1 (9.4%) Depression (6, 9.4%, 5) 
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unknown= 8.7%. 
Mean age= 42.6 
(Range N/A, 
SD= 17.4) 
Kellett et 
al. 2004 
N=335, sample 
of clinic 
attendees with 
mild intellectual 
disabilities. 
Mean age= 33.0 
(16-64, SD= 
10.65) 
BSI- 53 item self- 
report inventory of 
psychopathology, 
rated on five point 
Likert scale 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 
0.35 
8 (50.26%) Depression (16.19, 30.56%, 13), 
Anxiety (2.32, 4.39%, 11), 
Somatisation (1.91, 3.61%, 10), 
Cognitive impairment (1.73, 
3.27%, 8), Suicidal ideation 
(1.62, 3.06%, 6), Paranoia (1.44, 
2.72%, 5), Hostility (1.39, 2.63%, 
7), Anger (1.37, 2.59%, 4) 
 
  
1
 N/A not available from the details provided in the paper 
2 PCA Principal components analysis 
3
 P-AID Psychopathology Checklists for Adults with Intellectual Disability 
4 RSMB Reiss Screen For Maladaptive Behaviours 
5 MOSES  Multi-dimensional Observational Scale for Elderly Subjects 
6 CBCPID Clinical Behaviour Checklist for People with Intellectual Disabilities 
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There appear to be some common dimensions identified across studies. Table 1.3 lists 
those dimensions identified in at least two studies that used different instruments. 
Additional details of the instruments, dimensional labels and the relevant items of 
psychopathology extracted in the dimension are also provided.  
 
Table 1.3 Dimensions of psychopathology identified across studies in adults with 
intellectual disabilities 
 
 
General 
description of 
common factor 
Instrument  Dimension name- eigenvalue, % 
variance, number of items (Authors)  
 
Anxiety- N/A, N/A, 8  
(Matson et al. 1984) 
PIMRA-self report 
Anxiety- N/A (Watson et al. 1998) 
Anxiety- 1.88, 3.8%, 3 (Linaker 1991) 
Affective concerns- N/A  
(Watson et al. 1998)  
Anxiety- 6.03, 10.8%, 11  
(Balboni et al. 2000) 
PIMRA- informant 
Anxiety- 1.56, 6.0%, 5  
(Gustafsson & Sonnander 2005) 
P-AID Anxiety- 2.21, 14.5%, 5  
(Hove & Havik 2008) 
DASH-II Dementia/ anxiety- 2.9, 3.6%, 7  
(Sturmey et al. 2004) 
Anxiety 
BSI Anxiety- 2.32, 4.39%, 11  
(Kellet et al. 2004) 
PIMRA- informant Affective- N/A, N/A, 14   
(Matson et al. 1984) 
PAS-ADD 
checklist 
Depression 1- N/A, N/A, 6; Depression 
2- N/A, N/A/ 2 (Moss et al. 1998) 
PAS-ADD 
checklist 
Mood- 5.33, 19.7%, 8  
(Sturmey et al. 2005) 
PAS-ADD 
checklist 
Depression 1- 4.19, 15.50%, 7; 
Depression 2- 1.64, 6.06%, 2  
(Hatton & Taylor 2008) 
MOSES Irritability/ depression- 5.6, 14.6%, 11 
(Sturmey et al. 2003) 
Depression 
CBCPID Depression- 6, 9.4%, 5  
(Tsiouris et al. 2003) 
 BSI Depression- 16.19, 30.56%, 13  
(Kellet et al. 2004) 
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PAS-ADD 
checklist 
Hypomania- N/A, N/A, 3  
(Moss et al. 1998) 
Mania/ hypomania  
PAS-ADD 
checklist 
Hypomania- 1.72, 6.37%, 3  
(Hatton & Taylor 2008) 
Psychosis- N/A, N/A, 5   
(Matson et al. 1984) 
Psychosis- 2.09, 7.72%, 4 (Linaker 1991) 
Schizophrenic isolation- 2.01, 3.6%, 5 
(Balboni et al. 2000) 
Schizophrenic bizarreness- 1.96, 3.5%, 5 
(Balboni et al. 2000) 
PIMRA- informant 
Psychosis- 3.17, 12.2%, 7   
(Gustafsson & Sonnander 2005) 
PAS-ADD 
checklist 
Psychosis- N/A, N/A, 3 (Moss et al. 
1998) 
PAS-ADD 
checklist 
Psychosis- 1.83, 6.3%, 3  
(Sturmey et al. 2005) 
PAS-ADD 
checklist 
Psychosis- 2.09, 7.72%, 4   
(Hatton & Taylor 2008) 
RSMB Psychosis- 2.94, 11.3%, 8  
(Sturmey et al. 1996) 
Psychosis  
DASH-II Psychosis- 2.5, 3.1%, 3   
(Sturmey et al. 2004) 
P-AID Problem behaviour I (includes OCD)- 
4.56, 17.5%, 7  
Problem behaviour II- 1.21, 8.2%, 2 
(Hove & Havik 2008) 
RSMB Extrapersonal maladaptive behaviour - 
6.24, 24%, 9 
Intrapersonal maladaptive behaviour- 
2.31, 8.9%, 6  
(Sturmey et al. 1996) 
DASH-II Emotional lability/ antisocial- 9.1, 
11.1%, 9 (Sturmey et al. 2004) 
Problem behaviours  
PIMRA- informant Unlabelled (problem behaviours)- N/A 
(Watson et al. 1998) 
DASH-II  Sleep- 2.20, 8.1%, 3   
(Sturmey et al. 2005) 
Sleep problems- 2.46, 9.10, 3   
(Hatton & Taylor 2008) 
Sleep problems 
PAS-ADD 
checklist 
Sleep disorder- 2.8, 3.4%, 3   
(Sturmey et al. 2004) 
Somatoform- N/A, N/A, 5  
(Matson et al. 1984) 
Somatoform PIMRA- informant 
 
 Somatoform difficulty-N/A  
(Watson et al. 1988)  
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Somatoform- 5.06, 10.3%, 8  
(Linaker 1991) 
Somatoform- 2.74, 4.9%, 9 
(Balboni et al. 2000) 
Somatoform- 4.29, 16.5%, 5  
(Gustafsson & Sonnander 2005)  
BSI Somatisation- 1.91, 3.61%, 10   
(Kellet et al. 2004) 
PIMRA- informant Autistic traits- 1.69, 3.4%, 3   
(Linaker 1991) 
Autism 
PAS-ADD 
checklist 
Autistic spectrum - N/A, N/A, 3  
(Moss et al. 1998) 
PIMRA- informant Avoidant/ anxious- 1.53 3.1%, 3  
(Linaker 1991) 
Phobic anxiety- N/A, N/A, 5  
(Moss et al.1998) 
Phobic anxiety/ 
avoidance 
PAS-ADD 
checklist 
Panic- 2.11, 7.80%, 3  
(Hatton & Taylor 2008) 
 
 
From table 1.3, it appears that the dimensions of anxiety, depression, psychosis and 
problem behaviours are extracted more consistently across studies, using a greater 
range of assessment instruments of psychopathology. This suggests that these 
dimensions may have greater validity, compared to the sleep problems, somatoform, 
autism and phobic anxiety/avoidance dimensions- each of which are only reported 
across two instruments. However, part of this effect may be explained by the format 
and content of the specific instruments used in the different studies. For example, the 
PIMRA only has one question on sleep problems and therefore it is unlikely that a 
sleep problems dimension would ever be identified using the PIMRA.  
 
A further point of interest is the variation across studies that use the same instrument. 
Throughout table 1.3, it is evident that even where an instrument identifies a similar 
dimension across studies, the individual items that load onto the dimension can vary 
considerably. For example, the anxiety dimension of psychopathology is consistently 
identified across the studies that use the PIMRA. However, despite some degree of 
overlap, the individual items that loaded onto the dimension can vary between studies. 
Examining the three studies that have examined the dimensional structure of the PAS-
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ADD checklist, there appears to be greater consistency in the items that load on to the 
relevant dimensions.  
 
The significant variation between samples is relevant. The inclusion of only inpatients 
(Linaker 1991), or participants with mild intellectual disabilities (Kellett et al. 2004) 
most clearly affects the generalisability of results. The samples in other studies vary 
considerably in sampling strategy, the distribution of level of intellectual disabilities 
and age. This variation in samples will interact with the wide variation in content, and 
approach of the instruments used to assess psychopathology across the studies in table 
1.2. For example, the use of a self report instrument with participants who have mild 
intellectual disabilities (Kellet et al. 2004) is likely to produce very different results to 
a study using a sample of adults with severe or profound intellectual disabilities, in 
which paid carers provide proxy reports of psychopathology (Sturmey et al. 2004). 
Assessing psychopathology across a range of developmental samples is a challenge in 
any study. Potentially, at least, this is a reason for further research to examine 
dimensional models of psychopathology in persons with intellectual disabilities. 
 
With regard to the assessments of psychopathology, it is also worth noting that the 
only instruments assessing psychopathology for which there is more than one relevant 
published study are the PIMRA and PAS-ADD checklist. The PIMRA and the PAS-
ADD checklist are screening instruments, and the PAS-ADD checklist includes a 
restricted range of psychopathology (29 items of psychopathology). Therefore, no 
comprehensive assessment of psychopathology has more than one exploratory factor 
analysis reported in the literature. 
 
A final point of note is that all the studies in table 1.2 use PCA as the method of factor 
analysis. However, PCA was designed for use with continuous variables and the 
variables in all the psychopathology instruments of assessment in table 1.2 are 
categorical- either binary or ordinal. The use of PCA in factor analyses of categorical 
variables has been shown to identify unstable and unreliable models (Linting et al. 
2007). Therefore, specific methods of factor analysis using categorical variables have 
been developed (Wood et al. 2002; Meulman & Heiser 2004). Since these methods 
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were not used in the studies in table 1.2, the models are likely to have limited 
reliability and stability. 
 
Overall, relatively few studies have used factor analysis to examine the dimensions of 
psychopathology in adults with intellectual disabilities and there are methodological 
limitations and variation across studies.  
 
1.7 The associations of psychopathology with socio-clinical variables  
The studies in section 1.5.2 that compared the associations of dimensional and 
categorical models of psychopathology with the severity and outcome of mental 
disorders controlled for a small number of potential confounders, such as gender, age, 
occupational status and ethnicity (van Os et al. 1999a; van Os et al. 1999b).  
Therefore, the evidence on the association of socio-clinical variables with 
psychopathology in adults with intellectual disabilities was reviewed.  
 
Population based studies of adults with intellectual studies are less likely to report 
findings significantly affected by sampling bias. Therefore, table 1.4 summarises the 
findings from studies that used population based samples to examine the independent 
associations of socio-clinical variables with psychopathology. The majority of studies 
in table 1.4 identified used categorical diagnostic classification systems, although two 
studies used continuous measures, not derived empirically using multivariate statistics 
(Taylor et al. 2004; Hove & Havik 2010). 
 
 
Several socio-clinical variables were associated with psychopathology across studies 
in table 1.4- gender, age, living circumstances, level of intellectual disabilities, 
epilepsy and Down syndrome.  These are examined separately in more detail below, 
followed by a discussion of the other socio-clinical variables shown to be less 
consistently associated with psychopathology.  
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Table 1.4: Population based studies examining the associations of psychopathology and socio-clinical variables  
 
Authors Sample (percentage 
of identified 
population) 
Measure of 
psychopathology 
Socio-clinical variables included in 
analysis 
Socio-clinical variables 
significantly associated with 
psychopathology  
Cooper & 
Bailey (2001) 
A random sample of 
207 adults from the 
Leicestershire 
Learning Disabilities 
Register. 109 men 
and 98 women. Mild 
ID114.2%, moderate 
22.2%. severe 40.3% 
and 23.3% profound. 
Psychiatric 
disorder diagnosed 
with the 
Diagnostic 
Criteria for 
Research- ICD-10. 
Level of intellectual disabilities-  Lower ability level associated 
with a greater risk of having a 
diagnosed psychiatric 
disorder. 
Taylor et al. 
(2004) 
1115 (98%) adults. 
664 men, 491 
women. Mean age= 
43.97 (SD±15.19 
years, range 17-92). 
PAS-ADD 
checklist 
subscales: 
• affective/ 
neurotic 
• psychosis 
• organic 
age; gender, residence type Female gender- affective/ 
neurotic 
Younger age- affective/ 
neurotic 
Living in hospital- psychosis 
Cooper et al. 
2007a; 
Cooper et al. 
2007b; 
Cooper et al. 
2007c; Jones 
et al. 2008 
1023 adults (562 
men, 461 women; 
mean age= 43.9 
±12.6 years: mild ID 
38.9%, moderate 
24.2%, severe 18.9%, 
profound ID18.0% 
2 Mental ill health 
(excluding 
specific phobias 
and autism 
spectrum 
disorders)  
3 Psychotic 
disorder 
4 Current DC-LD 
depressive episode 
5
 DC-LD problem 
behaviours 
age; gender; marital status; level of 
ability; presence of visual impairment; 
presence of hearing impairment; 
presence 
of epilepsy; presence of severe physical 
disabilities (quadriplegia); presence of 
mobility impairment; presence of 
communication impairment; presence of 
incontinence 
of urine; presence of incontinence 
of bowels; type of living or support 
arrangement; whether previously a 
longstay 
hospital resident, area-based measure 
of deprivation for the area in which the 
2 Female gender, lower ability 
level, number of life events, 
number of GP appointments, 
severe physical disability/ 
quadriplegia, not having 
mobility problems, urinary 
incontinence, smoker, living 
with a paid carer (rather than 
living with a family carer) 
3
 Visual impairment, ex long-
stay hospital resident, 
smoker, not having epilepsy 
4
 Female gender, number of 
life events, number of GP 
appointments, not having a 
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person 
lived; whether the person had any type 
of daytime occupation; number of 
consultations 
with the general practitioner or family 
physician within the preceding 12-month 
period; number of hospital admissions in 
the preceding 12-month period; number 
of 
life events in the preceding 12-month 
period; whether the person smoked 
hearing impairment, smoker 
5 Male gender, lower ability 
level, living in a congregate 
care setting, or with paid 
carer 
support (rather than living 
with a family carer), having 
attention deficit hyperactivity 
disorder (ADHD), urinary 
incontinence, visual 
impairment, not having Down 
syndrome, not having severe 
physical disability/ 
quadriplegia. 
Bailey 2007 Random sample of 
121 adults with 
moderate- profound 
ID. Men 62.0% and 
women 38.0%. 
(Mean age = 38.5 
years, SD= 1.30, 
range 20-77). 
Diagnosed with a 
mental disorder 
using DC-LD 
criteria 
Age; gender; developmental age in 
months; life event in last year; number of 
professionals, apart from GP involved in 
care; number of antipsychotic 
medications, number of physical 
illnesses; HoNOS6 score; HoNOS-LD7 
score. 
Higher HoNOS score and 
lower developmental age 
were associated with 
diagnosis of mental disorder. 
Hassiotis et 
al. 2008 
105 adults with 
borderline ID from 
the British National 
Survey of Psychiatry 
Morbidity (69 men, 
46 women) of 
specialist intellectual 
disability mental 
health services.  
Common mental 
disorders 
(agoraphobia, any 
phobia, depressive 
episode)8 
 
age; gender; social class; marital status; 
ethnicity; education level; debts; income 
support 
1.Younger age 
2. Female gender 
3. Asian ethnicity 
4. Social class 
5. Debts 
6. Receiving income support 
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Hove & Havik 
(2010) 
593 (65.8%)  adults. 
315 men, 278 
women; mean age 
41.8 (SD = 14.53, 
range 18–97). mild  
ID 21.6%, moderate 
41.0%, severe 18.0% 
and profound ID 
13.0% 
 
P-AID checklists 
for: 
• dementia  
• psychosis 
• depression 
• mania 
• anxiety 
disorders 
• problem 
behaviours 
• overall mental 
ill-health9 
age; gender; autism, genetic syndrome; 
neurological 
conditions; level of intellectual 
disabilities  
1. Older age- dementia 
2. Younger age- problem 
behaviour 
3. Autism- psychosis, 
anxiety, OCD10, problem  
behaviour, overall mental ill-
health 
4. Genetic syndrome- 
dementia 
5. No neurological condition- 
anxiety 
6. Social care- dementia, 
psychosis, depression, mania, 
anxiety disorders, problem 
behaviours, overall mental ill-
health 
7. More severe ID- anxiety, 
OCD, problem behaviours, 
overall mental ill-health 
 
1 ID  Intellectual disabilities 
2 Cooper et al. 2007a  
3
 Cooper et al. 2007b 
4
 Cooper et al. 2007c 
5 Jones et al. 2008 
6 HoNOS  Health of the Nation Outcome Scale (Wing et al. 1998) 
7
 HoNOS-LD  Health of the Nation Outcome Scale- Learning Disabilities (Roy et al. 2002) 
8
 Diagnosed with ICD-10 
9 Total score from sum of individual checklists 
10 OCD  Obsessional Compulsive Disorder 
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1.7.1 Psychopathology and gender 
Female gender was found to be associated with an increased risk of having a 
diagnosed mental disorder (Cooper et al. 2007a), affective/ neurotic psychopathology 
(Taylor et al. 2004; Cooper et al. 2007c; Hassiotis et al. 2008) and problem 
behaviours (Jones et al. 2008). Thus it appears that similar to findings from studies 
involving adults who do not have intellectual disabilities (Kessler et al. 1993; Bijl et 
al. 2002; Kessler et al. 2005), women with intellectual disabilities experience higher 
rates of affective/ neurotic psychopathology.  
 
Relevant to this thesis, an argument has been made that the use of categorical 
diagnostic classification systems may contribute to bias in the studies that find 
significant gender differences. It is suggested that the criteria within certain 
categorical diagnoses may preferentially represent the presentation of 
psychopathology for either women or men (Hartung & Widiger 1998). Indeed, 
whereas higher prevalence rates of depressive disorders are consistently found in 
studies using categorical models of depressive psychopathology, this was not the case 
in a study comparing dimensional and categorical models of psychopathology 
(Hildebrandt et al. 2003). 
 
1.7.2 Psychopathology and age 
The relationship between age and psychopathology is of particular relevance to fields 
of study that make use of developmental models of psychopathology, such as 
intellectual disabilities and the study of mental disorders experienced by children and 
adolescents.  
 
The overall risk of having any diagnosed mental disorder was not independently 
associated with age in the population based epidemiological studies in table 1.4 
(Bailey 2007; Cooper et al. 2007a). This contrasts from studies of adults who do not 
have intellectual disabilities where the overall rates of mental disorders decrease with 
increasing age (Kessler et al. 1993; Bijl et al. 2002).  
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For more specific psychopathology, younger age in table 1.4 was associated with 
affective/ neurotic psychopathology (Taylor et al. 2004; Hassiotis et al. 2008) and 
problem behaviours (Hove & Havik 2010). Older age was found to be associated with 
organic disorders (specifically dementia) in one study (Hove & Havik 2010) but not 
another (Taylor et al. 2004). 
 
1.7.3 Psychopathology and living circumstances 
It appears from the studies outlined in table 1.4 that living in circumstances with some 
degree of paid support is independently associated with psychopathology. Comparison 
between the studies is made difficult by the different samples, measures of 
psychopathology and descriptors of living circumstances used. However, living in 
hospital was found to be associated with psychosis (Taylor et al. 2004); compared to 
individuals living with family carers, living in a congregate setting such as nursing 
home was associated with problem behaviours (Jones et al. 2008) and individuals 
living with paid carer support were more likely to be diagnosed with any mental 
disorder (Cooper et al. 2007a) and problem behaviours (Jones et al. 2008).  
 
It is difficult to be clear about the direction of the association between 
psychopathology and living circumstances. On the one hand, perhaps individuals 
experiencing psychopathology are more likely to move to circumstances in which they 
receive some degree of paid support as part of a management plan. Alternatively, there 
could be factors associated with living with paid support that increase an individual’s 
risk of psychopathology, or act as precipitants for mental disorders. Either way, the 
findings from the studies to date highlight the relevance of studying further these 
associations. 
 
1.7.4 Psychopathology and level of intellectual disabilities 
As well as highlighting the need to examine the relationship between age and 
psychopathology, the use of developmental models of psychopathology in the field of 
intellectual disabilities also places a focus on the need to understand how 
psychopathology relates to an individual’s level of intellectual disabilities.  
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In table 1.4, lower ability level was associated with increased risk of having any 
mental disorder (Cooper & Bailey 2001;Cooper et al. 2007a; Bailey 2007; Hove & 
Havik 2010), and problem behaviours (Jones et al. 2008, Hove & Havik 2010).  
 
There are concerns that existing categorical diagnostic classification systems may be 
less reliable and valid when used to understand psychopathology in individuals with 
severe and profound intellectual disabilities. As described in section 1.5.1, a potential 
strength of dimensional models of psychopathology is their applicability across the 
range of developmental levels across childhood and adolescence (Achenbach, 
Edelbrock & Howell 1987; van der Oord, Koot et al. 1995; Leung & Wong 1998; 
Krenke & Kollmar 1999). The functional range of abilities of adults with mild-
profound intellectual disabilities can be conceptualised as similar to the developmental 
levels across childhood and adolescence (World Health Organisation 1994). 
Therefore, it is noteworthy in table 1.4 that few studies have examined the relationship 
between dimensional models of psychopathology and level of intellectual disabilities. 
Two studies use specific psychopathology checklists of symptoms (Taylor et al. 2004; 
Hove & Havik 2010) but only the study using the P-AID checklists examines the 
association between psychopathology and level of intellectual disabilities (Hove & 
Havik 2010). Given the potential advantages to, and the limited number of studies, 
using dimensional models of psychopathology across the full range of abilities there is 
a clear need for further work in this area.  
 
1.7.5 Psychopathology and epilepsy 
Epilepsy is the clinical variable most often examined against psychopathology in 
epidemiological studies. In table 1.4 it was not having epilepsy that was independently 
associated with a higher risk of psychosis (Cooper et al. 2007b) and anxiety (Hove & 
Havik 2010).  
 
No studies explicitly using dimensional models of psychopathology to examine the 
association with epilepsy were identified. However, a different approach was adopted 
in a population based study, which used data from the Leicestershire Learning 
Disability Register to examine the relationship between epilepsy and individual 
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psychological symptoms and problem behaviours (McGrother et al. 2006). Adjusting 
for age, sex and level of understanding (based on three categories describing an 
individual’s understanding of verbal communication), epilepsy was significantly 
associated with having one or more psychological symptoms, experiencing mood 
swings, or lethargy. Reporting any type of problem behaviour, or the specific 
behaviours- attention seeking, night-time disturbance, and uncooperative behaviours- 
were also significantly associated with epilepsy. Given the inconsistent findings from 
studies using categorical models of psychopathology, this study suggests the potential 
value of using alternative models of psychopathology to examine the relationships 
with clinical variables, such as epilepsy. 
 
1.7.6 Psychopathology and Down syndrome 
Individuals with Down syndrome were found to have lower rates of problem 
behaviours (Jones et al. 2008), and higher levels of organic psychopathology (Hove & 
Havik 2010) in the studies summarised in table 1.4.  
 
There were no significant associations between overall risk of mental disorders and 
Down syndrome in table 1.4. However, two other population based studies, have 
suggested that adults with Down syndrome experience lower rates of mental disorders 
than adults with intellectual disabilities who do not have Down syndrome (Mantry et 
al. 2007; Morgan et al. 2008). This confirms the findings from several previous 
studies that, similarly, used categorical models of psychopathology (Myers & 
Pueschel 1991; Collacott et al. 1992; Haveman et al. 1994). 
 
Apart from the Norwegian study above (Hove & Havik 2010), relatively few studies 
have examined psychopathology in adults with Down syndrome and intellectual 
disabilities using dimensional or continuous models of psychopathology. On the basis 
of the association of Down syndrome and dementia, several studies have examined 
qualitative differences in the organic psychopathology in adults with Down syndrome 
relative to comparison groups (Cooper & Prasher 1998; Ball et al. 2006; Deb et al. 
2007). However, no other studies were identified that used other dimensions of 
psychopathology, in adults with Down syndrome. 
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1.7.7 Psychopathology and other socio-clinical variables 
Sections 1.7.1- 1.7.6 above considered those variables identified as significantly 
associated with psychopathology across more than one of the population based studies 
in table 1.4. However, there are other socio-clinical variables identified as potentially 
relevant by a significant association in a single study. 
 
1.7.7.1 Psychopathology and autism 
Autism was found to be associated with higher scores on checklists for psychosis, 
OCD, anxiety, problem behaviours and overall mental ill-health (Hove & Havik 
2010). However, another study did not find an independent association between 
autism and problem behaviours (Jones et al. 2008). The two studies that reported 
contrasting findings on problem behaviours used different methods to identify a 
diagnosis of autism. One study used carer report of a known diagnosis of autism 
(Hove & Havik 2010), whilst the diagnosis was made as part of a comprehensive 
psychiatric assessment, using a structured checklist of ICD-10 criteria in the second 
study.  
 
One other study using continuous models of psychopathology was identified reporting 
psychopathology in adults with autism and intellectual disabilities (Hill & Furniss 
2006). They studied 82 individuals with autism and intellectual disabilities, and 
examined psychopathology using the DASH-II (Matson et al. 1991). Compared to 
participants with intellectual disabilities who di not have autism, individuals with 
autism were found to have higher mean scores on the DASH-II subscales representing 
organic, anxiety, mania, PDD/ autism and stereotypy dimensions of psychopathology 
(Hill & Furniss 2006). This study is included because it used a continuous measure of 
psychopathology, which is closer to a dimensional model than the categorical 
diagnoses used in the majority of studies in table 1.4. However, since this study used a 
clinic sample, the likely sampling bias makes the findings less reliable than reported in 
the population based studies.   
 
Looking further at studies using a categorical model of psychopathology, an analysis 
was done using the Glasgow data (Cooper et al. 2007a) using a matched control 
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design to examine the prevalence and incidence of mental disorders in adults with 
autism and intellectual disabilities (Melville et al. 2008). No difference in the 
prevalence, or incidence of any mental disorder, or problem behaviours was found 
between the participants with autism and intellectual disabilities, compared to the 
participants with intellectual disabilities who do not have autism. Overall then, there 
remains some ambiguity about the exact association between autism and 
psychopathology. However, from the findings described above it appears that 
continuous models of psychopathology are of potential relevance. 
 
1.7.7.2 Psychopathology and sensory impairments, incontinence and mobility 
Fewer studies have examined the relationships between psychopathology and sensory 
impairments, mobility problems and incontinence in adults with intellectual 
disabilities.  
 
From the Greater Glasgow population based epidemiological studies using categorical 
models of psychopathology in table 1.4, there is evidence for an independent 
association between urinary incontinence and the risk of any mental disorder (Cooper 
et al. 2007a) and problem behaviours (Jones et al. 2008). An association between 
urinary incontinence and mental disorders has also been described in adults who do 
not have intellectual disabilities (cited in Mantry et al. 2008).  
 
From the Glasgow studies, the associations with mobility problems, visual 
impairment, and hearing impairment are more complex. There is an association 
between having a visual impairment and psychosis (Cooper et al. 2007b) and problem 
behaviours (Jones et al. 2008). However, the association is reversed for mobility 
problems and hearing impairment. There is an independent association between not 
having mobility problems and being diagnosed with any mental disorder (Cooper et 
al. 2007a), and not having a hearing impairment and affective disorders (Cooper et al. 
2007c).  
 
There is a higher prevalence of sensory impairments in adults with intellectual 
disabilities. Some evidence suggests that there is an association between 
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psychopathology and hearing (van Gent et al. 2007) and visual impairments 
(Lupsakko et al. 2002) in individuals who do not have intellectual disabilities. 
However, no studies were identified showing a significant association between 
categorical models of psychopathology and sensory impairments in adults with 
intellectual disabilities (Carvill 2001). 
 
Overall, there is limited evidence for a relationship between psychopathology and 
sensory impairments, continence and mobility problems in adults with intellectual 
disabilities. Since dimensional models of psychopathology may have greater power 
when examining correlations between variables (Cohen 1983; MacCallum et al. 
2002), it may be particularly useful to explore the relationships between variables for 
which there is less evidence of an association with psychopathology. Therefore, the 
relationships between psychopathology and visual impairment, hearing impairment, 
mobility problems, urinary and bowel incontinence will be examined in this thesis. 
 
1.7.8 Summary of findings on socio-clinical variables associated with 
psychopathology in intellectual disabilities 
The evidence suggests that socio-clinical variables likely to be associated with 
psychopathology are gender, age, living circumstances, level of intellectual 
disabilities, a diagnosis of autism, Down syndrome, epilepsy, visual impairment, 
hearing impairment, mobility problems, urinary incontinence and bowel incontinence. 
These are potential confounders in the relationship between psychopathology and the 
severity and outcome of mental disorders. 
  
1.8 Psychopathology and measures of the severity of mental disorders  
General research suggests that, compared to categorical models of psychopathology, 
dimensional models may be more strongly associated with measures of severity. This 
section, examines the evidence for the relationship between psychopathology and the 
severity of mental disorders experience by adults with intellectual disabilities.  
 
A single instrument was used to measure the severity and outcome of mental disorders 
for example in the studies comparing dimensional and categorical models of 
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psychopathology from the UK700 study (van Os et al. 1999a; van Os et al. 1999b). 
The term severity of mental disorders is used to describe a cross-sectional measure. 
Longitudinal outcome is the term used to describe results from a follow-up study, 
where a measure is completed on at least two occasions. Studies examining the 
longitudinal outcome in intellectual disabilities are examined in section 1.9. 
 
No intellectual disabilities studies comparing the associations between dimensional 
and categorical models of psychopathology with severity of mental disorders were 
identified. Indeed, few studies have sought to understand how psychopathology relates 
to the severity of mental disorders experienced by adults with intellectual disabilities. 
To take account of the limited evidence–base, it is necessary to consider the results 
from a broader range of studies than would be necessary in other fields of research, for 
example, the studies which are not primarily designed to answer questions relating to 
psychopathology and severity, or have samples including persons with intellectual 
disabilities and other cognitive impairments (Endermann & Zimmermann 2009). 
Nonetheless, these studies offer some insight into our current understanding of the 
relationship between psychopathology and the severity of mental disorders.  
 
Quality of life was the measure of severity of mental disorders used in the studies 
summarised in table 1.5. These three studies used continuous measures of 
psychopathology, derived from the use of structured instruments for the assessment of 
psychopathology.  
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Table 1.5: Cross sectional studies reporting the associations between psychopathology and measures of severity for individuals 
with intellectual disabilities  
 
Authors Sample Measures of 
severity  
Variables included 
in analysis 
Significant 
correlates of 
outcome  
Comments 
Lunsky & Benson 
2001 
84 adults with mild 
intellectual 
disabilities living 
in the community. 
41 men, 43 
women; mean 
age=38 years 
(range 20-65).  
Quality of Life 
Questionnaire1 
(QoLQ) 
 
1. Depressive 
psychopathology- 
Birleson Depressive 
Short Scale2 (BDS-S) 
2. Social support self-
report for mentally 
retarded adults3 
(SSSR) 
3. Residential 
loneliness 
questionnaire4 (RLQ) 
4. Social strain- 
Inventory of Negative 
Social Interactions5 
(INSI)  
1. SSSR (r=.23, 
p<.05) 
2. RLQ (r=-.28, 
p<.05) 
3. BDS-S (r=-.55, 
p<.001) 
 
Only bivariate 
correlation results for 
the depressive 
psychopathology 
variable are reported 
in the paper 
 
Beadle-Brown et 
al. 2009 
86 adults with 
intellectual 
disabilities 
followed up over 
25 years (Original 
Camberwell 
cohort- 166 
children with 
intellectual 
disabilities living 
in a defined 
geographical area 
Quality of Life- 
Lifestyle 
Satisfaction Scale6 
(LSS)  
1. Skills & behaviour 
Schedule of 
Handicaps 
Behaviours and 
Scales7 (HBS)  
2. Adaptive 
functioning- Adaptive 
Behaviour Skills- part 
2 (ABS)8 
3. Performance IQ  
4. Type of residential 
placement 
1. ABS (t=2.347, 
p<.05) 
2. IQ below 50 
(t=-3.295, p<.001) 
3. Presence of 
problem behaviour 
(t=-2.206, p<.05) 
 
Proxy respondents 
completed the LSS 
for 72 (84%) of the 
sample. Small study 
of inter-rater 
reliability showed 
that proxy responses 
had good level of 
agreement with 
responses from 
participants with mild 
intellectual 
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in London. Mean 
age=34 years 
(SD=4.3; range 27-
41) 
5. Social impairment 
6. Presence of 
challenging behaviour 
(Y/N) 
7. IQ below 50 
disabilities. 
Endermann & 
Zimmermann 
(2009) 
36 individuals 
(90% of total 
population) 
admitted, in 2005, 
to specialist 
epilepsy unit for 
individuals with 
cognitive 
impairments. 22 
men, 14 women; 
mean age= 25.6 
years (S.D. = 6.0; 
median = 24.0; 
range = 18–40) 
Health Related 
Quality of Life 
(HRQoL)- Quality 
of Life in Epilepsy 
Inventory -31 
(QOLIE-31)9 
1. Age at onset of 
epilepsy 
2. Number of 
different seizure 
types 
3. Duration of 
epilepsy 
4. Number of AEDs 
5. Neuroticism- 
NEO-FFI 
6. Anxiety- HADS10 
7. Depression- 
HADS 
Lower HRQoL: 
1. Younger age at 
onset of epilepsy 
(β=-.27, p<.05) 
2.  Higher 
neuroticism- NEO-
FFI 11(β=-.72, 
p<.001) 
 
Neuroticism, anxiety 
and depression were 
all significantly 
correlated (p<.001) 
with HRQoL in the 
bivariate analyses, so 
only neuroticism was 
used in the 
multivariate analysis. 
The assumption is 
made that the results 
would have been the 
same if anxiety or 
depression had been 
used. 
 
1
 Schalock & Keith 1993 
2 Birleson 1981 
3
 Lunsky & Benson 1997 
4
 Chadsey-Rusch et al. 1992 
5 Lakey et al. 1994 
6
 Harner & Heal 1993 
7
 Wing & Gould 1978 
8 Nihira et al. 1993 
9
 Cramer et al. 1998 
10
 HADS:  Hospital Anxiety and Depression Scale (Zigmond & Snaith 1983) 
11
 NEO-FFI: Neo- Five Factor Inventory (Costa Jr & McCrae 1989) 
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The only finding reported across more than one study is the significant correlation 
between depressive psychopathology and lower quality of life in adults with mild 
intellectual disabilities (Lunsky & Benson 2001; Endermann & Zimmermann 2009). 
One study found that a measure representing the anxiety dimension of 
psychopathology (Endermann & Zimmermann 2009), and another that the presence of 
problem behaviour (Beadle-Brown et al. 2009), are correlated with measures of 
severity.  
 
These studies are limited in the scope of the evidence they provide on the relationship 
between psychopathology and measures of severity. Firstly, each of the three studies 
only uses one measure of severity, which is a quality of life measure in all three 
studies. This is an issue because it is generally recognised that there are advantages to 
the use of multiple measures of severity and outcome (Slade 2002). The second 
limitation is related to the limited range of psychopathology included in the analyses. 
None of the studies have used a broad measure of psychopathology, and two studies 
have only included a measure of a single form of psychopathology (Lunsky & Benson 
2001: Beadle-Brown et al. 2009). As a consequence there are unanswered questions 
about the relationship between different types of psychopathology and severity- 
specifically with reference to problem behaviours and other psychopathology. Finally, 
the findings are limited by aspects of the samples used.  Only the study by Beadle-
Brown et al. (2009) used participants with a range of abilities. The other two studies 
were limited to participants with mild intellectual disabilities (Lunsky & Benson 2001; 
Endermann & Zimmermann 2009) and Endermann & Zimmermann (2009) only 
included individuals with complex epilepsy. Given these limitations, combined with 
the small number of studies, caution is needed regarding the generalisability of the 
findings.   
 
In terms of other variables found to be associated with severity, the main finding of 
interest is that a lower level of adaptive functioning and lower IQ was correlated with 
increased severity (Beadle-Brown et al. 2009). This could not be examined in the two 
other studies which were limited to participants with mild intellectual disabilities 
(Lunsky & Benson 2001; Endermann & Zimmermann 2009).  
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There is a far larger body of evidence examining the cross-sectional correlations 
between variables that correlate with quality of life than is shown in table 1.5 
(Schalock 2004). However, these are the only studies identified that included some 
measure of psychopathology in the analysis. This is surprising as research that 
involves adults with mental disorders who do not have intellectual disabilities has 
closely studied the relationship between psychopathology and quality of life (Ruggeri 
et al. 2002; Eack & Newhill 2007) as well as other measures of severity (Malla et al. 
2002; Drukker et al. 2008). Such work has offered insights into the extent to which 
psychopathology contributes to the severity of a disorder, or need for care. 
 
1.8.1 Summary of findings on the association of psychopathology and the severity 
of mental disorders in intellectual disabilities 
Overall, there is limited evidence on the relationship of psychopathology and the 
severity of mental disorders experienced by adults with intellectual disabilities. No 
studies comparing the associations between dimensional and categorical models of 
psychopathology with severity of mental disorders were identified. However, using 
continuous measures, depressive, anxiety and problem behaviour psychopathology 
were associated with greater severity. Increased severity of intellectual disabilities 
may be associated with the severity of mental disorders.  
 
1.9 Psychopathology and the longitudinal outcome of mental 
disorders  
The final area where dimensional models of psychopathology have been found to be 
of interest is in studying the relationships between psychopathology and longitudinal 
outcome. 
 
No studies of the associations between dimensional models of psychopathology and 
longitudinal outcome in adults with intellectual disabilities and mental disorders were 
identified. Therefore, to describe the evidence base that psychopathology is related to 
outcome of mental disorders experienced by adults with intellectual disabilities, the 
findings from two types of longitudinal studies are discussed: 
• studies of adults with intellectual disabilities and mental disorders using specific 
clinical services 
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• examining childhood psychopathology, and other socio-clinical variables, as 
predictors of adult outcomes. 
 
 1.9.1 Longitudinal studies examining psychopathology in users of specific clinical 
services 
The studies identified, which consider the association between psychopathology and 
outcome, are limited to studies of users of inpatient services for adults with intellectual 
disabilities and mental disorders.   The three studies are summarised in table 1.6.  
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Table 1.6: Studies reporting psychopathology as a predictor of outcome for individuals with intellectual disabilities  
 
Authors Sample Measures of 
outcome (duration 
of follow-up) 
Predictors of 
outcome included in 
analysis 
Significant 
predictors of 
outcome (t, p) 
Comments 
van Minnen et al. 
1997 
50 individuals mild 
intellectual 
disabilities, 
randomised to 
inpatient (20 men, 
5 women; mean 
age=31.4±12.6 
years) or outreach 
(18 men, 7 women; 
mean 
age=31.0±10.8 
years) treatment.  
Combined score 
from the PIMRA 
and RSMB (28 
weeks) 
 
1. Psychopathology- 
combined PIMRA & 
RSMB score 
2. Aggressive 
behaviour- SAB1 
3. Social competence- 
SCS2 
4. Previous 
hospitalizations at 
baseline  
1. Aggressive 
behaviour- SAB (-
3.14, .003) 
2. Social 
competence- SCS 
(2.03, .049) 
3. Previous 
hospitalizations at 
baseline (1.99, 
.052) 
The analysis 
examining predictors 
of outcome  included 
participants in both 
treatment groups  
Final model 
explained 46% of the 
variance in the 
outcome. 
 
Xenitidis et al. 
2004 
71 individuals 
admitted to 
inpatient services 
over 35 month 
period (36 men, 35 
women. Mean 
age=34.55 years 
(SD ±13.11); Mild 
ID= 58, Moderate= 
10, Severe= 3 
1. Total number of 
symptoms on the 
PAS-ADD3 
2. Disability- total 
DAS4 score  
3. Behavioural 
impairment- DAS- 
behavioural score  
4. Overall 
functioning- GAF  
5. Severity of Mental 
Health Problem- 
total TAG5 score (12 
months) 
1. Gender 
2. Age 
3. Psychopathology- 
total PAS-ADD 
symptoms  
4. Autism 
5. Epilepsy 
6. Length of inpatient 
stay 
7. Diagnosis of 
psychosis 
8. Legal status  
None Outcome measure 
was calculated as 
mean of baseline and 
follow-up score. 
Each of the 5 
outcome measures 
used as dependant 
variable in 
multivariate analyses 
to examine predictors 
of outcome  
 64 
 
Spiller et al. 2007 Random sample of 
115 users (69 men, 
46 women) of 
specialist 
intellectual 
disability mental 
health services. 
Mild ID = 72, 
moderate= 29, 
severe= 14. 
Service consumption 1. ICD-10 categorical 
diagnosis 
2. Psychosis 
symptom score 
3. Affective/ neurotic 
symptom score 
4. Organic symptom 
score 
5. Gender 
6. Age 
7. Ethnicity 
8. Level of ID 
9. Residence type 
10. Contact with 
behaviour support 
team 
Heavy service use 
associated with: 
1. Diagnosis of 
schizophrenia 
spectrum disorder 
(F20-27) 
2. Higher baseline 
affective/ neurotic 
symptom score 
 
Categorical diagnoses 
made by two 
consultant 
psychiatrists  based 
on data from a 
standardised 
assessment.. 
Affective/ neurotic, 
organic and psychotic 
psychopathology 
scores were 
calculated from the 
PAS-ADD checklist 
completed by an 
informant. 
 
 
1SAB Scale for Aggressive Behaviour for People with Mental Retardation (Kraijer & Kema 1981) 
2 SCS Social Competence Sclae for People with Mental Retardation (Kraijer & Kema 1981) 
3 PAS-ADD Psychiatric Assessment Schedule for Adults with Developmental Disability (Moss et al. 1997) 
4 DAS  Disability Assessment Scale (Holmes et al. 1982) 
5 TAG Threshold Assessment Grid (Slade et al. 2000) 
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Although there are different findings across the three studies, the results are of interest 
to examining the relationship between psychopathology and longitudinal outcome. 
Therefore, it is worth examining the methodology and results of the studies in more 
detail (Van Minnen et al. 1997; Xenitidis et al. 2004, Spiller et al. 2007). To 
summarise the results: 
• two studies found that general measures of psychopathology were not predictive of 
outcome (Van Minnen et al. 1997; Xenitidis et al. 2004)  
• higher scores on a continuous measure of neurotic/ affective psychopathology and 
a categorical diagnosis of a schizophrenia spectrum disorder predicted increased 
service use, but not continuous measures of psychosis and organic 
psychopathology (Spiller et al. 2007)  
• only one study included problem behaviour at baseline as an independent variable, 
and found it predicted poorer outcome (Van Minnen et al. 1997)  
 
The only consistent finding across studies was that an overall measure of 
psychopathology- measured with the PIMRA and RSMB in one study (Van Minnen et 
al. 1997) and the PAS-ADD in another (Xenitidis et al. 2004)- was not associated with 
longitudinal outcome. Since the measures of psychopathology used in these studies 
were incorporated into the measures of outcome at follow up, it is surprising that 
neither study found a significant association. One possible explanation relates to the 
process used to complete the measures of psychopathology and the reliability of the 
measures. Both studies collected data prospectively, but it is not clear whether the 
same raters completed the measures at baseline and follow-up. The inter-rater 
reliability of the psychopathology items on the Dutch version of the PIMRA (van 
Minnen et al. 1994) and RSMB (van Minnen et al. 1995), and the PAS-ADD (Moss et 
al. 1998) have all been shown to be low. Such low reliability could affect the findings 
of prospective follow-up studies, and may explain the absence of a correlation 
between psychopathology at baseline and follow-up. 
 
 In keeping with the finding in the cross-sectional study by Endermann & 
Zimmermann (2009) discussed in section 1.8, a continuous measure of neurotic/ 
affective psychopathology was found to be significantly associated with outcome in 
users of specialist intellectual disabilities mental health services (Spiller et al. 2007). It 
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is noteworthy that the psychosis and organic dimensions of psychopathology did not 
predict outcome (Spiller et al. 2007). Since only 7 (6.2%) of the participants had a 
diagnosis of dementia, the reason that the organic dimension of psychopathology did 
not predict outcome may be due to the small number of participants with 
psychopathology on this dimension. However, as 28 (24.3%) of participants were 
diagnosed with a schizophrenia spectrum disorder (ICD-10 categories F20-27) this is 
unlikely to be the case for the psychosis dimension of psychopathology. and 
furthermore, the categorical measure of psychosis did predict outcome. A more likely 
explanation is that the psychosis dimension on the PAS-ADD checklist comprises 
only three items (suspicious/ paranoid; strange experiences; strange beliefs) whereas 
the neurotic/ affective dimension has 19 individual items of psychopathology (Moss et 
al. 1998). The lack of coverage of psychosis psychopathology has been previously 
recognised (Cooper et al. 2007a) and makes it likely that even individuals with active 
psychosis may not score on this psychopathology dimension of the PAS-ADD 
checklist. A specific measure of problem behaviours was also associated with outcome 
(van Minnen et al. 1997). However, these findings are as likely to be affected by 
issues related to inter-rater reliability described previously. 
 
A final point of interest from table 1.6 is the differing result for the two studies that 
examine level of ability as a predictor of outcome (Van Minnen et al. 1997; Spiller et 
al. 2007). Although not identical to level of intellectual disabilities, a measure of 
social competence was found to be a significant predictor of outcome in the study by 
van Minnen et al. (1997); whilst level of intellectual disabilities did not predict 
outcome in the study by Spiller et al. (2007). Although it did not include any measure 
of psychopathology in the analysis, one other study has examined the specific question 
of whether individuals with more severe intellectual disabilities have poorer outcomes 
from the use of a specialist inpatient service (Lunsky et al. 2010). This study found 
that the GAF score at follow up was significantly correlated with the binary measure 
of the level of intellectual disability (mild, moderate/severe). Participants with mild 
intellectual disabilities experienced a significant improvement in the GAF score, but 
participants with moderate/ severe intellectual disabilities did not. However, the 
authors conclude that the between groups differences in the change in the GAF is 
attributable to a lack of sensitivity of the GAF when used to measure outcome in 
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individuals with more severe intellectual disabilities. From the description of the 
methods used to score the GAF, it appears that the effect of a person’s intellectual 
disabilities on functioning was used in scoring the GAF. A potential solution to this 
problem, as described in section 3.4.3.3, is the use of the modified scoring system 
(Hurley 2001).  
 
The suggestion that lower ability levels are associated with increased severity of 
mental disorders has been described in the study by Beadle-Brown et al. (2009) in 
section 1.8, and van Minnen et al. (1997) and Lunsky et al. (2010) in this section. 
However, since Lunsky et al. (2010) discount their finding that more severe 
intellectual disabilities is predictive of poorer outcome on methodological grounds, 
and Spiller et al. (2007) did not find that level of intellectual disabilities predicts 
outcome, the exact relationship between level of intellectual disabilities and outcome 
requires further study. 
 
1.9.2 Longitudinal studies examining childhood psychopathology and outcomes in 
adulthood 
The results presented in this thesis relate to psychopathology and outcomes in 
adulthood. Therefore, studies that follow-up children with intellectual disabilities do 
not provide directly comparable findings. In particular, the measures used to assess 
psychopathology in childhood and the length of follow up affect the generalisability of 
the results to the work of this thesis. Furthermore, since three of the studies in table 
1.7 below use psychopathology as the adult measure of outcome these studies could be 
considered as studies of the stability of psychopathology.  Despite these limitations, 
given the small number of relevant studies on psychopathology and outcome it is 
worth considering the evidence from longitudinal studies from childhood to 
adulthood.  
 
Overall, it appears from the results of the studies in table 1.7, that socio-economic 
disadvantage in childhood (McCarthy 2008) and level of ability (Maughan et al. 1999; 
McCarthy 2008; Beadle-Brown et al. 2009) are potentially more important childhood 
predictors of adult outcome than psychopathology. 
 
 68 
Table 1.7: Longitudinal studies reporting childhood psychopathology, and other variables, as predictors of adult outcomes  
 
Authors Sample Measures of 
outcome  
Childhhood 
variables included in 
analysis 
Significant 
predictors of 
outcome  
Comments 
Maughan et al. 
(1999) 
122 adults with 
mild intellectual 
disabilities 
interviewed at age 
33 years (51% of 
275 in original 
birth cohort). 49 
men, 51 women. 
Adult 
Psychopathology- 
Malaise Inventory 
(Rodgers et al. 1999) 
 
1. Childhood social 
disadvantage1 
2. Childhood sensory 
and neurological 
impairment 
3. General level of 
ability in childhood- 
reading 
comprehension and 
mathematics 
4. Childhood 
behaviour problems- 
Bristol Social 
Adjustment Guides 
(BSAG:(Stott 1978)2 
5. Contact with 
psychiatric services 
before age 16 
Data used in 
analysis was 
gathered at age 11 
and 16 years old. 
1. Childhood 
social 
disadvantage (OR 
= 1.4, CI = 1.0-2.0, 
P = 0.07) 
2. Childhood 
sensory and 
neurological 
problems (OR = 
3.1, CI = 1.0-9.6, P 
= 0.05) 
 
Additional data is 
provided for a 
comparison sample of 
8554 individuals who 
do not have 
intellectual 
disabilities (71.1% of 
original birth cohort) 
Beadle-Brown et 
al. (2009) 
86 adults with 
intellectual 
disabilities 
followed up over 
25 years (Original 
Camberwell 
cohort- 166 
children with 
intellectual 
disabilities living 
1. Quality of Life- 
Lifestyle 
Satisfaction Scale 
(LSS; Harner & 
Heal 1993)  
Childhood ratings 
carried out at age 11 
years.  
1. Skills & behaviour- 
Schedule of 
Handicaps 
Behaviours and 
Scales (HBS; Wing & 
Gould 1978)3 
2. Adaptive 
Higher quality of 
life age 33 was 
only significantly 
associated with 
higher independent 
living skills in 
childhood (F = 
5.847, P < 0.02) 
 
Proxy respondents 
completed the LSS 
for 72 (84%) of the 
sample. Small study 
of inter-rater 
reliability showed 
that proxy responses 
had good level of 
agreement with 
responses from 
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in a defined 
geographical area 
in London. Mean 
age=34 years 
(SD=4.3; range 27-
41) 
functioning- Adaptive 
Behaviour Skills- part 
2 (ABS) 
3. Cognitive ability- 
Leiter International 
Performance Scales 
(Leiter 1980) &  the 
Reynell Language 
Development Scales 
(Reynell 1987) 
4. Time spent in 
institutional care 
5. Social impairment  
6. Autistic on ICD-10 
participants with mild 
intellectual 
disabilities. 
McCarthy & Boyd 
2001 
52 individuals with 
Down syndrome- 
28 men, 24 
women; mean age= 
26.63 years, SD = 
3.45, range= 22- 33 
years (Original 
childhood cohort of 
193; mean age 
10.65 years, SD = 
3.49, range= 6-17 
years).  
Adult psychiatric 
disorder- assessed 
using the PAS-ADD 
(Moss et al. 1997) 
1. Childhood level of 
functioning- Adaptive 
Behaviour Scale 
(ABS; Nihira et al. 
1974) 
2. Problem 
behaviours- Rutter 
A2 & B2 scales 
(Rutter 1970) 
3. ICD-10 psychiatric 
disorder 
4. Childhood 
externalising disorder  
5. Social class- based 
on father’s 
occupation 
6. Quality of parental 
marriage 
7. Parental ill-health 
Parental social 
class (p<.05)  
 
Social class was 
dichotomised into 
two group comprising 
classes I-III 
(professional/ 
managerial/ skilled) 
and  IV-V (semi-
skilled/ unskilled). 
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McCarthy (2008) 50 individuals with 
Down syndrome- 
26 men, 24 
women; mean age= 
26.6 years, SD = 
3.48, range= 22- 33 
years (Original 
childhood cohort of 
193; mean age 
10.65 years, SD = 
3.49, range= 6-17 
years). 
Adult problem 
behaviours- 
Additional 
Behavioural 
Inventory (ABI; 
(Turner & Sloper 
1996) 
1. Childhood level of 
functioning- Adaptive 
Behaviour Scale 
(ABS; Nihira et al. 
1974) 
2. Problem 
behaviours- Rutter 
A2 & B2 scales  
3. ICD-10 psychiatric 
disorder 
4. Childhood 
externalising disorder  
5. Social class- based 
on father’s 
occupation 
6. Quality of parental 
marriage 
7. Parental ill-health 
1. ABS 
2. ICD-10 
psychiatric 
disorder 
3. Social class 
Social class was 
dichotomised into 
two group comprising 
classes I-II 
(professional/ 
managerial) and  III-
V (skilled/ semi-
skilled/ unskilled). 
 
 
† Eight-point social disadvantage index, including measures of childhood social class, family size, housing tenure and receptions into care. 
‡ The BSAG was used to construct separate scales representing antisocial problems, emotional problems and restlessness 
§ Used to derive separate scales for the analysis comprising basic self-care skills, educational skills, communication skills, independent living 
skills, social skills, abnormal behaviour and behaviour problems 
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Only the study examining problem behaviours in adults with Down syndrome found 
that childhood psychopathology was a significant predictor of outcome (McCarthy 
2008). Children with Down syndrome who met the criteria for a categorical diagnosis 
of an ICD-10 psychiatric disorder were more likely to have a severe problem 
behaviour, aged 33 years old (McCarthy 2008), although this was not a significant 
predictor of having an ICD-10 psychiatric disorder in adulthood (McCarthy & Boyd 
2001). Furthermore, problem behaviours in childhood did not predict adult outcome in 
the other three studies (Maughan et al. 1997; Beadle-Brown et al. 2009; McCarthy & 
Boyd 2001).  These inconsistent findings across studies are in keeping with the results 
described in the longitudinal studies of service users in section 1.9.2.1 above.  
 
Interestingly, Maughan et al. (1997) suggest that the lack of association between 
psychopathology in childhood and adulthood may be due to the poor sensitivity of the 
family and teacher-rated measures of childhood psychopathology.  Since such ratings 
of psychopathology are used across all four of the studies in table 1.7, this could 
perhaps partly explain the finding that childhood psychopathology is not a significant 
predictor of outcome in adulthood. Further limitations of the studies described here are 
the use of single measures of outcome across all four studies, samples limited to 
individuals with mild intellectual disabilities (Maughan et al. 1997) or Down syndrome 
(McCarthy & Boyd 2001; McCarthy 2008) and the inclusion of measures of 
psychopathology that are limited in scope.  
 
1.9.3 Summary of findings on the association of psychopathology and the 
longitudinal outcome of mental disorders in intellectual disabilities 
Overall, there is limited evidence on the relationship of psychopathology and the 
outcome of mental disorders experienced by adults with intellectual disabilities. No 
studies examining dimensional models of psychopathology and outcome, or comparing 
the associations between dimensional and categorical models of psychopathology with 
the outcome of mental disorders were identified. However, using continuous measures, 
neurotic/ affective and problem behaviour psychopathology were associated with 
longitudinal outcome. Further research on the association of level of intellectual 
disabilities and outcome is required. 
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1.10 Conclusions from the review of the literature  
The classification of mental disorders is dependent on the assessment of 
psychopathology and the use of categorical diagnostic classification systems, that are 
based on a categorical model of psychopathology. An important development was the 
publication of specific categorical diagnostic classification systems for the 
classification of mental disorders experienced by individuals with intellectual 
disabilities- DC-LD and DM-ID. These are based on the generic ICD and DSM 
categorical diagnostic classification systems. Few studies have examined the properties 
of DC-LD and DM-ID. However, research examining the characteristics of ICD and 
DSM has highlighted important strengths and limitations of categorical diagnostic 
classification systems, particularly with regard to validity and their utility in some 
types of research. As a consequence, dimensional models of psychopathology have 
been proposed as an important corollary to categorical diagnostic classification 
systems.  
 
The work done to examine the dimensions of psychopathology experienced by adults 
with intellectual disabilities is limited by small sample sizes, biased samples and the 
use of assessments that include a limited range of items of psychopathology. 
Furthermore, the methods of exploratory factor analysis used have methodological 
problems.  
 
Socio-clinical variables are important to consider as potential confounders in 
examining the relationship between psychopathology and other aspects of mental 
disorders. No studies have examined the associations of dimensional models of 
psychopathology and socio-clinical variables. However, studies have identified socio-
clinical variables that are associated with categorical models of psychopathology.  
 
There has been general research published comparing the associations of dimensional 
and categorical models of psychopathology with the severity and outcome of mental 
disorders.  No studies were identified examining the relevance of dimensional models 
of psychopathology to the severity and outcome of mental disorders experienced by 
adults with intellectual disabilities. Similarly, no studies comparing dimensional and 
categorical models of psychopathology in intellectual disabilities were identified. 
Therefore, relevant intellectual disabilities research using categorical models, or 
continuous measures, of psychopathology is needed.  
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Studies examining the relationship between psychopathology and the severity of 
mental disorders have tended to make use of measures of psychopathology which are 
limited in scope, eg. using either a broad, general measure of psychopathology or 
focussing on a single continuous measure of psychopathology, such as depressive 
psychopathology or problem behaviours. The samples included in the studies are 
biased towards individuals with mild intellectual disabilities. Finally, rather than 
making use of comprehensive assessments of severity, studies have largely used a 
single measure of severity- which to date have all been based on quality of life. 
 
The longitudinal studies examining psychopathology and outcome are limited by the 
focus on users of inpatient services as participants. Since this is likely to comprise 
individuals with the most severe mental disorders it introduces potential sampling bias, 
and limits the generalisability of the findings. The measures of psychopathology used 
in the studies have largely focussed on problem behaviour psychopathology, or have 
only used overall measures of psychopathology. Only a single study, used more than 
one measure of outcome (Spiller et al. 2007), in contrast to the recommended use of 
multiple measures of outcome in mental disorder studies (Slade 2002).  Finally, 
although one study includes several continuous measures of psychopathology 
(Xenitidis et al. 2004), these are not empirically derived from the PAS-ADD checklist, 
which is limited in scope and validity.   
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Chapter 2: Research aims and hypotheses 
2.1 Research aims  
Informed by the existing literature, five broad research aims were formulated: 
1. To explore the dimensional structure of psychopathology experienced by adults 
with intellectual disabilities 
2. To examine the associations of a dimensional model of psychopathology with 
socio-clinical variables 
3. To examine the relationship of a dimensional model of psychopathology with the 
severity of mental disorders. 
4. To understand the relationship between a dimensional model of psychopathology 
and the longitudinal outcome of mental disorders  
5. To compare the associations of dimensional and categorical models of 
psychopathology with the severity and outcome of mental disorders, experienced 
by adults with intellectual disabilities. 
 
2.2. Research hypotheses 
To meet these aims 12 null hypotheses were formulated for examination: 
 
Null hypothesis one: 
There are no stable, identifiable dimensions of psychopathology experienced by adults 
with intellectual disabilities. 
 
Null hypothesis two: 
There are no significant correlations between the individual dimensions of 
psychopathology experienced by adults with intellectual disabilities. 
 
Null hypothesis three: 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and socio-clinical variables: 
• gender  
• age 
• living circumstances 
• level of intellectual disabilities 
• diagnosis of autism 
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• Down syndrome 
• epilepsy 
• sensory impairments 
• mobility problems 
• incontinence. 
 
Null hypothesis four: 
There are no significant cross-sectional, multivariate relationships between 
dimensional measures of psychopathology and socio-clinical variables. 
 
Null hypothesis five: 
There are no significant bivariate relationships between dimensional measures of 
psychopathology and measures of the severity of mental disorders: 
• Health of the Nation Outcome Scales- Learning Disabilities total score (HoNOS-
LD)  
• Global Assessment of Functioning (GAF) 
• Clinical Global Impression (CGI) 
• Camberwell Assessment of Need for Adults with Developmental and Intellectual 
Disabilities (CANDID) - unmet needs, and met needs.  
 
Null hypothesis six: 
There are no significant bivariate relationships between socio-clinical variables and 
measures of the severity of mental disorders. 
 
Null hypothesis seven: 
There are no significant multivariate associations between dimensional measures of 
psychopathology, socio-clinical variables and measures of the severity of mental 
disorders. 
 
Null hypothesis eight: 
There are no significant differences in the associations of dimensional and categorical 
models of psychopathology with measures of the severity of mental disorders. 
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Null hypothesis nine: 
Dimensional measures of psychopathology are not significantly correlated to the 
longitudinal outcome of mental disorders. 
 
Null hypothesis ten: 
Socio-clinical measures are not significantly associated with the longitudinal outcome 
of mental disorders. 
 
Null hypothesis eleven: 
Dimensional measures of psychopathology and socio-clinical variables are not 
independently associated with the longitudinal outcome of mental disorders. 
 
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and categorical 
models of psychopathology with the longitudinal outcome of mental disorders. 
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Chapter 3: Methods 
There are two study designs used to answer the research hypotheses: 
1. A cross-sectional study examining the relationships between psychopathology, 
socio-clinical variables and measures of severity (research hypotheses one- eight) 
2. A four-five year follow-up study to examine outcome baseline psychopathology 
and socio-clinical variables as predictors of longitudinal outcome (research 
hypotheses nine- twelve). 
 
An illustration of the samples, measures and variables used to examine the research 
hypotheses is shown in figure 3.1.   
 
Data collected from three samples of participants is used to answer the research 
questions addressed in this thesis. PPS-LD data from both samples was used for the 
exploratory factor analyses to identify dimensions of psychopathology. Data on socio-
clinical variables and outcome measures was collected in studies involving individuals 
in samples 2 and 3 as participants. 
 
Professor S-A. Cooper collected all the data from sample 1. The data was entered into a 
database by a member of administrative staff.Data from sample 2 was collected by 
intellectual disabilities psychiatrists working in the University Centre of Excellence in 
Developmental Disabilities (UCEDD). Professor S-A. Cooper, higher trainees in 
intellectual disabilities psychiatry and basic trainees in psychiatry were involved at 
different stages in collecting the data. Craig Melville worked in the UCEDD from 
August 2001-August 2002, and again from August 2003 onwards. During these time 
periods he was directly involved in data collection, and in the training and supervision 
of other psychiatrists collecting data. All sample 2 data used in the analyses in this 
thesis was taken from clinical case notes and entered into a database by Craig Melville. 
 
All data for sample 3 was collected during face-to face interviews with participants and 
carers and entered into a database by Craig Melville. 
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Figure 3.1: Study design to illustrate samples, measures and variables to examine research hypotheses 
 
 
 
Samples 
 
 
Time point 
 
   
Measures 
 
 
 
 
 
Variables 
Sample 2 
N=150 
Sample 1 
N=274 
• dimension factor scores 
• dimension symptom counts 
• overall symptom count 
PPS-LD  
psychopathology 
Time 1 Time 2 
Socio-clinical variables Measures of severity 
and outcome 
• gender 
• age 
• living circumstances 
• level of intellectual disabilities 
• epilepsy 
• autism  
• Down syndrome 
• sensory impairments 
• mobility problems 
• incontinence 
• HoNOS-LD total score 
• CANDID- total, met & unmet needs 
• GAF score 
• CGI 
Sample 3 
N=40 
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3.1 Study participants 
 
3.1.1 Sample 1- North Northamptonshire 
Individuals in Sample 1 comprised all adults with intellectual disabilities living in North 
Northamptonshire, and referred to specialist intellectual disabilities psychiatric services 
during 1994-1999. The psychopathology data collected using the Psychopathology 
Present State-Learning Disabilities (PPS-LD) has not been reported previously.  
 
3.1.2 Sample 2- Glasgow 
Sample 2 comprises all individuals referred to the clinical service of the Glasgow 
University Centre for Excellence in Developmental Disabilities (UCEDD) between 2001 
and 2004. Participants were referred to the UCEDD clinical service for a full assessment 
of their needs, on the basis that symptoms, or changes in behaviour, were recognised as 
suggestive of mental disorders, warranting further assessment by specialist intellectual 
disabilities services. 
 
3.1.3 Sample 3 
Sample 3 (n=40, 26.7%) is a sub-sample of sample 2. Participants in sample 2 (n=150) 
were all invited to meet with C.Melville and take part in a follow-up interview. The mean 
time between the baseline assessment and follow-up interview was 52.3 months (range= 
46-69; SD=6.9).  
 
3.1.4 Comparison of samples 
A comparison of the socio-clinical variables in the three samples are shown in tables 3.1 
and 3.2.
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Table 3.1: Socio-clinical characteristics of samples 1 and 2 
 
Sample 1 
(n=274) 
Sample 2 
(n=150) 
  
Variable 
N % N % Statistic (p value) 
Female 134 48.9 68 45.3 Gender 
 Male 140 51.1 82 54.7 
χ²= 0.50 (.48) 
Mild 35 14.1 34 22.6 
Moderate 54 21.7 32 21.3 
Severe 73 29.3 33 22.0 
Level of 
intellectual 
disabilities 
 Profound 87 34.9 51 34.0 
 
χ²= 1.95 (.16) 
No 174 63.7 105 70.0 
Yes, seizures well 
controlled 
51 18.7 29 19.3 
Epilepsy 
 
Yes, seizures poorly 
controlled 
48 17.6 16 10.7 
χ²= 2.64 (.10) 
Good 29 10.6 72 48.3 
Good with glasses 153 55.8 50 33.7 
Poor with glasses 62 22.6 9 6.0 
Visual impairment 8 2.9 9 6.0 
Vision † 
 
Severe visual impairment 18 6.6 9 6.0 
χ²=.736 (.391) 
Good 230 90.6 131 87.9 
Good with hearing aid 9 3.5 6 4.0 
Poor with hearing aid 1 0.4 4 2.7 
Hearing impairment 13 5.1 5 3.4 
Hearing † 
 
Severe hearing 
impairment 
1 0.4 3 2.0 
χ²= 2.942 (.086) 
Full mobility 187 73.0 112 75.2 
Independent but poor 21 8.2 13 8.7 
Uses a stick/ walking aid 5 2.0 2 1.3 
Uses wheelchair outside 13 5.1 14 9.4 
Always uses wheelchair  12 4.7 2 1.3 
Mobility † 
 
Unable to weight bear 18 7.0 6 4.0 
χ²= 0.297 (.586) 
Fully continent 165 60.2 97 64.7 
Occasional accidents 45 16.4 16 10.7 
Incontinent only at night 12 4.4 8 5.3 
Urinary 
incontinence 
† 
Incontinent 52 19.0 29 19.3 
χ²= 0.141 (.708) 
Fully continent 202 73.7 112 74.7 
Occasional accidents 31 11.3 10 6.7 
Incontinent only at night 2 .7 1 .7 
Bowel 
incontinence 
† 
Incontinent 39 14.2 27 18.0 
χ²= 0.235 (.628) 
† At least one cell count was too small for analyses and therefore, for the purposes of 
the statistical analyses the variable was collapsed to the binary categories shown in 
table 3.5 
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Table 3.2: Socio-clinical characteristics of samples 2 and 3 
Sample 2 
(n=150) 
Sample 3 
(n=40) 
  
Variable  
N % N % Statistic (p value) 
Female 68 45.3 22 45.0 Gender 
 Male 82 54.7 18 55.0 
χ²= 1.932 (0.165) 
 
Mild 34 22.6 6 15.0 
Moderate 32 21.3 8 20.0 
Severe 33 22.0 10 25.0 
Level of 
intellectual 
disabilities 
 Profound 51 34.0 16 40.0 
χ²= 2.215 (0.529) 
Lives independently 27 18.1 5 12.5 
Family carer support  35 23.5 8 20.0 
Living 
circumstances 
Paid carer support  87 58.4 27 67.5 
χ²= 2.014 (0.365) 
Yes 24 16 6 15.0 Autism 
No 126 84 34 85.0 
χ²= 0.248 (0.618) 
Yes 19 12.7 6 15.0 Down 
syndrome No 131 87.3 34 85.0 
χ²= 0.050 (0.824) 
No 105 70.0 28 70.0 
Yes, seizures well 
controlled 
29 19.3 8 20.0 
Epilepsy 
 
Yes, seizures poorly 
controlled 
16 10.7 4 10.0 
χ²= .010 (0.995) 
Good 72 48.3 21 52.5 
Good with glasses 50 33.7 14 35.0 
Poor with glasses 9 6.0 1 2.5 
Visual impairment 9 6.0 2 5.0 
Vision † 
 
Severe visual impairment 9 6.0 2 5.0 
χ²=4.153 (.528) 
Good 131 87.9 33 82.5 
Good with hearing aid 6 4.0 2 5.0 
Poor with hearing aid 4 2.7 3 7.5 
Hearing impairment 5 3.4 1 2.5 
Hearing † 
 
Severe hearing impairment 3 2.0 1 2.5 
χ²= 5.543 (0.353) 
Full mobility 112 75.2 33 82.5 
Independent but poor 13 8.7 3 7.5 
Uses a stick/ walking aid 2 1.3 0 0 
Uses wheelchair outside 14 9.4 1 2.5 
Always uses wheelchair  2 1.3 0 0 
Mobility † 
 
Unable to weight bear 6 4.0 3 7.5 
χ²= 8.915 (0.178) 
Fully continent 97 64.7 25 62.5 
Occasional accidents 16 10.7 3 7.5 
Incontinent only at night 8 5.3 1 2.5 
Urinary 
incontinence † 
Incontinent 29 19.3 11 27.5 
χ²= 3.219 (0.359) 
Fully continent 112 74.7 29 72.5 
Occasional accidents 10 6.7 0 0 
Incontinent only at night 1 .7 1 2.5 
Bowel 
incontinence † 
Incontinent 27 18.0 10 25.0 
χ²= 7.852 (0.063) 
† At least one cell count was too small for analyses and therefore, for the purposes of the 
statistical analyses the variable was collapsed to the binary categories shown in table 3.5 
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Data on the age of sample 1 participants at the time of data collection was available for 
269 (98.2%) individuals, who had a mean age of 34.7 years (range= 16-76; SD= 
13.0).The socio-clinical characteristics of the 150 individuals included in sample 2 are 
shown above in table 3.1. For sample 2, data on the age of the participants at the time of 
data collection was available for the whole sample, who had a mean age of 43.5 years 
(range= 17-74; SD= 13.0). The only between group difference for samples 1 and 2 was a 
significant difference in the mean age of samples 1 and 2 (t= - 6.7, p< 0.001).  
 
There was no significant difference (t= -.20; p=.984) in the mean age of sample 2 and 
sample 3 (43.53 years, SD= 11.94), or the socio-clinical variables in table 3.2, Therefore, 
sample 3 is representative of participants in sample 2. 
 
3.2 Ethical approval  
Participants in samples 2 and 3 lived in Scotland. The Adults with Incapacity (Scotland) 
Act, 2000 (Scottish Executive 2000) requires that research that involves adult participants 
who, potentially, do not have the capacity to make an informed decision on participating 
in research be considered for ethical approval by a designated Multi-centre Research 
Ethics Committee (MREC).  
 
Participants had the full range of intellectual disabilities, therefore, some individuals 
would not have the capacity to make an informed decision on participating in research. 
Ethical approval was, therefore, obtained from Scotland Research Committee A (the 
MREC that deals with all applications for ethical approval of studies involving 
participants who do not have capacity) and site specific approval was obtained from the 
local research ethics committee (LREC) of NHS Greater Glasgow, Primary Care Trust.  
 
3.3 Consent for participation in research 
In Scotland, research involving adults who do not have the capacity to make an informed 
decision regarding their participation as covered by part five of the Code of Practice of 
the Adults with Incapacity (Scotland) Act, 2000 (Scottish Executive 2000). As stated in 
the Act, 
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“Research on adults incapable of consenting is authorised under the Act provided that: 
it will further knowledge; 
it is of benefit to the adult or others in a similar condition; 
it entails little or no risk or discomfort; 
the adult is not objecting; 
consent has been obtained from a person with relevant powers; and 
the research has been approved by The Ethics Committee.”  
 
Since the provisions of the act make it clear that assessment of capacity should be 
decision specific, and not an all or nothing statement on the capacity of an individual, 
researchers are required to assess the capacity of each potential participants. Based on the 
Adults with Incapacity (Scotland) Act, 2000 (Scottish Executive 2000), to assess capacity 
the researcher should assess whether an individual can: 
• Understand in simple language what is involved in the research study, its purpose and 
nature and why it is being proposed  
• Understand any principle benefits, risks and alternatives 
• Understand in broad terms what will be the consequences of taking part in the 
research 
• Retain the information long enough to use it and weigh it in the balance in order to 
arrive at a decision  
• Express their decision, consistently, on whether to participate in research.  
If an individual is assessed as having capacity to make an informed decision about 
participation in research, they are invited to choose whether they would like to 
participate- in which case they are invited to sign a consent form. In circumstances where 
an individual does not have capacity, the Adults with Incapacity (Scotland) Act, 2000 
(Scottish Executive 2000) allows provision for consent to be given by the individual’s 
nearest relative, or welfare guardian. The letters of invitation to potential participants, 
information sheets and consent forms are reproduced in appendix I and II. 
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3.4 Measures 
All participants were assessed using a standardised methodology to assess the needs of 
individual's, based on a biopsychosocial-developmental model of health. The methods 
used include: 
• Psychiatric examination- a detailed clinical history and mental state examination; 
with an emphasis on assessing change in a person’s experiences, and level of 
functioning, within the context of the individual’s development. To ensure the 
consistency, and comprehensiveness of the assessment, areas to be specifically 
enquired about, in all sub-sections of the history, are included in a written protocol 
used in every new assessment (further details are provided in table 3.3) 
• A checklist of psychopathology – the Present Psychiatric State – Learning Disabilities 
(PPS-LD: Cooper 1997) 
• A standardised measure of level of adaptive functioning – Vineland Adaptive 
Behaviour Scale – survey form (Sparrow et al. 1984). 
 
The standardised psychiatric examination schedule is based on accepted practice for 
taking a clinical history and mental state examination, with specified items to be assessed 
in each subsection, as outlined in table 3.3 below. Additional information on an 
individual’s development, health and functioning are sought from an informant, such as a 
family or paid carer. Relevant information on previous contact with health care services 
is summarised from case notes- often requested from statutory health care services, or 
institutions where individuals previously lived.  
 
Information from the psychiatric examination, and any relevant details from an informant 
history and case note review, is used to make a categorical diagnosis using the DC-LD 
(Royal College of Psychiatrists 2001), ICD-10 (World Health Organisation 1994) and 
DSM-IV-TR (American Psychiatric Association 2000). 
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3.4.1 Measures of psychopathology  
3.4.1.1 Psychiatric Present State- Learning Disabilities (PPS-LD) 
The Psychiatric Present State- Learning Disabilities examination (PPS-LD) was 
developed specifically for the identification of psychopathology experienced by adults 
with intellectual disabilities (Cooper 1997). The development of the PPS-LD was based 
upon the Schedules for Clinical Assessment in Neuropsychiatry (SCAN: World Health 
Organisation 1992). In comparison to SCAN, the PPS-LD uses language appropriate to 
the developmental level of persons with intellectual disabilities and includes items of 
psychopathology that are absent from the SCAN which commonly present in adults with 
intellectual disabilities. The PPS-LD is designed to identify a broad range of 
psychopathology, including symptoms relevant to anxiety disorders, obsessive-
compulsive disorders, affective disorders, cognitive impairment, and psychosis. In total 
there are 112 items on the instrument- 90 items on psychopathology, and 22 mental state 
items observed at the time of assessment.  
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Table 3.3: An outline of the standardised UCEDD psychiatric examination 
 
Subsection of history and examination Details 
History of presenting complaints Current psychopathology- form, duration and severity. Triggers and life events.  
Specifically assess whether any psychopathology suggestive of ADHD, ASD 
(reciprocal social interaction, social communication, repetitive & restricted 
repertoire of activities), and/ or problem behaviours are present. PPS-LD for the 
assessment of psychopathology 
Past psychiatric history Any episodes of mental disorders documented in case notes- symptomatology, 
diagnosis, treatment, and outcome. Dates of episodes of mental disorders. 
Past medical history Any physical disorders documented in case notes- symptomatology, diagnosis, 
treatment and outcome. Specifically assess whether epilepsy is present or not, and 
status of vision and hearing (and when last tested), mobility, hand use and 
continence. Relevant investigations and results. Make statement on risk of 
osteoporosis, GORD, nutrition/ weight status and mental disorders. 
Drug history Current medication- name, dose, administration and side effects. Include previous 
allergies or adverse events. 
Personal and developmental history Chronological account of all available history, noting the source. Any relevant 
developmental history. Cause of intellectual disabilities. Current Vineland 
Adaptive Behaviour Scales scoring  
Current social circumstances Describe current accommodation and level of support. Detail occupational/ 
leisure activities/ hobbies. Social network and contact with family and friends.   
Detail smoking, alcohol and drug intake. Professional supports e.g. detail current 
contact with intellectual disabilities health services. e.g. dietician, 
physiotherapist, community nurse etc. 
Family history Parents’ and siblings’ occupation, place of residence and health.  Note any family 
history of psychiatric illness, epilepsy or learning disabilities.  
Mental state examination Appearance and behaviour; speech; mood and affect; thought form- rate, 
associations and possession; thought content- overvalued ideas, delusions; 
perceptions – psychotic phenomena, illusions; cognition – attention, 
concentration, memory, interest; insight. List positive and relevant negative 
findings from PPS-LD 
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Psychiatrists with specialist training and experience of working with adults with 
intellectual disabilities are trained to use the PPS-LD. The PPS-LD can be completed 
with the individual with intellectual disabilities alone, with both the individual and a 
relevant informant, or with an informant alone. Prompts and appropriate questions 
relevant to each item of psychopathology are provided, with follow-up, clarifying 
questions available, to be used flexibly, depending on a respondent’s initial answer. All 
the items of psychopathology in the PPS-LD are rated by the psychiatrist. 
 
Psychopathology is rated based on an individual's functioning in the previous four weeks. 
The scoring system varies between items, with most rated on a binary scale (0=no, 2= 
yes). Three items of psychopathology (worry/ apprehension, tearfulness and reduced self 
care) are scored on a three point scale (0=no, 1=a bit, 2=yes).  Several questions on the 
PPS-LD rate several items of psychopathology together. For example, the question on 
sleep rates whether six forms of sleep disturbance are present (initial insomnia, mid-
insomnia, early morning wakening, increased sleep during the day, reversed sleep pattern 
and reduced need for sleep). Other questions that rate multiple items of psychopathology 
are on diurnal mood variation (no DMV, worse in evening, worse in morning), and the 
mental state item on affect (euthymic, irritable affect, depressed affect, euphoric affect).  
 
An item of psychopathology is scored positively, if it has been present in the past four 
weeks and associated with significant impairment. However, if on further questioning an 
interviewer determines that the item of psychopathology is long-standing, there is an 
option to rate the item as a trait characteristic (trait=7). Similarly, when an item of 
psychopathology is present, but is clearly a feature of an autism spectrum disorder a 
separate score can be recorded. For example, rituals as such as obsessional checking and 
repetitive behaviours could be rated positively (score = 2), or present as part of an autism 
spectrum disorder (score = 4).  
 
The rating of certain items of psychopathology is more dependent than others on an 
individual's level of communication, or intellectual disabilities. The clearest example of 
this is where an individual does not have any verbal communication, which makes it 
impossible to rate items that require some degree of self-report e.g. hopelessness, 
intrusive obsessional thoughts and terms of psychosis. For the purposes of completing the 
PPS-LD, if an individual does not use verbal communication at a level where they speak 
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in sentences, such items are not rated. Similarly, if for any reason the interviewer is 
unsure whether an item of psychopathology is present or not, this is indicated on the 
interview schedule and the reason written in long hand. Common reasons for this can be 
to do with an individual's level of intellectual disabilities, or an informant being unable to 
give a clear description due to a lack of knowledge of a particular aspect of an 
individual’s lifestyle e.g. sleep. 
 
Data collected using the PPS-LD was used in this thesis for the exploratory factor 
analysis to identify underlying dimensions of psychopathology experienced by adults 
with intellectual disabilities during episodes of mental disorders.  
 
3.4.1.2 DC-LD categorical diagnosis of mental disorder 
As part of the standardised method of assessment, a decision is made as to whether the 
psychopathology an individual has experienced meets the criteria for any diagnoses from 
one, or more, categorical diagnostic classification systems.  Since the publication of the 
DC-LD, a consensus process has been used to decide if an individual meets the criteria 
for diagnoses from DC-LD, ICD-10 and DSM-IV-TR. For the purposes of this thesis, the 
diagnoses from DC-LD are used, as the categorical model of psychopathology for 
comparison with the dimensional model of psychopathology. Details of DC-LD are in 
section 1.3.1.2. The DC-LD diagnoses for samples 2 and 3 are shown in table 3.4. 
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Table 3.4 DC-LD categorical diagnoses for samples 2 and 3. 
 
Sample 2 Sample 3 DC-LD mental disorders DC-LD diagnostic category Diagnostic 
code N % N % 
Unspecified dementia B1.1 3 2 1 2.5 
Dementia in Alzheimer’s disease, unspecified B1.2 1 0.67 0 0 
Dementia 
Vascular dementia, unspecified B1.3 1 0.67 0 0 
Schizophrenic/ delusional episode B3.1 5 3.33 2 5.0 
Schizoaffective episode B3.2 1 0.67 1 2.5 
Non-affective psychotic 
disorders 
Other non-affective psychotic episode B3.3 1 0.67 1 2.5 
Depressive episode B4.1 45 30.67 9 22.5 
BPAD1, current depressive episode  B4.1i 1 0.67 1 2.5 
BPAD, currently in remission B4.1ii 1 0.67 1 2.5 
Recurrent depressive disorder, currently in 
episode 
B4.1iii 6 4 2 5.0 
Depressive episode with psychotic symptoms B4.1xa 1 0.67 1 2.5 
Manic episode B4.2 1 0.67 0 0 
Affective disorders 
Bipolar affective disorder, current episode 
mixed 
B4.3i 1 0.67 2 5.0 
Agoraphobia B5.1 3 2 1 2.5 
Specific phobia B5.3 3 2 0 0 
Panic disorder B5.4 2 1.3 0 0 
Generalised anxiety disorder B5.5 4 2.7 2 5.0 
Obsessional compulsive disorder B5.8 2 1.2 1 2.5 
Adjustment disorder B5.10 4 2.7 0 0 
Neurotic & stress related 
disorders 
Post-traumatic stress disorder F43.1 † 1 0.67 0 0 
Eating disorder Pica B6.9 1 0.67 0 0 
Hyperkinetic disorders Attention-deficit hyperactivity disorder B7.1 5 3.33 1 2.5 
Physically aggressive behaviour D1.3 2 1.2 0 0 Problem behaviours 
Self-injurious behaviour D1.5 1 0.67 0 0 
Does not meet criteria for 
any categorical diagnosis  
N/A N/A 54 36.0 14 35.0 
1
 Bipolar Affective Disorder  † ICD-10 diagnostic code 
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3.4.2 Socio-clinical variables 
The socio-clinical variables in the analyses were chosen on the basis of the literature 
review of the associations of psychopathology and socio-clinical variables in section 1.7: 
• gender  
• age in years, at time 1 (the time of referral to specialist services) 
• living circumstances  
• level of intellectual disabilities 
• diagnosis of autism 
• Down syndrome 
• epilepsy 
• visual impairment 
• hearing impairment 
• mobility problems 
• urinary incontinence 
• bowel incontinence 
 
The variable describing an individual’s living circumstances was based on the 
accommodation where the person lived. The different geographical settings that sample 1 
and sample 2 lived in meant that the original categories used for data collection were not 
identical. Therefore, to allow comparison the categories were collapsed into three- lives 
independently with no support from paid carers; lives in own tenancy, or registered 
residential/ nursing home with support from paid carers; lives with parents or other  
family members. 
 
The variables epilepsy, visual impairment, hearing impairment, mobility problems, 
urinary incontinence and bowel incontinence are coded as part of the PPS-LD. For the 
epilepsy variable, seizures are categorized as well controlled if they occur at a frequency 
of once per month, or less and poorly controlled at a frequency of more than once a 
month. Since several cell counts were too low for the purposes of statistical analyses, the 
original categories in the PPS-LD for visual impairment, hearing impairment, mobility 
problems, urinary incontinence and bowel incontinence were collapsed to binary 
categories. This is shown in table 3.5.  
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Table 3.5: Transformation of variables for purposes of analyses 
 
 
Variable name PPS-LD category Collapsed  binary 
category 
Good 
Good with glasses 
Good 
Poor with glasses 
Poor 
 
 
Visual 
impairment 
Severe visual impairment 
 
Visual impairment 
Good 
Good with hearing aid 
Good 
Poor with hearing aid 
Poor 
 
Hearing 
impairment 
Severe hearing impairment 
 
Hearing impairment 
Full mobility Full mobility 
Independent but poor 
Uses stick or frame 
Uses a wheelchair only when 
outside 
Uses a wheelchair all the time 
 
 
 
Mobility 
problems 
Cannot weight bear/ immobile 
 
 
Mobility problems 
Continent Continent 
Occasional accidents 
Incontinent at night only 
 
Urinary 
continence 
Incontinent 
Incontinent 
Continent Continent 
Occasional accidents 
Incontinent at night only 
 
Bowel continence 
Incontinent 
Incontinent 
 
A diagnosis of autism which had previously made and recorded in the case notes was 
reviewed as part of the structured psychiatric assessment. In circumstances where an 
individual was believed to have autism by family or paid carers, or clinical services, but 
no formal record of the process and diagnosis was available a diagnostic assessment was 
carried out at the time of the original psychiatric assessment. 
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3.4.2.1 Level of intellectual disabilities- Vineland’s Adaptive Behaviour Scales 
The Vineland’s Adaptive Behaviour Scales are widely used as a measure of intellectual 
functioning, and adaptive behaviour. The instrument is completed with a carer, or other 
informant, and assesses a person’s level of abilities in three domains: 
• Communication  
• Daily Living Skills 
• Social Functioning. 
 
A standardised scoring system generates raw scores for each domain. Using tables 
derived from population normative data, age equivalent scores for each domain are 
calculated. These age equivalent scores are indicative of the level of intellectual 
disabilities as described in ICD-10: 
• 0- 3 years equivalent to profound intellectual disabilities 
• 3-6 years equivalent to severe intellectual disabilities 
• 6-9 years equivalent to moderate intellectual disabilities 
• 9-12 years equivalent to mild intellectual disabilities. 
 
 
3.4.3 Measures of severity and outcome 
It is suggested that severity and outcome measurement in mental disorders should involve 
the use a battery of measures, encompassing multiple domains (Jacobson et al. 1999; 
Slade 2002). Models of outcome measurement have been proposed for use in mental 
health for adults who do not have intellectual disabilities.  For example, a systematic 
review of the use of outcome measures, categorised them into seven domains- well being, 
cognition/ emotion, behaviour, physical health, interpersonal, society, services (Slade 
2002). Although studies involving participants with intellectual disabilities have used 
instruments relevant to these domains, outcome measures in general are less well 
established in the field of intellectual disabilities. Few studies have established the 
psychometric properties of instruments used to measure outcome, and in particular 
evidence is lacking on the sensitivity to change of measures used in mental ill health. 
 
In order to examine the research null hypotheses, measures were chosen that could be 
applied across all level of abilities, and diagnoses of mental disorders. 
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3.4.3.1 Health of the Nation Outcome Scales- Learning Disabilities (HONOS-LD) 
The Health of the Nation Outcome Scales (HoNOS) are a family of parallel instruments 
developed as a measure of outcome for use with individuals with mental disorders (Wing 
1998). Conceived as a simple scale to provide a structured measurement of outcome, the 
HoNOS scales encompass key aspects of mental health and social functioning. Unlike 
most outcome measures, HoNOS is designed to be used with individuals with mental 
disorders, regardless of the diagnosis and the original version has been used to measure 
outcome in research and routine clinical practice. The original generic scale has been 
shown to be reliable, valid and sensitive to change (Pirkis et al. 2005) and served as the 
basis for the development of versions of the HoNOS for use with children and 
adolescents (HoNOSCA), older people (HoNOS65+) and groups of individuals with 
different needs, such as adults with intellectual disabilities.  
 
The Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-
LD) was developed to take into account the specific needs of individuals with intellectual 
disabilities (Roy et al. 2002). HoNOS-LD has 22 items, which are rated on a five point 
scale (0= no problem, 1 = mild problem, 2 = moderate problem, 3 =severe problem, 4 = 
very severe problem). For each individual item, there is a specific descriptor for each 
rating on the five-point scale. The scores for each of the 22 items are added together to 
give a total (HoNOS-LD total, range = 0-44). In table 3.6 below, the names of the items 
included in HoNOS-LD are provided. 
 
The original work to develop HoNOS-LD suggested it had adequate reliability, and 
validity and sensitivity to change to be used as a measure of outcome (Roy et al. 2002). 
Subsequently, there have been relatively few published studies that have reported on its 
use in research, or clinical settings. A recent study reported that it is a more reliable and 
valid measure of outcome in adults with mild/borderline intellectual disabilities than the 
generic HoNOS (Tenneij et al. 2009). Significant between group differences in the 
HoNOS-LD total score (Dowling et al. 2006) were described in a randomised controlled 
trial of a bereavement intervention, confirming that it has adequate sensitivity to change. 
Finally, in a follow-up study to look at the effectiveness of a specialist intellectual 
disabilities clinical service, HoNOS-LD was shown to have good discriminant validity- 
between inpatient and community service users- and was sensitive to change over time 
(Hall et al. 2006).  
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3.4.3.2 Camberwell Assessment of Need- Intellectual Disabilities (CANDID) 
The measurement of the needs of individuals with mental disorders is well established, 
with several available instruments and a significant theoretical and research evidence 
base.  
 
A commonly used instrument to measure needs is the Camberwell Assessment of Need 
(CAN), which has been shown to have good reliability and validity (Phelan et al 1995). 
Needs measured using the CAN have been shown to be associated with quality of life 
(Slade et al. 1999; Slade et al. 2004) and has been used to examine the utility of 
dimensions of psychopathology (van Os et al. 1999a). Similar to the HoNOS, the CAN 
has been used to develop a family of instruments for use across different clinical groups.  
 
For the purpose of measuring need in adults with intellectual disabilities and mental 
disorders, the Camberwell Assessment of Need for Adults with Developmental and 
Intellectual Disabilities (CANDID; Xenitidis et al. 2000) was developed by modifying 
the CAN (Phelan et al. 1995). Like all versions of the CAN, there is a short (CANDID-S) 
and a research version of the CANDID (CANDID-R). The description below refers to the 
CANDID-R which was the version used in the study described in this thesis. The 
CANDID-R measures need across 25 domains (see table 3.6), in keeping with a 
biopsychosocial model of health. The timescale used to rate the CANIDID-R is the four 
weeks prior to the interview and participants are asked to rate whether a need is present, 
and if so whether it is currently met or unmet  Only if a need is present are the other three 
sections of CANDID-R completed-section 2 rates how much help the person receives 
from friends or relatives with the need; section 3 rates how much help the person receives 
from local services; section 4 rates whether the person is receiving the right type of help, 
and their satisfaction with the amount of help they receive). For rating need in the 25 
domains, there are four possible scores: 
• no need (score=0) 
• met need (score=1) 
• unmet need (score=2) 
• unknown (score=9). 
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The ratings for each domain are combined to give three summary variables- total number 
of unmet needs,  total number of met needs,  total number of needs (calculated by adding 
together the number of met and unmet needs). In conceptualising results from the 
CANDID-R as a measure of outcome it is worth noting that a lower number of unmet 
needs, and higher number of met needs are considered indicative of a better outcome. 
 
It is standard practice to report all three summary variables, as will be done for 
descriptive statistics in the results in chapter 4. Since the total needs variable is a 
composite of the unmet and met needs variable, including it in statistical analyses would 
contravene best practice guidance on avoiding the use of data more than once in analyses. 
Therefore, the total needs variable was not included in bivariate and multivariate to 
answer the research hypotheses. 
 
CANDID been shown to be a reliable and valid measure of met, and unmet health needs 
in adults with intellectual disabilities (Xenitidis et al. 2000). CANDID-S has been used in 
several studies since its publication and found to be a valid measure of need (Strydom et 
al. 2005; Hall et al. 2006), have discriminant validity (Hall et al. 2006) and be sensitive 
to change over time (Hall et al. 2006). 
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Table 3.6: Individual items rated on the HONOS-LD and CANDID 
 
 
HoNOS-LD items  CANDID items 
1. Behaviour problems- directed to others 1. Accommodation 
2. Behaviour problems- directed to self 2. Food 
3a. Behaviour destructive to property 3. Looking after the home 
3b. Problems with personal behaviours 4. Self-care 
3c. Stereotyped and ritualistic behaviours 5. Daytime activities 
3d. Anxiety, phobias, obsessive compulsive behaviour 6. General physical health 
3e. Other problem behaviours 7. Eyesight/ hearing 
4. Attention and concentration 8. Mobility 
5. Memory and orientation 9. Seizures 
6. Communication (problems in understanding) 10. Major mental health problems 
7. Communication (problems in expression) 11. Other mental health problems 
8. Problems with hallucinations and delusions 12. Information 
9. Problems with mood changes 13. Exploitation risk 
10. Problems with sleeping 14. Safety to self 
11. Problems with eating and drinking 15. Safety to others 
12. Physical problems 16. Inappropriate behaviour 
13. Seizures 17. Substance misuse 
14. Activities of daily living at home 18. Communication 
15. Activities of daily living outside the home 19. Social relationships 
16. Level of self-care 20. Sexual expression 
17. Problems with relationships 21. Caring for someone else 
18. Occupation and activities 22. Basic education 
23. Transport 
24. Money budgeting 
 
25. Welfare benefits 
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3.4.3.3 Global Assessment of Functioning (GAF) 
In keeping with recommendations to include a global measure of functioning in multi- 
dimensional batteries of outcome measures, the GAF (American Psychiatric Association 
2000) was used. It was completed based on case note data for all participants from 
sample two, and completed a second time for individuals, from sample two, who 
participated in the follow-up, research interview.  
 
GAF provides a single measure of social, occupational and psychological functioning in 
adults, on a continuous scale ranging from 1-100, with 100 representing the best possible 
functioning. The 100 point scale is divided into 10 subsections, each one covering 10 
points on the scale e.g. 1-10, 11-20 etc. Each subsection has written symptom and 
behavioural descriptors.  
 
The instructions for completing the GAF in DSM-IV TR were followed, rating the week 
prior to the interview date. Starting at the top subsection (100-91) the person scoring the 
GAF considers, “ is either the individuals symptom severity OR level of functioning 
worse than indicated in the range description?”. If so, the person scoring the GAF moves 
down the scale until the subsection with descriptors that best matches the individual’s 
symptom severity OR level of functioning is reached, whichever is worse. The person 
then double checks that the correct subsection has been selected, the lower subsection has 
examined to ensure that the descriptors are too severe on both symptom severity and 
length of functioning. To determine the specific GAF rating within the 10- point range, 
the person scoring the GAF consider whether the individual is functioning at the higher 
or lower end of the 10 point range, and selects an appropriate score. 
 
There is a little available data on the psychometric properties of the GAF from studies 
including adults with intellectual disabilities as participants. One study examined the 
inter-rater reliability of GAF scores rated by 19 health professionals, some of whom did 
not work with persons with intellectual disabilities. Participants rated case vignettes 
describing psychopathology experienced by adults with intellectual disabilities on the 
caseloads of psychiatrists. The participants received training to use the GAF as indicated 
in DSM-III-R (Oliver et al. 2003). Overall inter-rater reliability was fair (r= .49), and the 
authors concluded that the GAF was unreliable for use in intellectual disabilities, if used 
as described in DSM-III-R. 
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A second study used the GAF as one of several measures of the severity and outcome of 
mental disorders in adults with intellectual disabilities (Hall et al. 2006). Two groups of 
service users were included in the study- inpatients (n= 19) and outpatients (n= 18) 
receiving care from specialist, community intellectual disabilities services. Other 
measures used at baseline and follow-up at six months were the HoNOS-LD, CANDID-S 
and the Threshold Assessment Grid (TAG, Slade et al. 2000). The TAG is a method of 
assessing clinical risk developed for use with adults who do not have intellectual 
disabilities. All ratings were completed by unblinded intellectual disabilities psychiatrists, 
who rated the standard scoring method for the GAF. Although the two groups differed on 
the HoNOS-LD (t= -2.068, p= .046), CANDID-S unmet needs (U=72.5, p= .040) and 
TAG (t=-4.038, p<.001) at baseline, there was no between group difference in the GAF 
scores (t=1.424, p=.163). Whilst the GAF had poor discriminant validity between 
inpatient and community service users, it had similar sensitivity to change to the HoNOS-
LD, CANDID-S and TAG- in both groups (Hall et al. 2006). 
 
The issues with the inter-rater-reliability and discriminant validity of the GAF in these 
studies is likely to be due to the use of the standard method of scoring (Oliver et al. 2003; 
Hall et al. 2006). A problem arises when scoring the GAF for individuals with 
intellectual disabilities because the impact of a person’s intellectual disabilities on  level 
of functioning, could give an artificially low score (Hurley, 2001; Shedlack et al. 2005; 
Hurley et al. 2007). To take account of this, the GAF was rated in this thesis using an 
adapted methodology (Hurley, 2001). Similar to the recommended scoring system for 
persons with physical disabilities, the impact on functioning of impairments due to 
intellectual disabilities is excluded from the GAF rating. The rating is based solely on 
symptoms and level of functioning where there has been a clear change in functioning 
related to the onset of psychopathology, associated with an episode of a mental disorder.  
 
3.4.3.4 Clinical Global Impression (CGI) 
Given the limited evidence on the use of the GAF in studies with adults with intellectual 
disabilities as participants, the CGI was rated as a second global measure of functioning, 
at the same time as the GAF. 
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The CGI scales are designed to be completed by a clinician. Only the CGI scale that rates 
severity of illness was used for the study. The most severe level of illness over the past 
week was rated, on a seven point scale: 
1. normal, not ill at all 
2. borderline mentally ill 
3. mildly ill 
4. moderately ill 
5. markedly ill 
6. severely ill 
7. among the most severely ill. 
 
The CGI has been shown to be reliable in studies that include adults who do not have 
intellectual disabilities as participants (Dahlke et al. 1992; Zaider et al. 2003). However, 
although the CGI has been used in adults with mental disorders and intellectual 
disabilities (Van den Borre et al. 1993; McDougle et al. 1998) no studies have previously 
examined the psychometric properties of the CGI when used in intellectual disabilities 
research.  
 
3.4.3.5 Calculating the scores for the measures of longitudinal outcome 
Cross-sectional scores at time 1 for the five measures were used as the measure of the 
severity of mental disorders. For individuals in sample 2, who participated in the follow-
up study, the longitudinal measures of outcome used in the analyses were based on the 
change in the measures of severity between time 1 and time 2. For each measure, this was 
calculated by subtracting the score on the measure of outcome at time 2 (follow up) from 
the score at time 1 (baseline). 
 
The scoring format of the GAF differs from the other four measures. A higher score on 
the GAF represents a lower severity, whereas for the HoNOS-LD, CGI and CANDID-R a 
higher score represents a greater severity. Therefore, to facilitate comparison across the 
five measures the polarity of the GAF score representing longitudinal outcome was 
reversed. 
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Therefore, for all measures: 
• a negative score represents a poorer outcome than a positive score i.e. the score on the 
measure at time 2 is greater than at time 1 
• a higher positive score represents a better longitudinal outcome than a lower positive 
score 
• a higher negative score represents a poorer longitudinal outcome than a lower 
negative score.  
 
Table 3.7 provides details of the methods of assessment used to collect data from the 
three samples, organised in the domains of psychopathology, level of functioning and the 
severity of mental disorders. 
 
Table 3.7: Methods of assessment used to collect data from samples 1, 2 and 3 
 
 
 Domain and method of assessment  
Sample Psychopathology Level of functioning Severity 
Sample 1 Standardised psychiatric 
examination 
PPS-LD 
Vineland’s Adapative 
Behaviour Scales 
N/A 
Sample 2 Standardised psychiatric 
examination 
PPS-LD 
 
Vineland’s Adapative 
Behaviour Scales 
HoNOS-LD 
GAF 
CGI 
CANDID-R 
Sample 3 Standardised psychiatric 
examination 
PPS-LD 
Vineland’s Adapative 
Behaviour Scales 
HoNOS-LD 
GAF 
CGI 
CANDID-R 
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3.5 Statistics and analysis of data 
Quantitative data relevant to the work reported in this thesis was first entered into SPSS 
version 15.0. However, since the data from the PPS-LD for use in the EFA is binary 
appropriate methods of factor analysis were used, using TESTFACT 4 software 
(Woods et al. 2003). 
 
A general description of statistical methods used to test multiple null research 
hypotheses is given followed by any methods specific to each null hypothesis. 
 
3.5.1 Methods to assess whether variables are distributed normally 
Parametric statistical tests are preferred in any analysis, since they are more reliable and 
powerful than non-parametric tests. A key assumption in the use of parametric tests is 
that the variables used in the analysis are normally distributed. Therefore, to decide on 
the use of parametric or non-parametric tests, the distribution of the continuous 
measures of psychopathology, age and measures of severity and outcome was explored 
using a histogram and normal distribution plot.  Statistical tests of the skewness, 
kurtosis and difference of the distribution from normality were also calculated. 
 
The histogram and normal distribution plot allowed a visual comparison of the 
distribution of the variable of interest against the normal distribution. In the histograms, 
a line representing the normal distribution is superimposed on the histogram. A variable 
with a normal distribution will be represented by a straight diagonal line in a normal 
probability plot. Superimposing a straight line on the normal probability plot allows 
visual inspection of how similar the distribution of a variable is to the normal 
distribution.  
 
Skewness refers to the symmetry of the distribution. A normally distributed variable is 
symmetrically distributed around the mean and has a skewness score of zero. If a 
variable has a frequency distribution clustered around the lower values, and a longer 
tail moving towards the higher values then it has a positive skew, and the skewness 
score will be greater than zero. Alternatively, higher frequencies of the higher values 
and a longer tail towards the lower values is a negative skew and the skewness score is 
less than zero.  
 
 102 
Kurtosis refers to the peakedness of a distribution. Whereas the normal distribution 
follows the shape of a bell, variables with high frequencies of values in the tails on 
either side of the mean, have a flat distribution and a negative kurtosis score- described 
as a platykurtic distribution. If there is a higher frequency of values clustering close to 
the mean the variable will have a pointed distribution and a positive kurtosis score- 
described as a leptokurtic distribution. 
 
To obtain a standardised measure of skewness and kurtosis, the z-scores are calculated, 
by dividing the original scores by the standard error of the respective score. If the z-
score is greater than 1.96 the skewness or kurtosis of the distribution differs from the 
normal distribution at a level of significance of p < .05, with the significance level 
increasing to p < .01 if the z-score is greater than 2.58 and p < .001 above z-scores of 
3.58. 
 
As well as the skewness and kurtosis z-scores, there are two tests available that 
examine whether the overall distribution differs significantly from normality- the 
Kolmogorov-Smirnov and Shapiro-Wilk test. Since the Shapiro-Wilk test is more 
reliable, particularly when used with samples greater than 30, only it was used in the 
analyses. The closer the Shapiro-Wilk test score is to 1, the closer the distribution is to 
a normal distribution, and p values represent the significance of any difference from 
normality. 
 
Where the graphical and statistical methods suggest the distribution of a variable differs 
significantly from normality, data transformations were carried out in an attempt to 
move the distribution closer to normality. These transformations are of particular 
relevance when the distribution of a variable differs from the normal distribution due to 
skewness, rather than kurtosis. Three data transformations for positively skewed data 
are taking the square root (√ X), the logarithm (log10 X) and the inverse of the variable 
(1/X). Since these have an increasing hierarchical effect on positively skewed data they 
were used sequentially. The square root transformation was tried first and the graphical 
and statistical methods described above were then repeated to test whether the 
distribution was now closer to normality. If there was still a significant difference from 
normality, the logarithmic transformation and, if needed, the inverse transformations 
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were tested using similar methods. The least transformation which moves the 
distribution of the variable closer to normality was used.   
 
There are problems with the use of square root, logarithmic and inverse transformations 
with variables with negative values, zeros or many scores between zero and one. This is 
an issue that is relevant to all the variables but particularly the dimension factor scores, 
which include negative values. To take account of this, prior to any transformation a 
constant was added to each individual variable to anchor them all at a minimum score 
of one. For the dimension symptom counts and overall measures of psychopathology, 
one was added to each variable score so that the minimum score of each variable is one. 
Since the dimension factor scores have negative values a different method of 
calculating the constant was needed. First the minimum value for the dimension factor 
score was identified. This minimum value was converted to a positive integer and the 
constant calculated by adding one. For example, for a dimension with a minimum score 
factor score of – 1.92, the constant is calculated as 1.92 + 1 and added to the original 
score for each case.  
 
These methods were used to examine the distribution of measures of psychopathology, 
age and measures of severity and outcome, prior to their use in bivariate and 
multivariate analyses.  
 
3.5.2 Methods to test null research hypothesis one 
 
Data on psychopathology from the PPS-LD was used to examine null hypothesis one, 
rather than data collected using the standardised psychiatric examination. 
 
Psychopathology data collected using the PPS-LD has improved reliability compared to 
psychopathology data collected using the standardised psychiatric examination. The 
Null hypothesis one: 
There are no stable, identifiable dimensions of psychopathology experienced by 
adults with intellectual disabilities. 
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reliability of the PPS-LD is maximised by the structured format, use of language and 
prompts appropriate to the level of functioning of adults with intellectual disabilities and 
the consistent description of criteria which are required to be met for the item of 
psychopathology to be rated positively.  
 
Further contributions to the reliability of the use of the PPS-LD come from training on 
the use of the PPS-LD. All intellectual disabilities psychiatrists involved in data 
collection received training on the use of the PPS-LD, including shadowing a senior 
intellectual disabilities psychiatrist to observe the use of the PPS-LD, and completing the 
PPS-LD in parallel with the senior intellectual disabilities psychiatrist to check the inter-
reliability reliability of the ratings of psychopathology. 
 
3.5.2.1 Exploratory factor analysis to identify dimensions of psychopathology 
To examine the dimensions of psychopathology experienced by adults with intellectual 
disabilities an exploratory factor analysis (EFA) was carried out on data gathered using 
the PPS-LD. Factor analysis is a commonly used statistical method that examines the 
correlations between variables, in order to identify variables that cluster together and 
define latent dimensions underlying a dataset. A model is created with a number of 
common factors, with variables clustering together and loading onto specific common 
factors and not others. Like any statistical analysis, the reliability of the factor analysis is 
dependant on the quality of the available data. Furthermore, there are some key decisions 
for the researcher to make, depending on the data and aims of the analysis. For the 
purposes of this EFA published “best practice” guidelines were followed (Costello & 
Osborne 2005) for: 
• the sample size and case: variable ratio 
• the statistical method used for factor extraction– common factor analysis 
• method to decide on number of factors retained for rotation after factor extraction- 
scree test 
• method of rotation- oblique 
• minimum accepted item loading to a factor to ensure factor reliability= 0.32  
• minimum number of items loading onto a factor to ensure factor stability= 3. 
 
Expanded details of these aspects of the EFA are given in separate sections below.  
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3.5.2.2 Sample size required for exploratory factor analysis 
General guidelines on the sample size required to generate a stable factor solution from 
EFA suggest that the ratio of cases to variables should be at least 5:1 (Costello & 
Osborne 2005), with a total sample size of 300 (Tabachnik & Fidell 2001). To achieve 
these two requirements, PPS-LD data from sample 1 (n=274) and sample 2 (n=150) was 
merged to give a sample size of 424. Since the EFA examines associations between 
variables, cases that only scored positively for one or less items of psychopathology (n= 
84) were excluded leaving 340 cases for the EFA, with a case: variable of 8:1 (outlined in 
figure 3.2). 
 
3.5.2.3 Items of psychopathology included in the EFA 
All items on the PPS-LD were converted to a binary score (0=not present, 2=present). 
For the three items scored on a three point scale (worry/ apprehension, tearfulness, 
reduced self care), where an individual scored positively, regardless of the extent (1=a 
bit, 2=yes) the item was scored as present. Since this thesis is focussed on 
psychopathology experienced as part of an episode of mental disorders, where an item 
was rated as present as a trait/ characteristic (trait=7) this was converted to a score of not 
present. 
 
For the two PPS-LD questions that rate multiple items of psychopathology (sleep 
problems and diurnal mood variation) separate variables were created: 
1. Original question- sleep problems  
• initial insomnia (0=not present, 2=present) 
• mid-insomnia (0=not present, 2=present) 
• early morning wakening (0=not present, 2=present) 
• increased sleep during the day (0=not present, 2=present) 
• reversed sleep pattern (0=not present, 2=present) 
• reduced need for sleep (0=not present, 2=present) 
2. Original question- diurnal variation in mood 
• mood worse in evening (0=not present, 2=present) 
• mood worse in morning (0=not present, 2=present) 
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3.5.2.4 Selection of items of psychopathology for entry into the EFA 
To maximise the stability of the solution extracted via the EFA careful consideration was 
given to which items from the PPS-LD to include in the EFA. Only items from the PPS-
LD directly related to the presence of a specific item of psychopathology were considered 
for inclusion in the EFA. Figure 3.2 outlines the process used to decide which of the PPS-
LD items were used for the EFA. 
 
Since the mental state items and items of psychopathology are fundamentally different, it 
was decided to exclude the 22 items of the examination from the EFA. These mental state 
items are rated by the clinician rating the PPS-LD based on observation during the 
clinical interview. In contrast, the items of psychopathology are rated based upon the 
description by participants and carers of the person’s mood, behaviour and functioning 
over the past four weeks. Exclusion of the mental state items left 90 items of 
psychopathology for possible inclusion in the EFA. 
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Figure 3.2: Flowchart of selection of PPS-LD items for inclusion in exploratory factor 
analysis  
 
 
Does PPS-LD item relate directly to psychopathology 
over past 4 weeks  
Is the item of psychopathology scored positively in 
at least 5% of the sample? 
No 
N= 14 
Yes  
N= 41 
Is rating of the item dependant on the participant 
communicating verbally in sentences? 
No 
N= 55 
Yes 
N= 11 
EFA including items of psychopathology able to 
be rated for entire sample  
 
Number of items = 41 
Number of cases = 330 
Case: item ratio = 8:1 
Total PPS-LD items (excluding MSE items) 
N= 90 
Yes (Table 8) 
N= 66 
No- exclusion of items 
rating onset, duration and 
previous psychopathology 
N= 24 
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Twenty four items relating to the presence of physical health problems, previous episodes 
of mental disorders, onset of symptoms and previous response to treatment were 
excluded, leaving a total number of 66 PPS-LD items shown in table 3.5.  
 
There are 11 items in the PPS-LD which are highly dependant on verbal communication, 
and recommended not to be rated unless an individual uses sentences to communicate. A 
significant number of individuals in sample 1 and sample 2 were unable to self-report on 
these items of psychopathology. Therefore, as indicated in table 3.7, these items were 
excluded from the exploratory factor analysis.  
 
The reliability of a factor solution can be affected by the inclusion of items that score 
positively infrequently (low variance), or where two or more items are strongly correlated 
(correlation coefficient > 0.9 = high collinearity). To screen for this the frequency of 
occurrence of, and correlation between, individual items were examined. 
 
There were 14 items of psychopathology from the PPS-LD which scored positively in 
less than 5% of cases, and were excluded from the EFA (see table 3.7). Since there were 
no items with correlations > 0.9, no items met the criteria for high collinearity. Therefore, 
a total of 41 items of psychopathology from the PPS-LD were retained for inclusion in 
the EFA, highlighted in bold in table 3.7.  
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Table 3.8: Items of psychopathology in the PPS-LD  
 
 
 I. Worry, anxiety and phobias 34 Loss of financial skills * 
1 Worrying 35 Word finding problems * 
2 Generalised anxiety 36 Change in personality 
3 Agoraphobia 37 Loss of energy 
4 Social phobia * 38 Increased energy levels 
5 Animal phobia  V. Sleep, appetite, & concentration 
6 Specific phobia 39 Initial insomnia 
7 Increased need for reassurance 40 Mid-insomnia 
8 Increased somatic complaints  41 Early morning wakening 
 II. Obsessional phenomena 42 Increased daytime sleeping 
9 Rituals 43 Reversed sleep pattern * 
10 Excessive orderliness 44 Reduced need for sleep * 
11 Obsessional cleanliness * 45 Loss of appetite 
12 Intrusive, distressing thoughts † 46 Increased appetite 
 III. Changes in mood 47 Weight loss 
13 Low mood 48 Increased weight 
14 Increased mood lability 49 Diurnal variation-worse in the 
morning 
15 Irritable mood 50 Diurnal variation-worse in the 
evening 
16 Social withdrawal 51 Less able to concentrate 
17 Anhedonia 52 Loss of interest in sex * 
18 Tearfulness  VI. Changes in behaviour 
19 Ideas of guilt † 53 Increased verbal aggression 
20 Preoccupied with morbid thoughts † 54 Reduced verbal aggression * 
21 Loss of self-esteem † 55 Increased physical aggression 
22 Loss of hope for the future † 56 Reduced physical aggression * 
23 Expansive mood * 57 Self harm/ self-injurious behaviour 
 IV. Functioning, activities & 
energy 
58 Inappropriate sexual behaviour/ 
libido 
24 Reduced quantity of speech 59 Reckless, irresponsible behaviour * 
25 Increased quantity of speech 60 Social disinhibition * 
26 Reduced self-care skills  VII. Psychosis 
27 Reduced cognitive functioning 61 Delusions † 
28 Forgetting names 62 Auditory hallucinations † 
29 Gets lost in familiar places 63 Visual hallucination † 
30 Reduced verbal comprehension 64 Schneider’s first rank symptoms † 
31 Memory problems 65 Impossible, bizarre delusions † 
32 Mixing up day and night * 66 Mood incongruous delusions † 
33 Loss of literary skills*   
 
* Items rated positively in less than 5% of cases 
† Items only rated if the individual communicates verbally in sentences. 
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3.5.2.5 Extraction of factors 
The two commonest methods of factor analysis used are common factor analysis (CFA) 
and principal components analysis (PCA). There are concerns over the use of these 
methods with categorical data, and several alternative statistical methods have been 
developed to take account of this, such as non-linear PCA, used in CATPCA in SPSS 
(Meulman et al. 2004), and item factor analysis, used in TESTFACT (Woods et al. 
2003). Item factor analysis and TESTFACT were used as these were more specifically 
developed for use with binary data, and have been used previously in EFA of 
psychopathology binary data (Allardyce et al. 2007a). 
 
A key decision for a researcher is the number of factors to extract. The first factor 
extracted comprises the combination of items accounting for the greatest amount of 
variance. Subsequent factors extracted account for gradually reducing amounts of 
variance (Field 2005a). Rather than accepting the maximum number of factors extracted, 
the majority of which account for a too small an amount of variance to be relevant, and 
are unstable, the researcher has to decide how many factors to extract for the final factor 
solution. Although there are no absolute rules on which to base this decision, some 
general guidance is available on how best to manually select the number of factors to 
extract. 
 
One method is to base the decision on the eigenvalues of extracted factors (reported for 
studies in table 1.2). The eigenvalue is the sum of the squared item loadings on a factor, 
and represents the total amount of variance accounted for by a factor.  To calculate the 
proportion of the total variance accounted for by a factor the eigenvalue of the factor is 
divided by the number of the variables in the factor analysis. For example, if there are 20 
variables in the dataset, an extracted factor with an eigenvalue of 1, accounts for 0.05, or 
5%, of the total variance.  Commonly, researchers take the decision to include all factors 
with an eigenvalues greater than one. However, recommended best-practice suggests that 
this is the least appropriate strategy (Costello & Osborne 2005). Research has suggested 
that there are some circumstances when extracting all factors with an eigenvalue greater 
than one is more likely to be accurate, such as when the number of variables is less than 
30. However, as long as the sample size is more than 200 the recommended method is to 
use the scree test (Field  2005a). 
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The scree test is carried out by plotting each eigenvalues (y-axis) against the relevant 
factor (x-axis). Such a scree plot has a typical shape (see figure 3.3 for an example), 
characterised by a steep line, representing the eigenvalues of the initial factors extracted, 
followed by a long tail of factors accounting for a smaller proportion of the total variance, 
with much smaller eigenvalues. The initial number of factors to extract is one less than 
the factor at which the break point in the scree plot occurs.  
 
In figure 3.3 below, the break point occurs at factor 4 and so the suggested starting point 
is the extraction of three factors. However, it is common practice to also carry out 
analyses extracting one more and one less factor than suggested by the scree plot. To 
decide on the final factor solution, interpretation of the three analyses is carried out to 
examine aspects relevant to factor stability- the number of items loading onto a factor, 
and the strength of the item loadings- and finally the practical relevance of the factor 
solutions. It can be seen from figure 3.3 that extracting factors with eigenvalues above 
one would suggest a six factor solution, and can, therefore, potentially produce a quite 
different factor solution.  
 
Figure 3.3: The use of eigenvalues in a scree plot to determine the number of 
factors to extract 
0
1
2
3
4
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Factor number
Eigenvalue
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3.5.2.6 The significance of item loadings on factors 
When a factor analysis is carried out, a loading for each item to the individual factors is 
calculated. The researcher decides which items are significant to the factor, usually by 
examining the size of the item loadings on the factor. A standard approach- again based 
on general guidance, rather than hard and fast rules- is to set a cut off for the minimum 
item loading accepted as significant.  
 
An item loading is the correlation of the item and the factors, and so the squared item 
loading represents the amount of an item’s total variance accounted for by the factor. 
The minimum item loading accepted as significant is usually taken as 0.32, since this 
translates to the factor accounting for 10% of the variance of the item (Field 2005a). A 
second approach links the statistical significance of an item loading to the sample size, 
with the recommendation that for a sample size of 200 a significant item loading is 
greater than 0.364, and for a sample size of 300 an item loading of 0.298 is significant. 
Since the sample size used in the EFA reported in chapter 3 is greater than 300, a 
minimum item loading of 0.32 will ensure greater stability of the factor solution.  
 
A second issue relevant to factor stability is the number of items with loadings above 
the accepted cut-off for significance- in this case, 0.32. The consensus is that factors 
with less than three items with significant loadings are unstable (Costello & Osborne 
2005). Hence, it was decided that only factors with three or more items, and with 
loadings greater than 0.32 would be retained in the final factor solution 
 
3.5.2.7 Rotation of factors  
Best practice suggests that rotation of initial factors should always be carried out to 
examine whether it produces a clear and more meaningful solution (Costello & 
Osborne 2005). 
 
In exploratory factor analysis, the initial solution extracts factors based on the relative 
size of their contribution to the total variance. This tends to lead to the extraction of one 
general factor accounting for a large part of the variance, and several additional factors 
making smaller, and smaller, contributions to the overall variance (Field 2005a). As 
part of this initial solution items can load onto several different factors- known as cross-
loading. By maximising the loading of individual items onto the factor they make the 
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biggest contribution to, rotation of the factors minimises the cross-loading of items 
across multiple factors and therefore, derives a factor solution that is more 
straightforward, and potentially easier to interpret (Field 2005a). 
 
A graphical representation of factor solutions helps to explain rotation of factors (Field 
2005a). Figure 3.4 below has a graphical representation of a factor analysis. Six items 
included in the factor analysis are represented in the figure by the letters a-f. A two 
factor solution is shown with factor I represented on the x axis and factor II on the y 
axis (adapted from Field 2005a). The loadings for individual items to the two factors 
can be derived by drawing a perpendicular line to factor I (x-axis) and factor II (y-axis). 
It is clear that there are two clusters of items a-c and d-f. For the unrotated factors, the 
axes are represented by the x and y axes, the axes for the orthogonal rotated factors by 
broken lines and the axes for the oblique rotated factors by bold lines.  
 
From the un-rotated solution, variables a-c have high loadings on factor I, and d-f have 
moderate loadings on both factors (cross-loading).  
 
There are two methods of rotation- orthogonal and oblique. The assumption for 
orthogonal rotation is that the factors are uncorrelated, and therefore the axes are held at 
90 degrees to one another. In an oblique rotation, the factors are allowed to correlate 
and so the axes are free floating (not always maintained at 90 degrees). The oblique 
rotation in figure 4 shows that when the axes are allowed to correlate, items can load 
together strongly to the most relevant factor. Following the oblique rotation the high 
loading of items a-c on factor I are maintained whilst maximising the loading of items 
d-f on factor II on which it has the greater loadings.  
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Figure 3.4:  Graphical representation of orthogonal and oblique rotations of a 
two factor solution 
 
 
-1
-0.9
-0.8
-0.7
-0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Factor I
Factor II
 
 
 
Since oblique rotation is recommended as best practice (Costello & Osborne 2005), and 
previous research highlighted the potential relevance of correlations between dimensions 
of psychopathology in defining higher order internalising and externalising dimensions, 
an oblique rotation using the PROMAX methodology used in the EFA.  
 
Orthogonal 
rotation factor II 
Oblique rotation 
factor II 
Orthogonal 
rotation factor I 
Oblique rotation 
factor I 
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3.5.2.8 Examining the stability of the factor solution 
To assess the stability of the factor solution the sample (n=330) was randomly split and 
the factor analysis repeated separately for the two random samples (Tabachnik & Fidell 
2001). To maintain the minimum case: item ratio of 5:1 each sample needed a minimum 
of 205 cases.  
 
SPSS was used to select a random sample of 205 cases from the 330 used in the EFA.  
The EFA extracting four factors was run for this first random sample. A second random 
sample of 205 cases was selected from the original 330 and the EFA run again. To 
compare the stability of the factor solution across the two halves, Pearson product 
moment correlations were done to compare the item loadings between the two factor 
solutions (Tabachnik & Fidell 2001).  
 
3.5.2.9 Calculation of measures representing dimensions of psychopathology 
The rotated factor solution was used to derive measures for each dimension of 
psychopathology, based on calculated factor scores.  A factor score is a composite 
measure representing the degree to which an individual scores positively on the items 
with high loadings onto a dimension (Hair et al. 1998a). For example, if an exploratory 
factor analysis extracts a dimension labelled depression, an individual’s factor score on 
the hypothetical depression dimension represents the extent to which they reported 
experiencing the items of psychopathology loading above the accepted cut-off on the 
dimension. Factor scores have been used in previous studies examining the relationship 
between dimensions of psychopathology, socio-clinical variables and outcome (Van Os 
et al. 1996; van Os et al 1999a; van Os et al 1999b; Dikeos et al. 2006; Prisciandaro & 
Roberts 2009). The regression method is used to calculate the dimension factor scores 
(Hair et al. 1998a). 
 
It is recommended that more than one method be used to derive measures representing 
the dimensions extracted from an EFA (Grice 2001). The second measures used here 
were the dimension symptom counts. These have been used for comparison with the 
dimension factor scores in previous studies of psychopathology (Van Os et al. 1996; van 
Os et al 1999a). Whereas dimension factor scores are a composite measure of all the 
items used in the EFA, the dimension symptom count are based solely on items shown to 
load significantly to the individual factors (Hair et al. 1998a). Using the example of a 
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hypothetical depressive dimension of psychopathology, whereas the dimension factor 
score includes a score representing the items with significant loadings to the factor, and 
the other items of psychopathology, the dimension symptom count only counts the 
number of the items with significant loadings that an individual scores positively for. 
Therefore, dimension symptom counts are more in keeping with a summated scale model 
(Hair et al. 1998a) to represent the dimension of psychopathology, and are used here as 
the coarse measure of the dimensions of psychopathology. The use of these different 
measures to represent dimensions of psychopathology in the statistical analyses, will 
allow consideration of the potential advantages and disadvantages of each scoring 
method. 
 
To further examine the utility of measures of the dimensions of psychopathology 
identified in the EFA, two overall measures of psychopathology relevant to the 
dimensions were also used in the analyses. The total dimension factor score and the total 
dimension symptom count for each participant were calculated by adding together the 
individual scores for the identified dimensions.  
 
A third overall measure of psychopathology, unrelated to the dimensional model of 
psychopathology was derived from the PPS-LD. The EFA PPS-LD symptom count- 41 is 
calculated for each participant by counting the number of items of psychopathology rated 
positively, from the 41 PPS-LD items of psychopathology included in the EFA. The 
inclusion of the three overall measures of psychopathology allow consideration of 
whether the dimensional model of psychopathology can be used to derive an overall 
measure of greater relevance than the simple EFA PPS-LD symptom count- 41. 
 
3.5.3 Methods to test null research hypothesis two 
 
Null hypothesis two: 
There are no significant correlations between the individual dimensions of 
psychopathology experienced by adults with intellectual disabilities. 
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3.5.3.1 Examining the correlations between individual dimensions of 
psychopathology 
Research on dimensional models of psychopathology experienced by children, 
adolescents and adults, who do not have intellectual disabilities, has identified higher 
order internalising and externalising dimensions (see section 1.5.1: Achenbach & 
Edelbrock 1978; Cantwell 1996; Slade & Watson 2006; Slade 2007). To examine 
whether the higher order dimensions are relevant to psychopathology experienced by 
adults with intellectual disabilities, the Pearson correlation coefficients for individual 
dimensions identified in the EFA are examined.  
 
3.5.4 Methods used to test null research hypotheses examining bivariate 
associations 
 
 
Where continuous measures are normally distributed, the Pearson correlations are 
used to examine bivariate correlations between variables. For variables which have a 
distribution significantly different from normality, non-parametric methods are used to 
calculate Spearman’s correlation coefficient.  
Null hypothesis three: 
There are no significant cross-sectional, bivariate relationships between 
dimensional measures of psychopathology and socio-clinical variables 
Null hypothesis five: 
There are no significant bivariate relationships between dimensional measures  
of psychopathology and measures of the severity of mental disorders: 
Null hypothesis six: 
There are no significant bivariate relationships between socio-clinical variables  
and measures of the severity of mental disorders. 
Null hypothesis nine: 
Dimensional measures of psychopathology are not significantly correlated to  
the longitudinal outcome of mental disorders. 
Null hypothesis ten: 
Socio-clinical measures are not significantly associated with the longitudinal 
outcome of mental disorders. 
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For the binary categorical variables (gender, diagnosis of autism, Down syndrome, 
visual impairment, hearing impairment, urinary incontinence, bowel incontinence and 
mobility problems) Student t-tests were used to examine whether there are significant 
between group differences in continuous variables with a normal distribution.  The 
Mann-Whitney test was used to examine between group differences in continuous 
variables with distributions significantly different from normality. 
 
For the categorical variables with more than two groups (level of intellectual 
disabilities and epilepsy), analysis of variance (ANOVA) is used to test whether there 
is a significant difference in the means of continuous variables with a normal 
distribution. Where there is a significant between group difference on the ANOVA, 
post-hoc Bonferroni comparison tests are used to examine which pairwise group 
differences are significant. For variables that do not have a normal distribution, the χ² 
from the Kruskall-Wallis test is used as the non-parametric equivalent to the ANOVA. 
Post-hoc Mann-Whitney tests are used to examine individual between group 
differences. 
 
The parametric Student t-test and ANOVA are based on the assumption that there is 
homogeneity of variance in the data. Levene’s test for equality of variances is used to 
examine if there is homogeneity of variance in data used in the Student t-test and 
ANOVA. If the result from the Levene’s test is significant (p < .05) the results 
reported are for equal variances not assumed. In the case of ANOVA the Welch F 
statistic is reported if Levene’s test indicates that the assumption of homogeneity of 
variance is violated. 
 
For all bivariate analyses, associations with a significance value of p < .05 are 
highlighted in the results tables. However, to take account of multiple testing, inflating 
the risk of a Type I error, a Bonferroni correction was used to adjust the level of 
significance according to the number of groups, by dividing the accepted level of 
significance for single tests (p < .05) by the number of comparisons (one less than the 
number of groups). Each categorical group is used as the index variable against which 
the other categorical groups are compared in the post-hoc tests i.e. mild intellectual 
disabilities was used as the index variable against which moderate, severe and 
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profound intellectual disabilities are compared- then repeated with the moderate 
intellectual disabilities group as the index variable. Thus, the number of comparisons 
for each of the four groups defining the level of intellectual disabilities variable is 
three (mild-moderate, mild-severe, mild-profound etc). Therefore, the accepted level 
of significance is p < .0167 (.05/3). The accepted level of significance for the epilepsy 
variable- defined with three groups and therefore requiring two comparisons against 
each index categorical group (no epilepsy- well controlled seizures, no epilepsy- 
poorly controlled seizures) is p < .025. 
 
3.5.5 Methods used to test null research hypotheses examining multivariate 
associations 
 
Null hypothesis four: 
There are no significant cross-sectional, multivariate relationships between 
measures of psychopathology and socio-clinical variables. 
Null hypothesis seven: 
There are no significant multivariate associations between dimensional measures 
of psychopathology, socio-clinical variables and measures of the severity of 
mental disorders. 
Null hypothesis eight: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with measures of the severity of mental 
disorders  
Null hypothesis eleven: 
Dimensional measures of psychopathology, and socio-clinical variables at 
baseline, are not independently associated with the longitudinal outcome of 
mental disorders. 
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with the longitudinal outcome of mental 
disorders. 
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Since the dependent variables of interest are continuous variables (measures of 
psychopathology, severity and outcome) linear regressions were used to explore the 
independent relationships with the measures of psychopathology and socio-clinical 
variables. Given the exploratory nature of the analyses, measures of psychopathology 
and socio-clinical variables associated with the measures of outcome at a significance 
of p < .1 were included in the linear regression analyses. 
 
Stepwise backward linear regression was used for all analyses. At each step of the 
analysis, the independent variable with the lowest correlation to the dependant 
variable is removed. However, a removal criterion was set in order that only those 
variables with of p<.05 were retained within the final model. 
 
To include categorical variables in linear regression analysis dummy variables were 
used for any variables with more than two groups, such as the variables living 
circumstances, level of intellectual disabilities and epilepsy. All other categorical 
variables with two groups are already coded as binary measures and can be used in 
linear regression. 
 
The number of dummy variables required is one less than the number of groups in the 
original variable. In the case of level of intellectual disabilities there are four groups 
(mild, moderate, severe and profound) so three dummy variables are required. These 
dummy variables are established against mild intellectual disabilities as the baseline 
variable, such that this group are recoded as 0 in all the dummy variables. Each other 
group is coded as 1 only once, for the dummy variable with the same name.   
 
To examine if the assumption of homoscedasticity for linear regression is met, and 
check for cases which are outliers, plots of the residuals were examined for all the 
final regression models (Field 2005). Residuals are the values representing the 
difference between the value predicted by the regression model and the value observed 
in the sample. Therefore, the closer the regression model fits the data the closer to zero 
the residuals are. 
 
To allow comparison of residuals across regression models that use different variables 
in the analyses, standardised residuals are calculated. This is achieved by converting 
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the residuals into z-scores, calculated by taking each residual value, subtracting the 
mean of all the residuals, and dividing by the standard deviation of all the residuals, 
This converts the residuals to a known distribution, with a mean of zero and a standard 
distribution of one. By calculating standardised residuals across regression models, 
rules based on the normal distribution can be set as to what constitutes an acceptable 
standardised residual (Field 2005b): 
• standardised residuals greater than 3.29 are highly likely to be outliers 
• if more than 1% of the sample have standardised residuals greater than 2.58 the 
level of error in the model is unacceptable 
• if more than 5% of the sample have standardised residuals greater than 1.96 the 
regression model is a poor representation of the data. 
 
In all cases plots of the standardised residuals against the standardised predicted 
values were made, examining the data points against the criteria above, and looking 
for evidence of heteroscedasticity on the basis that there unequal variance across the 
range of the standardised predicted values. In order to assist in the process of 
identifying outliers with standardised residuals greater than 1.96, case-wise 
diagnostics reporting the observed value, predicted value, residual and standardised 
residual are reported for all cases. 
 
To test for strong correlations between significant predictors in the regression models 
(multicollinearity) the variance inflation factor (VIF) for each significant dependant 
variable is calculated. These are compared against the guidelines that suggest a VIF 
above 10 is indicative of significant multicollinearity (Field 2005b), and an average 
VIF for the dependant variables retained in the model greater than 1 is suggestive that 
multicollinearity is influencing the results of the regression. 
 
For the final regression models, four test statistics are reported for each independent 
variable retained in the model: 
• unstandardised coefficient (B) 
• standard error of B 
• standardised coefficient (β) 
• significance (p). 
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For multiple linear regression, these statistics represent the effect of the independent 
variable on the dependent variable when the effects of all other variables are 
controlled for (Hair et al. 1998b). The unstandardised and standardised coefficients 
provide a measure of the extent to which a change in the independent variable affects 
the dependent variable (Hair et al. 1998b). The unstandardised coefficient represents 
the change in the dependant variable if the independent variable changes by a single 
unit. Since the standardised coefficients are comparable across variables, regardless of 
the unit of measurement, they are perhaps of greater relevance for regression models 
with multiple variables, as used here. The standardised coefficient is the number of 
standard deviations the independent variable increases by if the dependent variable 
changes by a single standard deviation (Hair et al. 1998b).  
 
An overall statistic (R²) is provided for each regression model to represent how well 
the model represents the data. The R² statistic is a measure of the proportion of the 
overall variance in the dependent variable explained by the final regression model. It 
can be converted to a percentage such that if R²= .50 then the model explains 50% of 
the variance in the dependent variable (Hair et al. 1998b). 
 
3.5.5.1 Regression analyses using the measures of longitudinal outcome as the 
dependent variable 
There is a recognized need to consider the potential influence on a measure of 
longitudinal outcome, calculated as a change score over time, of the baseline score on 
the measure at time 1 (Lord 1967).  Since the baseline score and the longitudinal 
change score can be correlated, various methods of adjusting for the baseline value are 
described (Wainer 1991).  
 
In this thesis, the regression analyses that used longitudinal change scores as the 
dependant variable were adjusted for the baseline score on the measure. This approach 
adopted is in keeping with previous studies examining the associations of dimensional 
and categorical models of psychopathology with longitudinal outcome (van Os et al. 
1996; Dikeos et al. 2006). 
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3.5.6 Methods used to test null research hypotheses comparing dimensional and 
categorical models of psychopathology 
 
A binary variable representing a categorical model of psychopathology was derived on 
the basis of whether or not an individual meets criteria for a DC-LD diagnosis of 
mental disorder. As shown in table 3.4, at baseline 96 (64%) individuals met the 
criteria for a DC-LD categorical diagnosis. 
 
Comparisons are made between the relationships of dimensional and categorical 
models to the measures of the severity and the longitudinal outcome of mental 
disorders. To achieve this, the measures of severity and outcome are used as the 
dependant variables in three separate linear regression models using: 
1. only the variables representing the dimensional of psychopathology  
2. only the binary variable representing the categorical model of psychopathology 
3. the variables representing both the dimensional and categorical models of 
psychopathology 
 
The regression analyses, including the dimensional measures of psychopathology, are 
carried out in relation to null hypotheses seven and eleven. The same socio-clinical 
variables included in these analyses, on the basis of the results of the bivariate 
analyses, were included in the two other sets of linear regression described above. 
These separate analyses are run for each of the measures of severity and outcome.  
 
Null hypothesis eight: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with measures of the severity of mental 
disorders  
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with the longitudinal outcome of mental 
disorders 
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The three regression models above with each measure of severity and outcome as the 
dependant variable are compared to examine if the variables representing the 
dimensional and categorical models are retained as significant (van Os et al. 1996). 
Two results from the regression analyses were examined to compare  the dimensional 
and categorical models of psychopathology: 
• the standardised coefficient (β)- representing the size of the effect of each 
psychopathology variable on the dependent variable  
• R²- the proportion of the variance of the dependent variable explained by the 
overall regression model. 
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Chapter 4: Results 
This chapter is organised in relation to the 12 research hypotheses from chapter 2. For 
convenience, these are stated at the start of the relevant section. 
 
4.1 Identifying dimensions of psychopathology from the PPS-LD 
 
 
As described in section 3.5.2.4, problems can arise in EFA if there are items included 
which are not significantly correlated with any other items, or if variables are too 
highly correlated (multi-collinearity, defined as r ≥ .9). This was checked in a 
correlation matrix. All items of psychopathology were significantly correlated with at 
least one other item and there were no items with correlation co-efficients above 0.9. 
Therefore, all 41 items were retained for the EFA. 
 
 
The scree plot in figure 4.1 below was used as a guide to the predicted number of 
factors to extract from the EFA. From an initial EFA, the eigenvalues of the factors 
extracted were plotted and the scree plot examined to find the break point in the slope 
between the initial steep gradient- representing the initial factors with greater, more 
significant, eigenvalues- and the more gradual sloping gradient, with the smaller 
eigenvalues representing the vast majority of factors.  
 
 
 
 
Null hypothesis one: 
There are no stable, identifiable dimensions of psychopathology experienced by 
adults with intellectual disabilities. 
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Figure 4.1: Scree plot of eigenvalues of first 20 factors extracted. 
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In figure 4.1, the eigenvalues of the first 20 factors extracted are plotted. It appears 
that the break point occurs at factor 4, suggesting that the final solution will have three 
extracted factors. Guidelines for EFA best practice (Costello & Osborne 2005) 
recommend examining the solutions with one more, and one less factors, than 
suggested by the scree plot. This allows consideration of the relevance and coherence 
of different factor solutions. Therefore, the factor solutions with two, three and four 
factors extracted were examined. 
 
In tables 4.1, 4.2 and 4.3 below, the non-rotated and the rotated (Promax oblique 
rotation is used in all EFAs) solutions are shown for the two, three and four factor 
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solutions. The loading for each item of psychopathology to the specific factors is 
reported and loadings greater than or equal to 0.32 highlighted in bold. 
 
Based on the number of items loading onto the factors and the size of the item 
loadings, all three solutions in tables 4.1, 4.2 and 4.3 have adequate stability. Since the 
four factor solution accounts for a greater percentage of the total variance, if the items 
loading onto the four factors seem coherent and interpretable then the four factor 
solution would be accepted as the final solution. To consider this further the four 
factors were examined in some detail.  
 
The nature of EFA is such that as the number of factors extracted increases the 
percentage of the total variance explained by each additional factor decreases. 
Therefore, we might expect that there would be fewer items loading significantly onto 
these factors with lower percentage variances, and the actual items loadings would be 
smaller.  
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Table 4.1: Non-rotated and rotated two factor solutions for EFA with 41 items of 
psychopathology. 
 
Non-rotated solution Rotated solution 
Factor Factor 
  
1 2 1 2 
worry .145 .169 .225 -.102 
generalised anxiety .113 .220 .232 -.163 
agoraphobia .103 .062 .123 -.017 
animal phobia .034 .128 .107 -.110 
specific phobia -.091 -.054 -.109 .017 
rituals -.081 -.040 -.091 .005 
orderliness -.139 -.042 -.140 -.017 
low mood .662 .158 .641 .119 
labile mood .343 .260 .445 -.108 
irritability .460 .290 .560 -.089 
social withdraw .631 .082 .567 .178 
anhedonia .707 .019 .589 .269 
talk loss .552 -.209 .318 .423 
talk gain .091 .121 .151 -.078 
tearfulness .469 .193 .506 .006 
reduced self care .663 -.170 .433 .431 
loss of energy .588 -.190 .359 .419 
increased energy .074 .269 .231 -.226 
loss of cognitive skills .322 -.651 -.151 .750 
name loss .202 -.575 -.200 .629 
place loss .161 -.666 -.291 .698 
reduced comprehension .336 -.653 -.141 .758 
loss of memory .282 -.694 -.211 .775 
change in personality .321 -.535 -.077 .639 
initial insomnia  .228 .257 .349 -.151 
mid-insomnia  .276 .230 .371 -.107 
early morning wakening  .195 .231 .306 -.140 
increased daytime sleep .255 -.052 .175 .153 
loss of appetite .512 .156 .517 .059 
increased appetite .069 -.058 .020 .083 
weight loss .386 .170 .423 -.005 
weight gain .023 .001 .020 .008 
diurnal variation - evening .161 .081 .183 -.011 
diurnal variation -morning .173 .187 .260 -.108 
reduced concentration .534 .071 .481 .149 
increased verbal aggression .367 .298 .488 -.135 
increased physical aggression .332 .311 .469 -.161 
need for reassurance .490 .131 .483 .074 
self harm/ SIB .214 .302 .367 -.201 
somatic concerns .226 .152 .281 -.053 
sexual behaviour .190 .147 .249 -.063 
eigenvalue 5.16 3.51 4.84 4.03 
% total variance 12.5 8.54 11.80 9.83 
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Table 4.2: Non-rotated and rotated three factor solution for the EFA of 41 items 
of psychopathology 
Non-rotated solution Rotated solution  
Factor Factor 
  
1 2 3 1 2 3 
worry .145 .169 -.026 .146 -.123 .112 
generalised anxiety .113 .220 -.085 .177 -.201 .073 
agoraphobia .103 .062 -.131 .187 -.079 -.046 
animal phobia .034 .128 .026 .018 .096 .097 
specific phobia -.091 -.054 -.076 -.009 -.006 -.127 
rituals -.081 -.040 .271 -.281 .122 .185 
orderliness -.139 -.042 .247 -.304 .098 .143 
low mood .662 .158 -.225 .674 -.048 .129 
labile mood .343 .260 .260 .070 -.035 .477 
irritability .460 .290 .336 .096 .000 .601 
social withdraw .631 .082 -.226 .643 .011 .080 
anhedonia .707 .019 -.313 .758 .054 .002 
talk loss .552 -.209 -.172 .505 .274 -.042 
talk gain .091 .121 .353 -.203 .057 .397 
tearfulness .469 .193 -.031 .385 -.057 .241 
reduced self care .663 -.170 -.068 .505 .311 .109 
loss of energy .588 -.190 -.296 .633 .217 -.127 
increased energy .074 .269 .254 -.117 -.121 .376 
loss of cognitive skills .322 -.651 .149 .024 .737 -.061 
name loss .202 -.575 .182 -.078 .648 -.041 
place loss .161 -.666 .207 -.139 .729 -.078 
reduced comprehension .336 -.653 .266 -.060 .790 .045 
loss of memory .282 -.694 .197 -.049 .784 -.054 
change in personality .321 -.535 .121 .061 .621 -.029 
initial insomnia  .228 .257 .166 .063 -.102 .352 
mid-insomnia  .276 .230 .076 .166 -.101 .278 
early morning wakening  .195 .231 .158 .042 -.091 .320 
increased daytime sleep .255 -.052 -.120 .272 .070 -.033 
loss of appetite .512 .156 -.454 .751 -.180 -.127 
increased appetite .069 -.058 .295 -.196 .189 .254 
weight loss .386 .170 -.350 .579 -.186 -.078 
weight gain .023 .001 .253 -.187 .107 .229 
diurnal variation - evening .161 .081 -.057 .172 -.051 .049 
diurnal variation -morning .173 .187 .185 -.001 -.047 .315 
reduced concentration .534 .071 .176 .249 .155 .387 
increased verbal aggression .367 .298 .496 -.099 .031 .709 
increased physical aggression .332 .311 .441 -.078 -.013 .655 
need for reassurance .490 .131 .037 .337 .032 .278 
self harm/ SIB .214 .302 .398 -.128 -.055 .569 
somatic concerns .226 .152 .100 .101 -.034 .243 
sexual behaviour .190 .147 .199 -.005 -.001 .314 
eigenvalue 5.16 3.51 2.32 4.16 3.61 3.30 
% total variance 12.50 8.54 5.66 10.15 8.80 8.04 
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Table 4.3: Non-rotated and rotated four factor solution for EFA of 41 items of 
psychopathology 
Non-rotated solution Rotated solution 
Factor Factor 
 
1 2 3 4 1 2 3 4 
worry .145 .169 -.026 .543 .022 -.045 -.173 .603 
generalised anxiety .113 .220 -.085 .513 .056 -.126 -.193 .570 
agoraphobia .103 .062 -.131 .365 .104 -.027 -.223 .378 
animal phobia .034 .128 .026 .017 .007 -.093 .078 .052 
specific phobia -.091 -.054 -.076 -.019 -.002 -.009 -.105 -.055 
rituals -.081 -.040 .271 .108 -.293 .134 .108 .130 
orderliness -.139 -.042 .247 .153 -.325 .117 .047 .163 
low mood .662 .158 -.225 -.083 .665 -.055 .165 .016 
labile mood .343 .260 .260 -.047 .063 -.040 .448 .101 
irritability .460 .290 .336 -.031 .084 -.002 .552 .153 
social withdraw .631 .082 -.226 -.012 .625 .013 .086 .067 
anhedonia .707 .019 -.313 -.098 .759 .044 .063 -.035 
talk loss .552 -.209 -.172 -.094 .524 .260 .021 -.083 
talk gain .091 .121 .353 .313 -.269 .100 .194 .410 
tearfulness .469 .193 -.031 -.058 .376 -.061 .248 .050 
reduced self care .663 -.170 -.068 -.006 .504 .309 .111 .048 
loss of energy .588 -.190 -.296 -.045 .637 .211 -.078 -.043 
increased energy .074 .269 .254 .263 -.183 -.082 .199 .374 
loss of cognitive skills .322 -.651 .149 .039 .054 .733 -.063 -.030 
name loss .202 -.575 .182 -.106 -.020 .625 .025 -.173 
place loss .161 -.666 .207 .043 -.105 .724 -.082 -.045 
reduced comprehension .336 -.653 .266 .161 -.053 .802 -.030 .112 
loss of memory .282 -.694 .197 .028 -.013 .777 -.052 -.049 
change in personality .321 -.535 .121 .129 .065 .631 -.081 .082 
initial insomnia  .228 .257 .166 .350 -.025 -.051 .136 .469 
mid-insomnia  .276 .230 .076 .036 .141 -.093 .230 .140 
early morning wakening  .195 .231 .158 .083 .011 -.077 .242 .188 
increased daytime sleep .255 -.052 -.120 -.132 .295 .052 .042 -.125 
loss of appetite .512 .156 -.454 .097 .704 -.161 -.154 .140 
increased appetite .069 -.058 .295 .309 -.251 .229 .071 .355 
weight loss .386 .170 -.350 .012 .553 -.179 -.070 .055 
weight gain .023 .001 .253 .263 -.236 .141 .070 .339 
diurnal variation - evening .161 .081 -.057 .346 .092 -.001 -.128 .382 
diurnal variation -morning .173 .187 .185 -.225 .034 -.077 .392 -.131 
reduced concentration .534 .071 .176 -.077 .255 .144 .388 .046 
increased verbal aggression .367 .298 .496 -.290 -.054 -.009 .775 -.096 
increased physical aggression .332 .311 .441 -.394 -.013 -.066 .779 -.212 
need for reassurance .490 .131 .037 .210 .278 .063 .147 .321 
self harm/ SIB .214 .302 .398 -.169 -.107 -.077 .588 -.011 
somatic concerns .226 .152 .100 .202 .048 -.005 .115 .287 
sexual behaviour .190 .147 .199 -.141 .015 -.020 .350 -.051 
eigenvalue 5.16 3.51 2.32 1.85 4.02 3.57 3.06 2.23 
% total variance 12.50 8.54 5.66 4.51 9.80 8.70 7.47 5.44 
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Although the labelling and interpretation of the dimensions extracted from EFA is a 
crucial part of the research process, this aspect is discussed less often in best practice 
guidelines (Costello & Osborne 2005), or textbooks on factor analysis. Since 
interpretation of the results of EFA is largely subjective researchers are recommended 
to fully consider alternative labels for extracted factors (Ford et al, 1986), aiming for a 
simple, recognisable label that adequately represents the items that load to the factor 
(Child, 2006). 
 
Factor one in the rotated solution comprises nine items of psychopathology; 
• low mood 
• social withdrawal 
• anhedonia 
• reduced verbal communication 
• tearfulness 
• reduced self-care 
• lower energy levels 
• loss of appetite 
• weight loss 
 
Since eight of the nine items have loadings to the depressive dimension greater than 
0.5, this dimension would be expected to have good reliability and stability (Hair et al 
1998a). It is perhaps surprising that none of the four items relating to sleep load 
significantly to the depressive dimension. However, overall, the dimension appears 
coherent and is readily interpretable. 
 
Several possible factor labels to represent this dimension of psychopathology were 
considered including depressive, internalising psychopathology and bio-psycho-social 
withdrawal. 
 
Two main reasons to label this dimension of psychopathology with the term 
depressive were considered. The nine items of psychopathology extracted in this first 
dimension are included amongst criteria for depressive disorders in existing 
categorical diagnostic classification systems. There is overlap between the items of 
psychopathology extracted here from the PPS-LD data, and items of psychopathology 
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in dimensions labelled with the term depressive in studies in table 1.2. Thus, using the 
depressive label would be consistent with existing categorical diagnostic classification 
systems, previous studies and would be familiar to clinicians and researchers. 
 
All nine items of psychopathology represent affective or behaviour changes that 
largely impact on the individual, rather than other people or the surrounding 
environment. Therefore, this dimension could be appropriately labelled with the term 
internalising psychopathology. However, as described in section 1.5.1, this is a term 
that is commonly used to describe a higher order dimension of psychopathology 
experienced by children and adolescents. The higher order internalising dimension of 
psychopathology represents a dimension that includes a broader range of 
psychopathology than the nine items extracted here, including affective, generalised 
anxiety, phobic and panic psychopathology. Since the internalising term is a distinct 
concept in the psychopathology literature, to avoid confusion it was decided not to use 
this as a label for the first dimension. 
 
It was recognised that at least some of the items of psychopathology extracted in the 
first dimension were not directly related to changes in affect or mood. For example 
social withdrawal, reduced verbal communication and reduced self-care all represent 
changes in behaviour that can occur without any affective changes. The label psycho-
social withdrawal was considered as it seemed to describe both the affective and 
behavioural change represented by the majority of items of psychopathology in the 
first factor. However, this label does not really capture three items of psychopathology 
that are often to be considered biological in nature- lower energy levels, loss of 
appetite and weight loss. Therefore, bio-psycho-social withdrawal may be a more 
comprehensive representation of the items of psychopathology extracted in the first 
factor. 
 
Although the depressive and bio-psycho-social withdrawal labels both appear to 
adequately represent the nine items of psychopathology in the first dimension, it was 
decided to label this as a depressive dimension. The reason for this is that it is in 
keeping with the labelling of similar dimensions in previous intellectual disabilities 
studies, thus facilitating comparison with previous research. 
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The second dimension extracted from the PPS-LD data had six items: 
• change in cognitive functioning 
• forgetting the names of familiar people 
• getting lost in familiar places 
• reduced verbal comprehension 
• memory problems 
• change in personality. 
 
Labels considered in naming this dimension of psychopathology included confusion, 
organic and cognitive impairment. Since the label confusion was felt to be non-
specific, and could be interpreted as representing an individual’s experience of brief 
periods of subjective uncertainty, it was discounted and organic and cognitive 
considered further. 
 
Both these terms meet the criteria of being good descriptions of the six items of 
psychopathology in the second dimension of psychopathology extracted. Clinicians 
and researchers would be likely to readily accept that there is a relationship between 
the items of psychopathology and either of these terms. One issue considered was the 
fact that change in cognitive functioning was one of the items of psychopathology that 
loaded to the dimension. Since the term organic could encompass this and the five 
additional items it was decided that it was preferable as the label for this dimension. 
 
One point of interest from the depressive and organic dimensions is that the item of 
psychopathology indicative of a reduction in self-care skills is primarily loaded onto 
the depressive dimension. Although the reduced self-care item has a loading of 0.309 
to the organic dimension (accepted as significant by some of the studies in table 1.2), 
there is a stronger loading of 0.504 to the depressive dimension. Nonetheless, overall 
the organic dimension does appear coherent and relevant to the assessment of 
psychopathology and mental disorders. 
 
The third dimension extracted in the EFA was more problematic to label. This 
dimension included eight individual items of psychopathology: 
• increased mood lability 
• increased irritability 
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• diurnal variation in mood-worse in the morning 
• reduced concentration 
• increased verbal aggression  
• increased physical aggression 
• increased self-injurious or self-harming behaviour 
• a change in sexual behaviour. 
 
Of the eight items of psychopathology that loaded to this dimension four represented 
changes in behaviour (verbal aggression, physical aggression, self-injurious and 
change in sexual behaviour) and three involved affective changes (mood lability, 
increased irritability, diurnal variation in mood-worse in the morning). Although the 
final item of psychopathology (reduced concentration) stood alone, it was recognised 
that it is often described by individuals experiencing affective changes. Therefore, this 
dimension was conceptualised as being made up of four items of behaviour change 
and four affective items.  
 
Clearly, the labels affective change and behaviour change would only represent half of 
the items in the dimension, and so were discounted. However, the combined term 
behaviour-affective was considered, along with instability, and externalising 
psychopathology.  
 
Similar to the term internalising psychopathology described above, the term 
externalising psychopathology is used to represent a higher order dimension of 
psychopathology. This dimension usually includes conduct, anti-social or problem 
behaviour psychopathology, hyperactivity and inattention. To avoid confusion with 
the construct represented by externalising psychopathology in the literature this label 
was not considered further. 
 
The term instability encapsulates the fact that each of the items of psychopathology 
extracted in the third dimension represents a change from baseline. However, all items 
on the PPS-LD are only rated positively if there has been a change. Therefore, the 
concept of change could equally apply to all the dimensions. Furthermore, the term 
instability implies that an affect or behaviour is unstable, changing rapidly and 
frequently. Whilst this feature is likely to be true for mood lability, it is less likely to 
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be the case for other items of psychopathology loading to this dimension. For 
example, an individual may experience increased irritability or poor concentration as 
persistent changes that do not fluctuate over time. Due to these issues around the 
meaning of the term instability, it was discounted as a potential label for the third 
dimension. However, in section 5.1.5 the relevance of change or instability to the 
overall multi-dimensional model of psychopathology is discussed. 
 
The label finally accepted for the third dimension was, therefore, behaviour-affective. 
It was felt that this label adequately describes the balance in the different items of 
psychopathology in the dimension. Importantly, behaviour-affective is a 
straightforward term, familiar to psychopathology researchers and the use of the term 
affective differentiates this dimension from the depressive dimension. 
 
Finally, the fourth dimension included 10 items of psychopathology: 
• worrying 
• generalised anxiety 
• agoraphobia 
• increased verbal communication 
• increased energy levels 
• initial insomnia greater than one hour 
• increased appetite 
• weight gain 
• diurnal mood variation- worse in the evening 
• increased need for reassurance. 
 
Terms considered as a potential label for this dimension included over-arousal, over- 
activation and anxiety. 
 
An aspect of the terms overarousal and overactivation considered was their use in the 
literature to link psychopathology with a specific biologically-based system. For 
example, sympathetic overarousal and externalising behaviour in children, or 
hemispheric and temporal overactivation in schizophrenia. Although both these terms 
seem applicable to the items of psychopathology that loaded to this dimension, at this 
stage in researching the multi-dimensional model any label would ideally be 
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descriptive. Without further research investigating causative mechanisms it is 
preferable to avoid the use of terms that imply involvement of specific biological 
systems. Therefore, overarousal and overactivation were not considered appropriate 
labels for this dimension. However, the concepts of arousal and activation are further 
discussed in section 5.1.5, in relation to constructs of relevance to a multi-dimensional 
model of psychopathology. 
 
Instead, the descriptive term anxiety was decided upon. Similar to labels used for the 
other dimensions it is simple and concisely describes the items that load to the fourth 
dimension. Each of the 10 items of psychopathology is readily associated to the label 
anxiety, and the label distinguishes this dimension from the previous three.  
 
Perhaps the items rating increased verbal communication and increased energy levels 
need further consideration but overall, like the other three factors, the anxiety 
dimension is readily interpretable. 
 
Although the scree plot in figure 4.1 suggested examining two, three and four factor 
solutions there are two specific reasons to look at additional solutions. Firstly, factor 
four in table 4.3 has 10 items loading above 0.32- significantly greater than the 
minimum of three suggested by best practice guidance. This suggests that there may 
well be additional stable factors that could be extracted. The second reason for 
extending the examination of solutions to those with more factors relates to the 
previous studies that have used EFA to examine the structure of psychopathology 
experienced by adults with intellectual disabilities (see section 1.6.1). Since there were 
eight dimensions of psychopathology identified across studies, the extraction of a 
greater number of factors than in the four dimensional model above might have been 
predicted. For these reasons, five and six factor solutions were examined to look at 
whether there are additional coherent dimensions that emerge from the data. 
 
The rejection of the six factor solution is straightforward. In table 4.5, there are only 
two items with loadings greater than 0.32 to the sixth factor. Therefore, the six factor 
solution does not meet the requirement that there are at least three items loading onto a 
factor to ensure stability. A decision on which solution to accept as the final 
dimensional model in thus narrowed to between the four and five factor solutions. In 
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table 4.4, we can see that in the five factor solution all the factors meet the criterion 
for at least three items loading to each factor- with five items loading to factor five: 
• increased verbal communication 
• increased energy levels 
• initial insomnia greater than one hour 
• mid-insomnia greater than one hour 
• early morning wakening greater than one hour. 
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Table 4.4: Non-rotated and rotated five factor solution for EFA of 41 items of 
psychopathology 
 
Non-rotated solution Rotated solution  
Factor Factor 
  
1 2 3 4 5 1 2 3 4 5 
worry .145 .169 -.026 .543 -.152 .009 -.081 -.162 .623 .096 
generalised anxiety .113 .220 -.085 .513 -.036 .046 -.136 -.209 .549 .179 
agoraphobia .103 .062 -.131 .365 -.208 .082 -.073 -.184 .452 -.074 
animal phobia .034 .128 .026 .017 -.181 -.011 -.128 -.120 -.114 -.116 
specific phobia -.091 -.054 -.076 -.019 -.034 -.010 -.016 -.087 -.028 -.081 
rituals -.081 -.040 .271 .108 .220 -.264 .180 .045 .003 .296 
orderliness -.139 -.042 .247 .153 .052 -.311 .127 .026 .105 .150 
low mood .662 .158 -.225 -.083 -.108 .661 -.080 .181 .078 -.087 
labile mood .343 .260 .260 -.047 -.115 .075 -.064 .453 .100 .056 
irritability .460 .290 .336 -.031 -.272 .091 -.061 .589 .202 -.035 
social withdraw .631 .082 -.226 -.012 -.037 .625 .002 .085 .099 -.020 
anhedonia .707 .019 -.313 -.098 .019 .762 .045 .054 -.006 -.033 
talk loss .552 -.209 -.172 -.094 -.122 .523 .230 .054 .001 -.179 
talk gain .091 .121 .353 .313 .266 -.231 .153 .100 .230 .485 
tearfulness .469 .193 -.031 -.058 -.004 .385 -.063 .234 .042 .060 
reduced self care .663 -.170 -.068 -.006 .020 .521 .308 .098 .052 .029 
loss of energy .588 -.190 -.296 -.045 -.179 .626 .168 -.030 .075 -.243 
increased energy .074 .269 .254 .263 .531 -.133 .029 .040 .092 .703 
loss of cognitive skills .322 -.651 .149 .039 .041 .081 .733 -.065 -.032 -.014 
name loss .202 -.575 .182 -.106 .117 .011 .644 .009 -.205 .018 
place loss .161 -.666 .207 .043 .185 -.068 .756 -.117 -.111 .112 
reduced comprehension .336 -.653 .266 .161 .100 -.015 .813 -.054 .064 .117 
loss of memory .282 -.694 .197 .028 .094 .021 .789 -.065 -.075 .030 
change in personality .321 -.535 .121 .129 -.114 .078 .599 -.051 .134 -.102 
initial insomnia  .228 .257 .166 .350 .140 -.004 -.024 .070 .352 .375 
mid-insomnia  .276 .230 .076 .036 .406 .179 -.008 .112 -.054 .474 
early morning wakening  .195 .231 .158 .083 .415 .052 .010 .119 -.022 .514 
increased daytime sleep .255 -.052 -.120 -.132 .052 .300 .062 .033 -.122 -.021 
loss of appetite .512 .156 -.454 .097 .285 .710 -.103 -.231 .060 .235 
increased appetite .069 -.058 .295 .309 -.232 -.250 .176 .109 .397 -.014 
weight loss .386 .170 -.350 .012 .337 .566 -.108 -.158 -.055 .273 
weight gain .023 .001 .253 .263 -.532 -.261 .026 .184 .478 -.299 
diurnal variation - evening .161 .081 -.057 .346 -.048 .087 -.014 -.133 .381 .094 
diurnal variation -morning .173 .187 .185 -.225 -.104 .040 -.097 .409 -.111 -.053 
reduced concentration .534 .071 .176 -.077 .043 .281 .150 .359 .002 .138 
increased verbal aggression .367 .298 .496 -.290 -.039 -.021 -.016 .760 -.146 .122 
increased physical aggression .332 .311 .441 -.394 -.047 .015 -.073 .772 -.245 .062 
need for reassurance .490 .131 .037 .210 -.175 .278 .023 .166 .362 .010 
self harm/ SIB .214 .302 .398 -.169 .024 -.081 -.070 .560 -.080 .174 
somatic concerns .226 .152 .100 .202 -.157 .046 -.040 .134 .315 .019 
sexual behaviour .190 .147 .199 -.141 -.058 .026 -.031 .353 -.054 .014 
eigenvalue 5.16 3.51 2.32 1.85 1.62 4.03 3.56 2.91 2.13 1.95 
% total variance 12.50 8.54 5.66 4.51 3.95 9.83 8.68 7.10 5.20 4.476 
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Table 4.5: Non-rotated and rotated six factor solution for EFA of 41 items of 
psychopathology 
 
Non-rotated solution Rotated solution 
Factor Factor 
  
1 2 3 4 5 6 1 2 3 4 5 6 
worry .145 .169 -.026 .543 -.152 -.139 .012 -.066 -.186 .619 .143 -.085 
generalised anxiety .113 .220 -.085 .513 -.036 .226 .110 -.161 -.193 .509 .109 .264 
agoraphobia .103 .062 -.131 .365 -.208 .265 .136 -.103 -.165 .419 -.146 .240 
animal phobia .034 .128 .026 .017 .181 .128 .015 -.138 .122 .098 -.140 .116 
specific phobia -.091 -.054 -.076 -.019 -.034 -.011 -.021 -.015 -.087 -.029 -.077 -.030 
rituals -.081 -.040 .271 .108 .220 .677 -.122 .104 .118 -.047 .070 .767 
orderliness -.139 -.042 .247 .153 .052 .680 -.175 .051 .096 .059 -.069 .746 
low mood .662 .158 -.225 -.083 -.108 -.125 .634 -.068 .158 .079 -.035 -.237 
labile mood .343 .260 .260 -.047 -.115 .006 .087 -.066 .445 .118 .058 .018 
irritability .460 .290 .336 -.031 -.272 -.122 .082 -.049 .562 .240 .012 -.117 
social withdraw .631 .082 -.226 -.012 -.037 .037 .633 -.004 .081 .084 -.022 -.056 
anhedonia .707 .019 -.313 -.098 .019 -.002 .758 .042 .048 -.023 -.023 -.120 
talk loss .552 -.209 -.172 -.094 -.122 .053 .530 .221 .053 -.006 -.184 -.047 
talk gain .091 .121 .353 .313 .266 -.122 -.203 .166 .087 .236 .502 .058 
tearfulness .469 .193 -.031 -.058 -.004 -.047 .381 -.059 .223 .045 .079 -.087 
reduced self care .663 -.170 -.068 -.006 .020 .020 .541 .302 .094 .044 .025 -.020 
loss of energy .588 -.190 -.296 -.045 -.179 .163 .646 .147 -.021 .053 -.277 .025 
increased energy .074 .269 .254 .263 .531 -.065 -.095 .037 .038 .079 .693 .125 
loss of cognitive skills .322 -.651 .149 .039 .041 .008 .111 .727 -.064 -.028 -.023 .055 
name loss .202 -.575 .182 -.106 .117 .039 .038 .635 .016 -.199 -.004 .085 
place loss .161 -.666 .207 .043 .185 -.169 -.064 .770 -.130 -.094 .149 -.067 
reduced comprehension .336 -.653 .266 .161 .100 -.071 .017 .816 -.062 .074 .126 .037 
loss of memory .282 -.694 .197 .028 .094 -.012 .050 .785 -.065 -.067 .024 .057 
change in personality .321 -.535 .121 .129 -.114 -.004 .101 .595 -.056 .141 -.100 .022 
initial insomnia  .228 .257 .166 .350 .140 .007 .034 -.025 .066 .341 .363 .112 
mid-insomnia  .276 .230 .076 .036 .406 -.224 .168 .017 .091 -.052 .525 -.135 
early morning wakening  .195 .231 .158 .083 .415 -.222 .046 .035 .100 -.017 .562 -.101 
increased daytime sleep .255 -.052 -.120 -.132 .052 .062 .306 .054 .039 -.132 -.038 .007 
loss of appetite .512 .156 -.454 .097 .285 .002 .716 -.104 -.231 .017 .232 -.065 
increased appetite .069 -.058 .295 .309 -.232 -.294 -.274 .207 .070 .434 .079 -.201 
weight loss .386 .170 -.350 .012 .337 .124 .591 -.122 -.143 -.099 .228 .077 
weight gain .023 .001 .253 .263 -.532 -.131 -.276 .040 .156 .514 -.241 -.116 
diurnal variation - evening .161 .081 -.057 .346 -.048 -.219 .069 .009 -.161 .384 .163 -.182 
diurnal variation -morning .173 .187 .185 -.225 -.104 .126 .055 -.111 .417 -.099 -.087 .096 
reduced concentration .534 .071 .176 -.077 .043 .209 .335 .125 .374 -.006 .072 .210 
increased verbal aggression .367 .298 .496 -.290 -.039 -.040 -.017 -.012 .749 -.106 .133 .000 
increased physical aggression .332 .311 .441 -.394 -.047 .035 .022 -.077 .769 -.210 .052 .042 
need for reassurance .490 .131 .037 .210 -.175 .204 .331 -.002 .175 .345 -.045 .183 
self harm/ SIB .214 .302 .398 -.169 .024 -.033 -.074 -.066 .552 -.052 .180 .022 
somatic concerns .226 .152 .100 .202 -.157 .075 .073 -.049 .132 .312 .001 .087 
sexual behaviour .190 .147 .199 -.141 -.058 .177 .058 -.051 .367 -.050 -.039 .169 
eigenvalue 5.16 3.51 2.32 1.85 1.62 1.61 4.05 3.52 2.86 2.10 1.98 1.67 
% total variance 12.50 8.54 5.66 4.51 3.95 3.90 9.88 8.59 6.98 5.12 4.83 4.07 
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This suggests that the factors have adequate stability. For the first time in any of the 
factor solutions, there is cross-loading of an item across factors. The initial insomnia 
item loads significantly to factors four and five. An overlap between factors four and 
five is also supported by the finding that two items that loaded onto factor four, in the 
four factor solution in table 4.3, now load onto factor five- increased verbal 
communication and increased energy. 
 
The rotated four factor solution accounts for 31.4% of the total variance, whilst the 
rotated five factor solution accounts for 35.3%, suggesting that the fifth factor may 
make a significant contribution to the overall dimensional model. However, some 
issues arise when the coherence and interpretability of factor five is considered. It is 
possible to conceptualise the five items in factor five as a mania/ hypomania 
dimension of psychopathology. The increased verbal communication and energy items 
of psychopathology are often experienced by individuals with hypomania. Similarly, 
the three sleep problem items could be conceptualised as part of a mania/ hypomania 
dimension.  
 
Although factor five is interpretable and makes a sizeable contribution to the five 
factor solution explaining a greater proportion of the total variance, there are reasons 
to be cautious over accepting the five factor solution. Three of the items in factor five 
(increased verbal communication, increased energy levels and initial insomnia) load 
significantly onto the anxiety dimension in the four factor solution. Therefore, it could 
be argued that the only additional contribution to the overall dimensional model is the 
inclusion of the mid-insomnia and early morning wakening items.  
 
Perhaps of greatest relevance is the fact that for the first time cross-loading of an item 
of psychopathology appears in the five factor solution. The cross-loading of initial 
insomnia across the anxiety and mania/ hypomania dimension could be interpreted as 
evidence that the dimensional model based on the five factor solution is less coherent 
and reliable. It is certainly recognised that it is preferable to have no cross-loading of 
items across factors in a rotated solution (Costello & Osborne 2005). 
 
Overall, there are arguments for and against using the five factor solution as the basis 
of the dimensional model of psychopathology. However, since there is cross-loading 
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within the five factor solution, the four factor solution is chosen as the final solution 
on which to base the proposed dimensional model of psychopathology. 
 
In order to examine the stability of the four factor solution, two separate random 
samples were selected from the sample used for the EFA (n= 330).  To maintain the 
minimum case:item ratio of 5:1 each sample would need a minimum of 205 cases.  
 
SPSS was used to examine a random sample of 205 cases from the 330 used in the 
EFA.  The EFA extracting four factors was run for this first random sample. A second 
random sample of 205 cases was selected and the EFA run again. The results are 
shown in tables 4.6 and 4.7 below. 
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Table 4.6: Non-rotated and rotated four factor solution from EFA of 41 items of 
psychopathology for random sample 1 (n=205)  
 
Non-rotated solution Rotated solution 
Factor Factor 
 
1 2 3 4 1 2 3 4 
worry .158 -.128 .004 .504 .090 -.027 -.210 .550 
generalised anxiety .174 -.218 -.004 .267 .110 -.143 -.040 .336 
agoraphobia .173 -.088 -.166 .162 .236 -.128 -.091 .171 
animal phobia .036 -.080 -.019 -.112 .040 .079 -.095 -.095 
specific phobia -.109 .056 .005 -.001 -.085 -.051 .041 -.025 
rituals -.038 -.016 .343 -.273 -.252 .071 .423 -.188 
orderliness -.166 -.063 .346 -.168 -.365 .027 .337 -.093 
low mood .691 -.101 -.212 .021 .683 -.081 .074 .097 
labile mood .365 -.248 .234 .044 .107 -.087 .349 .209 
irritability .485 -.223 .364 .075 .115 .003 .461 .285 
social withdraw .675 .007 -.245 -.003 .704 .001 .023 .038 
anhedonia .692 .023 -.294 -.135 .757 -.019 .065 -.104 
talk loss .489 .279 -.273 -.043 .601 .210 -.120 -.094 
talk gain .157 -.107 .538 .135 -.255 .141 .418 .311 
tearfulness .587 -.144 .029 .041 .432 -.041 .229 .168 
reduced self care .641 .200 -.100 -.053 .597 .220 .094 -.022 
loss of energy .563 .212 -.282 -.034 .659 .156 -.088 -.062 
increased energy .096 -.230 .331 .061 -.172 -.066 .323 .205 
loss of cognitive skills .218 .595 .228 .006 .071 .657 .052 -.033 
name loss .055 .635 .175 -.198 -.009 .626 .070 -.281 
place loss .054 .671 .158 .162 -.010 .701 -.172 .062 
reduced comprehension .200 .655 .341 .159 -.019 .773 .022 .130 
loss of memory .122 .608 .313 .093 -.065 .701 .031 .056 
change in personality .223 .562 .039 .059 .199 .565 -.114 -.019 
initial insomnia  .239 -.155 .121 .303 .081 -.025 .036 .398 
mid-insomnia  .381 -.119 .043 .148 .257 -.024 .102 .241 
early morning wakening  .231 -.082 .106 .083 .101 .005 .131 .160 
increased daytime sleep .165 .247 -.162 -.029 .265 .182 -.134 -.097 
loss of appetite .603 -.091 -.399 .119 .736 -.139 -.161 .131 
increased appetite -.030 -.001 .246 .542 -.213 .160 -.146 .590 
weight loss .472 -.085 -.288 -.088 .567 -.137 .007 -.067 
weight gain -.068 -.076 .304 .474 -.287 .099 -.048 .547 
diurnal variation - evening .133 -.128 -.061 .365 .120 -.074 -.184 .393 
diurnal variation -morning .182 -.097 .231 -.373 -.005 -.030 .492 -.263 
reduced concentration .578 .012 .226 -.101 .311 .155 .415 .041 
increased verbal aggression .443 -.196 .416 -.248 .063 -.001 .673 -.034 
increased physical aggression .453 -.193 .370 -.353 .106 -.028 .704 -.147 
need for reassurance .509 -.042 .092 -.158 .332 .082 .150 .265 
self harm/ SIB .266 -.272 .357 -.139 -.050 -.100 .531 .049 
somatic concerns .279 -.131 .183 .141 .107 -.008 .128 .286 
sexual behaviour .139 -.103 .204 -.291 -.025 -.040 .410 -.194 
eigenvalue 5.49 3.11 2.58 1.87 4.72 3.09 3.06 2.28 
% total variance 13.39 7.58 6.29 4.56 11.5 7.54 7.46 5.56 
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Table 4.7: Non-rotated and rotated four factor solution for EFA of 41 items of 
psychopathology for random sample 2 (n=205)  
Non-rotated solution Rotated solution 
Factor Factor 
 
1 2 3 4 1 2 3 4 
worry .027 -.103 -.038 .345 .088 -.054 -.142 .337 
generalised anxiety -.002 -.174 -.121 .378 .122 -.152 -.206 .354 
agoraphobia .072 .009 -.202 .170 .205 -.033 -.193 .124 
animal phobia .024 -.120 .035 -.013 -.010 -.091 .087 .018 
specific phobia -.063 .184 -.037 .055 -.012 .147 -.146 .010 
rituals -.067 .003 .246 .208 -.187 .121 .056 .266 
orderliness -.165 -.007 .250 .075 -.284 .076 .084 .136 
low mood .671 -.142 -.241 -.041 .672 -.105 .172 -.039 
labile mood .341 -.247 .272 -.125 .065 -.061 .490 .031 
irritability .508 -.262 .244 -.208 .202 -.066 .584 -.043 
social withdraw .615 .014 -.255 .067 .656 .034 .033 .027 
anhedonia .714 .011 -.289 .053 .753 .033 .057 .010 
talk loss .511 .234 -.223 -.121 .535 .196 .023 -.189 
talk gain .083 -.047 .333 .556 -.084 .190 .038 .642 
tearfulness .482 -.145 .032 -.105 .338 -.039 .327 -.032 
reduced self care .637 .207 -.122 .012 .583 .256 .098 -.020 
loss of energy .538 .234 -.391 -.063 .674 .140 -.117 -.183 
increased energy .052 -.253 .435 .549 -.182 .042 .176 .701 
loss of cognitive skills .265 .661 .195 .054 .101 .726 -.002 .008 
name loss .198 .637 .142 -.022 .074 .659 -.025 -.081 
place loss .094 .717 .262 .047 -.076 .770 -.040 -.001 
reduced comprehension .186 .734 .256 .159 .015 .817 -.064 .107 
loss of memory .249 .703 .245 .114 .064 .790 -.015 .071 
change in personality .212 .629 .044 .013 .153 .620 -.106 -.074 
initial insomnia  .201 -.251 .325 .221 -.035 -.019 .310 .367 
mid-insomnia  .293 -.175 .322 .234 .042 .066 .314 .370 
early morning wakening  .178 -.172 .282 .200 -.025 .025 .251 .318 
increased daytime sleep .381 .080 -.134 .019 .389 .091 .024 -.010 
loss of appetite .512 -.184 -.368 .363 .683 -.167 -.163 .303 
increased appetite .046 .157 .286 .032 -.145 .271 .161 .091 
weight loss .459 -.200 -.257 .361 .568 -.146 -.096 .154 
weight gain .055 .123 .120 .182 -.057 .144 .154 .334 
diurnal variation - evening .068 -.126 -.041 .367 .125 -.064 -.129 .364 
diurnal variation -morning .270 -.143 .059 -.351 .123 -.101 .371 -.272 
reduced concentration .597 -.102 .014 .020 .456 .031 .287 .082 
increased verbal aggression .418 -.230 .505 -.311 -.052 .040 .776 -.074 
increased physical aggression .429 -.278 .379 -.408 .025 -.067 .749 -.195 
need for reassurance .524 -.100 -.039 .047 .438 .001 .205 .087 
self harm/ SIB .294 -.291 .463 -.121 -.099 -.028 .626 .096 
somatic concerns .233 -.149 .062 .018 .139 -.060 .188 .079 
sexual behaviour .310 -.119 .264 -.083 .054 .051 .407 .042 
eigenvalue 5.28 3.78 2.57 2.04 4.37 3.63 3.31 2.25 
% total variance 12.88 9.22 6.27 4.98 10.66 8.85 8.07 5.49 
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To examine the stability of the four factor solution the correlations between item 
loadings from the rotated factors from the EFA using the two random samples were 
calculated. In table 4.8, the Pearson correlations and level of significance are shown. 
 
Table 4.8: Correlation of items loadings from rotated four factor solution, using 
two random samples  
 
 
 Pearson correlation Level of significance 
Factor 1- depression 0.954 p< 0.001 
Factor 2- organic 0.968 p< 0.001 
Factor 3- behaviour- affective 0.809 p< 0.001 
Factor 4- anxiety 0.591 p= .003 
 
 
 
The significant correlations in table 4.8 suggest that the extracted four factor solution 
has good stability. However, whilst the factor solutions in table 4.6 and table 4.7 
remain coherent to a dimensional model of psychopathology, with dimensions labelled 
as depressive, organic, behaviour-affective and anxiety, there are differences in the 
loadings of individual items, compared to the four factors in the original EFA (table 
4.3). To allow comparison, table 4.9 below lists the items with loadings greater than 
0.32 from the four factor solutions, extracted from the three EFAs.  
 
In table 4.9, any changes in the EFAs using the two random samples, in comparison to 
the original EFA are highlighted in bold. One further point to note is that the item 
rating agoraphobia loads significantly to the anxiety dimension only in the original 
EFA. 
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Table 4.9: Item loadings to the four factor solutions from the three separate EFAs. 
 
 Factor 1- depressive Factor 2- organic Factor 3- behaviour-affective Factor 4- anxiety 
Original EFA  
(n=330) 
low mood 
social withdrawal 
anhedonia 
reduced verbal communication 
tearfulness 
reduced self-care  
lower energy levels 
loss of appetite 
weight loss 
change in cognitive functioning 
forgetting the names of familiar 
people 
getting lost in familiar places 
reduced verbal comprehension 
memory problems 
change in personality 
increased mood lability 
increased irritability 
diurnal variation in mood- worse in 
the morning 
reduced concentration 
increased verbal aggression 
increased physical aggression 
increased self harming or self-
injurious behaviour 
inappropriate sexual behaviour 
worrying 
generalised anxiety 
agoraphobia 
increased verbal 
communication 
increased energy levels 
initial insomnia greater than 
one hour 
increased appetite  
weight gain 
diurnal mood variation- worse 
in the evening 
increased need for reassurance 
Random sample 1 
(n=205) 
low mood 
social withdrawal 
anhedonia 
reduced verbal communication 
tearfulness 
reduced self-care  
lower energy levels 
loss of appetite 
weight loss 
increased need for 
reassurance 
change in cognitive functioning 
forgetting the names of familiar 
people 
getting lost in familiar places 
reduced verbal comprehension 
memory problems 
change in personality 
rituals 
excessive orderliness 
increased mood lability 
increased irritability 
diurnal variation in mood- worse in 
the morning 
reduced concentration 
increased verbal aggression 
increased physical aggression 
increased self harming or self-
injurious behaviour 
inappropriate sexual behaviour 
worrying 
generalised anxiety 
increased verbal 
communication 
increased energy levels 
initial insomnia greater than 
one hour 
increased appetite  
weight gain 
diurnal mood variation- worse 
in the evening 
 
Random sample 2 
(n=205) 
low mood 
social withdrawal 
anhedonia 
reduced verbal communication 
tearfulness 
reduced self-care  
lower energy levels 
increased daytime sleeping 
loss of appetite 
weight loss  
reduced concentration 
increased need for 
reassurance 
change in cognitive functioning 
forgetting the names of familiar 
people 
getting lost in familiar places 
reduced verbal comprehension 
memory problems 
change in personality 
increased mood lability 
increased irritability 
tearfulness 
diurnal variation in mood- worse in 
the morning 
increased verbal aggression 
increased physical aggression 
increased self harming or self-
injurious behaviour 
inappropriate sexual behaviour 
worrying 
generalised anxiety 
increased verbal 
communication 
increased energy levels 
initial insomnia > one hour 
mid-insomnia> one hour 
increased appetite  
weight gain 
diurnal mood variation- worse 
in the evening 
increased need for reassurance 
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Although some differences exist, overall it appears from table 4.9 that the items 
loading to the four factors are largely unchanged across the three EFAs. The items 
loading to the depressive dimension in the original EFA load significantly to the 
depressive dimension in the EFAs using the two random samples. However, two 
additions to the item loadings to the depressive dimension are noted with an item 
moving from the original behaviour-affective dimension (concentration) and the 
original anxiety dimension (increased need for reassurance). 
 
Perhaps the most interesting changes in the loadings are the four items that appear for 
the first time in the EFAs using the random samples- increased daytime sleeping loads 
to the depressive dimension, rituals and excessive orderliness load to the behaviour-
affective dimension, and mid-insomnia loads to the anxiety dimension.  
 
Despite these minor differences in the dimensions identified, the strong correlations 
between dimensions in the three, separate four factor solutions indicate that this 
dimensional model of psychopathology is statistically stable. Therefore, null 
hypothesis one is rejected. 
 
4.2 The correlations between the four dimensions of psychopathology 
 
 
The correlations between the four factors from the rotated solution from the original 
EFA are shown in table 4.10. There were no significant correlations between the four 
dimensions of psychopathology. On the one hand this is a positive finding as it 
demonstrates the four factors stand alone as independent dimensions of 
psychopathology. However, from studies involving children, adolescents and adults 
who do not have intellectual disabilities it might have been expected to find greater 
correlations between the depressive and anxiety dimensions of psychopathology. Thus 
it would appear that the dimensions are independent, with no evidence for any higher 
order dimensions. Therefore, the null hypothesis is accepted. 
Null hypothesis two: 
There are no significant correlations between the individual dimensions of 
psychopathology experienced by adults with intellectual disabilities. 
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Table 4.10: The correlations between the dimensions of psychopathology from 
the four factor solution. 
 
 Depressive Organic Behavioural-
affective 
Anxiety 
Depressive 1.000 .194 .261 .227 
Organic 
.194 1.000 .079 .014 
Behavioural-affective 
.261 .079 1.000 .256 
Anxiety 
.227 .014 .256 1.000 
 
 
 
4.3 The bivariate relationship between psychopathology and socio-
clinical variables 
 
Prior to considering the specific hypotheses relevant to dimensional models of 
psychopathology and socio-clinical variables, the distributions of the variables are 
explored.  
 
4.3.1 The distribution of the measures of psychopathology  
Descriptive data and the normal distribution statistics for the measures representing 
the dimensional model of psychopathology (see section 3.5.1) are reported in table 
4.11 below: 
• imension factor scores for depressive, organic, behavioural-affective and anxiety  
• the total dimension factor score 
• dimension symptom counts for depressive, organic, behavioural-affective and 
anxiety  
• the total dimension symptom count 
• the EFA PPS-LD symptom count- 41. 
Null hypothesis three: 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and socio-clinical variables. 
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From table 4.11, the z-scores for skewness and kurtosis and the Shapiro-Wilk test 
results suggest that the three overall measures of psychopathology (total dimension 
factor score, total dimension symptom count and EFA PPS-LD symptom count- 41) 
have normal distributions. Visual confirmation of this was provided in the histograms 
with superimposed normal distribution curves and the normal probability plots for 
these variables. Given that these overall measures of psychopathology have a normal 
distribution, the use of parametric statistical tests is considered valid for these 
variables.  
 
As well as informing a decision on whether or not to use parametric statistics, 
examining the distribution of each of the three overall measures allows consideration 
of whether psychopathology experienced by adults with intellectual disabilities has a 
continuous or bimodal distribution. To illustrate this, the histogram for the total 
dimension factor score is shown in figure 4.2. Examining figure 4.2, there do not 
appear to be any clear break points in the distribution, or a two peaked distribution 
suggestive of bimodality. Thus, along with the evidence to support a normal 
distribution in table 4.11, it appears that psychopathology assessed using the PPS-LD 
is best considered as a continuous measure. This suggests that a dimensional rather 
than categorical model of psychopathology may be appropriate.  
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Table 4.11: Summary and normality data of the dimensional and overall measure of psychopathology  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
  Skewness Kurtosis Normality test 
  
 
Mean 
 
Min 
 
Max 
 
SD S z-score§ K z-score§ Shapiro-Wilk p 
Depressive .16 -1.92 2.14 .99 .067 .337 -.909 2.301* 
.978* .018 
Organic .08 -.91 4.48 1.00 1.914 9.618*** 3.668 9.286*** 
.748*** .000 
Behaviour-
affective 
.31 -1.40 2.77 .94 .442 2.221* -.518 1.311 
.972** .004 
Anxiety .24 -1.77 3.44 1.05 .487 2.447* .204 .516 
.981* .039 
 
Dimension 
factor scores 
Total .78 -3.32 5.88 1.96 .204 
 
1.01 -.35 .89 .99 .216 
Depressive 3.63 0 9.00 2.50 .169 .849 -1.02 2.582** 
.944*** .000 
Organic .67 0 6.00 1.31 2.011 10.106*** 3.517 8.904*** 
.582*** .000 
Behaviour-
affective 
2.79 0 8.00 1.88 .433 2.176* -.540 1.367 
.940*** .000 
Anxiety 2.57 0 7.00 1.69 .554 2.784** -.154 .390 
.932*** .000 
 
Dimension 
symptom 
counts 
Total 9.66 1 19.0 3.96 .17 
 
.85 -.52 1.32 .98 .05 
EFA PPS-LD symptom count- 
41 
11.12 2 22 4.13 .33 
 
1.66 -.31 .78 .98 .050 
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Figure 4.2: A histogram showing the distribution of the total dimension factor 
score 
Total dimension factor score
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In contrast to the three overall measures of psychopathology, the Shapiro-Wilk tests in 
table 4.11 suggest that all eight measures of psychopathology (the four individual 
dimension factor scores and symptom counts) differ significantly from the normal 
distribution. The distribution of all variables is positively skewed to different extents- 
the depressive dimension factor scores are the least positively skewed, and the organic 
dimension factor scores have the greatest positive skew. To try and move the 
distribution of the variables closer to normality, initially a square root and logarithmic 
transformation were applied separately to the dimensional measures of 
psychopathology. The statistical results of the distributions of the transformed 
variables are shown in table 4.12 below. It appears that the square root transformation 
has moved the distribution of the depressive, behaviour-affective and anxiety factor 
scores closer to normality. For all three variables, the skewness and kurtosis z-scores, 
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and Shapiro-Wilk test are no longer significant, suggesting that the distributions no 
longer differ from normality. This was confirmed in the histograms and normal 
probability plots for square root transformed depressive, behaviour-affective and 
anxiety factor scores. 
 
However, neither the square root nor logarithmic transformations moved the organic 
dimension factor score closer to a normal distribution on the statistical measures in 
table 4.12. Therefore, an inverse transformation was tried and lead to some 
improvement in the skewness (-.499; z-score= 2.508) and kurtosis (-.550; z-score= 
1.392). However, the Shapiro-Wilk score (.949; p< .001) suggested that the 
distribution was still significantly different from normality. Overall, none of the 
transformations moved the distribution of the organic dimension factor score closer to 
normality. Therefore, non-parametric methods were used in subsequent analyses using 
the organic dimension factor score. 
 
In table 4.12, it is apparent that the square root and logarithmic transformations did not 
move the distribution of the four dimension symptom counts towards normality. The 
Shapiro-Wilk test remains significant for the transformed depressive, organic, 
behaviour-affective and anxiety dimension symptom counts. Therefore, the inverse 
transformation of these was carried out there but there was no significant shift in the 
skewness and kurtosis, and the Shapiro-Wilk score in table 4.13 confirms that the 
distributions of the dimension symptom count variables differed significantly from 
normality. 
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Table 4.12: Statistical tests of skewness, kurtosis and normality for square root and logarithmic transformed measures of psychopathology  
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
 Square root transformation Logarithmic transformation 
 Skewness Kurtosis Normality test Skewness Kurtosis Normality test 
 S z-
score§ 
K z-
score§ 
Shapiro
-Wilk 
p S z-score§ K z-
score§ 
Shapiro-
Wilk 
p 
Depressive 
-.231 1.161 -.736 1.863 .982 .160 -.585 2.940** -.165 .418 .975* .035 
Organic 1.496 7.517*** 1.619 4.099*** .845*** .000 1.144 5.749*** .438 1.109 .893*** .000 
Behaviour-
affective .103 .518 -.658 1.666 .983 .193 -.274 1.377 -.419 1.061 .986 .342 
 
Dimension 
factor scores 
Anxiety 
-.015 .075 -.088 .414 .992 .759 -.549 2.759** .315 .797 .967** .008 
Depressive 
-.256 1.286 -1.036 2.623** .942*** .000 -.709 3.563*** -.600 1.519 .931*** .000 
Organic 1.659 8.337*** 1.544 3.909*** .655*** .000 1.433 7.201*** .483 1.223 .655*** .000 
Behaviour-
affective -.040 .201 -.796 2.015* .952** .001 -.554 2.784** -.433 1.096 .906*** .000 
 
Dimension 
symptom 
counts Anxiety 
.038 .191 -.596 1.509 .950*** .000 -.509 2.558* -.286 .724 .947*** .000 
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Table 4.13: Statistical tests of skewness, kurtosis and normality for the inverse 
transformation of the symptom counts of the four dimensions of psychopathology  
 
 
 
Z-score values are calculated by dividing the statistic score by the standard errors 
.199 for skewness and .395 for kurtosis. 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
 
 
All of the distributions remain positively skewed, most obviously for the organic 
dimension symptom count, illustrated in figure 4.3. Part of the reason for this is the 
number of cases with zero scores on each the specific symptom count. This effect has 
been described previously for research using symptom count distributions (Melzer, 
2002). Therefore, as for the organic dimension factor score, the analyses involving the 
individual dimension symptom counts will use non-parametric statistical methods. 
Inverse transformation  
Skewness Kurtosis Normality test 
Symptom 
count 
stat z-score stat z-score S-W p 
Depressive 1.546 7.769*** 1.153 2.919** .723*** .000 
Organic 
-1.208 6.056*** -.405 1.025 .589*** .000 
Behaviour-
affective 1.618 8.131*** 1.960 4.962*** .761*** .001 
Anxiety 1.673 8.407*** 2.458 6.223*** .768*** .000 
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Figure 4.3: The histogram showing the distribution of the organic dimension 
symptom count 
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4.3.2 Distribution of age 
The mean age of sample 2 is 43.5 years (range= 17-74; SD ± 13.1). Although, the 
Shapiro-Wilk test statistic approaches significance (.982; p= 0.053), the non-
significant skewness z-score of 0.317, and a non-significant kurtosis z-score of 1.56 
(z-score ≥ ± 1.96, is significant at p < 0.05) suggest there is a slightly flat 
distribution unlikely to be improved by transformation. Since, age in years has a 
distribution which is close to normality, it is assumed that it can be reliably used in 
parametric analyses. 
 
4.3.3 The association of psychopathology with gender 
The descriptive statistics and results of statistical analyses examining the 
relationship between gender and psychopathology are shown in table 4.14. In the 
final two columns, the results of the Student t-tests and non-parametric Mann-
Whitney tests suggest that there are no significant gender differences in any of the 
dimensional measures of psychopathology. 
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Table 4.14: The relationship between gender and dimensional measures of psychopathology 
 
 
Gender Mean 
 
 
Min - Max SD statistic 
 
 
p 
male .14 -1.85 - 2.12 1.06 Depressive‡ 
female .19 -1.92 - 2.14 .92 
-.458 .647 
male .113 -.91 - 4.48 1.02 Organic  
female .032 -.86 - 4.03 .98 
.614† .539 
male .35 -1.40 - 2.77 .99 Behaviour-
affective‡ 
  
female .25 -1.22 - 2.57 .88 .459 .647 
male .18 -1.77 - 2.69 1.00 Anxiety‡ 
  female .30 -1.71 - 3.44 1.10 
-.685 .494 
male .78 -3.32 - 5.05 2.07 
 
 
 
 
 
 
Dimension factor 
scores 
Total 
  female .78 -3.08 - 5.88 1.84 .010 .992 
male 3.57 0 - 9 2.65 Depressive  
  female 3.71 0 - 9 2.33 
-.384† .701 
male .73 0 - 6 1.35 Organic  
  female .60 0 - 6 1.26 
.678† .497 
male 2.88 0 - 8 2.02 Behaviour-
affective  
  
female 2.68 0 - 7 1.71 .547† .584 
male 2.44 0 - 8 1.54 Anxiety  
  female 2.72 0 - 7 1.86 
-.534† .593 
male 9.62 1 - 18 4.23 
 
 
 
 
 
Dimension symptom 
counts 
Total  
  female 9.71 2 -19 3.65 
-.135 .892 
male 11.27 2 -20 4.28 EFA PPS-LD symptom count- 41  
  female 11.09 2 - 22 3.8 
.274 .785 
 
‡ The square root transformed variable was used in the statistic analysis 
† Non- parametric z-score from Mann-Whitney test 
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4.3.4 The relationship between psychopathology and age 
The dimensional measures of psychopathology are examined against continuous and 
categorical measures of age, and the correlations reported in table 4.15. 
 
Table 4.15: The relationship between age and measures of psychopathology. 
 
 
 
 Age in years 
 
Measure of 
psychopathology R 
 
 
p 
Depressive‡ .214** .009 
Organic .098† .234 
Behaviour-affective‡  
 
-.217** .008 
Anxiety‡ 
 
-.210* .010 
 
 
 
 
Dimension factor 
scores 
Total -.016 .850 
Depressive  .171†* .038 
Organic  
  
.174†* .034 
Behaviour-affective  
  
-.230†** .005 
Anxiety  
  
-.215†** .009 
 
 
 
 
Dimension 
symptom counts 
Total -.018 .829 
EFA PPS-LD symptom count- 41  
-.035 .669 
 
 
* significant at the p< .05 level  
** significant at the p< .01 level 
‡ the square root transformed variable is used in the analyses 
† Non-parametric Spearman’s correlation co-efficient  
§ Non- parametric z-score from Mann-Whitney test 
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Some interesting results were seen in table 4.15. Age in years is significantly 
correlated to the depressive, behaviour-affective and anxiety factor scores, and all 
four dimension symptom counts. However, the direction of the correlation is not the 
same for all four dimensions of psychopathology. The depressive factor score, 
depressive symptom count and the organic dimension symptom count, are positively 
correlated with age in years i.e. the factor score and symptom counts increase as age 
increases. In contrast, there is an inverse correlation between age and the factor 
scores, and symptom counts, for the behaviour-affective and anxiety dimensions.  
 
4.3.5 Psychopathology and living circumstances 
Table 4.16 shows that only the organic and behaviour-affective dimension factor 
scores were significantly associated with living circumstances.  
 
A Bonferroni correction was used to take account of the multiple comparisons in the 
post-hoc tests. Since there are two separate comparisons for each variable the 
accepted levels of significance are p < .025, p < .005 and p< .0005. Mann-Whitney 
tests were used for the post-hoc tests for the organic dimension factor score. There 
are significant differences between individuals living independently compared to 
individuals with support from family carers (z=-3.201, p=.001) and individuals 
living with support from family carers against paid carers (z=-2.635, p=.008)  Post 
hoc Bonferroni tests found that the only significant difference in the behaviour-
affective factor score was between individuals living independently and with paid 
carers (mean difference= 0.1744, p= .014).   
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Table 4.16: The relationship between living circumstances and psychopathology  
 
 
* significant at the p< .05 level   
** significant at the p< .01 level 
† Non-parametric Kruskall-Wallis test  
‡ square root transformed variable used in the analyses 
 
 
 
Living 
circumstances Mean SD Min Max 
 
 
F 
 
 
p 
Independent 1.79 .30 1.00 2.25 
Family carer 1.69 .29 1.13 2.16 
Depressive‡ 
 
Paid carer 1.73 .29 1.03 2.24 
.846 .431 
Independent 
-.20 .75 -.91 2.18 
Family carer .35 1.01 -.59 2.82 
Organic  
  
  
Paid carer .052 1.04 -.86 4.48 
 
 
11.26†** 
 
 
.004 
Independent 1.48 .21 1.00 1.84 
Family carer 1.63 .26 1.18 2.20 
Behaviour-
affective‡  
Paid carer 1.66 .30 1.01 .27 
4.176* .017 
Independent 1.78 .28 -1.68 2.64 
Family carer 1.65 .29 -1.25 3.44 
Anxiety‡  
  
 
Paid carer 1.71 .31 -1.77 1.95 
1.409 .248 
Independent .46 1.97 -2.97 5.88 
Family carer .72 1.81 -3.32 4.54 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor 
scores 
 
Total 
  
 
Paid carer .91 2.03 -3.08 5.05 
.573 .565 
Independent 4.00 2.43 0 8 
Family carer 3.29 2.56 0 8 
Depressive 
  
  
  
Paid carer 3.66 2.51 0 9 
1.241† .538 
Independent .41 .89 0 3 
Family carer .97 1.44 0 4 
Organic 
Paid carer .63 1.35 0 6 
3.206† .201 
Independent 2.04 1.37 0 4 
Family carer 2.86 1.87 0 6 
Behaviour-
affective  
  
Paid carer 2.99 1.98 0 8 
4.513† .105 
Independent 2.89 1.85 0 7 
Family carer 2.29 1.66 0 6 
Anxiety 
  
  
Paid carer 2.59 1.66 0 7 
1.844† .398 
Independent 9.33 4.10 2 19 
Family carer 9.40 4.13 1 17 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  
  
Paid carer 9.86 3.89 2 18 
.277 .758 
Independent 10.70 4.11 1.23 2.44 
Family carer 11.00 4.09 1.02 2.34 
EFA  PPS-LD symptom 
count- 41  
  
  
Paid carer 11.41 4.07 1.00 2.49 
.361 .698 
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4.3.6 Psychopathology and level of intellectual disabilities 
The descriptive statistics for the measures of psychopathology are shown for participants 
with mild to profound intellectual disabilities in table 4.17. 
 
Post hoc, Bonferroni test results in table 4.18 clarify the nature of the between group 
differences for the psychopathology variables with significant differences from the initial 
ANOVA tests. Mann-Whitney tests were used as the post-hoc tests for the organic 
dimension factor score and behaviour-affective symptom count, which were initially 
examined using the non-parametric Kruskall-Wallis test and the results shown in table 
4.19.  
 
Several of the analyses in table 4.18 and 4.19 would be significant if the accepted 
minimum level of significance was p < .05. However, to take account of the multiple 
comparisons a Bonferroni correction is used. Since there are three separate comparisons 
for each variable the accepted levels of significance are p < .0167, p < .003 and p< .0003. 
 
4.3.7 Psychopathology and categorical clinical variables 
Tables 4.20-4.24 show the results of analyses examining the associations between the 
dimensional measures of psychopathology and categorical social variables- epilepsy, 
diagnosis of autism, Down syndrome, visual impairment, hearing impairment, mobility 
problems, urinary incontinence and bowel incontinence.  
 
The only variable that was significantly associated with epilepsy was the anxiety 
dimension factor score. Post hoc Bonferroni tests found that the only significant between 
group difference was between the non-epilepsy group and individuals with poorly 
controlled seizures (mean difference= 0.29, p=.001). 
 161 
Table 4.17: The relationship between intellectual disabilities and psychopathology 
 
 
Intellectual 
disabilities Mean SD Min Max 
F p 
mild .05 .96 -1.92 2.14 
moderate .34 .92 -1.50 2.01 
severe .13 .97 -1.69 2.06 
Depressive‡ 
 
profound .15 1.08 -1.85 2.12 
.521 .669 
mild 
-.13 .74 -.91 2.18 
moderate .24 1.26 -.63 4.48 
severe .42 1.13 -.86 2.82 
Organic  
  
  
  
profound 
-.11 .81 -.71 2.55 
 
 
8.255†* 
 
 
.041 
mild 
-.11 .62 -1.25 1.61 
moderate .51 .93 -.70 2.57 
severe .22 1.09 -1.36 2.77 
Behaviour-
affective‡  
  
  
  
profound .52 .94 -1.40 2.45 
3.712* .013 
mild .26 1.05 -1.68 2.64 
moderate .72 1.10 -1.25 3.44 
severe 
-.16 .91 -1.77 1.95 
Anxiety‡  
  
  
  
profound .19 1.00 -1.71 2.60 
4.116** .008 
mild .07 1.99 -3.08 4.64 
moderate 1.81 1.95 -.68 5.88 
severe .62 1.58 -2.89 4.05 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor scores 
 
Total 
  
  
  
profound .74 1.98 -3.32 5.05 
4.750** .003 
mild 3.38 2.44 0 8 
moderate 4.06 2.38 0 9 
severe 3.55 2.36 0 9 
Depressive 
  
  
  
profound 3.59 2.74 0 8 
 
 
1.393† 
 
 
.707 
mild .47 .90 0 3 
moderate .84 1.70 0 6 
severe 1.09 1.51 0 4 
Organic 
profound .43 1.06 0 4 
 
 
4.895† 
 
 
.180 
mild 2.06 1.46 0 6 
moderate 3.19 1.70 0 7 
severe 2.55 2.14 0 8 
Behaviour-
affective  
  
  
  
profound 3.18 1.94 0 7 
 
 
10.077†* 
 
 
.018 
mild 2.62 1.88 0 7 
moderate 3.26 1.79 0 7 
severe 2.09 1.31 0 5 
Anxiety 
  
  
  
profound 2.43 1.64 0 7 
 
 
7.003† 
 
 
.072 
mild 8.53 4.19 2 17 
moderate 11.35 3.77 7 19 
severe 9.27 3.28 3 17 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  
  
  
profound 9.63 4.09 1 18 
3.038* .031 
mild 9.8 4.20 2 17 
moderate 12.94 4.12 7 22 
severe 10.70 3.34 4 18 
 
EFA  PPS-LD symptom 
count- 41  
 
profound 11.35 4.06 2 19 
 
 
3.554* 
 
 
.016 
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Table 4.18: Post hoc Bonferroni tests of ANOVA between group differences for level of intellectual disabilities and measures of 
psychopathology 
 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mean 
Difference 
(I-J) 
Std. 
Error p 
95% Confidence 
Interval 
mild moderate 
-.184 .069 .050 -.369 .0001 
  severe 
-.087 .068 1.000 -.268 .095 
Behaviour affective‡ 
  
  
  
  profound 
-.183 .062 .020 -.348 -.019 
moderate mild .135 .073 .407 -.061 .331 
  severe .258* .074 .004 .060 .456 
 Anxiety‡ 
  
  
  
  profound 
.154 .067 .141 -.026 .334 
mild moderate -1.74** .470 .002 -2.999 -.484 
  severe 
-.547 .463 1.000 -1.784 .690 
Dimension  factor scores 
Total 
  
  
  profound 
-.671 .419 .668 -1.793 .450 
mild moderate 
-1.13 .457 .085 -2.356 .0868 
  severe -.487 .449 1.000 -1.689 .715 
Behaviour-affective  
  
  
  profound 
-1.11 .407 .041 -2.207 -.0286 
mild moderate 
-2.825 .965 .024 -5.406 -.245 
  severe 
-.743 .949 1.000 -3.283 1.796 
Dimension symptom 
counts Total 
  
  
  profound 
-1.098 .860 1.000 -3.399 1.203 
mild moderate 
-3.112* .984 .011 -5.743 -.481 
  severe 
-.873 .968 1.000 -3.462 1.716 
  
 EFA PPS-LD symptom count- 41 
 
  profound 
-1.529 .878 .500 -3.876 .817 
 
* significant at the p< .0167 level ** significant at the p < .003 
‡ the square root transformed variable is used in the analyses 
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Table 4.19: The non-parametric post hoc tests for the between group differences for level of intellectual disabilities and the organic 
dimension factor score and behaviour-affective and anxiety symptom counts 
 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mann-Whitney 
U z p 
moderate mild 410 -1.537 .124 
  severe 486 -.343 .732 
  profound 559 -2.214 .027 
severe mild 400 -2.019 .043 
  moderate 486 -.343 .732 
 
 
 
Dimension  factor scores 
Organic 
  
  
  
  
  
  profound 606 -2.157 .031 
mild moderate 326 -2.693* .007 
  severe 518 -552 .581 
Behaviour-affective  
  
  
  profound 571 -2.696* .007 
mild moderate 1332 -2.366 .018 
  severe 1541 -1.740 .082 
 
 
 
 
Dimension symptom 
counts 
Anxiety  
  profound 2361 -.563 .574 
 
* significant at the p< .0167 level  
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Table 4.20: The relationship between epilepsy and psychopathology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< .01 level 
‡ square root transformed variable used   
† Non- parametric χ² from Kruskall-Wallis test  
 
 
 
 Epilepsy Mean SD Min Max 
 
 
F 
 
 
p 
no .24 1.00 -1.92 2.14 
good control -.12 .93 -1.20 1.88 
Depressive‡ 
 
poor control .15 .99 -1.12 2.12 
1.394 .251 
no .05 .93 -.91 2.82 
good control -.002 1.06 -.69 4.48 
Organic  
  
poor control .43 1.31 -.59 4.02 
2.846† .241 
no .25 .93 -1.39 2.57 
good control .46 1.00 -1.07 2.77 
Behaviour-
affective ‡ 
  poor control .43 .90 -.80 1.78 
.765 .467 
no .40 1.04 -1.77 3.44 
good control .02 .82 -1.56 2.27 
Anxiety ‡ 
  
   poor control -.49 1.14 -1.72 1.70 
7.020** .001 
no .94 1.86 -2.96 5.88 
good control .36 2.20 -3.32 4.96 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor scores 
 
Total 
  
  poor control .53 2.16 -3.08 4.27 
1.118 .330 
no 3.86 2.49 0 9 
good control 2.93 2.36 0 8 
Depressive 
  
  
  
poor control 3.40 2.75 0 8 
 
3.294† 
 
.193 
no .66 1.24 0 4 
good control .48 1.30 0 6 
Organic 
poor control 1.13 1.73 0 6 
3.798† 
 
.150 
no 2.64 1.82 0 7 
good control 3.10 2.04 0 8 
Behaviour-
affective  
  poor control 3.20 1.97 0 6 
2.133† 
 
.344 
no 2.77 1.72 0 7 
good control 2.24 1.48 0 6 
Anxiety 
  
  poor control 1.80 1.66 0 5 
5.588† .061 
no 9.92 3.76 2 19 
good control 8.76 4.28 1 17 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  
  poor control 9.53 4.69 1 17 
.990 .374 
no 11.44 3.91 4 22 
good control 10.44 4.40 2 19 
EFA PPS-LD symptom count- 
41  
  
  
poor control 10.87 4.52 2 18 
.724 .487 
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Table 4.21: The relationship between autism, Down syndrome and psychopathology. 
 
 
 Autism Down syndrome 
 
 Yes (n=19) No (n=131) Yes (n=24) No (n=126) 
 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
Depression ‡ 
-.07 1.05 .20 .98 1.130 .260 .35 .99 .13 .99 -1.000 .319 
Organic  
-.31 .39 .13 1.05 -1.337† .181 .74 1.14 -.05 .92 -3.388**† .001 
Behaviour-
affective‡  
 
.30 1.14 .31 .91 .209 .835 -.0002 .91 .36 .93 1.824 .070 
Anxiety ‡ 
 
.40 .46 .21 1.11 -1.895§ .063 .20 .99 .24 1.06 .166 .868 
 
 
 
 
 
 
Dimension factor 
scores 
Total 
.33 2.12 .85 1.94 1.086 .279 1.29 1.67 .68 2.00 -1.385 .168 
Depressive  2.95 2.63 3.73 2.48 -1.367† .172 4.33 2.44 3.50 2.50 1.625† .104 
Organic  
  
.16 .50 .75 1.37 -1.779† .075 1.50 1.64 .51 1.18 3.263**† .001 
Behaviour-affective  
  
3.00 2.24 2.75 1.83 -.286† .775 1.96 1.81 2.94 1.86 -2.371*† .018 
Anxiety  
  
3.00 1.15 2.51 1.75 -1.749† .080 2.25 1.54 2.63 1.72 -.847† .397 
 
 
 
 
Dimension 
symptom counts 
Total 9.11 4.67 9.74 3.87 .649 .517 10.04 3.51 9.58 4.05 -.517 .606 
EFA PPS-LD symptom count- 41  10.58 4.57 11.28 3.99 .698 .486 11.75 3.57 11.08 4.16 -.739 .461 
 
** significant at the p< .01 level 
‡ the square root transformed variable is used in the analyses 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed 
† Non- parametric z score from Mann-Whitney test 
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Table 4.22: The relationship between sensory impairments and psychopathology. 
 
 
 Visual impairment Hearing impairment 
 
 Yes (n=27) No (n=122) Yes (n=12) No (n=137) 
 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
Depressive‡ 
.26 .97 .14 1.00 -.636 .526 .10 .98 .17 .99 .213 .831 
Organic  
-.25 .58 .15 1.06 -2.198*† .028 .04 1.08 .08 .99 -.467† .640 
Behaviour-affective‡  
.28 .88 .31 .95 .090 .929 .30 .75 .31 .95 -.085 .932 
Anxiety ‡ 
.11 .98 .27 1.06 .640 .523 .46 1.31 .22 1.02 -.653 .515 
 
 
 
 
 
 
Dimension 
factor scores 
Total 
.41 1.58 .87 2.04 1.101 .273 .90 1.36 .77 2.01 -.210 .834 
Depressive  3.93 2.51 3.57 2.51 -.638† .524 3.50 2.32 3.64 2.53 -.063† .950 
Organic  
.37 .74 .74 1.40 -.826† .409 .67 1.56 .67 1.29 -.506† .613 
Behaviour-affective 2.59 1.78 2.83 1.91 -.495† .621 2.50 1.62 2.81 1.90 -.478† .633 
Anxiety  
  
2.26 1.63 2.64 1.71 -1.047† .295 2.75 2.01 2.55 1.67 -.341† .733 
 
 
 
 
Dimension 
symptom 
counts 
Total 9.15 3.22 9.77 4.11 .737 .462 9.42 2.91 9.68 4.05 .219 .827 
EFA PPS-LD symptom count- 41  10.78 3.50 11.28 4.18 .578 .564 11.25 2.34 11.18 4.19 -.088§ .931 
 
** significant at the p< 0.01 level 
‡ the square root transformed variable is used in the analyses 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed 
† Non- parametric z-score from Mann-Whitney test 
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Table 4.23: The relationship between mobility problems and psychopathology. 
 
 
 Mobility problems 
 
 Yes (n=37) No (n=113) 
 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
Depressive‡ 
.17 1.03 .16 .98 -.020 .984 
Organic  
.16 1.12 .05 .96 -.009† .993 
Behaviour-
affective‡  
 
.20 .89 .34 .95 .790 .431 
Anxiety‡  
 
-.27 1.01 .40 1.01 3.755*** .000 
 
 
 
 
 
 
Dimension factor 
scores 
Total 
.25 1.79 .96 2.00 1.912 .058 
Depressive  3.62 2.74 3.64 2.43 -.031† .975 
Organic  
  
.76 1.46 .64 1.26 -.230† .818 
Behaviour-affective  
  
2.46 1.79 2.89 1.90 -1.146† .252 
Anxiety  
  
1.79 1.53 2.83 1.67 -3.360**† .001 
 
 
 
 
Dimension 
symptom counts 
Total 8.62 3.91 10.00 3.94 1.849 .067 
EFA PPS-LD symptom count- 41  10.24 3.70 11.50 4.14 1.641 .103 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
† Non- parametric z score from Mann-Whitney test 
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Table 4.24: The relationship between incontinence and psychopathology. 
 
 
 Urinary incontinence Bowel incontinence 
 
 Yes (n=53) No (n=97) Yes (n=38) No (n=112) 
 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
Depressive ‡ 
.26 .98 .11 1.00 -.946 .346 .25 1.02 .13 .98 -.600 .549 
Organic  
.23 1.23 -.01 .83 -.345† .730 .17 1.14 .04 .95 -.100† .920 
Behaviour-affective‡  
.55 .94 .17 .91 -2.383* .018 .45 .94 .26 .94 -1.073 .285 
Anxiety ‡ 
 
-.03 1.06 .38 1.02 2.475* .014 -.17 1.08 .38 1.00 3.142** .002 
 
 
 
 
 
 
Dimension 
factor scores 
Total 1.00 2.08 .66 1.89 -1.040 .300 .69 2.09 .81 1.93 .332 .741 
Depressive  4.00 2.67 3.43 2.40 -1.306† .192 3.87 2.70 3.55 2.44 -.735† .463 
Organic  
  
.83 1.57 .58 1.14 -.598† .550 .74 1.43 .65 1.27 -.113† .910 
Behaviour-affective 3.11 1.90 2.60 1.86 -1.577† .115 2.89 1.93 2.75 1.87 -.473† .636 
Anxiety 2.17 1.67 2.79 1.67 -2.362*† .018 1.97 1.71 2.77 1.64 -2.687**† .007 
 
 
 
 
Dimension 
symptom 
counts 
Total 10.11 4.05 9.41 3.92 -1.042 .299 9.47 4.15 9.72 3.92 .331 .741 
EFA PPS-LD symptom count- 41  11.75 4.11 10.88 4.02 -1.268 .207 11.05 4.26 11.23 4.01 .237 .813 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
‡ the square root transformed variable is used in the analyses 
† Non- parametric z score from Mann-Whitney test  
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Since there are several significant associations between measures of psychopathology 
and socio-clinical variables the null hypothesis is rejected. 
 
4.4 Multivariate associations between measures of psychopathology 
and socio-clinical variables 
 
Several of the socio-clinical variables may be correlated, such as level of intellectual 
disabilities and epilepsy. To take account of such cross-correlations, multiple linear 
regression was used to explore whether any socio-clinical variables associated with the 
measures of psychopathology in the bivariate analyses are independently associated.  
 
Tables 4.25 and 4.26 give the results of the multivariate analyses for the dimension 
factor scores and dimension symptom counts. Each table provides the p value from the 
bivariate analyses in section 4.3, and the results of the multiple linear regression analysis 
for those variables retained in the final model. Since level of intellectual disabilities was 
the only socio-clinical variable significantly associated with the overall measure of 
psychopathology, EFA PPS-LD symptom count- 41, in the bivariate analyses, there is 
no requirement for a multivariate analysis.  
 
 
 
 
Null hypothesis four: 
There are no significant cross-sectional, multivariate relationships between 
dimensional measures of psychopathology and socio-clinical variables. 
 
 170 
 
 
Table 4.25: Multivariate associations of socio-clinical variables with dimension factor scores 
 
Bivariate associations (p< .1) Multivariate associations 
Dimension of 
psychopathology Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive ‡ 
Continuous measure of age (years)  .009**  .005 .002 .214 .009** .046 
Independent- 
family carer Not retained in the model Living circumstances .004** 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
Not retained in the model 
 
Mild-severe .467
a
 .192 .195 .016* Categorical measure of intellectual disabilities .041* 
 
Mild- profound Not retained in the model 
Down syndrome .001** 
 
.800 .208 .296 .000*** 
 
 
 
 
 
 
Organic 
Visual impairment .028* 
 
Not retained in the model 
.156 
Continuous measure of age (years) .008**  -.005 .002 -.208 .010* 
Independent- 
family carer Not retained in the model Living circumstances .017* 
Independent- 
paid carer Not retained in the model 
Mild-moderate 
.181 .067 .258 .008** 
Mild-severe 
.136 .067 .198 .046* Categorical measure of intellectual disabilities .013* 
Mild-profound 
.195 .060 .326 .001** 
 
 
 
 
 
 
 
 
Behaviour-affective 
‡ 
 
Down syndrome .070 
 
-.135 .061 -.175 .028* 
.141 
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Visual impairment .090 
 
Not retained in the model  
Urinary incontinence .018* 
 
Not retained in the model  
Continuous measure of age (years) .010*  -.004 .002 -.163 .035* 
Mild-moderate 
.148 .060 .198 .015* 
Mild-severe 
Not retained in the model Categorical measure of intellectual disabilities .013* 
Mild-profound 
Not retained in the model 
Diagnosis of autism .063 
 
Not retained in the model 
Urinary incontinence .014* 
 
Not retained in the model 
Bowel incontinence .002** 
 
-.143 .063 -.205 .024* 
No epilepsy- 
poor seizure 
control 
-.215 .077 -.213 .006** 
Epilepsy .001** 
No epilepsy- 
good seizure 
control 
Not retained in the model 
 
 
 
 
 
 
 
 
 
 
 
Anxiety‡ 
Mobility problems .000*** 
 
-.115 .057 -.163 .048* 
.232 
Mild-moderate 
1.298 .383 .269 .001** 
Mild-severe 
Not retained in the model Categorical measure of intellectual disabilities .003** 
Mild-profound 
Not retained in the model 
 
 
 
 
Total 
Mobility problems .058 
 
Not retained in the model 
.073 
 
* significant at the p< .05 level ** significant at the p< .01 level *** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
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Table 4.26: Multivariate associations of socio-clinical variables with dimension symptom counts 
 
Bivariate associations (p< .1) Multivariate associations 
Dimension of 
psychopathology Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive 
Continuous measure of age (years) .038*  .032 .016 .166 .043* .028 
Continuous measure of age (years) .034*  .020 .008 .199 .012* 
Down syndrome .001** 
 
.987 .276 .278 .000*** 
 
 
 
Organic 
Autism .075 
 
Not retained in the model 
.117 
Continuous measure of age (years) .005**  -.027 .012 -.188 .021* 
Mild-moderate 
1.116 .440 .242 .012* 
Mild-severe 
Not retained in the model Categorical measure of intellectual disabilities .018* 
Mild-profound 
1.229 .396 .311 .002** 
 
 
 
 
 
Behaviour-affective  
 
Down syndrome .018* 
 
-1.112 .401 -.218 .006** 
.141 
Continuous measure of age (years) .009**  -.022 .010 -.172 .031* 
Mild-moderate 
.656 .328 .158 .048 
Mild-severe 
Not retained in the model Categorical measure of intellectual disabilities .072 
Mild-profound 
Not retained in the model 
Diagnosis of autism .080 
 
Not retained in the model 
 
 
 
 
 
 
 
 
Anxiety 
Urinary incontinence .018* 
 
Not retained in the model 
.127 
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Bowel incontinence .007** 
 
Not retained in the model 
Epilepsy .061 
 
Not retained in the model 
Mobility problems .001** 
 
-.816 .313 -.209 .010 
 
Mild-moderate 
2.143 .783 .220 .007** 
Mild-severe 
Not retained in the model Categorical measure of intellectual disabilities .031* 
Mild-profound 
Not retained in the model 
 
 
 
 
Total 
Mobility problems .067 
 
Not retained in the model 
.048 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
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Although the final regression models for the factor score and symptom count for a 
specific dimension of psychopathology are similar overall, there are some interesting 
differences. For example, older age is independently associated with higher scores on 
the organic dimension symptom count, but not the organic dimension factor score. A 
final point to note is that the three overall measures of psychopathology are only 
independently associated with level of intellectual disabilities. These points of note and 
others are considered fully in the discussion in chapter 5. 
 
With specific reference to null hypothesis four, there are socio-clinical variables 
independently associated with each of the eight dimension factor scores and symptom 
counts, and the overall measures of psychopathology. Therefore, the null hypothesis is 
rejected. 
 
 4.5 The cross-sectional relationship between psychopathology and 
measures of the severity of mental disorders 
 
This section examines the relationships between the dimensional and overall measures 
of psychopathology and the six measures of the severity of mental disorders.  
 
Prior to investigating the hypothesis, Table 4.27 reports the descriptive statistics and 
results of tests examining the skewness, kurtosis and overall distribution of the six 
measures of severity, in comparison to the normal distribution. It appears that the 
HONOS-LD total score, CGI rating, CANDID met needs and CANDID total needs have 
a distribution that does not differ significantly from normal. Therefore, it is appropriate 
to use parametric statistical tests in analyses including these variables. 
 
However, results from table 4.27 suggest that the distribution of GAF and the CANDID 
unmet needs scores differ significantly from normality. The difference from normality in 
Null hypothesis five: 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and the severity of mental disorders. 
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the distribution of the GAF scores is accounted for by the significant kurtosis score, 
indicative of a flat distribution. Since transforming the data has more of an effect on a 
skewed distribution, than an abnormal kurtosis, it is unlikely to move the GAF 
distribution closer to the normal distribution. Therefore, any analyses using the GAF 
scores will make use of non-parametric tests. 
 
The distribution of the CANDID-R unmet needs scores in table 4.27 is positively 
skewed. Square root and logarithmic transformations were used in an attempt to move 
the distribution closer to normality, and the results shown in table 4.28. The distribution 
of the square root transformed CANDID-R unmet needs scores still differ significantly 
from normality due to a significant positive skew, in table 4.28. A logarithmic 
transformation has a greater effect on a positive skew than a square root transformation; 
however in table 4.28 we can see that it has flipped the distribution to a significant 
negative skew. An inverse transformation was not carried out, since it would further 
increase the negative skew seen in the logarithmic transformed variable. Since none of 
the transformations have moved the CANDID-R unmet needs scores closer to the 
normal distribution, the original CANDID-R unmet needs variable will be used in 
analyses, using non-parametric statistical tests. 
 
As described previously, the CANDID-R total needs variable was not included in 
analyses as it is simply a composite measure of the unmet and met needs. Statistical 
analyses examining the correlations between the five variables representing the 
measures of severity of mental disorder and the dimensional factor scores, dimensional 
symptom counts and overall measures of psychopathology are given in table 4.29-4.31. 
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Table 4.27: Summary and normality data of the measures of severity at baseline.  
 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
  
 
 Skewness Kurtosis Normality test 
Outcome measure 
 
Mean 
 
Min 
 
Max 
 
SD S z-score§ K z-score§ Shapiro-Wilk p 
HoNOS-LD total  23.64 6 48 8.85 .380 1.910 -.410 1.038 .986 .08 
GAF 49.36 18 73 13.33 -.080 .402 -.952 2.41* .973** .005 
CGI 3.71 1 6 1.029 .039 .452 -.417 1.056 .991 .335 
CANDID- unmet  5.80 0 16 3.13 .946 4.754*** 1.091 2.762** .933*** .000 
CANDID- met 9.38 2 18 3.36 -.355 
 
1.784 -.161 .408 .980 .050 
CANDID- total 15.19 9 21 2.561 -.322 1.618 -.356 .901 .990 .203 
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Table 4.28: Statistical tests of skewness, kurtosis and normality for square root and logarithmic transformed CANDID-R 
unmet needs scores 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
 
 
 
 Square root transformation Logarithmic transformation 
 Skewness Kurtosis Normality 
test 
Skewness Kurtosis Normality 
test 
 S z-score§ K z-score§ Shapiro
-Wilk 
p S z-score§ K z-score§ Shapiro-
Wilk 
p 
CANDID-R 
unmet needs .393 1.975* .036 .091 .967** .001 -.410 2.060* .515 1.058 .962*** .000 
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Although there is some variation across the measures of psychopathology, certain 
commonalities can be identified. In all cases where a significant correlation exists, a 
higher level of psychopathology is correlated with a greater score on the measure of 
severity of mental disorder indicative of a poorer outcome. Whilst there are differences 
between the results when dimension factor scores and symptom counts are used in the 
analyses, the factor scores and symptom counts for all four dimensions of 
psychopathology are correlated with at least one measure of the severity of mental 
disorders. The three overall measures of psychopathology- total dimension factor score, 
total dimension symptom count and EFA PSS-LD symptom count-41- are correlated 
with all the measures of severity of mental disorder. 
 
Given the strong correlations between the measures of psychopathology and severity of 
mental disorder at baseline the null hypothesis is rejected. 
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Table 4.29: The correlations between measures of severity of mental disorder and dimension factor scores. 
 
 
Depressive factor 
score‡ 
Organic factor 
score 
Behaviour-
affective factor 
score‡ 
Anxiety factor 
score‡ Total factor score 
 
R p       R† p R p R p      R p 
HoNOS-LD total score 
.421*** .000 .104 .207 .348*** .000 .098 .236 .551*** .000 
GAF† 
-.475*** .000 -.258** .001 -.243** .003 -.055 .506 -.583*** .000 
CGI 
 
.494*** .000 .245** .003 .220** .007 .082 .319 .562*** .000 
CANDID-R unmet 
needs† 
  
.158 .054 
.143 .082 .175* .033 .125 .130 .326*** .000 
CANDID-R met needs 
 
-.153 .063 -.057 .490 .106 .200 -.206* .012 -.185* .024 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
‡ The square root transformed variable was used in the statistic analysis 
† Non-parametric Spearman’s correlation co-efficient  
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Table 4.30: The correlations between measures of severity of mental disorder and dimension symptom counts 
 
 
Depressive 
symptom count 
Organic 
symptom count 
Behaviour-
affective symptom 
count 
Anxiety 
symptom count 
Total symptom 
count 
 
R† p       R† p R† p R† p       R p 
HoNOS-LD total score .416*** .000 .207* .011 .359*** .000 .135 .101 .585*** .000 
GAF -.500*** .000 -.318*** .000 -.262** .001 -.050 .546 -.587†*** .000 
CGI 
 
.543*** .000 .227** .001 .254** .002 .072 .386 .590*** .000 
CANDID-R unmet needs 
  
.165* .044 .243** .003 .206* .012 .117 .157 .322†*** .000 
CANDID-R met needs 
 
-.139 .090 -.144 .080 .075 -.363 -.184* .025 -.184* .025 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
† Non-parametric Spearman’s correlation co-efficient  
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Table 4.31: The correlations between measures of severity of mental 
disorder and the overall PPS-LD symptom count 
 
EFA PPS-LD 
symptom count - 41 
 
      R p 
HoNOS-LD total score .576* .000 
GAF 
-.590*** .000 
CGI 
 
.568*** .000 
CANDID-R unmet needs 
  
.308** .003 
CANDID-R met needs 
 
-.163* .047 
 
 
* significant at the p< 0.05 level  
** significant at the p< 0.01 level  
*** significant at the p< 0.001 level 
† Non-parametric Spearman’s correlation co-efficient  
 
 
 
 
 182 
4.6 Bivariate associations between socio-clinical variables and the 
severity of mental disorders 
 
4.6.1 The association between gender and measures of severity of mental disorder  
The descriptive statistics and results of Student t-tests and Mann-Whitney tests, 
examining the relationship between gender and measures of severity of mental 
disorder are shown in table 4.32. There are no significant gender differences in any 
of the measures of severity of mental disorder. 
 
Table 4.32: The relationship between gender and measures of severity of mental 
disorder  
 
 
† Non- parametric z-score from Mann-Whitney test 
§ Levene’s test found the between group variance is significant so the t-test results 
are for equal variances not assumed 
 Gender Mean SD statistic 
 
 
p 
male 23.67 9.86 HoNOS-LD total score 
female 23.60 7.55 
.045§ .964 
male 50.10 14.452 GAF 
female 48.47 11.904 -.827† .408 
male 3.70 1.078 CGI 
  female 3.72 .975 -.099 .921 
male 5.84 2.777 CANDID-R unmet 
needs 
  
female 5.75 3.534 -.697† .486 
male 9.32 3.320 CANDID-R met needs 
  female 9.46 3.431 -.243 .808 
Null hypothesis six: 
There are no significant bivariate relationships between socio-clinical variables 
and measures of the severity of mental disorders. 
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4.6.2 The association between age and measures of severity of mental disorder  
The correlation between the continuous measure of age and measures of age were 
examined and results shown in table 4.33. There is a significant indirect correlation 
between CANDID-R unmet needs and age, suggesting that younger participants have 
higher level of unmet needs. Although its does not reach statistical significance, the 
opposite result is found for met needs- with a direct correlation between age and met 
needs suggesting older participants have higher met needs.  
 
Table 4.33: The relationship between age and measures of severity of mental 
disorder 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< 0.05 level  
† Non-parametric Spearman’s correlation co-efficient  
  
 
 
4.6.3 Living circumstances and measures of severity of mental disorder 
In table 4.34 there are significant between group differences in the CANDID-R unmet, 
and met needs. For the CANDID-R unmet needs post hoc Mann-Whitney tests found 
significant between group differences for individuals living independently against 
participants living with family carers (z=-2.53, p=.012), and living independently 
against living with support from paid carers (z=-2.876, p=.004). All three between group 
comparisons for the CANDID-R met needs were significant on the post hoc Bonferroni 
 
Continuous measure 
(age in years) 
 R 
p 
HoNOS-LD total score 
-.093 .260 
GAF 
-.060† 
.468 
CGI 
 
.075 .364 
CANDID-R unmet needs 
  
-.177†* .031 
CANDID-R met needs 
 
.153 .062 
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tests- independent against family carer (mean difference=-3.174, p< .000), independent 
against paid carer (mean difference=-4.960, p<.000) and family against paid carer (mean 
difference=-1.787, p=.005).  
 
 
Table 4.34: The relationship between living circumstances and measures of severity 
of mental disorder  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< 0.05 level  
** significant at the p< 0.01 level 
† Non-parametric Kruskall-Wallis test 
  
 
 
 
 
Living 
circumstances Mean SD Min Max 
 
 
F 
 
 
p 
Independent 22.56 7.62 6 35 
Family carer 21.11 8.47 8 42 
 
 
HoNOS-LD 
 
Paid carer 24.99 9.17 8 48 
2.700 .071 
Independent 52.67 10.00 36 72 
Family carer 50.69 15.13 18 73 
 
GAF 
  
  
  
Paid carer 
47.79 13.36 23 72 
2.995† .224 
Independent 3.41 .84 1 5 
Family carer 3.60 1.17 2 6 
CGI 
  
  
  
Paid carer 3.85 1.01 2 6 
2.217 .113 
Independent 8.00 4.81 0 16 
Family carer 5.34 2.84 2 13 
CANDID-R 
unmet needs 
  
  
  
Paid carer 
5.30 2.21 1 11 
9.317†** .009 
Independent 5.74 3.44 2 13 
Family carer 8.91 3.03 3 14 
CANDID-R 
met needs 
  
  
  
Paid carer 
10.70 2.49 5 18 
32.702*** .000 
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4.6.4 The association between level of intellectual disabilities and measures of 
severity of mental disorder  
The descriptive statistics for the measures of severity of mental disorder and results for 
the initial analyses using ANOVA are shown for participants with mild, moderate, 
severe and profound intellectual disabilities in table 4.35. There are significant 
associations between level of intellectual disabilities and the HoNOS-LD score, CGI, 
and CANDID-R met needs. The result of the ANOVA for the CANDID-R unmet needs 
approaches significance (F=6.788, p=.079) and therefore level of intellectual disabilities 
will be included in the multivariate analysis for all measures of severity of mental 
disorder 
 
Post hoc, Bonferroni test results in table 4.36 and non-parametric Mann Whitney tests 
for the CANDID-R unmet needs in table 4.37 clarify the nature of the between group 
differences for the measures of severity of mental disorder with significant with 
significant between group differences from the initial ANOVA tests. 
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Table 4.35: The relationship between level of intellectual disabilities and measures 
of severity of mental disorder  
 
 
 
 
* significant at the p< 0.05 level  
** significant at the p< 0.01 level 
*** significant at the p< 0.001 level 
† Non-parametric Kruskall-Wallis test 
 
  
  
 
 
  
 
 
 
Level of 
intellectual 
disabilities Mean SD Min Max 
 
 
F 
 
 
p 
mild 19.65 7.511 6 35 
moderate 24.42 8.245 8 42 
severe 23.12 7.672 11 40 
HoNOS-LD 
total score 
 
profound 26.16 9.908 8 48 
4.036** .009 
mild 54.47 11.08 36 73 
moderate 47.42 13.03 23 70 
severe 47.73 11.44 28 68 
GAF 
  
  
  profound 48.18 15.36 18 72 
6.222† .101 
mild 3.32 .88 1 5 
moderate 4.06 1.03 2 6 
severe 3.73 .88 2 5 
CGI 
  
  
profound 3.75 1.15 2 6 
2.964* .034 
mild 5.65 4.07 -1.68 2.64 
moderate 7.13 3.54 -1.25 3.44 
severe 5.36 2.16 -1.77 1.95 
CANDID-R unmet 
needs 
  
  
  
profound 5.37 2.50 -1.71 2.60 
6.788† .079 
mild 7.26 3.50 2 13 
moderate 8.23 3.20 3 14 
severe 10.48 2.59 6 18 
CANDID-R  
met needs 
  
  
  
profound 10.78 2.87 3 16 
12.086*** .000 
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Table 4.36: Post hoc Bonferroni tests of ANOVA between group differences for level of 
intellectual disabilities and measures of severity of mental disorder 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mean 
Difference 
(I-J) 
Std. 
Error p 
95% Confidence 
Interval 
mild moderate 
-4.77 2.13 .161 -10.48 .93 
  severe 
-3.47 2.10 .600 -9.09 2.14 
 
HoNOS-LD total 
  
  profound 
-6.51* 1.90 .005 -11.60 -1.42 
mild moderate 
-.74* .25 .022 -1.41 -.07 
  severe 
-.40 .25 .622 -1.06 .26 
 
CGI 
  
  
  profound 
-.42 .22 .366 -1.02 .18 
mild moderate 
-.96 .75 1.000 -2.98 1.06 
  severe 
-3.22*** .74 .000 -5.20 -1.24 
  profound 
-3.52*** .67 .000 -5.32 -1.72 
moderate mild .96 .75 1.000 -1.06 2.98 
 severe 
-2.26 .76 .021 -4.29 -.23 
 
 
 
CANDID-R met needs 
  
  
 profound 
-2.56* .69 .002 -4.41 -.71 
 
 
* significant at the p< .0167 level  
** significant at the p < .003  
*** significant at the p < .0003 
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Table 4.37: The non-parametric post hoc tests for the between group differences for 
level of intellectual disabilities and the CANDID-R unmet needs measure 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mann-Whitney 
U z p 
mild moderate 378 -1.968 .049 
 severe 520 -.519 .604 
 profound 827 -.368 .713 
moderate mild            378 -1.968 .049 
  severe 362 -2.032 .042 
 
CANDID-R unmet 
needs 
  
 profound 543 -2.388* .016 
 
* significant at the p< .0167 level  
** significant at the p < .003  
*** significant at the p < .0003 
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Although these results are of interest, the exact relationship between level of intellectual 
disabilities and the measures of severity of mental disorder is not a straightforward linear 
effect. To understand this further plots of the mean scores on the measures of severity of 
mental disorder against level of intellectual disabilities are shown in figures 4.4- 4.8.   
 
 
  
Figure 4.4: Plot of mean baseline HoNOS-LD score against level of intellectual 
disabilities  
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Figure 4.5: Plot of mean baseline GAF score against level of intellectual 
disabilities  
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Figure 4.6: Plot of mean baseline CGI score against level of intellectual disabilities  
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Figure 4.7: Plot of mean baseline CANDID-R unmet against level of intellectual 
disabilities  
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Figure 4.8: Plot of mean baseline CANDID-R met against level of intellectual 
disabilities  
 
 
 
Level of intellectual disability
profoundseveremoderatemild
M
ea
n
 
 
C
A
N
D
ID
-
R
 
M
et
 
N
ee
ds
11
10
9
8
7
 
 194 
 
It appears from figures 4.4- 4.8, that there is only a linear relationship between level of 
intellectual disabilities and CANDID-R met needs. For the other measures, the mean 
scores for the participants with moderate intellectual disabilities stands out as possibly 
discrepant with the overall relationship. Possible reasons for these varying and 
complex relationships between level of intellectual disabilities and measures of 
severity of mental disorder are considered further in chapter 5. 
 
4.6.5 The association between categorical socio-clinical variables and measures of 
severity of mental disorder  
Table 4.38 shows the results of the ANOVA examining the associations between the 
measures of severity of mental disorder and epilepsy. From the post-hoc Bonferroni 
tests the only results of significant is that individuals with well controlled seizures (less 
than one/ month) have higher levels of met needs (mean difference= -2.502, p= .001) 
on the CANDID-R, compared to people who do not have epilepsy.  
 
There are no significant differences in measures of severity of mental disorder related 
to whether an individual has Down syndrome or a diagnosis of autism (table 4.39). 
However, some other categorical socio-clinical variables are significantly associated 
with the measures of need on the CANDID-R: 
• individuals with visual impairment have higher unmet and met needs (table 4.40)  
• having mobility problems is associated with higher met needs (table 4.41) 
• participants with either urinary incontinence or bowel incontinence have 
significantly higher CANDID-R met needs (table 4.42). 
 195 
 
 
Table 4.38: The relationship between epilepsy and measures of severity of mental 
disorder  
 
 
** significant at the p< .01 level 
† Non- parametric χ² from Kruskall-Wallis test  
 
 
  Epilepsy Mean SD Min Max 
 
 
F 
 
 
p 
no 23.27 8.87 6 48 
good control 23.72 7.37 10 36 
 
 
HoNOS-LD total score 
 
poor control 26.07 11.26 8 42 
.656 .521 
no 48.68 12.90 18 72 
good control 53.03 13.45 23 72 
 
GAF 
  
  
  
poor control 
47.00 15.59 27 73 
3.187† .203 
no 3.78 1.01 1 6 
good control 3.48 .99 2 6 
CGI 
  
  
  
poor control 3.67 1.23 2 5 
.970 .381 
no 6.06 3.31 0 16 
good control 5.21 2.46 1 11 
CANDID-R unmet needs 
  
  
  
poor control 5.13 2.97 0 10 
1.532 .465 
no 8.70 3.23 2 14 
good control 11.21 2.76 6 18 
CANDID-R met needs 
  
  
  
poor control 10.60 3.85 4 16 
8.104*** .000 
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Table 4.39: The relationship between autism, Down syndrome and measures of severity of mental disorder 
 
 
 Autism Down syndrome 
 Yes (n=19) No (n=131) Yes (n=24) No (n=126) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
 statistic 
 
p 
 
 
HoNOS-LD total score 
 
25.58 12.38 23.35 8.23 -.759§ .456 22.50 9.49 23.86 8.74 .686 .494 
GAF 
 
48.26 16.49 49.52 12.87 -.219† .827 47.96 12.39 49.62 13.53 -.677† .499 
CGI 
3.74 1.15 3.71 1.02 -.115 .909 3.75 .90 3.70 1.06 -.200 .842 
CANDID-R unmet needs 
  
  
  
6.00 3.09 5.77 3.15 -.691† .489 5.13 2.29 5.93 3.26 -1.125† .261 
CANDID-R met needs 
  
 
9.32 3.15 9.39 3.40 .092 .927 10.25 2.67 9.22 3.46 -.200 .842 
 
 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed 
† Non- parametric z score from Mann-Whitney test 
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Table 4.40: The relationship between sensory impairments and measures of severity of mental disorder 
 
 
 Visual impairment Hearing impairment 
 Yes (n=27) No (n=123) Yes (n=12) No (n=133) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 23.78 10.11 23.61 8.59 -.091 .928 20.00 8.42 23.96 8.842 1.491 .138 
GAF 51.63 12.67 48.85 13.47 -1.080† .280 51.08 13.15 49.20 13.38 -.440† .660 
CGI 
 
3.56 .93 3.75 1.05 .869 .386 3.50 1.00 3.73 1.03 .741 .460 
CANDID-R unmet 
needs 
 
4.52 2.59 6.08 3.18 -2.390†* .017 5.33 3.73 5.84 3.09 -.774† .439 
CANDID-R met 
needs 
 
11.11 2.81 9.00 3.36 -3.035** .003 10.50 4.48 9.28 3.25 -1.203 .231 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
† Non- parametric z-score from Mann-Whitney test 
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Table 4.41: The relationship between mobility problems and measures of 
severity of mental disorder  
 
 
 Mobility problems 
 Yes (n=37) No (n=113) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 
22.97 8.60 23.86 8.96 .526 .600 
GAF 48.65 14.71 49.59 12.91 
-1.501† .133 
CGI 
 
3.70 1.15 3.71 .99 .059 .953 
CANDID-R unmet needs 
 
5.22 2.56 5.99 3.29 
-1.029† .303 
CANDID-R met needs 
 
10.92 3.13 8.88 3.29 -3.314** .001 
 
 
** significant at the p< .01 level 
† Non- parametric z-score from Mann-Whitney test 
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Table 4.42: The relationship between incontinence and measures of severity of mental disorder  
 
 
 Urinary incontinence Bowel incontinence 
 Yes (n=53) No (n=97) Yes (n=38) No (n=112) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HONOS-LD total 26.06 8.94 22.30 8.55 -2.524* .013 26.74 9.43 22.58 8.43 -2.548* .012 
GAF 47.55 13.99 50.35 12.92 -1.127† .260 47.61 14.53 49.95 12.91 -.889† .374 
CGI 
 
3.83 1.07 3.65 1.01 -1.048 .297 3.79 1.19 3.68 .97 -.541 .590 
CANDID-R unmet 
needs 
 
5.38 2.40 6.03 3.47 -.822† .411 5.11 1.98 6.04 3.42 -.1.106† .269 
CANDID-R met 
needs 
 
11.04 2.77 8.47 3.32 -4.787*** .000 11.00 2.59 8.83 3.42 -3.572*** .000 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
*** significant at the p< 0.001 level 
† Non- parametric z-score from Mann-Whitney test 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed  
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The only measure of severity of mental disorder other than CANDID-R significantly 
related to any of these categorical socio-clinical variables is the HONOS-LD- 
individuals with urinary or bowel incontinence have significantly higher scores, 
suggestive of a greater severity of mental disorder.  
 
The complex relationships between the baseline measures of severity of mental 
disorders and socio-clinical variables need further clarification in multivariate 
statistical tests. However, the findings that there are significant bivariate associations 
between the measures of severity of mental disorder at baseline and the socio-clinical 
variables in this section means that null hypothesis six is rejected. 
 
4.7 Multivariate associations between measures of psychopathology, 
socio-clinical variables and severity of mental disorder 
 
This section examines which variables, found to be associated with the measures of 
severity of mental disorder in bivariate analyses in section 4.6, are independently 
associated in multivariate linear regression. The variables that are significantly 
associated with the measures of severity of mental disorder (p<.05), and variables with 
associations approaching significance (.05 < p < .1) are included in separate linear 
regression analyses, using each of the measures of severity of mental disorder as the 
dependant variable. Separate regression analyses are shown for psychopathology 
dimension factor scores and symptom counts, and the three overall measures of 
psychopathology. 
 
4.7.1 Psychopathology and socio-clinical variables independently associated with 
HoNOS-LD 
There was only one difference between the regression models using the HoNOS-LD 
total score as the dependant variable in the linear regression analyses that include the 
Null hypothesis seven: 
There are no significant multivariate associations between dimensional measures 
of psychopathology, socio-clinical variables and measures of the severity of mental 
disorders. 
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dimension factor scores (table 4.43) and dimension symptom counts (table 4.44). The 
regression model that includes the factor scores includes two dimensions of 
psychopathology- depressive and behaviour-affective- whilst the symptom count 
model has three- depressive, organic and behaviour-affective. Otherwise the models 
are similar: 
• both multivariate analyses retain only the mild- profound intellectual disabilities 
between group difference in the HoNOS-LD as independently significant 
• urinary and bowel incontinence were excluded from both models. 
 
It is likely that the reason that urinary and bowel incontinence are excluded from both 
models, in table 4.43 and 4.44, is that they are strongly correlated with the level of 
intellectual disabilities i.e. individuals with profound intellectual disabilities are more 
likely to experience urinary and bowel incontinence than individuals with mild 
intellectual disabilities.  
 
The overall measures of psychopathology based on the results of the EFA dimensions 
of psychopathology, the total dimension factor score and total dimension symptom 
count, are also independently associated with the HoNOS-LD score (table 4.45 and 
4.46).  
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Table 4.43: Multivariate associations of dimension factor scores and socio-clinical variables with 
baseline HoNOS-LD scores  
 
Bivariate associations (p<0.1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension factor score‡ .000***  13.120 2.068 .431 .000*** 
Behaviour-affective dimension factor 
score‡ .000*** 
 
10.297 2.135 .332 .000*** 
Mild- moderate Not retained in the model 
Mild-severe Not retained in the model Categorical measure of intellectual disabilities .009** 
Mild- profound 2.983 1.280 .160 .021* 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
.330 
 
‡ the square root transformed variable is used in the analyses 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level
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Table 4.44: Multivariate associations of dimension symptom counts and 
socio-clinical variables with baseline HoNOS-LD scores  
 
Bivariate associations (p<0.1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension symptom count .000*** 
 
1.360 .241 .385 .000*** 
Organic dimension symptom count .011* 
 
1.390 .469 .205 .004** 
Behaviour-affective dimension symptom 
count .000*** 
 
1.554 .318 .330 .000*** 
Mild- moderate Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of intellectual 
disabilities .009** 
 
Mild- profound 3.501 1.243 .188 .006** 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
.378 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.45: Multivariate associations of total dimension factor score, and socio-clinical 
variables with baseline HoNOS-LD scores  
 
Bivariate associations (p<0.1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension factor score .000*** 
 
2.512 .298 .557 .000*** 
Mild- moderate 
Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of intellectual 
disabilities .009** 
 
Mild- profound 2.545 1.437 .137 .049* 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
.366 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.46: Multivariate associations of total dimension symptom count and socio-clinical 
variables with baseline HoNOS-LD scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension symptom count .000*** 
 
1.317 .143 .590 .000*** .404 
Mild- moderate Not retained in the model 
 
Mild-severe Not retained in the model 
 
Categorical measure of intellectual 
disabilities .009** 
 
Mild- profound 2.398 1.394 .129 .048*  
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Contrasting results for the overall measure of psychopathology based on the symptom 
count from the PPS-LD are shown in table 4.47. Whilst the EFA PPS-LD symptom 
count- 41 measures of psychopathology was retained as significant in the regression 
model, the results for the socio-clinical variables were different to the results for the 
regression analyses that were done for overall the measures of psychopathology related 
to the dimensional model of psychopathology (tables 4.45 & 4.46 above). 
 
Table 4.47: Multivariate associations of EFA PPS-LD symptom count- 41, and 
socio-clinical variables with baseline HoNOS-LD scores  
 
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
EFA PPS-LD symptom 
count-41 .000*** 
 
1.264 .142 .580 .000*** 
Mild- moderate Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of 
intellectual disabilities .009** 
 
Mild- profound Not retained in the model 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
4.390 1.320 .217 .001** 
.379 
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4.7.2 Psychopathology and socio-clinical variables independently associated with 
GAF scores 
None of the socio-clinical variables were significantly associated with the GAF score 
in the bivariate analyses reported in section 4.6. Therefore, the results in this section 
are only for GAF regression models for analyses with factor scores, and symptom 
counts for the depressive, organic and behaviour-affective dimensions of 
psychopathology. 
 
 
Table 4.48: Multivariate associations of dimension factor scores with baseline 
GAF scores  
 
 
 
‡ the square root transformed variable is used in the analyses 
 
Table 4.49: Multivariate associations of dimension symptom counts with baseline 
GAF scores  
 
 
Bivariate associations (p<0.1) Multivariate associations 
Variable p B SE B β 
 
p 
 
R² 
Depressive dimension  .000*** -2.183 .358 -.410 .000*** 
Organic dimension  .000** -3.123 .692 -.306 .000*** 
Behaviour-affective dimension  .001** -1.988 .468 -.280 .000*** 
.392 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
 
Bivariate associations (p<0.1) Multivariate associations 
Variable p B SE B β 
 
p 
 
R² 
Depressive dimension ‡ .000*** -19.272 3.020 -.420 .000*** 
Organic dimension  .001** -4.359 .884 -.326 .000*** 
Behaviour-affective dimension 
 ‡ .003** -13.373 3.051 -.286 .000*** 
.387 
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The results in tables 4.48 and 4.49 using the factor score and symptom count measures 
representing the three dimensions of psychopathology are very similar- with strong 
correlations with the GAF scores. The reasons why only the anxiety dimension of 
psychopathology is not significantly correlated with the GAF scores will be considered 
further in chapter 5. 
 
There are no potential covariates to include in a regression analysis with the overall 
measures of psychopathology. To allow comparison, table 4.50 shows the statistics 
from simple regression analyses with each of the three overall measures of 
psychopathology. 
 
Table 4.50: Simple regression statistics for the overall measures of psychopathology 
with GAF scores at baseline 
 
 
Bivariate associations (p<.1) Multivariate associations 
Variable p B SE B β 
 
p 
 
R² 
Total dimension factor score .000*** -3.910 .458 -.576 .000*** .332 
Total dimension symptom count .000*** -1.969 .225 -.585 .000*** .343 
EFA PPS-LD symptom count- 41 .000*** -1.900 .221 -.579 .000*** .335 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
4.7.3 Psychopathology and socio-clinical variables independently associated with 
CGI scores  
Although the categorical measure of level of intellectual disabilities was associated 
with the CGI scores in the bivariate analysis, it was not retained in any of the final 
multivariate regression models. The dummy categorical variables representing level of 
intellectual disabilities are shown in the models including individual dimensions of 
psychopathology factor scores and dimension counts in table 4.51 & 4.52. Although the 
dummy categorical variables were included in the separate analyses for the overall 
measures of psychopathology, they are not shown in table 4.53. 
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Table 4.51: Multivariate associations of dimension factor scores and level of 
intellectual disabilities with baseline CGI scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension ‡ .000***  1.616 .237 .457 .000*** 
Organic dimension  .003** 
 
.275 .069 .266 .000*** 
Behaviour-affective 
dimension ‡ .003** 
 
.914 .239 .253 .000*** 
Mild- moderate 
Not retained in the model 
 
Mild- severe Not retained in the model 
Categorical measure of 
intellectual disabilities .034* 
 
Mild- profound Not retained in the model 
.366 
 
 
‡ the square root transformed variable is used in the analyses 
 
Table 4.52: Multivariate associations of dimension symptom counts and level of 
intellectual disabilities with baseline CGI scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension  .000*** 
 
.192 .028 .468 .000*** 
Organic dimension  .001** 
 
.183 .054 .232 .001** 
Behaviour-affective 
dimension  .002** 
 
.135 .036 .248 .000*** 
Mild- moderate 
Not retained in the model 
 
Mild- severe Not retained in the model 
Categorical measure of  
intellectual disabilities .034* 
 
Mild- profound Not retained in the model 
.386 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.53: Multivariate associations for the overall measures of psychopathology 
with baseline CGI scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p B SE B β 
 
p 
 
R² 
Total dimension factor score .000*** .295 .036 .562 .000*** 
.316 
Total dimension symptom count .000*** .153 .017 .590 .000*** 
.349 
EFA PPS-LD symptom count- 41 .000*** .144 .017 .568 .000*** 
 
.322 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
 
4.7.4 Psychopathology and socio-clinical variables independently associated with 
the number of CANDID-R unmet needs at baseline 
The results for the multivariate analyses examining variables associated with the 
CANDID-R unmet needs, and including the dimensional factor scores and symptom 
counts are shown in table 4.54 and 4.55 respectively. From table 4.54, none of the 
psychopathology dimension factor scores are independently associated with the 
number of unmet needs on the CANDID-R. However, the organic and behaviour-
affective dimension symptom counts are retained in the final regression model in table 
4.55. 
 
As for the HoNOS-LD and the GAF and regression models for the three overall 
measures of psychopathology are very similar with retention of the measure of 
psychopathology and the same socio-clinical variables- age, living circumstances, level 
of intellectual disabilities and visual impairment- in each model (tables 4.56 -4.58). 
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Table 4.54: Multivariate associations of dimension factor scores and socio-clinical 
variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p<0.1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Behaviour-affective dimension 
factor score‡ .033* 
 
Not retained in the model 
Age  .031* 
 
-.035 .020 -.147 .048* 
Independent- 
family carer -4.045 .795 -549 .000*** Living circumstance .009** 
Independent- 
paid carer -3.772 .794 -.595 .000*** 
Mild- moderate 
2.233 .747 .290 .003** 
 
Mild-severe 1.783 .811 .237 .030* 
Categorical measure of 
intellectual disabilities .079 
 
Mild- profound 1.510 .755 .229 .047* 
Visual impairment .017* 
 
-1.701 .610 -.210 .006** 
.263 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses
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Table 4.55: Multivariate associations of dimension symptom counts and socio-clinical 
variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension  .044* 
 
Not retained in the model 
Organic dimension  .003** 
 
.433 .190 .181 .024* 
Behaviour-affective dimension .012* 
 
.296 .124 .178 .018* 
Age  .031* 
 
-.050 .019 -.208 .010* 
Independent- 
 family carer -4.417 .761 -.599 .000*** Living circumstances .009** 
Independent-  
paid carer -3.740 .749 -.590 .000*** 
Mild- moderate 
1.908 .715 .248 .008** 
 
Mild-severe 1.413 .777 .188 .041* 
Categorical measure of  
intellectual disabilities .079 
 
Mild- profound 1.425 .719 .216 .030* 
Visual impairment .017* 
 
-1.546 .582 -.191 .009** 
.339 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.56: Multivariate associations of total dimension factor score and socio-clinical 
variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension factor score .000*** 
 
.477 .116 .299 .000*** 
Age  .031* 
 
-.042 .018 -.176 .023* 
Independent- 
family carer -3.906 .755 -.530 .000*** Living circumstances .009** 
Independent-  
paid carer -3.623 .745 -.572 .000*** 
Mild- moderate 
1.642 .731 .213 .026* 
 
Mild-severe 1.632 .776 .217 .037* 
Categorical measure of 
 intellectual disabilities .079 
 
Mild- profound 1.373 .721 .209 .048* 
Visual impairment .017* 
 
-1.559 .584 -.192 .009** 
.328 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.57: Multivariate associations of total dimension symptom count and socio-
clinical variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension factor score .000*** .226 .057 .285 .000*** 
Age  .031* -.042 .018 -.176 .023* 
Independent-  
family carer -3.817 .758 -.518 .000*** Living circumstances .009** 
Independent-  
paid carer -3.539 .747 -.558 .000*** 
Mild- moderate 
1.801 .726 .234 .014* 
 
Mild-severe 1.674 .778 .222 .033* 
Categorical measure of  
intellectual disabilities .079 
 
Mild- profound 1.403 .723 .213 .046* 
Visual impairment .017* -1.615 .585 -.199 .007** 
.328 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.58: Multivariate associations of EFA PPS-LD symptom count-41 and socio-
clinical variables with baseline CANDID-R unmet needs  
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
EFA PPS-LD symptom count-41 .000*** .210 .056 .272 .000*** 
Age  .031* -.042 .018 -.173 .026* 
Independent-  
family carer -3.841 .762 -.521 .000*** Living circumstances .009** 
Independent- paid 
carer 
-3.535 .751 -.558 .000*** 
Mild- moderate 
1.780 .733 .231 .016* 
 
Mild-severe 1.647 .783 .219 .037* 
Categorical measure of  
intellectual disabilities .079 
 
Mild- profound 1.329 .729 .202 .049* 
Visual impairment .017* 
 
-1.646 .588 -.203 .006** 
.316 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level
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4.7.5 Psychopathology and socio-clinical variables independently associated with 
the number of CANDID-R met needs at baseline 
The results of the multivariate analyses examining the relationships between the 
dimensional measures of psychopathology, socio-clinical variables and the met needs 
on the CANDID-R are shown in tables 4.59 and 4.60. This was the first measure of 
severity of mental disorder for which there was no bivariate association with the 
behaviour-affective dimension of psychopathology.  
 
Interestingly, the anxiety dimension factor score and symptom counts are not retained 
in either regression model, respectively. However, the other dimensions of 
psychopathology are retained and remain indirectly associated with the CANDID-R 
met needs. Furthermore, more socio-clinical variables are associated with the 
CANDID-R met needs than any other measure of severity of mental disorder- age, 
level of intellectual disabilities, epilepsy, visual impairment, mobility problems, 
urinary incontinence and bowel incontinence. 
 
We can see in tables 4.61-4.63, below that including the overall measures of 
psychopathology in the regression models results in the same socio-clinical variables 
being retained in the model as for the analyses that use the measures representing the 
individual dimensions of psychopathology in tables 4.59 and 4.60. Overall, whilst the 
results for the regression analyses using the different measures of psychopathology in 
tables 4.59-4.63 are very similar, the results are very different than for the other 
measures of severity of mental disorder. Potential reasons for this difference will be 
explored in the discussion in chapter 5. 
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Table 4.59: Multivariate associations of dimension factor scores and socio-clinical 
variables with at baseline CANDID-R met needs  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension ‡ .063 -1.788 .747 -.155 .018* 
Anxiety dimension ‡ .012* Not retained in the model 
Age  .062 .041 .018 .160 .021* 
Independent-  
family carer 2.969 .680 .376 .000*** Living circumstances .000*** 
Independent-  
paid carer 3.862 .619 .568 .000*** 
Mild- moderate 
1.609 .701 .195 .023* 
 
Mild-severe 2.948 .690 .365 .000*** 
Categorical measure of  
intellectual disabilities .000*** 
 
Mild- profound 2.794 .678 .396 .000*** 
No-  
well controlled 2.040 .578 .241 .001** 
Epilepsy .000*** 
No-  
poor control 1.492 .760 .134 .032 
Visual impairment .003** 1.947 .555 .224 .001** 
Mobility problems .001** Not retained in the model 
Urinary incontinence .000*** 1.163 .478 .166 .016* 
Bowel incontinence .000*** Not retained in the model 
.482 
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
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Table 4.60: Multivariate associations of dimension symptom counts and socio-
clinical variables with baseline CANDID-R met needs 
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension  .063 -.176 .087 -.131 .045* 
Organic dimension .080 -.400 .169 -.156 .019* 
Anxiety dimension  .012* Not retained in the model 
Age  .062 .048 .017 .187 .007** 
Independent-  
family carer 3.214 .674 .407 .000*** Living circumstances .000*** 
Independent-  
paid carer 3.896 .606 .573 .000*** 
Mild- moderate 
1.609 .701 .195 .023* 
 
Mild-severe 2.948 .690 .365 .000*** 
Categorical measure of  
intellectual disabilities .000*** 
 
Mild- profound 2.794 .678 .396 .000*** 
No-  
well controlled 1.663 .535 .197 .002** 
Epilepsy .000*** 
No-  
poor control 1.423 .703 .128 .045* 
Visual impairment .003** 1.832 .547 .211 .001** 
Mobility problems .001** Not retained in the model 
Urinary incontinence .000*** 1.279 .472 .183 .008** 
Bowel incontinence .000*** Not retained in the model 
.491 
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.61: Multivariate associations of total dimension factor score and socio-
clinical variables with baseline CANDID-R met needs 
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension factor score .024* -.308 .119 -.180 .011* 
Age  .062 .042 .018 .162 .019* 
Independent- 
family carer 3.152 .668 .399 .000*** Living circumstances .000*** 
Independent- 
paid carer 4.206 .606 .619 .000*** 
Mild- moderate 
1.609 .701 .195 .023* 
 
Mild-severe 2.948 .690 .365 .000*** 
Categorical measure of  
intellectual disabilities .000*** 
 
Mild- profound 2.794 .678 .396 .000*** 
No-  
well controlled 2.040 .578 .241 .001** 
Epilepsy .000*** 
No-  
poor control 1.492 .760 .134 .032 
Visual impairment .003** 1.646 .584 .189 .006** 
Mobility problems .001** Not retained in the model 
Urinary incontinence .000*** 1.287 .539 .184 .018* 
Bowel incontinence .000*** Not retained in the model 
.482 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.62: Multivariate associations of total dimension symptom count and socio-
clinical variables with baseline CANDID-R met needs 
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension symptom 
 count .024* 
 
-.149 .058 -.176 .011* 
Age  .062 
 
.042 .018 .162 .019* 
Independent-  
family carer 3.077 .670 .389 .000*** Living circumstances .000*** 
Independent- 
paid carer 4.130 .607 .608 .000*** 
Mild- moderate 
1.500 .691 .182 .032* 
 
Mild-severe 2.895 .689 .359 .000*** 
Categorical measure of  
intellectual disabilities .000*** 
 
Mild- profound 2.758 .677 .391 .000*** 
No-  
well controlled 2.037 .578 .241 .001** 
Epilepsy .000*** 
No- 
poor control 1.556 .759 .140 .042* 
Visual impairment .003** 
 
1.680 .583 .193 .005** 
Mobility problems .001** 
 
Not retained in the model 
Urinary incontinence .000*** 
 
1.278 .539 .183 .019* 
Bowel incontinence .000*** 
 
Not retained in the model 
.478 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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Table 4.63: Multivariate associations of EFA PPS-LD symptom count-41 and socio-
clinical variables with baseline CANDID-R met needs  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
EFA PPS-LD symptom  
count- 41 .047* -.141 .057 -.171 .014* 
Age  .062 .041 .018 .160 .021* 
Independent- 
family carer 3.107 .672 .393 .000 Living circumstances .000*** 
Independent- 
paid carer 4.145 .609 .610 .000 
Mild- moderate 
1.520 .695 .184 .003** 
 
Mild-severe 2.915 .690 .361 .000*** 
Categorical measure of 
intellectual disabilities .000*** 
 
Mild- profound 2.805 .679 .397 .000*** 
No-  
well controlled 2.063 .578 .244 .001** 
Epilepsy .000*** 
No-  
poor control 1.532 .760 .138 .041* 
Visual impairment .003** 1.697 .584 .195 .004** 
Mobility problems .001** Not retained in the model 
Urinary incontinence .000*** 1.278 .540 .183 .019** 
Bowel incontinence .000*** Not retained in the model 
.475 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
   
  
Since there are dimensional and overall measures of psychopathology, and socio-
clinical variables independently associated with all five measures of the severity of 
mental disorders, the null hypothesis is rejected.  
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4.8 Comparing the contribution of dimensional and categorical 
models of psychopathology to the severity of mental disorders  
 
In section 4.3.4, dimensional measures of psychopathology were shown to be 
independently related to measures of the severity of mental disorders. This section 
examines whether categorical diagnoses from DC-LD are related to the severity of 
mental disorders. 
 
4.8.1 Examining the relationship of a categorical diagnosis to severity of mental 
disorder  
The binary variable of whether or not an individual meets the criteria for a DC-LD 
categorical diagnosis replaces the dimensional measures in the regression analyses in 
section 4.7. The variable for categorical diagnosis was retained as significant in the 
regression analyses for the HoNOS-LD total score table 4.64.  
 
Although no socio-clinical variables were associated with the GAF score at baseline 
simple linear regression was run to examine if there was a significant association 
between having a categorical diagnosis. The association approached significance 
(B=4.108, SE B= 2.348, β=.143, p= 0.082) but did not meet the accepted level of 
significance (p < .05). Similarly, having a categorical diagnosis was not associated 
with the CGI, baseline number of unmet or met needs on the CANDID-R (tables 4.65- 
4.67). 
Null hypothesis eight: 
There are no significant differences in the associations of dimensional and categorical 
models of psychopathology with measures of the severity of mental disorders 
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Table 4.64: Multivariate associations of categorical DC-LD diagnosis and socio-
clinical variables with baseline HoNOS-LD scores  
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Categorical diagnosis of 
mental disorder on DC-LD 
(Y/N) 
N/A 
 
3.405 1.516 .178 .026* 
Mild- moderate 4.750 2.104 .219 .025* 
Mild-severe 4.017 2.084 .189 .046* Categorical measure of intellectual disabilities .009** 
Mild- profound 6.610 1.876 .356 .001* * 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
.108 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
 
Table 4.65: Multivariate associations of categorical DC-LD diagnosis and socio-
clinical variables with baseline CGI scores  
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Categorical diagnosis of 
mental disorder on DC-LD 
(Y/N) 
N/A 
 
Not retained in the model 
Mild- moderate 4.750 2.104 .219 .025* 
Mild-severe Not retained in the model Categorical measure of intellectual disabilities .034* 
Mild- profound Not retained in the model 
.080 
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Table 4.66: Multivariate associations of categorical DC-LD diagnosis and socio-
clinical variables with CANDID-R unmet needs at baseline 
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Categorical diagnosis of mental 
disorder on DC-LD (Y/N) N/A 
 
Not retained in the model 
Age  .031* 
 
-.035 .020 -.147 .048* 
Independent- 
family carer -4.045 .795 -.549 .000*** Living circumstance .009** 
Independent- 
paid carer -3.772 .794 -.595 .000*** 
Mild- moderate 
2.233 .747 .290 .003** 
 
Mild-severe 1.783 .811 .237 .030* 
Categorical measure of 
intellectual disabilities .079 
 
Mild- profound 1.510 .755 .229 .047* 
Visual impairment .017* 
 
-1.701 .610 -.210 .006** 
.263 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level
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Table 4.67: Multivariate associations of categorical DC-LD diagnosis and socio-clinical 
variables with CANDID-R met needs at baseline 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Categorical diagnosis of mental 
disorder on DC-LD (Y/N) N/A 
 
Not retained in the model 
Age  .062 
 
.030 .018 .118 .044* 
Independent- 
family carer 2.803 .716 .355 .000*** Living circumstances .000*** 
Independent- 
paid carer 3.660 .678 .539 .000*** 
Mild- moderate 
Not retained in the model 
 
Mild-severe 1.156 .620 .143 .048* 
Categorical measure of 
intellectual disabilities .000*** 
 
Mild- profound 1.309 .552 .185 .019* 
No- well 
controlled 1.935 .550 .229 .001** 
Epilepsy .000*** 
No- poor 
control 1.619 .714 .145 .025* 
Visual impairment .003** 
 
1.821 .565 .209 .002** 
Mobility problems .001** 
 
Not retained in the model 
Urinary incontinence .000*** 
 
1.163 .478 .166 .016* 
Bowel incontinence .000*** 
 
Not retained in the model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.453 
* significant at the p< .05 level ** significant at the p< .01 level **** significant at the p< .001 level
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4.8.2 Examining whether dimensional and categorical models of psychopathology 
are both retained as independently associated with the severity of mental 
disorders  
Since having a DC-LD categorical diagnosis was only retained as significantly 
associated with the HoNOS-LD total score this was the only measure for which the 
final regression analysis, including both models of psychopathology, could be 
examined.  However, the variable representing the categorical model was not retained 
as significant in the regression models for the dimension factor scores and symptom 
counts in tables 4.68 and 4.69. 
 
This suggests that no additional variance in the HoNOS-LD total score was explained 
by the categorical model, over and above the variance accounted for by the 
dimensional model of psychopathology. Therefore, it was concluded that the 
dimensional model of psychopathology was more strongly related to the severity of 
mental disorder. The null hypothesis is rejected. 
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Table 4.68: Regression model examining dimension factor scores, DC-LD categorical 
diagnosis and socio-clinical variables with baseline HoNOS-LD scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension factor score‡ .000***  13.120 2.068 .431 .000*** 
Behaviour-affective dimension factor 
score‡ .000*** 
 
10.297 2.135 .332 .000*** 
Categorical diagnosis of mental disorder 
on DC-LD (Y/N) N/A 
 
Not retained in the model 
Mild- moderate Not retained in the model 
Mild-severe Not retained in the model Categorical measure of intellectual disabilities .009** 
Mild- profound 2.983 1.280 .160 .021* 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
.330 
 
 
‡ the square root transformed variable is used in the analyses 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level
 228 
Table 4.69: Regression model examining dimension symptom counts, DC-LD categorical diagnosis 
and socio-clinical variables with baseline HoNOS-LD scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension symptom count .000*** 
 
1.360 .241 .385 .000*** 
Organic dimension symptom count .011* 
 
1.390 .469 .205 .004** 
Behaviour-affective dimension symptom 
count .000*** 
 
1.554 .318 .330 .000*** 
Categorical diagnosis of mental disorder 
on DC-LD (Y/N) N/A 
 
Not retained in the model 
Mild- moderate Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of intellectual 
disabilities .009** 
 
Mild- profound 3.501 1.243 .188 .006** 
Urinary incontinence .013* 
 
Not retained in the model 
Bowel incontinence .012* 
 
Not retained in the model 
.378 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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4.9 The association of psychopathology and the longitudinal outcome 
of mental disorders  
 
This section considers the relationship between psychopathology and outcome. 
Whereas the cross-sectional relationships are better conceptualised at looking at the 
relationships of psychopathology and socio-clinical variables with severity of mental 
disorders, by following up individuals with intellectual disabilities and mental 
disorders, the extent to which psychopathology and other variables at baseline are a 
significant predictor of outcome is examined.  
 
As described in chapter 3.4.3.5, the longitudinal outcome was taken as the change in 
the measure of outcome between baseline and follow up. Since higher scores on the 
GAF and CANDID-R met needs variables represents a better outcome, the sign of the 
longitudinal outcome score was reversed for these variables in order that all five 
outcome measures can be compared. 
 
4.9.1 Change in the measures of outcome over time 
Prior to addressing the null hypothesis, table 4.70 shows the mean scores and standard 
deviation of the measures of outcome at baseline and follow-up, and the results of 
statistical tests to examine if there is a significant change in the measures over time. 
There is a significant change in all the measures of outcome over time.  
 
 
Null hypothesis nine: 
Dimensional measures of psychopathology are not significantly correlated to the 
longitudinal outcome of mental disorders. 
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Table 4.70: The significance of change in measures of outcome over time 
 
 
 
* p < .05 
** p < .01 
*** p < .001 
 
 
 
4.9.2 Examining the distribution of the longitudinal measures of outcome  
Table 4.71 shows the results of tests examining the skewness, kurtosis and overall 
distribution of the six longitudinal measures of outcome, in comparison to the normal 
distribution. None of the measures are significantly different from the normal 
distribution and therefore parametric tests are used in the analyses. 
 
 Baseline Follow-up Change over 
time 
Wilcoxon signed 
ranks test 
Outcome 
measure 
Mean SD Mean SD Mean SD Z p 
HoNOS-
LD total  25.50 8.93 16.68 11.28 
-8.82 13.85 -3.442 .001** 
GAF 44.40 11.547 57.75 17.86 -13.35 13.33 -3.552 .000*** 
CGI 3.93 1.02 2.85 1.48 
-1.08 1.65 -3.579 .000*** 
CANDID- 
unmet  
6.35 3.09 3.40 3.947 -2.95 4.19 -3.778 .000*** 
CANDID- 
met 9.80 2.92 12.85 4.07 
-3.05 3.82 -4.261 
 
.000*** 
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4.9.3 The correlations of baseline psychopathology and longitudinal measures of 
outcome 
To examine whether baseline psychopathology dimension factor scores and symptom 
counts are significant predictors of longitudinal outcome, correlations are shown in 
table 4.72 and 4.73. The correlations of the EFA PPS-LD symptom count- 41 overall 
measure of psychopathology with the measures of longitudinal outcome are shown in 
table 4.74.  
 
The dimensional and overall measures of psychopathology are significantly correlated 
with the longitudinal change in the HoNOS-LD, GAF and CGI scores. However, only 
the three overall measures of psychopathology at baseline are correlated with the 
change in the CANDID-R unmet needs, and there are no significant correlations 
between baseline psychopathology and change in the CANDID-R met needs. 
 
Null hypothesis nine is rejected. 
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Table 4.71 Summary and normality data of the longitudinal measures of outcome  
 
 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.374 for skewness and 0.733 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
  
  
  
 Skewness Kurtosis Normality test 
Outcome measure 
 
Mean 
 
Min 
 
Max 
 
SD S z-score§ K z-score§ Shapiro-Wilk p 
HONOS-LD total  8.82 -21 33 13.85 -.236 .63 -.598 .815 
.978 .605 
GAF 13.35 -17 49 13.33 .035 .009 -.973 1.327 
.954 .104 
CGI 1.08 -2 5 1.65 .018 .048 -.442 .603 .951 .084 
CANDID- unmet  2.95 -6 10 4.19 -.336 .898 -.912 1.244 
.942 .051 
CANDID- met -3.05 -11 4 3.82 -.183 
 
.489 -.950 1.296 
.958 .148 
CANDID- total -.25 -6 10 3.00 .924 2.47* 2.63 3.588*** 
.923 .010* 
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Table 4.72: The correlations between psychopathology dimension factor scores and longitudinal outcomes 
 
 
 
 
 
* 
significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
‡ The square root transformed variable was used in the statistical analysis 
† Non-parametric Spearman’s correlation co-efficient 
 
Depressive factor 
score‡ 
Organic factor 
score 
Behaviour-
affective factor 
score‡ 
Anxiety factor 
score‡ Total factor score 
Outcome variable change   R p 
R† p R p R p R p 
 
HONOS-LD total score 
.373* .018 -.216 .180 .518** .001 .167 .303 .414** .008 
GAF 
.460** .003 .039 .813 .437** .005 .121 .456 .555*** .000 
CGI 
 
.420** .007 .062 .705 .446** .004 .032 .846 .457** .003 
CANDID-R unmet needs 
  
.227 .159 .106 .515 .253 .115 .086 .599 .378* .016 
CANDID-R met needs 
 
.047 .772 -.043 .792 .005 .978 .105 .518 .107 .513 
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Table 4.73: The correlations between psychopathology dimension symptoms counts and longitudinal outcomes 
 
 
Depressive 
symptom count 
Organic 
symptom count 
Behaviour-
affective symptom 
count 
Anxiety 
symptom count 
Total symptom 
count 
Outcome change  
variable  R† p 
R† p R† p R† p R p 
 
HoNOS-LD total score 
.409** .009 -.266 .097 .432** .005 .135 .407 .450** .004 
GAF 
.556*** .000 .006 .971 .361* .022 .033 .841 .562*** .000 
CGI 
 
.509** .001 -.051 .757 .365* .020 .025 .880 .504** .001 
CANDID-R unmet 
needs 
  
.299 .060 .052 .750 .193 .234 .045 .784 .329* .038 
CANDID-R met needs 
 
.034 .835 .060 .713 .061 .711 .075 .645 .090 .581 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
† Non-parametric Spearman’s correlation co-efficient  
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Table 4.74: The correlations between baseline EFA PPS-LD symptom count- 41 
and longitudinal outcome  
 
 EFA PPS-LD symptom count - 41 
Outcome change variable 
              R p 
 
HoNOS-LD total score .485** .002 
GAF 
.581*** .000 
CGI 
 
.516** .001 
CANDID-R unmet needs 
  
.367* .020 
CANDID-R met needs 
 
.063 .700 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
 
 
4.10 Baseline socio-clinical variables as predictors of longitudinal 
outcome 
 
4.10.1 Gender as a predictor of longitudinal outcome 
In table 4.75, there is no significant difference in longitudinal outcome between women 
and men. However, as the result for the CGI measure approaches significance (.05 < p 
< .1), gender will be included as a dependant variable in the linear regression to 
examine the interaction of covariates in the prediction of longitudinal change in the 
CGI.
Null hypothesis ten: 
Socio-clinical measures are not significantly associated with the longitudinal 
outcome of mental disorders. 
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Table 4.75: The relationship between gender and measures of longitudinal 
outcome  
 
 
 
  
4.10.2 Age as a predictor of longitudinal outcome 
No significant correlation was found between age and longitudinal outcome in table 
4.76. 
 
Table 4.76: The relationship between age and measures of longitudinal outcome. 
 
Age in years 
 R 
p 
HoNOS-LD total score 
.005 .975 
GAF 
-.064 
.696 
CGI 
-.033 .839 
CANDID-R unmet 
needs 
  
.054 .742 
CANDID-R met needs 
.091 .271 
 
 
 
 
 Gender Mean SD statistic 
 
 
p 
male 11.28 12.04 HoNOS-LD total score 
female 6.82 15.15 
1.014 .317 
male 16.94 20.75 GAF 
female 10.41 18.57 1.050 .300 
male 1.56 1.58 CGI 
  female .68 1.64 1.701 .097 
male 4.06 3.86 CANDID-R unmet 
needs 
  
female 2.05 4.33 1.534 .133 
male 3.50 4.37 CANDID-R met needs 
  female 2.68 3.37 .669 .508 
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4.10.3 Living circumstances and longitudinal outcome 
Table 4.77 shows the correlations between baseline living circumstances and 
longitudinal outcome. From the post hoc Bonferroni tests, the only significant between 
group differences were for individuals living independently against with support from 
paid carers for GAF (mean difference= -25.31, p=.021) and CGI (mean difference= -
2.28, p= .011). There were no significant between group differences for the HoNOS-
LD. 
 
4.10.4 Level of intellectual disabilities as a predictor of longitudinal outcome 
The descriptive statistics for the measures of longitudinal outcome and results for the 
initial analyses using ANOVA are shown for participants with mild, moderate, severe 
and profound intellectual disabilities in table 4.78. The only measure of longitudinal 
outcome for which there are no significant between group differences is the change in 
the CANDID-R met needs over time.  
 
Post hoc Bonferroni test results in table 4.79 clarify the nature of the between group 
differences for the measures of longitudinal outcome that showed significant between 
group differences from the initial ANOVA tests. Since there are four variables and 
three comparisons, the appropriate conservative level of significance is used (p< .0167) 
for the post-hoc analysis.  
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Table 4.77: The relationship between living circumstances and longitudinal 
measures of outcome  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< .05 level  
** significant at the p< .01 level 
 
  
  
  
 
 
 
 
 
 
  
  
  
  
  
 
 
 
 
 
 
 
Living 
circumstances Mean SD Min Max 
 
 
F 
 
 
p 
Independent 
-3.00 3.39 -7.00 2.00 
Family carer 3.00 14.81 -15.00 31.00 
 
 
HoNOS-LD 
 
Paid carer 12.74 13.17 -21.00 33.00 
4.204 .023 
Independent 
-7.60 9.74 -16.00 3.00 
Family carer 11.75 23.37 -17.00 44.00 
 
GAF 
  
  
  
Paid carer 
17.70 17.61 -16.00 49.00 
4.113 .024 
Independent 
-.80 .84 -2.00 1.00 
Family carer .88 1.64 -1.00 3.00 
CGI 
  
  
  
Paid carer 1.48 1.55 -2.00 5.00 
4.900 .013 
Independent 6.22 6.04 -6.00 16.00 
Family carer 4.43 3.47 -3.00 12.00 
CANDID-R 
unmet needs 
  
  
  
Paid carer 
4.66 2.51 -3.00 10.00 
2.315 .102 
Independent 6.22 6.04 -6.00 16.00 
Family carer 4.43 3.47 -3.00 12.00 
CANDID-R 
met needs 
  
  
  
Paid carer 
4.66 2.51 -3.00 10.00 
1.084 .341 
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Table 4.78: The relationship between level of intellectual disabilities and measures 
of longitudinal outcome  
 
* significant at the p< .05 level  
** significant at the p< .01 level 
*** significant at the p< .001 level 
 
  
  
  
 
 
 
Level of 
intellectual 
disabilities Mean SD Min Max 
 
 
F 
 
 
p 
mild 
-7.33 7.39 -17 2 
moderate 8.38 15.08 -11 33 
severe 7.90 14.18 -21 23 
 
 
HoNOS-LD 
Total score 
 
profound 15.69 9.90 -1 31 
5.432** .003 
mild 
-7.50 8.34 -16 3 
moderate 14.00 24.69 -17 44 
severe 12.60 14.32 -16 29 
 
GAF 
  
  
  
profound 
21.31 18.07 -14 49 
3.837* .018 
mild 
-.83 .75 -2 0 
moderate 1.13 1.64 -1 3 
severe 1.00 1.41 -2 3 
CGI 
  
  
profound 1.81 1.56 -1 5 
4.827** .006 
mild 4.24 4.81 -6 14 
moderate 6.19 4.23 -2 16 
severe 4.64 2.42 -3 10 
CANDID-R 
unmet needs 
  
  
  
profound 
4.69 2.82 -3 12 
6.994** .001 
mild 5.50 4.17 -3 12 
moderate 5.45 5.43 -6 14 
severe 6.21 7.75 -11 18 
CANDID-R  
met needs 
  
  
  
profound 6.33 7.63 -10 16 
1.933 .142 
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Table 4.79: Post hoc Bonferroni tests of ANOVA between group differences for level of 
intellectual disabilities and measures of longitudinal outcome 
 
 
 
Dependent 
Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level 
of intellectual 
disability categories 
Mean 
Difference 
(I-J) 
Std. 
Error p 
95% Confidence 
Interval 
mild moderate 
-15.71 6.46 .121 -33.74 2.32 
  severe 
-15.23 6.17 .111 -32.47 2.01 
HoNOS-LD total 
  
  profound 
-23.02** 5.72 .002 -39.00 -7.04 
mild moderate 
-21.50 9.59 .188 -48.28 5.28 
  severe 
-20.10 9.17 .210 -45.71 5.51 
GAF 
  profound 
-28.81* 8.50 .010 -52.55 -5.07 
mild moderate 
-1.96 .79 .104 -4.15 .23 
  severe 
-1.83 .75 .118 -3.93 .26 
CGI 
  
  
  
  profound 
-2.65* .70 .003 -4.59 -.70 
mild moderate -6.50* 1.87 .008 -11.73 -1.27 
  severe 
-7.10** 1.79 .002 -12.10 -2.10 
CANDID-R unmet 
needs 
  
  
  profound 
-7.19** 1.66 .001 -11.82 -2.55 
  
* significant at the p< .0167 level 
** significant at the p < .003 
*** significant at the p < .0003
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4.10.5 Categorical socio-clinical variables as predictors of longitudinal outcome 
The only longitudinal measure of outcome, in table 4.80, significantly different across 
the three categories within the epilepsy variable is the CGI. Although the post hoc 
Bonferroni tests do not show any significant between group differences, the epilepsy 
variable will be included in the linear regression analyses for the CGI. 
 
 
Table 4.80: The relationship between epilepsy and measures of longitudinal 
outcome 
 
 
 
* significant at the p< .05 level 
  
A diagnosis of autism, Down syndrome (table 4.81), visual impairment (table 4.82) and 
mobility problems (table 4.83) are not associated with any of the longitudinal measures 
of outcome. The significant associations for the variables representing hearing 
impairment (table 4.82), urinary incontinence and bowel incontinence (table 4.84) are 
solely with the longitudinal change in the HoNOS-LD, GAF and CGI. 
 
 
 
 Epilepsy Mean SD Min Max 
 
 
F 
 
 
p 
no 8.25 13.36 -21 31 
good control 13.38 14.17 -15 33 
 
 
HoNOS-LD total 
score 
 
poor control 
3.75 18.04 -17 26 
.714 .496 
no 12.54 18.55 -17 49 
good control 22.50 20.09 -11 48 
 
GAF 
  
  
  
poor control 
.75 22.71 -16 34 
1.791 .181 
no .96 1.48 -2 5 
good control 2.13 1.55 -1 4 
CGI 
  
  
  
poor control 
-.25 2.22 -2 3 
3.305* .048 
no 2.86 4.08 -4 2.86 
good control 4.88 3.56 -2 4.88 
CANDID-R unmet 
needs 
  
  
  
poor control 
-.25 5.06 -6 -.25 
2.131 .133 
no 3.25 3.90 -11 2 
good control 3.13 4.42 -8 4 
CANDID-R met needs 
  
  
  
poor control 1.50 1.91 -3 1 
.357 .702 
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Table 4.81: The relationship between autism, Down syndrome and measures of longitudinal 
outcome 
 
 
Autism Down syndrome 
Yes (n=6) No (n=34) Yes (n=6) No (n=34) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
 statistic 
 
p 
 
 
HoNOS-LD total score 
 
7.33 9.69 9.09 14.56 .283 .779 3.33 16.16 9.79 13.44 1.055 .298 
GAF 
 
8.17 21.17 14.26 19.51 .698 .490 15.00 26.84 13.06 18.56 -.221 .826 
CGI 
.67 1.37 1.15 1.71 .651 .519 .67 1.97 1.15 1.62 .651 .519 
CANDID-R unmet needs 
  
  
  
1.33 4.08 3.24 4.21 1.025 .312 3.83 3.19 2.79 4.37 -.555 .582 
CANDID-R met needs 
  
 
1.67 3.14 3.29 3.92 .960 .343 2.67 4.03 3.12 3.84 .263 .794 
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Table 4.82: The relationship between sensory impairments and measures of longitudinal outcome 
 
Visual impairment Hearing impairment 
Yes (n=5) No (n=35) Yes (n=5) No (n=35) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 6.00 15.51 9.23 13.79 .483 .632 -4.60 13.07 10.74 13.02 2.464* .018 
GAF 4.00 23.22 14.69 19.05 1.145 .260 -12.00 5.43 16.97 18.15 7.404§*** .000 
CGI 
 
.20 1.79 1.20 1.62 1.274 .210 -.80 .84 1.34 1.57 2.968** .005 
CANDID-R unmet 
needs 
 
1.20 5.17 3.20 4.06 .997 .325 .80 3.11 3.26 4.27 1.234 .225 
CANDID-R met 
needs 
 
2.20 3.96 3.17 3.85 .527 .602 1.20 4.15 3.31 3.76 1.162 .252 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
† Non- parametric z-score from Mann-Whitney test   
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed  
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Table 4.83: The relationship between mobility problems and measures of 
longitudinal outcome 
 
 
Mobility problems 
Yes (n=7) No (n=33) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 9.29 16.59 8.73 13.49 -.096 .924 
GAF 14.71 25.90 13.06 18.50 -.200 .842 
CGI 
 
1.29 2.56 1.03 1.45 -.255§ .806 
CANDID-R unmet 
needs 
 
3.43 3.55 2.85 4.36 -.329 .744 
CANDID-R met 
needs 
 
3.57 3.87 2.94 3.86 .393 .697 
 
 
** significant at the p< .01 level 
 
§ Levene’s test found the between group variance is significant so 
the t-test results are for equal variances not assumed 
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Table 4.84: The relationship between incontinence and measures of longitudinal outcome 
 
 
Urinary incontinence Bowel incontinence 
Yes (n=15) No (n=25) Yes (n=11) No (n=29) 
 Mean 
 
SD Mean 
 
SD 
 
statistic 
 
p 
 
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 13.87 11.44 5.80 14.48 -1.837 .074 15.00 13.18 6.48 13.58 -1.785 .082 
GAF 22.67 15.73 7.76 19.84 -2.476* .018 24.45 17.84 9.14 18.84 -2.328* .025 
CGI 
 
1.67 1.50 .72 1.67 -1.802 .080 1.91 1.64 .76 1.57 -2.042* .048 
CANDID-R unmet 
needs 
 
3.93 3.75 2.36 4.41 -1.154 .256 2.91 3.67 2.97 4.44 .038 .970 
CANDID-R met 
needs 
 
3.27 3.58 2.92 4.03 .274 .785 2.82 3.25 3.14 4.07 -.233 .817 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
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Since several of the socio-clinical variables at baseline are significantly related to 
longitudinal outcome the null hypothesis is rejected. 
 
4.11 Examining measures of psychopathology and socio-clinical 
variables as independent predictors of longitudinal outcome. 
 
Linear regression is used to examine which baseline variables predict longitudinal 
outcome (dependant variables in the linear regression). As for the previous analyses, 
separate multiple linear regression analyses are carried out using the psychopathology 
dimensional factor scores, dimensional symptom counts and the three overall measures 
of psychopathology. All regression analyses are adjusted for the baseline score on the 
specific measure of outcome. 
 
4.11.1 Independent predictors of longitudinal outcome measured with the HoNOS-
LD total score 
Different dimension factor scores, and symptom counts are significant predictors of 
longitudinal outcome on the HoNOS-LD in tables 4.85 and 4.86. Only the behaviour-
affective factor score at baseline is an independent predictor, whilst the depressive and 
organic symptom counts predict longitudinal outcome on the HoNOS-LD. The other 
independent predictors of outcome across the two regression analyses is the level of 
intellectual disabilities. 
 
Null hypothesis eleven: 
Dimensional measures of psychopathology, and socio-clinical variables are not 
independently associated with the longitudinal outcome of mental disorders. 
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Table 4.85: Multivariate associations of dimension factor scores and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive 
dimension factor 
score‡ 
.018* 
 
Not retained in the model 
Behaviour-
affective 
dimension factor 
score‡ 
.001** 
 
13.898 6.255 .292 .033* 
Independent-
family carer Not retained in the model Living 
circumstances 023* Independent- 
paid carer Not retained in the model 
Mild- moderate 
14.990 6.002 .439 .018* 
 
Mild-severe 15.342 5.478 .486 .008** 
Categorical 
measure of 
intellectual 
disabilities 
.003** 
 
Mild- profound 18.733 5.374 .671 .001** 
Hearing 
impairment .018* 
 
Not retained in the model 
Urinary 
incontinence .074 
 
Not retained in the model 
Bowel 
incontinence .082 
 
Not retained in the model 
.546 
 248 
 
 
Table 4.86: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension 
symptom count .009** 
 
1.633 .737 .297 .034* 
Organic dimension 
symptom count .097 
 
-3.727 1.279 -.382 .006** 
Behaviour-affective 
dimension symptom 
count 
.004** 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .023* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
17.731 5.588 .519 .003** 
 
Mild-severe 19.513 5.424 .618 .001** 
Categorical measure 
of intellectual 
disabilities 
.003** 
 
Mild- profound 18.854 5.187 .676 .001** 
Hearing impairment .018* 
 
Not retained in the model 
Urinary incontinence .074 
 
Not retained in the model 
Bowel incontinence .082 
 
Not retained in the model 
.601 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
 
All three overall measures of psychopathology were retained as independent predictors 
of outcome in the regression models. The results are shown in table 4.87-4.89 for the 
linear regression analysis with the total dimension factor score, total dimension 
symptom count and the EFS PPS-LD symptom count- 41, respectively. 
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Table 4.87: Multivariate associations of total dimension factor score and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension factor 
score 
.008** 
 
3.210 .858 .427 .001** 
Independent-
family carer Not retained in the model Living circumstances .023* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
20.119 5.843 .589 .002** 
 
Mild-severe 18.762 5.545 .594 .002** 
Categorical measure of 
intellectual disabilities .003** 
 
Mild- profound 24.124 5.058 .864 .000*** 
Hearing impairment .018* 
 
Not retained in the model 
Urinary incontinence .074 
 
Not retained in the model 
Bowel incontinence .082 
 
Not retained in the model 
.546 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
 
 
  
  
 
 
 
  
  
  
  
  
 
 
 
  
  
 
 250 
 
Table 4.88: Multivariate associations of total dimension symptom count and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension 
symptom count .004** 
 
2.445 .435 .395 .001** 
Independent-
family carer Not retained in the model Living circumstances .023* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
17.438 5.164 .510 .001** 
 
Mild-severe 16.551 4.886 .524 .002** 
Categorical measure of 
intellectual disabilities .003** 
 
Mild- profound 16.723 4.914 .599 .002*** 
Hearing impairment .018* 
 
Not retained in the model 
Urinary incontinence .074 
 
Not retained in the model 
Bowel incontinence .082 
 
Not retained in the model 
.614 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.89: Multivariate associations of EFS PPS-LD symptom count- 41 and 
socio-clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
EFS PPS-LD symptom 
count- 41 .002** 
 
1.472 .401 .426 .001** 
Independent-
family carer Not retained in the model Living circumstances .023* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
16.773 4.664 .521 .002** 
 
Mild-severe 17.175 4.905 .584 .002** 
Categorical measure of 
intellectual disabilities .003** 
 
Mild- profound 21.849 5.375 .873 .000*** 
Hearing impairment .018* 
 
Not retained in the model 
Urinary incontinence .074 
 
Not retained in the model 
Bowel incontinence .082 
 
Not retained in the model 
.541 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level
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4.11.2 Independent predictors of longitudinal outcome measured with the GAF  
There is only one difference between the variables from the bivariate analysis included 
in the HoNOS-LD and GAF multivariate analyses- the organic dimension symptom 
count was not associated with the GAF. The independent predictors of longitudinal 
outcome on the GAF are, therefore, similar to those for the HoNOS-LD. 
 
In the regression models that include the depressive and behaviour-affective factor 
scores (table 4.90) and symptom counts (table 4.91) level of intellectual disabilities and 
hearing impairment were retained as independent predictors of longitudinal outcome on 
the GAF. However, whilst both dimensions are retained for the model using factor 
scores, only the depression symptom count is a significant predictor of outcome in the 
model shown in table 4.91. 
 
Similar to the findings for the HoNOS-LD in the previous section, all three overall 
measures of psychopathology were independent, significant predictors of longitudinal 
outcome on the GAF. The models for the overall measures of psychopathology were 
very similar. For each regression model, in addition to the overall measure of 
psychopathology, level of intellectual disabilities and hearing impairment are significant 
predictors of outcome, and the regression models account for 67.2-69.6% of the overall 
variance. The details of the regression models for all three overall measures of 
psychopathology are shown in table 4.92-4.94. 
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Table 4.90: Multivariate associations of dimension factor scores and socio-clinical 
variables with longitudinal change in GAF scores  
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive 
dimension factor 
score‡ 
.003** 
 
23.201 7.057 .342 .002** 
Behaviour-affective 
dimension factor 
score‡ 
.005** 
 
16.438 7.522 .244 .036* 
Independent-
family carer Not retained in the model Living 
circumstances .024* Independent 
paid carer Not retained in the model 
Mild- moderate 
18.860 8.247 .390 .029* 
 
Mild-severe 18.400 7.470 .412 .019* 
Categorical measure 
of intellectual 
disabilities 
.018* 
 
Mild- profound 18.470 7.691 .467 .022* 
Hearing impairment .000*** 
 
-28.252 6.226 -.483 .000*** 
Urinary 
incontinence .018* 
 
Not retained in the model 
Bowel incontinence .025* 
 
Not retained in the model 
.646 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
‡ the square root transformed variable is used in the analyses 
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Table 4.91: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension 
symptom count .000*** 
 
3.404 .800 .437 .000*** 
Behaviour-affective 
dimension symptom 
count 
.022* 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .024* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
22.585 7.472 .467 .005** 
 
Mild-severe 19.630 7.120 .439 .009** 
Categorical measure of 
intellectual disabilities .018* 
 
Mild- profound 21.808 6.848 .552 .003** 
Hearing impairment .000*** 
 
-28.089 6.033 -.480 .000*** 
Urinary incontinence .018* 
 
Not retained in the model 
Bowel incontinence .025* 
 
Not retained in the model 
.633 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.92: Multivariate associations of total dimension factor score and socio-
clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension 
factor score .000*** 
 
5.289 1.026 .496 .000*** 
Independent-
family carer Not retained in the model Living 
circumstances .024* Independent- 
paid carer Not retained in the model 
Mild- moderate 
14.097 8.094 .291 .041* 
 
Mild-severe 15.883 7.111 .355 .032* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound 21.318 6.444 .539 .002** 
Hearing 
impairment .000*** 
 
-30.514 5.526 -.521 .000*** 
Urinary 
incontinence .018* 
 
Not retained in the model 
Bowel incontinence .025* 
 
Not retained in the model 
.696 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.93: Multivariate associations of total dimension symptom count and socio-
clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension 
symptom count .000*** 
 
2.375 .527 .459 .000*** 
Independent-
family carer Not retained in the model Living 
circumstances .024* Independent- 
paid carer Not retained in the model 
Mild- moderate 
17.698 7.252 .366 .020* 
 
Mild-severe 16.318 6.900 .319 .037* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound 22.898 5.963 .554 .001** 
Hearing 
impairment .000*** 
 
-29.493 5.856 -.504 .000*** 
Urinary 
incontinence .018* 
 
Not retained in the model 
Bowel incontinence .025* 
 
Not retained in the model 
.672 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.94: Multivariate associations of EFA PPS-LD symptom count- 41 and 
socio-clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
EFS PPS-LD 
symptom count- 41 .000*** 
 
2.317 .495 .474 .000*** 
Independent-
family carer Not retained in the model Living 
circumstances .024* Independent- 
paid carer Not retained in the model 
Mild- moderate 
16.594 7.209 .343 .027* 
 
Mild-severe 17.558 7.967 .390 .012* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound 21.933 5.922 .531 .001** 
Hearing 
impairment .000*** 
 
-29.286 5.778 -.500 .000*** 
Urinary 
incontinence .018* 
 
Not retained in the model 
Bowel incontinence .025* 
 
Not retained in the model 
.681 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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4.11.3 Independent predictors of longitudinal outcome measured with the CGI 
In comparison to the HoNOS-LD and GAF, gender and epilepsy are added to the 
variables included in the analyses looking at the variables that are independent 
predictors of longitudinal outcome on the CGI. Epilepsy is retained across all the 
regression models but otherwise the variables at baseline that independently predict 
longitudinal outcome on the CGI are similar to those for the GAF. 
 
Tables 4.95 and 4.96 show the results of the linear regression analyses that include the 
depression and behaviour-affective dimension factor scores and symptom counts. 
Similar to findings for the GAF, both dimension factor scores, but only the depressive 
dimension symptom count, are significant independent predictors of outcome on the 
CGI. In addition to epilepsy, level of intellectual disabilities and hearing impairment are 
also significant predictors of outcome on the CGI. 
 
In contrast to the results for the HoNOS-LD and GAF linear regression analyses that 
included the three overall measures of psychopathology, the results are slightly different 
across the three final regression models with the CGI as the dependant variable. The 
common findings across the three models in tables 4.97-4.99 are: 
• all three overall measures of psychopathology are significant independent 
predictors of outcome on the CGI 
• only the mild-profound dummy variables for level of intellectual disabilities are 
retained 
• hearing impairment is retained across all three models 
• there are differences across the models in the results for the epilepsy variable. 
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Table 4.95: Multivariate associations of dimension factor scores and socio-
clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive 
dimension factor 
score‡ 
.007** 
 
2.136 .615 .373 .001** 
Behaviour-affective 
dimension factor 
score‡ 
.004** 
 
1.695 .614 .298 .009** 
Gender .097 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living 
circumstances .013* Independent- 
paid carer Not retained in the model 
Mild- moderate 
1.262 .696 .309 .079 
 
Mild-severe 1.478 .614 .392 .022* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound 1.746 .628 .523 .009** 
No- well 
controlled 1.084 .449 .265 .022* 
Epilepsy .048* 
No- poor 
control -1.139 .587 -.209 .041* 
Hearing 
impairment .005** 
 
-1.638 .532 -.331 .004** 
Urinary 
incontinence .080 
 
Not retained in the model 
Bowel incontinence .048* 
 
Not retained in the model 
.655 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
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Table 4.96: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in CGI scores  
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive dimension 
symptom count .001** 
 
.279 .071 .425 .000*** 
Behaviour-affective 
dimension symptom 
count 
.020* 
 
Not retained in the model 
Gender .097 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .013* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
1.591 .637 .389 .018* 
 
Mild-severe 1.597 .590 .423 .011* 
Categorical measure 
of intellectual 
disabilities 
.018* 
 
Mild- profound 2.053 .563 .616 .001** 
No- well 
controlled .910 .444 .223 .048* 
Epilepsy .048* 
No- poor 
control -1.057 .565 -.194 .046** 
Hearing impairment .005** 
 
-1.780 .553 -.360 .003** 
Urinary incontinence .080 
 
Not retained in the model 
Bowel incontinence .048* 
 
Not retained in the model 
.683 
 261 
Table 4.97: Multivariate associations of total dimension factor score and socio-
clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations (p<.1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension factor 
score 
.004** 
 
.454 .088 .505 .000*** 
Gender .097 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .013* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of 
intellectual disabilities .018* 
 
Mild- profound 1.025 .344 .307 .005** 
No- well 
controlled 1.427 .416 .349 .002** 
Epilepsy .048* 
No- poor 
control Not retained in the model 
Hearing impairment .005** 
 
-1.474 .497 -.298 .005** 
Urinary incontinence .080 
 
Not retained in the model 
Bowel incontinence .048* 
 
Not retained in the model 
.681 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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Table 4.98: Multivariate associations of total dimension symptom count and 
socio-clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Total dimension symptom 
count .001** 
 
.194 .045 .445 .000 
Gender .097 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .013* 
Independent- 
paid carer Not retained in the model. 
Mild- moderate 
Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of 
intellectual disabilities .018* 
 
Mild- profound .817 .345 .245 .024* 
No- well 
controlled 1.276 .427 .312 .005** 
Epilepsy .048* 
No- poor 
control -1.180 .568 -.217 .045* 
Hearing impairment .005** 
 
-1.569 .503 -.318 .004** 
Urinary incontinence .080 
 
Not retained in the model 
Bowel incontinence .048* 
 
Not retained in the model 
.694 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.99: Multivariate associations of EFA PPS-LD symptom count- 41 and 
socio-clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
EFA PPS-LD symptom count- 
41 .001** 
 
.175 .042 .423 .000*** 
Gender .097 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .013* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
Not retained in the model 
 
Mild-severe Not retained in the model 
Categorical measure of 
intellectual disabilities .018* 
 
Mild- profound .797 .350 .239 .029 
No- well 
controlled 1.073 .425 .263 .017 
Epilepsy .048* 
No- poor 
control -1.152 .563 -.212 .049 
Hearing impairment .005** 
 
-1.649 .507 -.334 .003 
Urinary incontinence .080 
 
Not retained in the model 
Bowel incontinence .048* 
 
Not retained in the model 
.687 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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4.11.4 Independent predictors of longitudinal outcome measured with CANDID-R 
unmet needs 
In the bivariate analyses, of the individual dimensional measures of psychopathology 
only the symptom count for the depressive dimension was found to be significantly 
correlated with the change in the CANDID-R unmet needs. However, it was not an 
independent predictor of outcome in the linear regression analyses in table 4.100. 
 
 
In fact, this was also the case for the three overall measures of psychopathology. 
Therefore, the only significant predictor of outcome on the CANDID-R unmet needs is 
level of intellectual disabilities, with the results in table 4.100 consistent across the 
analyses using the overall measures of psychopathology. 
 
Table 4.100: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in CANDID-R unmet needs 
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Depressive 
dimension symptom 
count 
.060 
 
Not retained in the model 
Mild- moderate 
6.500 1.874 .628 .001** 
 
Mild-severe 7.100 1.792 .742 .000*** 
Categorical measure 
of intellectual 
disabilities 
.012* 
 
Mild- profound 7.188 1.661 .850 .000*** 
.368 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
 
   
There were no variables associated with the CANDID-R met needs in the bivariate 
analyses. Therefore, it is concluded that there are no significant predictors of 
longitudinal outcome on the CANDID-R met needs. 
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However, the overall findings were that baseline measures of psychopathology and 
socio-clinical variables that predict longitudinal outcome. Therefore, the null hypothesis 
is rejected. 
 
4.12 Comparing the predictive validity of categorical and dimensional 
measures of psychopathology 
 
 
 
The regression models examining dimensional models of psychopathology, and socio-
clinical variables as predictors of longitudinal outcome were presented in section 4.11 
above. Measures representing dimensional models of psychopathology were significant, 
independent predictors of longitudinal outcome measured with the HoNOS-LD (tables 
4.85 and 4.86), GAF (tables 4.90 and 4.91) and CGI (4.95 and 4.96). To examine null 
hypothesis eleven, these models for dimensional models of psychopathology were 
compared to models using a categorical model of psychopathology (individual meets 
criteria for a DC-LD diagnosis of mental disorder) and models including both 
dimensional and categorical models. The socio-clinical variables with bivariate 
associations to the HoNOS-LD, GAF and CGI were also included in the linear 
regression analyses, to allow direct comparison between the models. 
 
4.12.1 Examining categorical diagnosis of mental disorder as a predictor of 
longitudinal outcome 
Twenty six individuals (65%) in sample 3 met the criteria for a DC-LD categorical 
diagnosis at baseline, shown in table 3.4. The binary variable was included in the linear 
regression analyses with longitudinal outcome on HoNOS-LD, GAF and CGI as the 
dependent variables. 
 
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with the longitudinal outcome of mental 
disorders.  
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The categorical model of psychopathology was not retained in the regression model for 
HoNOS-LD. However, the final models for GAF and CGI are shown in tables 4.101 
and 4.102. 
 
 
Table 4.101: Multivariate associations of categorical DC-LD diagnosis and 
socio-clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations (p< .1) Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Categorical diagnosis of 
mental disorder on DC-
LD (Y/N) 
N/A 
 
10.518 5.515 .259 .045* 
Independent-
family carer Not retained in the model Living circumstances .024* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
30.107 7.493 .622 .000*** 
 
Mild-severe 33.997 8.058 .760 .000*** 
Categorical measure of 
intellectual disabilities .018* 
 
Mild- profound 31.950 6.509 .809 .000*** 
Hearing impairment .000*** 
 
-36.181 6.893 -.618 .000*** 
Urinary incontinence .018* 
 
Not retained in the model 
Bowel incontinence .025* 
 
Not retained in the model 
.586 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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Table 4.102: Multivariate associations of categorical DC-LD diagnosis and 
socio-clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable p 
Dummy 
variable B SE B β 
 
p 
 
R² 
Categorical diagnosis 
of mental disorder on 
DC-LD (Y/N) 
N/A 
 
.879 .477 .257 .044 
Gender .097 
 
Not retained in the model 
Independent-
family carer Not retained in the model Living circumstances .013* 
Independent- 
paid carer Not retained in the model 
Mild- moderate 
2.605 .648 .638 .000*** 
 
Mild-severe 2.937 .697 .778 .000*** 
Categorical measure 
of intellectual 
disabilities 
.018* 
 
Mild- profound 2.890 .563 .867 .000*** 
No- well 
controlled Not retained in the model 
Epilepsy .048* 
No- poor 
control Not retained in the model 
Hearing impairment .005** 
 
-2.732 .596 -.553 .000*** 
Urinary incontinence .080 
 
Not retained in the model 
Bowel incontinence .048* 
 
Not retained in the model 
.565 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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The variable representing the categorical model of psychopathology was retained as a 
significant, independent predictor of outcome on the GAF and CGI. Comparing the 
standardised coefficients (β) across models, for longitudinal outcome on the GAF the 
depressive dimension factor score (β= .342) and symptom count (β= .437) are stronger 
predictors of outcome than the categorical model of psychopathology (β= .259), which 
is a stronger predictor than the behavioural affective dimension symptom score 
(β=.244). Similarly for longitudinal outcome on the CGI the depressive dimension 
factor score (β= .282) and symptom count (β= .437) are stronger predictors of outcome 
than the categorical model of psychopathology (β= .257), which is a stronger predictor 
than the behavioural affective dimension symptom score (β=.238).  
 
The final regression models using the dimensional model of psychopathology explain a 
greater proportion of the variance in longitudinal outcome on the GAF and CGI than the 
models using the categorical model of psychopathology. 
 
4.12.2 Examining whether categorical and dimensional models of psychopathology 
are co-predictors of longitudinal outcome 
To examine if the categorical and dimensional models of psychopathology have 
complimentary effects on predicting outcome, a final set of linear regression models 
were examined including both sets of variables, and run separately for dimension factor 
scores and dimensions symptom counts. However, the variable representing the 
categorical of psychopathology was not retained as significant in the final models for 
the longitudinal outcome on the HoNOS-LD, GAF and CGI, which were therefore 
unchanged from those reported in section 4.11 for the dimensional models. 
 
Therefore, the evidence suggests that dimensional models of psychopathology are better 
predictors of longitudinal outcome than categorical models, and are considered to have 
better predictive validity. Null hypothesis twelve is rejected. 
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4.13 Summary of results 
Prior to discussing the findings and implications in detail in Chapter 5, the results 
relevant to the twelve null hypotheses are summarised. 
 
Four dimensions were identified, interpreted as representing depressive, organic, 
behaviour-affective and anxiety dimensions of psychopathology. There were minor 
changes in the items of psychopathology included in the four dimensions extracted from 
the original EFA, and separate analyses using two random sub-samples. However, 
across the separate analyses there was excellent agreement in the loadings of individual 
items of psychopathology to the four dimensions. Therefore, the stability of the 
dimensions appears good. 
 
Since there were no significant correlations between the four dimensions, they appear to 
be independent dimensions of psychopathology. 
 
 
The socio-clinical variables significantly associated with the measures of 
psychopathology, in the bivariate analyses, are shown in table 4.103 below. Only gender 
and hearing impairment were not associated with any measure of psychopathology. 
 
Null hypothesis one: Rejected 
There are no stable, identifiable dimensions of psychopathology experienced by 
adults with intellectual disabilities. 
 
Null hypothesis two: Accepted 
There are no significant correlations between the individual dimensions of 
psychopathology experienced by adults with intellectual disabilities. 
 
Null hypothesis three: Rejected 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and socio-clinical variables. 
 
 270 
Table 4.103: Socio-clinical variables significantly associated with higher 
levels of psychopathology 
 
 
 
* Variables included in the multivariate analyses since they are associated with the 
specific measure of psychopathology with a significance level less than .1 but 
greater than .05 
 Socio-clinical variables 
Depressive Older age 
Living with family carers 
More severe level of intellectual disabilities 
Down syndrome 
 
Organic  
  
  Does not have visual impairment 
Younger age 
Living with paid carers 
Severe level of intellectual disabilities 
Down syndrome* 
Behaviour-affective  
  
  
  
Urinary incontinence 
Younger age 
Severe level of intellectual disabilities 
Does not have pilepsy 
Autism* 
Does not have mobility problems 
Does not have urinary incontinence 
Anxiety 
  
  
  
 
 
Does not have bowel incontinence 
Moderate intellectual disabilities 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor 
scores 
 
Total 
 Does not have mobility problems * 
Depressive Older age 
Older age 
Autism* 
Organic 
Down syndrome 
Younger age 
More severe level of intellectual disabilities 
Behaviour-affective  
  
  Does not have Down syndrome 
Younger age 
Moderate intellectual disabilities* 
Does not have epilepsy* 
Autism* 
Does not have mobility problems 
Does not have urinary incontinence 
Anxiety 
  
  
  
 
 
 
Does not have bowel incontinence 
Moderate intellectual disabilities 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  Does not have mobility problems * 
EFA  PPS-LD symptom count- 41  Moderate intellectual disabilities 
 271 
 
 
 
 
In table 4.104 the socio-clinical variables retained as independently associated with the 
measures of psychopathology are shown. The socio-clinical variables retained in the 
final regression models varies between the dimensional measures of psychopathology. It 
is evident that there are a greater number of socio-clinical variables associated with the 
dimensional measures of psychopathology, than with the three overall measures of 
psychopathology.  
Null hypothesis four: Rejected 
There are no significant cross-sectional, multivariate relationships between 
measures of psychopathology and socio-clinical variables. 
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Table 4.104: Socio-clinical variables retained as independently associated 
with measures of psychopathology in the final regression models  
 
 
 
 
 
 
 
 
 
 
 
 Socio-clinical variables 
Depressive Older age 
More severe level of intellectual disabilities Organic 
Down syndrome 
Younger age 
More severe level of intellectual disabilities 
Behaviour-affective 
 
  Down syndrome 
Younger age 
Moderate  intellectual disabilities 
Does not have epilepsy 
Does not have mobility problems 
Anxiety 
 
 
  
 Does not have bowel incontinence 
 
 
 
 
 
Dimension 
factor 
scores 
Total Moderate  intellectual disabilities 
Depressive Older age 
Older age Organic 
Down syndrome 
Younger age 
More severe level of intellectual disabilities 
Behaviour-affective  
  
  Down syndrome 
Younger age 
Moderate intellectual disabilities 
Anxiety 
  
  Mobility problems 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total Moderate intellectual disabilities 
EFA  PPS-LD symptom count- 41  Level of intellectual disabilities 
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Each of the four dimensional factor scores, and symptom counts, were correlated with 
one or more measure of severity. These correlations are summarised in table 4.105. The 
only clear difference between the correlations of factor scores and symptom counts for 
an individual dimension of psychopathology is seen for the organic dimension. All three 
overall measures of psychopathology were significantly correlated with each of the five 
measures of severity.  
 
Null hypothesis five: Rejected 
There are no significant cross-sectional, bivariate relationships between 
dimensional measures of psychopathology and measures of the severity of mental 
disorders. 
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Table 4.105: Summary of the dimensional measures of psychopathology 
correlated with the measures of severity  
 
 
a higher level of psychopathology is associated with greater severity of 
mental disorder on all measures 
 
* Variables included in the multivariate analyses since they are associated 
with the measure of severity with a significance level less than .1 but greater 
than .05 
 
 
Measure of severity Dimension factor score Dimension symptom count 
Depressive a Depressive 
Behaviour-affective Organic 
Behaviour-affective 
 
 
HoNOS-LD 
Total 
Total 
Depressive Depressive 
Organic Organic 
Behaviour-affective Behaviour-affective 
 
 
 
GAF 
Total Total 
Depressive Depressive 
Organic Organic 
Behaviour-affective Behaviour-affective 
 
 
CGI 
Total Total 
Depressive* Depressive 
Organic* Organic 
Behaviour-affective Behaviour-affective 
 
 
CANDID-R unmet 
needs 
Total Total 
Depressive* Depressive* 
Anxiety Organic* 
Anxiety 
 
 
CANDID-R met needs  
Total 
Total 
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Of the socio-clinical variables included in the analysis, gender, Down syndrome and 
hearing impairment were not associated with any of the measures of severity. The cross-
sectional relationships between the other variables and the measures of severity are 
shown in table 4.106. 
 
 
Table 4.107 summarises the dimensional measures of psychopathology and socio-
clinical variables independently associated with the measures of severity. The retained 
socio-clinical variables are identical in both sets of models. However, the dimension 
factor scores and symptom counts retained vary. The three overall measures of 
psychopathology were all retained as independently associated with the five measures 
of outcome. Identical socio-clinical variables were retained to those shown for each of 
the measures of outcome in table 4.107. 
 
 
 
 
Null hypothesis six: Rejected 
There are no significant bivariate relationships between socio-clinical variables and 
measures of the severity of mental disorders. 
Null hypothesis seven: Rejected 
There are no significant multivariate associations between dimensional measures of 
psychopathology, socio-clinical variables and measures of the severity of mental 
disorders. 
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Table 4.106: Socio-clinical variables significantly associated with 
greater severity of mental disorder 
 
 
 
 
Measure of severity Socio-clinical variable 
Living with a paid carer* 
More severe intellectual disabilities 
Urinary incontinence 
 
 
HoNOS-LD 
Bowel incontinence 
GAF No significant bivariate associations 
CGI Moderate intellectual disabilities 
Younger age 
Living indepedently 
Moderate intellectual disabilities* 
 
 
CANDID-R unmet needs 
Visual impairment 
Older age* 
Living with a family or paid carer 
More severe intellectual disabilities  
Autism* 
Epilepsy- well controlled seizures 
Visual impairment 
Mobility problems 
Urinary incontinence 
 
 
 
 
 
 
CANDID-R met needs  
Bowel incontinence 
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Table 4.107: Measures of psychopathology and socio-clinical variables 
independently associated with greater severity of mental disorder, apart from 
met needs 
 
Measure of 
severity Models including dimension factor 
scores and socio-clinical variables 
Models including dimension 
factor scores and socio-clinical 
variables 
Depressive dimension Depressive dimension 
Behaviour-affective dimension Organic dimension 
Behaviour-affective dimension 
HoNOS-LD 
Profound intellectual disabilities 
Profound intellectual disabilities 
Depressive dimension Depressive dimension 
Organic dimension Organic dimension 
GAF 
  
Behaviour-affective dimension Behaviour-affective dimension 
Depressive dimension Depressive dimension 
Organic dimension Organic dimension 
CGI 
Behaviour-affective dimension Behaviour-affective dimension 
Younger age Organic dimension 
Living independently Behaviour-affective dimension 
More severe intellectual disabilities Younger age 
Living  independently 
More severe intellectual disabilities 
CANDID-R 
unmet needs  
Does not have visual impairment 
Does not have visual impairment 
Depressive dimension Depressive dimension 
Older age Organic dimension 
Living with family or paid carer Older age 
Mores severe intellectual disabilities Living with family or paid carer 
Epilepsy- well controlled seizures More severe intellectual disabilities 
Visual impairment Epilepsy- well controlled seizures 
Visual impairment 
CANDID-R 
met needs 
Urinary incontinence 
Urinary incontinence 
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The categorical model of psychopathology was only significantly associated with 
severity measured on the HoNOS-LD. However, when both the dimensional and 
categorical models of psychopathology were included in the regression analysis the 
categorical model was not retained. Therefore, it appears that the categorical model does 
not explain any additional variance, over and above the dimensional model of 
psychopathology. It is concluded that the dimensional model of psychopathology is 
more strongly related to measures of the severity of mental disorders. 
 
 
Only the anxiety dimension of psychopathology was not significantly associated with 
any measure of outcome. No baseline measure of psychopathology was associated with 
longitudinal outcome measured on the CANDID-R met needs. 
 
 
 
 
 
Null hypothesis eight: Rejected 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with measures of the severity of mental 
disorders. 
 
Null hypothesis nine: Rejected 
Dimensional measures of psychopathology are not significantly correlated to  
the longitudinal outcome of mental disorders. 
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Table 4.108: Summary of the baseline measures of psychopathology correlated 
with poorer longitudinal outcome 
 
 
 
* Variables included in the multivariate analyses since they are associated 
with the specific measure of psychopathology with a significance level less 
than .1 but greater than .05 
 
 
Only the CANDID-R met needs was not associated with any socio-clinical 
variable.in table 4.109 
 
 
 
Measure of outcome Dimension factor score Dimension symptom count 
Depressive Depressive 
Behaviour-affective Organic* 
Behaviour-affective 
HoNOS-LD 
Total 
Total 
Depressive Depressive 
Behaviour-affective Behaviour-affective 
GAF 
Total Total 
Depressive Depressive 
Behaviour-affective Behaviour-affective 
CGI 
Total Total 
Depressive* CANDID-R unmet 
needs 
Total 
Total 
CANDID-R met needs  None None 
Null hypothesis ten: Rejected 
Socio-clinical measures are not significantly associated with the longitudinal outcome 
of mental disorders. 
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Table 4.109: Socio-clinical variables associated with poorer longitudinal 
outcome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Variables included in the multivariate analyses since they are 
associated with the specific measure of psychopathology with a 
significance level less than .1 but greater than .05 
 
Measure of severity Socio-clinical variable 
Living independently* 
Mild intellectual disabilities 
Hearing impairment 
Does not have urinary incontinence* 
HoNOS-LD 
Does not have bowel incontinence* 
Living independently 
Mild intellectual disabilities 
Hearing impairment 
Does not have urinary incontinence 
GAF 
Does not have bowel incontinence 
Gender* 
Living independently 
Mild intellectual disabilities 
Epilepsy 
Hearing impairment 
Does not have urinary incontinence * 
CGI 
Does not have bowel incontinence 
CANDID-R unmet needs Mild intellectual disabilities 
CANDID-R met needs  None 
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Varying combinations of measures of psychopathology and socio-clinical 
variables were retained as significant predictors of outcome on the HoNOS-LD, 
GAF, CGI and CANDID-R unmet needs, shown in table 4.110.  
 
 
 Table 4.110: Measures of psychopathology and socio-clinical variables 
independently associated with poorer longitudinal outcome 
 Models including dimension 
factor scores and socio-clinical 
variables 
Models including dimension 
factor scores and socio-clinical 
variables 
Behaviour-affective dimension Depressive dimension 
Organic dimension 
HoNOS-LD 
Mild intellectual disabilities 
Mild intellectual disabilities 
Depressive dimension Depressive dimension 
Behaviour-affective dimension Mild intellectual disabilities 
Mild  intellectual disabilities Hearing impairment 
GAF 
  
Hearing impairment  
Depressive dimension Depressive dimension 
Behaviour-affective dimension Mild intellectual disabilities 
Mild intellectual disabilities Epilepsy-poorly  seizure control 
Epilepsy-poorly  seizure control  
CGI 
Hearing impairment 
Hearing impairment 
CANDID-R 
unmet needs  
Level of intellectual disabilities Level of intellectual disabilities 
CANDID-R 
met needs 
No significant associations No significant associations 
Null hypothesis eleven: Rejected 
Dimensional measures of psychopathology, and socio-clinical variables are  
not independently associated with the longitudinal outcome of mental disorders. 
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The variable representing the categorical model of psychopathology was retained as a 
significant, independent predictor of outcome on the GAF and CGI. However, the 
dimensional model of psychopathology was also associated with the HoNOS-LD and 
was more strongly associated with the GAF and CGI. When both models were 
included in a regression analysis the categorical model of psychopathology was not 
retained in the final model. Therefore, it is concluded that the dimensional model of 
psychopathology is a better predictor of longitudinal outcome of mental disorders.  
Null hypothesis twelve: Rejected 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with the longitudinal outcome of mental 
disorders. 
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Chapter 5 Discussion 
This chapter aims to fully consider the findings from chapter 4 in the context of previous 
research. The first section discusses the principal findings in relation to the 12 research 
null hypotheses.  For the purposes of the discussion the null hypotheses are grouped 
together into five sections, corresponding to the research aims of the thesis: 
• the dimensional model of psychopathology  (Null hypotheses one and two) 
• the relationships between psychopathology and socio-clinical variables (Null 
hypotheses three and four) 
• psychopathology and the severity of mental disorders (Null hypotheses five to seven) 
• psychopathology as a predictor of the longitudinal outcome of mental disorders (Null 
hypotheses nine to eleven) 
• comparing dimensional and categorical models of psychopathology (null hypotheses 
eight and twelve). 
 
Following on from the discussion of the specific findings in comparison with previous 
literature, the strengths and limitations of the research carried out to address the 
hypotheses are considered in the second section. Finally, the implications of the findings 
for clinical practice and research in the field of mental disorders and intellectual 
disabilities are discussed. 
 
5.1. The multi-dimensional model of psychopathology  
Exploratory factor analysis of the PPS-LD data resulted in a model of psychopathology 
with four dimensions, labeled as depressive, organic, behavioural affective and anxiety. 
This multi-dimensional model explains just over 31% of the total variance in the 
psychopathology data collected using the PPS-LD. 
 
In the studies summarised in table 1.2, the different instruments used to assess 
psychopathology, the different samples, and even issues relating to the labelling of 
dimensions affects the comparison with the results in this thesis. For example, the PAS-
ADD checklist does not include items of psychopathology related to problem 
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behaviours, and Kellett et al. (2004) included only participants with mild intellectual 
disabilities. The issue with labelling is illustrated by the dimensions that include items 
describing affective psychopathology, in studies in table 1.2. These are described using 
different labels- such as depression, mood, anxiety, and dementia/ anxiety.  To add to the 
problems with labelling, confusingly, two studies using the PAS-ADD checklist included 
two separate dimensions labelled as depression (Moss et al. 1998; Hatton & Taylor 
2008). These variations between studies are considered where relevant below, in the 
comparisons of studies reporting multi-dimensional models of psychopathology. 
 
Compared with the previous studies (table 1.2), the number of dimensions identified and 
the overall variance explained in the model described in this thesis was placed towards 
the midpoint. The number of dimensions in the previous studies varies from one 
(Sturmey et al. 1996; Tsiouris et al. 2003) to nine (Linaker 1991). These models also 
vary considerably in the proportion of the overall variance in psychopathology they 
account for- ranging from 9.4% (Tsiouris et al. 2003) to 61.25% (Hatton & Taylor 
2008). Whilst accounting for a higher proportion of overall variance could be seen as 
desirable, it is not the case that a higher overall variance should be accepted at the 
expense of including additional factors, which are unstable, or un-interpretable. 
 
Compared to other studies in table 1.2, the methods used for the EFA in this thesis more 
closely followed best practice guidelines (Costello & Osborne 2005). Although this will 
have reduced the overall number of factors extracted, and therefore the proportion of the 
overall variance explained, it would have maximised the stability of the final multi-
dimensional model of psychopathology. In particular, a case: item ratio less than 5:1 
(Matson et al. 1984; Linaker 1991; Gustafsson & Sonnander 2005; Watson et al. 1988; 
Sturmey et al. 1996; Sturmey et al. 2003; Tsiouris et al. 2003), the use of eigenvalues to 
decide the number of factors extracted in models (Matson et al. 1984; Linaker, 1991; 
Balboni et al. 2000; Gustafsson & Sonnander 2005; Watson et al. 1988; Moss et al. 
1998; Hatton & Taylor 2008; Hove & Havik 2008; Kellet et al. 2004), acceptance of 
factors with less than three items (Moss et al. 1998; Hatton & Taylor 2008; Hove & 
Havik 2008) and cross-loading of items across factors (Moss et al. 1998; Sturmey et al. 
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2005; Sturmey et al. 1996; Kellet et al. 2004) have a negative effect on the stability of 
the final multi-dimensional models in studies reported in table 1.2. The methods of EFA 
used in a study will also have contributed to the difference in the proportion of variance 
models account for even when they have used the same instrument of assessment. A 
clear example of this is seen in the differing results from the three studies using the PAS-
ADD checklist (Moss et al. 1996; Sturmey et al. 2005; Hatton & Taylor 2008).  
 
The decisions on which items of psychopathology from the PPS-LD to include in the 
EFA is relevant to comparisons of the results with those of other studies. Items that 
occurred at an overall frequency less than 5%, or were dependent on the verbal 
communication of participants i.e. couldn’t be observed by an informant, were excluded 
from the EFA. This was done to improve the stability and generalisability of the final 
multi-dimensional model of psychopathology. Whilst this left 41 items of 
psychopathology for inclusion in the EFA, it had a differential effect on specific forms of 
psychopathology. For example, most items of affective or problem behaviour 
psychopathology are included in the EFA but this was not the case for other forms of 
psychopathology. Studies using the PIMRA (Matson 1984; Linaker 1993; Balboni 2000; 
Gustafsson & Sonnander 2005), PAS-ADD checklist (Moss et al. 1998; Sturmey et al. 
2005; Hatton & Taylor 2008), RSMB (Sturmey et al. 1996) and DASH-II (Sturmey et al. 
2004) identified psychosis dimensions of psychopathology. The exclusion of items of 
psychopathology relating to psychosis meant that this was not possible in this thesis. 
Therefore, the multi-dimensional model described here cannot be considered as 
representing all forms of psychopathology experienced by adults with intellectual 
disabilities. Rather, it is a model of commonly experienced psychopathology that can be 
identified, and reported, across the full range of abilities. 
 
Despite the differences between studies, the four dimensions are similar to dimensions 
reported in previous studies (table 1.2). Furthermore, equivalents to the depressive, 
organic, behaviour-affective and anxiety dimensions are included in the nine dimensions 
identified across studies using different instruments to assess psychopathology, listed in 
table 1.3. However, there are no previous studies that have reported a final model with 
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an identical combination of these four dimensions. Each of the four dimensions included 
in the final model, and aspects of the overall model, are discussed below.  
 
5.1.1 The depressive dimension of psychopathology 
In the EFA reported in section 4.1, the depressive dimension was extracted first- with 
nine items of psychopathology, representing the greatest proportion of the overall 
variance of the four dimensions (9.8%). A depressive dimension, or equivalent, was 
identified in seven previous studies using the informant version of the PIMRA (Matson 
et al. 1984; Watson et al. 1988), PAS-ADD checklist (Moss et al. 1996; Sturmey et al. 
2005; Hatton & Taylor 2008), MOSES (Sturmey et al. 2003), CBCPID (Tsiouris et al. 
2003) and BSI (Kellet et al. 2004) instruments of assessment, Furthermore, of the seven 
studies that identified a depressive dimension it was extracted as the first factor, 
explaining the highest variance, in five of the studies (Moss et al. 1996; Sturmey et al. 
2005; Hatton & Taylor 2008; Tsiouris et al. 2003; Kellet et al. 2004). Therefore, a 
depressive dimension of psychopathology is consistently identified across studies with 
adults with intellectual disabilities as participants, and accounts for a significant 
proportion of the psychopathology. This finding is in keeping with studies diagnosing 
mental disorders using categorical diagnostic classification systems. For example, a 
large-scale, population based study found that, after problem behaviours, DC-LD 
depressive disorder had the highest point prevalence (4.6%) of any mental disorder 
(Cooper et al. 2007c).  
 
Since a depressive dimension is identified within the majority of multi-dimensional 
models of psychopathology, it is relevant to consider possible reasons why it was not 
reported in a minority of studies in table 1.2. It is seen from the results of the study by 
Hove and Havik (20008) that depressive psychopathology is located within a dimension 
labelled as severe psychopathology. As well as depressive psychopathology, this 
dimension also includes psychopathology described as dementia, mania and psychosis. 
On closer inspection of the methodology used in the EFA, the items used in the analysis 
are the scores from the 18 checklists, rather than the 260 individual items of 
psychopathology. Thus, the results of this study do not present an empirically defined, 
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multi-dimensional model of psychopathology. Rather, the model describes which 
checklists of psychopathology correlate with one another. However, this study based the 
checklists on diagnostic criteria for specific categorical diagnoses in DC-LD- in turn 
derived form the ICD and DSM categorical classification systems. Therefore, rather than 
describing higher order dimensions of psychopathology (Achenbach & Edelbrock 1978; 
Cantwell 1996; Slade & Watson 2006; Slade 2007) the results describe the associations 
of DC-LD categories. This is maybe a reflection of the poor discriminant validity 
described for categorical diagnoses (section 1.4.2, Brown et al. 2001; Kessler et al. 
2005). Studying a multi-dimensional model of psychopathology could be achieved by 
using the data on the 260 individual items of psychopathology in the EFA (Hove and 
Havik, 2008). However, since the study by Hove & Havik (2008) is not a true EFA of 
individual items of psychopathology it will not be used further in the comparison of 
results. 
 
Of the five studies that extracted a multi-dimensional model of psychopathology from 
the informant version of the PIMRA, only two identified a depressive dimension 
(Matson et al. 1984; Watson et al. 1988). Since these five studies have used the same 
items of psychopathology, and a similar methodology for the EFA, it is not clear why the 
depressive dimension was not identified across all the studies. For example, the items 
that loaded to the affective dimensions in the studies by Matson et al. (1984) and Watson 
et al. (1988) are not extracted in any of the dimensions in the study by Linaker (1991), 
are distributed across the anxiety, adjustment and psychosomatic dimensions in Balboni 
et al. (2000) and across the psychosis and anxiety dimensions of Gustafson & Sonnander 
(2003).  All these studies have used methods of EFA that reduce the reliability and 
stability of the results. One additional potential explanation for the variations between 
studies using the PIMRA is that there is a problem with the 56 items of 
psychopathology. The PIMRA items of psychopathology are said to be based on criteria 
within DSM -III, organised into eight sub-scales (Matson et al. 1984): 
• schizophrenic disorders 
• affective disorders 
• psychosexual disorders 
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• adjustment disorders 
• anxiety disorders 
• somatoform disorders 
• personality disorders 
• inappropriate mental adjustment. 
 
It appears from the description of the questions included in the PIMRA that some items 
are similar to those in the PPS-LD depressive dimension (Matson et al. 1984). Therefore, 
the variation across studies is not due to an absence of relevant items.  However, within 
the PIMRA items there are some confusing questions, which seem to lack relevance to 
the assessment of psychopathology. For example, “Do you wish you were a tree instead 
of a man/ woman?....When things go bad for you do you feel OK?.... Is it bad to be 
sick?”. It could be that the inclusion of incongruous items leads to variation in the 
response to questions on psychopathology across studies- especially when it is being 
translated for use in different countries (Linaker 1991; Balboni et al. 2000; Gustafson & 
Sonnander 2005). This question over the PIMRA items highlights the influence that the 
items included in any EFA can have on the results. 
 
Of the items of psychopathology that loaded significantly to the depressive dimension in 
this thesis, all nine are included in the DC-LD criteria for depressive episode, seven are 
included within the ICD-10 criteria for depressive episode and eight in the DSM-IV-TR 
criteria for the categorical diagnosis of a major depressive disorder. The two items that 
are included in DC-LD but not ICD-10 criteria are “tearfulness” and “reduction of verbal 
communication”- which is also the item not included in DSM-IV criteria. Interestingly, 
the DM-ID notes that “has decreased or stopped talking” may be reported by informants, 
and should be considered as indicative of the DSM-IV-TR diagnostic criterion, 
psychomotor agitation or retardation. The depressive dimension is therefore most 
similar to the DC-LD depressive disorder category.  
 
Several instruments for assessment of psychopathology used in the EFA studies in table 
1.2 do not include items similar to “tearfulness” or “reduction in verbal communication” 
 289 
(PIMRA, PAS-ADD checklist, DASH-II, BSI). Of those that do, the equivalent items to 
“tearfulness” and “reduction in verbal communication” did not load to the depression 
dimension extracted from the MOSES (Sturmey et al. 2003) or CBCPID (Tsiouris et al. 
2003). Therefore, although this thesis provides some support for including these two 
additional criteria for depressive disorder in DC-LD, further work investigating the 
relevance of these items to the classification of depressive psychopathology is required.   
 
As well as the items of psychopathology extracted as part of the depressive dimension, it 
is useful to consider items that did not load to this dimension in the EFA. In DC-LD and 
DM-ID, irritable mood can be used as an alternative to depressed mood, as a key 
criterion that should be present. Therefore, it is of interest that “increased irritability” is 
not part of the depressive dimension from the PPS-LD data. Instead “increased 
irritability” is one of the items that load significantly to the behaviour-affective 
dimension. The irritability item loaded to similar mixed dimensions, comprising mood 
and problem behaviour items of psychopathology, in the studies using the RSMB 
(Sturmey et al. 1996), MOSES assessment instrument (Sturmey et al. 2003), DASH II 
(Sturmey et al. 2004) and BSI (Kellet et al. 2004). However, the results in studies using 
the PAS-ADD checklist varied considerably. In one study the irritability item loaded to 
the depressive dimension (Moss et al. 1998), in another it did not load to any of the three 
interpretable dimensions- including one labelled mood (Sturmey et al. 2005), and formed 
a second depressive dimension with one other item “attempts suicide/ talks about 
suicide” in the most recently published study (Hatton & Taylor 2008). Finally, the 
irritability item did not load to the depressive dimension from the CBCPID (Tsiouris et 
al. 2003). Therefore, in only one study does the irritability item load significantly to a 
coherent depressive dimension. There is stronger evidence, from the PPS-LD model in 
this thesis, and studies using four other assessment instruments (Sturmey et al. 1996; 
Sturmey et al. 2003; Sturmey et al. 2004; Kellet et al. 2004), for irritability forming part 
of a behaviour-affective dimension of psychopathology.  
 
Reduced concentration is also included in the diagnostic criteria for depressive episodes 
in DC-LD, ICD-10 and DSM-IV-TR. Similar to “increased irritability”, the PPS-LD 
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item “reduced concentration” loaded significantly to the behaviour-affective dimension 
rather than the depressive dimension of psychopathology. However, unlike “increased 
irritability”, there is less evidence from other studies to support the finding that “reduced 
concentration” loads to the behaviour-affective dimension. Instead, “reduced 
concentration” loads to different dimensions across studies in table 1.2- including 
depressive dimensions (PAS-ADD checklist- Sturmey et al. 2005; MOSES-Sturmey et 
al. 2003), a restlessness dimension (PAS-ADD checklist- Moss et al. 1998) and 
cognitive impairment/ organic dimensions (BSI- Kellet et al. 2004; PAS-ADD checklist- 
Hatton & Taylor 2008). Some of these differences could have been influenced by the 
different sample or methodologies in the studies- a view that is supported by there being 
different findings across the three studies using the PAS-ADD checklist (Moss et al. 
1998; Sturmey et al. 2005; Hatton & Taylor 2008). Alternatively, the variation across 
studies may suggest that psychopathology that relates to concentration is experienced 
across several different types of disorder. This is in keeping with the inclusion of items 
relating to concentration in diagnostic criteria for depressive disorders, manic episodes, 
generalised anxiety disorder, and ADHD in categorical diagnostic classification systems. 
Therefore, the relevance of the “reduced concentration” item of psychopathology to 
depressive, or other diagnostic, categories require further examination. 
 
The other items that were expected to be extracted as part of the depressive dimension 
are those items from the PPS-LD that relate to sleep problems. However, in the multi-
dimensional model reported here, none of the four items on sleep problems included in 
the EFA loaded to the depressive dimension. This isn’t too dissimilar to the findings 
from other studies. Of the seven studies that reported a depressive dimension in table 1.3, 
any form of sleep problem only loaded significantly to the depressive dimension in the 
study that used the CBCPID (Tsiouris et al. 2003). In the studies using the PAS-ADD 
checklist, two reported a specific sleep problem dimension (Moss et al. 1998; Hatton & 
Taylor, 2008), and the other extracted sleep problems in the restlessness dimension 
(Sturmey et al. 2005). Sleep problems were extracted as an item in the somatisation 
dimension of the BSI (Kellet et al. 2004) and did not load significantly to any dimension 
in studies using the PIMRA (Matson et al. 1984) and MOSES (Sturmey et al. 2003). 
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Although none of the four sleep problem items from the PPS-LD loaded significantly to 
the depressive dimension, initial insomnia was included in the anxiety dimension.  
 
This discussion of the depressive dimension raises a question of why certain items of 
psychopathology, often considered to be part of depressive psychopathology, load 
significantly to the behaviour-affective, and anxiety dimensions. 
 
5.1.2 The behaviour-affective dimension of psychopathology  
Eight items of psychopathology from the PPS-LD loaded significantly to the behaviour-
affective dimension of psychopathology. Four items relate to problem behaviours and 
four are commonly described affective symptoms- together accounting for 7.46% of the 
overall variance in the psychopathology. It is relevant to consider the fact that both 
affective and problem behaviour psychopathology load significantly to this dimension, 
with a view to developing an understanding of the relationship between problem 
behaviours and other forms of psychopathology. One point of interest is that this 
dimension does not easily map onto any one diagnostic category in DC-LD, DM-ID, 
ICD-10 or DSM-IV-TR. In fact, as discussed in section 5.1.1, the behaviour-affective 
dimension includes items of psychopathology that are often included in the diagnostic 
criteria for several different disorders.  
 
Four of the studies summarised in table 1.2 explicitly identify dimensions of 
psychopathology related to problem behaviours- using the PIMRA (Linaker 1991), 
RSMB (Sturmey et al. 1996), DASH II (Sturmey et al. 2004) and BSI (Kellet et al. 
2004). Of these, on inspection of the items of psychopathology that loaded to these 
dimensions, three are a mixture of problem behaviour and affective items of 
psychopathology (Sturmey et al. 1996; Sturmey et al. 2004; Kellet et al. 2004). 
Although not labelled as such, the irritability/ depression dimension extracted from the 
MOSES data (Sturmey et al. 2003) is also a mixed behaviour-affective dimension that 
includes items on oppositional problem behaviours, physical aggression and verbal 
aggression. The relative consistency of a behaviour-affective dimension across studies 
suggests that this may be a valid dimension of psychopathology experienced by adults 
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with intellectual disabilities. Similarly, DC-LD (Royal College of Psychiatrists 2001) 
and DM-ID (Fletcher et al. 2007) both recognize that affective disorders presenting with 
depressive and manic episodes may both be associated with an increase in problem 
behaviours in adults with intellectual disabilities. However, only the DC-LD criteria for 
a depressive episode lists an increase in problem behaviours as a specific item within the 
diagnostic criteria.  
 
The relationships between affective and problem behaviour psychopathology have been 
considered in previous studies. One relevant area is research on problem behaviours as 
potential depressive equivalents in adults with intellectual disabilities and depressive 
disorders. The studies have used categorical diagnostic classification systems with 
equivocal findings. Studies are split between those that have found a link between 
affective psychopathology and problem behaviours (Lowry & Sovner 1992; Charlot et 
al. 1993; Marston et al. 1997; Moss et al. 2000; Cain et al. 2003; Kishore et al. 2005; 
Tyrer et al. 2006; Hurley 2008) and those that do not (Holden & Gitlesen 2003; Tsiouris 
et al. 2003; Rojahn et al. 2004). The findings reported here, and in the four studies in 
table 1.2 that identified an equivalent behaviour-affective dimension (Sturmey et al. 
1996; Sturmey et al. 2003; Sturmey et al. 2004; Kellet et al. 2004) suggest that there is a 
link between affective psychopathology and problem behaviours. However, the findings 
suggest that this link may be distinct from depressive psychopathology. 
 
One explanation to examine is that the link between affective psychopathology and 
problem behaviours is explained by psychopathology related to mania/ hypomania. If 
this is the case then the behaviour-affective dimension from the PPS-LD would be better 
viewed as a mania/ hypomania dimension. This explanation is supported by the finding 
from several studies, using categorical diagnostic classification systems, that reported 
increased problem behaviours in individuals meeting diagnostic criteria for hypomania/ 
mania compared to depressive disorders (Cain et al. 2003; Holden & Gitlesen 2004; 
Hurley 2008). Furthermore, the items of psychopathology relevant to irritability 
(Sturmey et al. 1996; Sturmey et al. 2003; Sturmey et al. 2004; Kellet et al. 2004) and 
impaired concentration (Sturmey et al. 1996) that were extracted within the behaviour-
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affective dimension, in this and other studies, are common to the diagnostic criteria for 
depressive episode and manic episode in DC-LD and DM-ID. 
 
To examine this further, it is useful to consider the results in more detail. One point to 
note is that several items of psychopathology from the PPS-LD of potential relevance to 
a mania/ hypomania dimension were excluded from the EFA. The items expansive 
mood, reckless irresponsible mood and social disinhibition were excluded as they were 
reported by less than 5% of participants. A low base rate of these items of 
psychopathology is in keeping with reported low incidence and prevalence rates of 
hypomania/ mania (Smiley et al. 2007; Cooper et al. 2007c). Although other relevant 
items from the PPS-LD were included, without the full range of items, a mania/ 
hypomania dimension is less likely to be extracted from any EFA.  
 
In considering whether the behaviour-affective dimension is better considered as a 
mania/ hypomania dimension, the results from the EFA that extracted five dimensions of 
psychopathology are important. This five-dimension model was rejected because of 
cross-loading of items between the anxiety and fifth dimensions. The fifth dimension 
included five items of psychopathology- increased verbal communication, increased 
energy levels, initial insomnia greater than one hour, mid-insomnia greater than one 
hour, early morning wakening greater than one hour. Although not entirely coherent, the 
fifth dimension was recognised as a possible mania/ hypomania dimension. However, it 
can be seen that no items from the behaviour-affective dimension in the four factor 
solution moved to this fifth dimension. Rather, the items of psychopathology that loaded 
to the fifth dimension were previously included in the anxiety dimension in the four 
factor solution. If the behaviour-affective dimension is more accurately considered a 
mania/ hypomania dimension, at least some items of psychopathology would have 
loaded significantly to the fifth dimension. This suggests that the link between affective 
psychopathology and problem behaviours in the PPS-LD is not due to mania/ 
hypomania.  
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Two of the assessment instruments used in the studies that reported an equivalent to the 
behaviour-affective dimensions include items of psychopathology related to 
mania/hypomania, such as euphoric/ elevated mood and over activity (RSMB- Sturmey 
et al. 1996; DASH-II- Sturmey et al. 2004). In neither of these studies do these items of 
psychopathology load significantly to the equivalent of the behaviour-affective 
dimension. The absence of items relevant to mania/ hypomania in the studies reporting 
behaviour-affective dimension using the MOSES (Sturmey et al. 2003) and BSI (Kellett 
et al. 2004) preclude the results from clarifying this issue. A lack of relevant items of 
psychopathology also explains why from all the studies in table 1.2 only two, both using 
the PAS-ADD checklist, report a specific mania/ hypomania dimension of 
psychopathology (Moss et al. 1998; Hatton & Taylor 2008). However, since the PAS-
ADD checklist does not have items on problem behaviours these two studies do not 
provide any additional data relevant to this issue. 
 
To summarise, results from studies using categorical diagnostic classification systems 
are equivocal on whether problem behaviours and depressive psychopathology are 
associated Although there are fewer studies using categorical models of mania/ 
hypomania, the evidence more consistently reports a specific association between a 
diagnosis of mania/ hypomania and problems behaviours. However, the studies using 
dimensional models of psychopathology, suggest the link between affective 
psychopathology and problem behaviours, may be distinct from depressive or mania/ 
hypomania psychopathology. Since this issue cuts across the multi-dimensional model of 
psychopathology it is discussed further in section 5.1.5 
 
5.1.3 The anxiety dimension of psychopathology 
Anxiety was the final dimension of psychopathology extracted from the PPS-LD data. 
Ten items of psychopathology loaded to the dimension, which explained 5.49% of the 
overall variance in the psychopathology. Similar anxiety dimensions were identified 
using the PIMRA (Matson et al. 1984; Linaker 1991; Balboni et al. 2000; Gustafsson & 
Sonnander 2005; Watson et al. 1988), PAS-ADD checklist (Moss et al. 1998; Hatton & 
Taylor 2008), DASH-II (Sturmey et al. 2004), and the BSI (Kellett et al. 2004). 
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However, the DASH-II dimension is distinct since, of the seven items that load to the 
dementia/ anxiety dimension four are related to cognitive impairment, and the three 
anxiety items are visibly sweats with certain objects/ situations, trembles/ shakes for no 
obvious reason and extremely happy/ cheerful for no reason. 
 
Examining the PPS-LD anxiety dimension in more detail, the items labeled generalized 
anxiety and agoraphobia stand out from the others that loaded significantly to the 
dimension. Firstly, whilst the other items describe individual changes in behaviour or 
mood, these two items are more accurately thought of as combinations of items of 
psychopathology. In the PPS-LD, the item of psychopathology labeled generalized 
anxiety includes prompts for the characteristic free-floating anxiety and fear, autonomic 
arousal symptoms, and symptoms of tension. Similarly, the agoraphobia item of 
psychopathology incorporates prompts on characteristic symptoms that are triggered by 
identifiable situations and are associated with avoidance. Thus, both these items in the 
PPS-LD are composite measures, requiring several items of psychopathology to be 
present before they can be rated positively. For the purposes of using EFA to identify a 
multi-dimensional model of psychopathology, it would be preferable for each of the 
items of psychopathology within the composite items to be rated individually. These 
additional items could then be included in the EFA, and may add to our understanding of 
anxiety psychopathology experienced by adults with intellectual disabilities.  
 
One reason why it is preferable to include individual items of psychopathology is that 
anxiety dimensions from intellectual disabilities studies appear different to results from 
studies with participants who do not have intellectual disabilities. Many studies that 
include anxiety related psychopathology identify two distinct dimensions (Watson 
2005), labeled with various terms to represent a general distress dimension (often 
including depressive psychopathology and free floating symptoms, restlessness, tension) 
and an anxious, fear dimension (including avoidance, panic, phobic and obsessional 
symptoms). In contrast, the multi-dimensional model of psychopathology identified from 
the PPS-LD, and other assessment instruments in table 1.2, generally report a single 
dimension that includes both generalized and fear/ phobic items of psychopathology 
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(Matson et al. 1984; Linaker 1991; Balboni et al. 2000; Gustafsson & Sonnander 2005; 
Watson et al. 1988; Moss et al. 1998; Sturmey et al. 2004; Kellett et al. 2004). Although 
one study reported separate anxiety and avoidant/ anxious dimensions (Linaker 1991), 
both dimensions are made up of general anxiety psychopathology with no items relating 
to phobic behaviours, panic or avoidance.  
 
It may be that individuals with intellectual disabilities experience, and report, anxiety 
psychopathology differently from individuals who do not have intellectual disabilities. 
However, similar to the PPS-LD, none of the assessment instruments used in the 
previous studies included a comprehensive range of items relevant to all forms of anxiety 
psychopathology. This may explain why the results are different from the studies 
involving participants who do not have intellectual disabilities. Future studies with the 
PPS-LD, or other assessment instruments, should consider including additional, or more 
specific, items relevant to anxiety psychopathology.  
 
It is interesting to note that the items increased appetite and weight gain from the PPS-
LD load significantly to the anxiety dimension. Of the other assessment instruments in 
table 1.2, only the PAS-ADD checklist asks about either of these items of 
psychopathology; increased appetite loads to the anxiety dimension in one study (Moss 
et al. 1998) and the hypomania dimension in another (Hatton & Taylor 2008). This 
apparent association between anxiety psychopathology and increased appetite and 
weight gain would benefit from further study. However, this finding is relevant to the 
significantly increased prevalence of obesity in children (Emerson 2009) and adults 
(Melville et al. 2007; Bhaumik et al. 2008; Melville et al. 2008) with intellectual 
disabilities. 
 
An association between anxiety and weight gain (Stice 2002; Torres & Nowson 2007), 
and anxiety and obesity (Jorm et al. 2003; Scott et al. 2008) has been described in 
individuals who do not have intellectual disabilities. However, no intellectual disabilities 
studies to date have reported an association between anxiety and weight gain, or obesity. 
There is a general lack of understanding of the determinants of obesity in individuals 
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with intellectual disabilities, and few studies have examined the relationships with 
psychopathology (Melville et al. 2007). However, two recent population based studies 
found no significant, independent associations between obesity (defined as a body mass 
index greater than 30) and a diagnosis of a mental disorder (Melville et al. 2008) or 
problem behaviours (Melville et al. 2008; Bhaumik et al. 2008). The loading of 
increased appetite and weight gain to the anxiety dimension in this study, suggests that 
there is value in examining the relationships between psychopathology, weight gain and 
dimensional models of psychopathology in adults with intellectual disabilities. 
 
5.1.4 The organic dimension of psychopathology 
The six items of psychopathology that were extracted in the organic dimension 
accounted for 8.7% of the total variance in the psychopathology. All six items that were 
extracted are included as relevant items of psychopathology within DC-LD diagnostic 
criteria for dementia. The criteria in ICD-10 and DSM-IV-TR are somewhat different in 
that rather than listing specific items of psychopathology, broader descriptions of 
psychopathology associated with neurological impairment are used. These include 
memory impairment, aphasia (language disturbance), apraxia (impaired ability to carry 
our motor activities), agnosia (failure to recognize objects) and disturbance in executive 
functioning (i.e. planning, organizing, sequencing and abstracting). Despite these 
differences between the categorical diagnostic classification systems, overall the items 
included in the organic dimension of psychopathology are in keeping with commonly 
reported phenomena reported as part of organic disorders, such as dementia. 
 
It is worth noting that several items of psychopathology that are often considered 
indicative of organic disorders were excluded from the EFA as they were reported in less 
than 5% of cases: 
• mixing up day and night 
• loss of literary skills 
• loss of financial skills 
• word finding difficulties. 
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It is likely that the items on literary and financial skills, and word finding difficulties are 
identified infrequently because many of the participants with intellectual disabilities 
have low baseline levels of abilities relevant to these items. Therefore, it is difficult for 
informants and clinicians to detect change in these domains of functioning. The reason 
why the item on “mixing up day and night” is reported infrequently is less clear. Perhaps 
this is explained by the fact that the majority of participants receive support from carers.  
Prompts from carers about time of day, and routines around waking and sleep, may be 
strong enough to counter-act any change in this area of functioning due to organic 
disorders. 
 
From a statistical point of view there are reasons to exclude from EFA items of 
psychopathology that occur infrequently, as the low variance has a negative impact on 
the stability and reliability of the final model (Hair et al. 1998a). By reducing the number 
of relevant items included in the EFA, inevitably the number of potential items that can 
be extracted is reduced. However, this does not reduce the potential face validity of the 
dimension, since these items are occurring at low frequencies in the total sample.  
 
Of previous studies, three identified similar dimensions to the organic dimension 
reported here (DASH-II- Sturmey et al. 2004; BSI-Kellett et al. 2004; PAS-ADD 
checklist- Hatton & Taylor 2008). The PIMRA (Matson et al. 1984), RSMB (Sturmey et 
al. 1996) and CBCPID (Tsiouris et al. 2003) assessment instruments do not include 
items of psychopathology relevant to change in memory and other cognitive functioning, 
explaining why no equivalent to the organic dimension were reported. Since the MOSES 
is designed for use with older adults, the absence of an organic dimension from the final 
model is noteworthy (Sturmey et al. 2003). The authors describe a self-help dimension 
accounting for 20.6% of the overall variance that includes items of psychopathology 
relating to change in dressing, bathing, grooming, incontinence & toileting, and an item 
relating to problems with awareness of time. It is surprising that only one of the items 
rating change in cognitive functioning loaded significantly to this dimension. On the 
basis of the self-help dimension, the authors suggest the MOSES would be useful for the 
diagnosis of dementia and one study has shown that the MOSES differentiates between 
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individuals with intellectual disabilities and Alzheimer’s type dementia (Dalton et al. 
2002). However, since memory impairment is central to current concepts of dementia the 
absence of the item rating memory impairment from the self-help dimension suggests the 
MOSES requires further study before being used routinely in clinical or research 
settings. 
 
A coherent organic dimension is consistently extracted when assessment instruments 
include relevant items of psychopathology. Therefore, it is necessary to include the 
organic dimension within comprehensive methods of assessment and management of 
mental disorders experienced by adults with intellectual disabilities.  
 
5.1.5 General issues of relevance to the multi-dimensional model of 
psychopathology 
The prior discussion of the individual dimensions extracted within the PPS-LD multi-
dimensional model of psychopathology identified several issues relevant to the overall 
model.  
 
The finding that the four dimensions of psychopathology were not significantly 
correlated, suggests that there are no higher order internalising and externalising 
dimensions.  Rather, the finding of three independent dimensions including affective 
items of psychopathology- depressive, behaviour-affective and anxiety suggests a 
different model. Importantly, certain items of psychopathology (irritability and impaired 
concentration), included in the criteria for a diagnosis of depressive disorders in 
categorical diagnostic classification systems, are more strongly associated with the 
behaviour-affective dimensions in this and other studies. Finally, the consistent 
identification of a behaviour-affective dimension, distinct from depressive or mania/ 
hypomania psychopathology, may help to clarify the relationship between affective 
psychopathology and problem behaviours, and will also be discussed. 
 
Although, there were no significant correlations between the four dimensions, or cross-
loading of items to more than one dimension there may be useful links between the 
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dimensions that suggest areas of study to examine solutions to the poor validity of 
categorical models of psychopathology. For example, conceptualising a broader 
dimensional model of psychopathology that cuts across the boundaries of diagnostic 
categories may provide an understanding of the significant comorbidity between anxiety 
and depressive disorders. 
 
Of the four dimensions extracted in the EFA, the organic dimension appears to be 
qualitatively distinct from the other three dimensions, labelled depressive, behaviour-
affective and anxiety. The depressive, behaviour-affective and anxiety dimensions all 
include items of psychopathology that can be conceptualised as affective and 
behavioural. However, the organic dimension is made up of items of psychopathology 
linked to cognitive functioning and change in daily living skills. Therefore, the discussion 
of the broader aspects of a multi-dimensional model of psychopathology will be limited 
to consideration of the depressive, behaviour-affective and anxiety dimensions.  
 
The majority of items of psychopathology in the depressive, behaviour-affective and 
anxiety dimensions are related to affects or behaviours. This suggests that there may be 
value in examining an affective-behaviour model of psychopathology. The research 
literature recognises a close relationship between affects and behaviour. Although there is 
no single accepted conceptualisation of affects, the influence of affects on behaviour is 
central to the definition, and function of affects (Mauss et al. 2005). Therefore, the term 
affective model of psychopathology will be used to consider a global model of 
psychopathology based on the affective and behavioural items of psychopathology in the 
depressive, behaviour-affective and anxiety dimensions.   
 
As stated in section 4.1, items of psychopathology on the PPS-LD were only rated 
positively if there was a clear change from an individual’s baseline functioning. 
Therefore, affective change, or stability, can be viewed as an overarching aspect of the 
three affective dimensions of psychopathology extracted from the PPS-LD data; in turn 
affective stability is encapsulated within the construct of affect regulation within the 
research literature. 
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The study of affect regulation has been heavily influenced by work in the fields of 
developmental psychology and psychopathology. It is clear from the literature is that the 
term affect regulation is used to refer to a complex and diverse range of processes which 
are central to affective and psychological functioning (Gross & Thompson 2007). Given 
this complexity, it is perhaps not surprising that there does not seem to a single accepted 
definition of what is meant by affect regulation (Cole et al. 2004). However, several key 
aspects of affect regulation are important to mention prior to a discussion of the multi-
dimensional model of psychopathology. 
 
Importantly for the consideration of the relevance of affect regulation across the 
depressive, behaviour-affective and anxiety dimensions of psychopathology identified in 
this thesis, affect regulation does not seem to be specific to which affects are being 
regulated. Rather, affect regulation refers to changes or processes that apply equally 
across affects, and therefore, potentially, across the three distinct affective dimensions.  
 
Each of the three dimensions includes affective and behavioural items of 
psychopathology. Within the construct of affect regulation it is recognised that two 
related phenomena can be identified, and described, as regulating and regulated (Cole et 
al. 2004). Therefore, emotion regulation can be applied to changes in specific affects, as 
in the case of sadness in the depressive dimensions (affect as regulated), and the effects 
of changes in affects on behaviour e.g. increased verbal and physical aggression related 
to changes in irritability/ anger (affect as regulated) . 
 
Finally, affect regulation involves both internal and external processes. For example, one 
model of affect regulation proposes five families of processes (Gross & Thompson 2007):  
• situation selection e.g. avoidance of situations known to provoke negative affect 
• situation modification e.g. moving to a quieter area of a busy centre to reduce fear 
• attentional deployment e.g. concentrating on the non-aversive aspects of a situation 
• cognitive change e.g. using learnt cognitive strategies to reappraise an intense affect 
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• response modulation e.g. using learnt strategies or drugs to alter affects or associated 
behaviours. 
 
The finding that affect regulation involves internal and external processes has specific 
relevance to an affect regulation model of psychopathology experienced by adults with 
intellectual disabilities. In section 1.3.1, the challenges inherent in the assessment and 
measurement of psychopathology in adults with intellectual disabilities were described. 
Similarly, only a minority of adults with intellectual disabilities will have the level of 
verbal communication and cognitive abilities necessary to the study of internal processes 
involved in affect regulation. This is particularly relevant to the cognitive change family 
in the model above. On the other hand, the other four families of processes include 
readily observable processes or behaviours, which could be either directly observed or 
reported by informants. Furthermore, the importance of situational and environmental 
elements to affect regulation suggests that appropriate support from others, or 
environmental modifications may impact on psychopathology. 
 
To summarise, the construct of affect regulation: 
• appears to apply across dimensions of psychopathology 
•  incorporates affective and behavioural items of psychopathology  
• can be studied using self and proxy report, or direct observation  
• potentially offers opportunities to develop novel interventions. 
 
This suggests that affect regulation is an area of research that could offer insights into 
psychopathology experienced by adults with intellectual disabilities. Since the construct 
of affect regulation has emerged from the disciplines of developmental psychology and 
psychopathology (Cicchetti et al. 1995), it is surprising that relatively few studies have 
involved individuals with intellectual disabilities. For example, the ability to regulate 
affect has been shown to impact on the development of problem behaviours and 
difficulties with interpersonal relationships in typically developing children (Eisenberg et 
al. 2001; Spinrad et al. 2006) and children with developmental delay (Crnic et al. 2004). 
However, affect regulation does not seemed to have been examined in relationship to 
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psychopathology experienced by adults with intellectual disabilities. Given the relevance 
of affect regulation to the findings in this thesis and the potential applicability of the 
construct across the boundaries of categorical diagnostic classification systems suggests 
that further research is merited. 
 
Affective arousal or activation is another construct of relevance to the depressive, 
behaviour-affective and anxiety dimensions of psychopathology. Arousal and valence 
were proposed as the two key dimensions underlying the circumplex model of affect 
(Russell 1980) and subsequently incorporated into integrated models of affective states 
(Posner et al, 2005). Neurobiological research has begun to report evidence to support 
proposed distinct neural circuitry underlying the dimensions of affective arousal and 
valence (Gerber et al. 2008; Posner et al. 2009). 
 
There are items of psychopathology in each of the depressive, behaviour-affective and 
anxiety dimensions that can be interpreted as changes in affective arousal: 
• depressive dimension (under-arousal)- low mood, social withdrawal, anhedonia, 
lower energy levels and reduced appetite 
• behaviour-affective dimension (over-arousal)- increased mood lability, increased 
irritability, increased verbal and physical aggression 
• anxiety dimension (over-arousal)- generalised anxiety, increased verbal 
communication, increased energy, initial insomnia, increased appetite. 
 
Therefore, affective arousal appears to be a construct that appears to be relevant to 
psychopathology commonly experienced by adults with intellectual disabilities. Despite 
models recognising the relevance of affective arousal to psychopathology (Bradley et al. 
2000), compared to affect regulation, overall, there is less evidence on the relationship 
between affective arousal and psychopathology. Part of the reason for this may be that 
arousal has been incorporated into the broader model of affect regulation (Fox & Calkins, 
2003: Schore 2005), or the focus of arousal research has been on psychophysiology and 
autonomic arousal (Brown, Chorpita & Barlow 1998). Regardless, the evidence available 
suggests that the construct of affective arousal should be considered for further study of 
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psychopathology. For example, a putative model examining the relationships between 
attachment, affective arousal and problem behaviours experienced by individuals with 
intellectual disabilities has been proposed (Janssen et al. 2002). 
 
Alongside arousal, valence was the second dimension of affect proposed by Russell 
(1980), conceptualised as comprising positive and negative affect. An established 
tripartite model of depression and anxiety psychopathology (Clark & Watson 1991) 
emerged from further study of the valence of affect. The description of three affective 
dimensions of psychopathology linked by in this thesis, and one other study in table 1.2 
(Kellett et al. 2004), is very similar to this tripartite model. Using EFA, and other 
multivariate statistical methods of analysis, this tripartite model has been shown, to 
explain the relationship between depressive, anxiety and other affective psychopathology 
(Clark & Watson 1991). However, the tripartite model has seldom been examined in 
relation to psychopathology experienced by adults with intellectual disabilities.  
  
This tripartite model emerged from a broader model that proposes that there are two 
independent dimensions of affect, termed negative affect and positive affect. The 
negative affect dimension consists of psychopathology reflecting unpleasant affective 
states, associated with distress- such as sadness, fear, and disgust (Watson & Tellegen 
1985; Clark & Watson 1991; Watson et al. 1995). The positive affect dimension includes 
states such as happiness, engagement and energy (Clark & Watson 1991; Watson et al. 
1995). Rather than being two opposite ends of a single dimension, studies have shown 
that these two dimensions are relatively independent (Watson et al. 1988; Clark & 
Watson 1988). Initial studies of the two dimensional model of affect in individuals with 
mood and anxiety disorders suggested that a characteristic distribution could be 
identified with three dimensions of psychopathology, called the tripartite model. The 
three dimensions of psychopathology in the tripartite model are: 
• a depressive dimension- comprising increased scores on the negative affect 
dimension and low scores on the positive affect dimension 
• an anxiety dimension- with high scores on the dimensions of negative affect and 
positive affect (representing hyperarousal) 
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• a general distress dimension- that includes items of psychopathology common to 
various emotionally distressed states, including irritability, impaired concentration 
and restlessness (Watson et al. 1995). 
 
The tripartite model has been shown to be a valid model of affective psychopathology in 
children and adolescents (Joiner & Lonigan 2000; Chorpita & Daleiden 2002; Cannon & 
Weems 2006) and adults (Watson et al. 1995; Brown et al. 1998; Beck et al. 2003; Cook 
et al. 2004). In fact the level of evidence is such that some authors have called for the 
tripartite model to be incorporated into DSM-V (Watson 2005). However, the 
intellectual disabilities studies on psychopathology are clearly not at this level.  
 
Although the study by Kellett et al. (2004) identified three dimensions of affective 
psychopathology the authors did not consider the results against the tripartite model of 
depression and anxiety psychopathology. One study used EFA to examine the 
dimensional structure of psychopathology assessed with the Beck Depression Inventory-
II (BDI-II) and Beck Anxiety Inventory (BAI; Lindsay & Skene 2007). The authors 
concluded that a two dimensional structure- representing depression and anxiety- best 
fitted the data. This result contrasts with EFA of data from the BDI-II and BAI in college 
students (Joiner 1996) which found that the data best fitted a tripartite model; perhaps 
suggesting that there is a difference in psychopathology identified by these assessment 
instruments when used with adults with intellectual disabilities. No other intellectual 
disabilities studies examining the tripartite model of depression and anxiety 
psychopathology were identified. 
 
The results of the EFA using PPS-LD data appears to be a reasonable fit for the tripartite 
model of depression and anxiety psychopathology. Characteristic affective items of 
psychopathology described in the tripartite model (Clark & Watson 1991), are included 
in the depressive (low mood, anhedonia, reduced energy), anxiety (hyperarousal- 
increased energy, increased verbal communication, initial insomnia) and general distress 
(irritability, impaired concentration) dimensions. As in the tripartite model (Watson et al. 
1995), the three dimensions are not correlated and can thus be considered relatively 
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independent. Despite the possible relevance of the tripartite model of depression and 
anxiety psychopathology, this finding needs further study. Nonetheless, since problem 
behaviour psychopathology was included in the tripartite model described here, and in 
the three affective dimensions described by Kellett et al. (2004), perhaps the tripartite 
model can further our understanding on the relationship between problem behaviours 
and affective psychopathology. 
 
As described in section 5.1.3, research that has used categorical models of 
psychopathology has produced inconsistent evidence on whether there is an association 
between depressive psychopathology and problem behaviours. The PPS-LD multi-
dimensional model of psychopathology could be interpreted as suggesting that problem 
behaviours are associated with the general distress dimension of a tripartite model, rather 
than a depressive dimension. This has not been reported previously for adults with 
intellectual disabilities, and the relationship between the tripartite model and conduct 
problems in children and adolescents, or antisocial behaviours in adults, does not appear 
to have been studied previously. Thus, further work is needed to examine whether 
problem behaviours experienced by adults with intellectual disabilities are associated 
with the general distress dimension of a tripartite model.  
 
To achieve this, studies would collect data on a broad range of psychopathology, with a 
particular focus on including items relevant to affective and problem behaviour 
psychopathology. Although the PPS-LD includes items relevant to problem behaviours, 
these are limited to physical and verbal aggression, self-injurious behaviour and 
sexually-inappropriate behaviours. The assessment process could include structured 
instruments in addition to the PPS-LD. For example, structured assessments relevant to 
DC-LD criteria for problem behaviours have been devised for use in epidemiological 
studies (Jones et al. 2008; Hove & Havik 2009). Regardless of which instruments are 
used the key issue is to include the items of psychopathology relating to problem 
behaviours and other mental disorders in a single EFA.  
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The exclusion of items of psychopathology from the EFA will have impacted on the 
final multi-dimensional model of psychopathology identified from the PPS-LD. 
Essentially, the items of psychopathology included in the EFA are those which can be 
observed and reported by an informant, in circumstances where self-report 
psychopathology is not available. Most often an individual with intellectual disabilities is 
unable to self-report because the cognitive and communication demands for an item, or 
assessment instrument, are out with that person’s level of abilities. Rather than excluding 
items of psychopathology from the EFA another strategy is to only include participants 
with mild intellectual disabilities (Kellet et al. 2004). Whilst, this potentially increases 
the number of items of psychopathology included in, and, therefore, extracted from the 
EFA, the final result cannot be considered generalisable across the range of abilities of 
adults with intellectual disabilities. Excluding items from the EFA, and including only a 
sub-sample of participants, both have advantages and disadvantages depending on the 
research questions being examined. Problem behaviours are more prevalent in 
individuals with more severe intellectual disabilities (Jones et al. 2008). Therefore, if 
future studies are going to examine further the relationship between affective 
psychopathology and problem behaviours, it would be preferable to include individuals 
across the full range of abilities. Hence, it is likely that the strategy used in this thesis 
will be used- resulting in inclusion of only those items of psychopathology that can 
either be self-reported, or reported by an appropriate informant. 
 
From the original 90 PPS-LD items of psychopathology, 25 were not included based on 
a base rate of less than 5%, or on the basis that the required cognitive and verbal 
communication abilities for an item was not achieved across the entire sample. Items of 
psychopathology can be reported infrequently for several different reasons. Certain items 
of psychopathology are rarely reported within any clinical population or research 
sample. For example, items of psychotic psychopathology, such as made affect or 
delusional perception are reported at frequencies less than 5% in many studies 
(Andreasen & Flaum 1994; Nordgaard et al. 2008). The rate that items of 
psychopathology are reported also differs across cultures and ethnic minority groups 
(Ndetei & Vadher 1984; Kulhara & Chakrabarti 2001). Base rates of items of 
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psychopathology will also be affected by the cognitive and communication abilities of 
individuals with intellectual disabilities. Items that are dependent on individual self-
report and verbal communication will inevitably be less likely to be identified in studies 
involving adults with intellectual disabilities as participants. This effect acts to increase 
the number of items of psychopathology with low base rates in adults with intellectual 
disabilities.  
 
In conclusion, the multi-dimensional model of psychopathology from the PPS-LD raises 
issues relevant to future research on psychopathology and the clinical management of 
mental disorders experienced by adults with intellectual disabilities. 
 
5.2 The multi-dimensional model of psychopathology and socio-clinical 
variables 
Relatively few studies in the field of intellectual disabilities have examined the 
associations of socio-clinical variables with psychopathology. Therefore, there is a 
limited understanding of potential risk factors for psychopathology and mental disorders- 
compared to the evidence on risk for children, adolescents and adults who do not have 
intellectual disabilities. Although longitudinal, prospective studies are the gold standard 
research methodology to identify risk factors, more often putative risk factors are 
identified from cross-sectional studies. 
 
In this study, several socio-clinical variables were found to be independently associated 
with the multi-dimensional model of psychopathology. Since no previous studies 
examining the associations of socio-clinical variables with empirically derived multi-
dimensional models of psychopathology were identified in section 1.7, the results will be 
compared with population studies based on categorical models of psychopathology 
(table 1.4).  
 
Prior to comparing these results to previous studies there is an issue relevant to one study 
in table 1.4 to clarify. It is difficult to compare the results of this study with the study of 
Taylor et al. (2004). Female gender and younger age was found to be associated with 
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above threshold scores on the affective/ neurotic subscale on the PAS-ADD checklist 
(Taylor et al. 2004). However, the affective/ neurotic sub-scale lacks specificity, as it 
includes items of psychopathology that are relevant to the depressive, behaviour-
affective and anxiety dimensions. Therefore, rather than comparing the results of all 
three dimensions to this study it is excluded from the discussion. 
 
The socio-clinical variables were included in the analyses in this thesis because they 
were associated with psychopathology in the previous population-based studies 
identified. Several of these variables were not independently associated with any of the 
dimensional, or overall, measures of psychopathology- including gender, a diagnosis of 
autism, sensory impairments and urinary incontinence. Despite the negative finding, a 
discussion of gender is included below. The reason for this is gender was consistently 
shown to be associated with psychopathology across studies summarised in table 1.4, 
and additional evidence from other fields of research highlight the potential value of 
gender research in psychopathology. 
 
To explore whether the dimensional model can be used to derive overall measures of 
psychopathology, three overall measures were included in the analyses. All three overall 
measures were only independently associated with level of intellectual disabilities in the 
multivariate analyses examining measures of psychopathology and socio-clinical 
variables. In contrast, the dimensional measures of psychopathology were associated 
with a greater number, and varying, socio-clinical variables (table 4.103). Similar 
findings were found in the multivariate analyses that used the measures of severity and 
longitudinal outcome as the dependent variables. Therefore, it is concluded that there is 
little value in creating overall measures of psychopathology by adding together the 
individual factor scores, or dimension counts, from the dimensional model of 
psychopathology. The use of the individual dimensions provides results more likely to 
inform an understanding of the relationships between psychopathology, socio-clinical 
variables and  measures of severity and outcome. 
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In the studies summarised in table 1.4, the evidence for the associations of autism, 
sensory impairments and urinary incontinence with psychopathology is less convincing. 
Therefore, these variables are discussed in section 5.2.5 on categorical socio-clinical 
variables. 
 
5.2.1 Gender and psychopathology 
Gender was not associated with any of the four dimensions of psychopathology, the 
overall multi-dimensional model of psychopathology or the overall measure of 
psychopathology that was independent of the dimensional model (EFA PPS-LD 
symptom count- 41). This contrasts with the findings from studies using categorical 
diagnostic classification systems in table 1.4. Women were more likely to be diagnosed 
with any mental disorder (Cooper et al. 2007a; Hassiotis et al. 2008), depressive 
disorders (Cooper et al. 2007c) and problem behaviours (Jones et al. 2008). 
 
One possible explanation for the contrasting finding with these studies is the different 
samples used. The studies in table 1.4 used populations based samples. However, the 
sample used to examine the associations between the PPS-LD multi-dimensional model 
of psychopathology and socio-clinical variables was a clinical sample, comprising 
referrals to the Glasgow UCEDD over a defined time period. Therefore, participants 
included in the sample used in this study will have complained of, or been recognised by 
informants or professionals to be experiencing, problems suggestive of mental disorders. 
It would be expected that the UCEDD sample would be biased towards the inclusion of 
individuals with more severe psychopathology, in comparison to a population- based 
sample. Since this effect is likely to be similar for both genders in the sample it could act 
to mask any actual differences in the distribution of psychopathology against gender.  
 
An alternative explanation is that there is a gender bias that impacts on categorical 
diagnostic classification systems differentially from multi-dimensional models of 
psychopathology (Hartung & Widiger 1998). Ideally, diagnostic criteria should be 
gender neutral but this is difficult to achieve for disorders which present differently in 
females and males. Of relevance here is the suggestion that depressive disorders present 
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differently, with existing diagnostic criteria more closely describing psychopathology 
experienced by females (Kockler & Heun 2002). For example, studies show that women 
are more likely to report somatic depressive psychopathology such as appetite or sleep 
disturbance (Silverstein 1999). Any such gender bias has been shown to have been 
introduced into assessment instruments derived from diagnostic criteria (Cole et al. 
2000). Although this effect is unlikely to explain the differences in the findings between 
this study and the population based studies in table 1.4, it highlights the potential 
relevance of gender to psychopathology research. 
 
Research on the effects of gender bias upon the identification and management of 
psychopathology has largely involved participants who do not have intellectual 
disabilities. Studies have focussed on conduct problems (Hartung et al. 2006) and 
psychopathology relevant to attention, concentration and overactivity in children 
(Waschbusch & King 2006), and affective psychopathology (Piccinelli & Wilkinson 
2000) in adults. Several different influences have been identified including measurement 
bias i.e. assessment instruments include items that are more commonly reported by either 
men or women (Stommel et al. 1993); observer bias, i.e. informants or clinicians being 
more likely to report or rate positively psychopathology in males (Ohan & Visser 2009) 
and sampling bias, particularly within clinical samples (Hartung & Widiger 1998). 
Although very little research has examined the potential influence of gender bias on 
psychopathology experienced by individuals with intellectual disabilities, all of these 
influences of gender bias are potentially relevant. Of particular interest would be the 
influence of gender bias on informant reporting of psychopathology. For example, within 
the developing literature on staff attributions and problem behaviours no studies have 
examined whether staff make different attributions depending on gender (Willner & 
Smith 2008).  
 
It has been proposed that examining the relationship between gender and 
psychopathology can potentially contribute to an understanding of the pathophysiology 
of mental disorders (Rutter et al. 2003). Therefore, research on gender in relation to the 
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prevalence, presentation and assessment of psychopathology should be considered as a 
relevant area of study in the field of intellectual disabilities. 
 
5.2.2 Age and psychopathology 
In this study, younger age was associated with higher scores on the behaviour-affective 
and anxiety dimensions, and older age was associated with higher scores on the 
depressive dimension.  
 
One of the population-based studies in table 1.4 reported an association between younger 
age and problem behaviours (Hove & Havik 2010) but the other study that examined it 
found there was no independent relationship between age and problem behaviours (Jones 
et al. 2008). Although both these studies are based on the DC-LD criteria for problem 
behaviours, the study methodologies differed in how psychopathology was rated. The 
study by Jones et al. (2008) gathered data on problem behaviours using checklists 
derived for the DC-LD criteria and used the DC-LD categorical criteria to diagnose 
problem behaviours as being present. Hove & Havik (2010) also used checklists based 
on DC-LD criteria to gather the data on problem behaviours. However, the analysis was 
carried out using a derived overall problem behaviour score, rather than a categorical 
diagnosis of a problem behaviour. Therefore, the continuous measure of Hove & Havik 
(2010) is closer to the dimensional model of psychopathology used in this thesis. This 
may explain the similar results from these two studies, which contrast to the study using 
the categorical model of psychopathology (Jones et al. 2008). 
 
The use of dimensional and categorical models of psychopathology may also explain the 
different results on the relationship between age and the depressive dimension, and a 
categorical diagnosis of depressive disorder (Cooper et al. 2007c). However, the study 
using the scores from the DC-LD checklists as a continuous measure also did not find a 
significant association between age and the score from the DC-LD depression checklist 
(Hove & Havik 2010).  
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Population based samples in the studies using categorical diagnostic classification 
systems (Cooper et al. 2007c; Jones et al. 2008) have important advantages over the 
study described here. In particular, population-based samples are more representative 
and less likely to influence the findings through sampling bias. This could explain the 
different results examining the associations of psychopathology with age. For example, 
health professionals may be less likely to refer older people with problem behaviours for 
assessment, assuming that the psychopathology is long-standing, or an integral feature of 
ageing, and unlikely to respond to available management options. Despite this 
possibility, the agreement in the findings for problem behaviours with Hove and Havik 
(2010) raises the possibility that there are advantages to the use of dimensional, or 
continuous, models of psychopathology in research. 
 
However, looking beyond the limited intellectual disabilities research, there is no 
consistent pattern in the relationship between age and depressive psychopathology (Jorm 
2000; Stordal et al. 2003). Therefore, the different results could be attributable to 
challenges inherent to research examining the relationship between age and 
psychopathology. Certainly, data from longitudinal studies would help to clarify any 
changes in the risk of depressive psychopathology with age (Jorm 2000) and would also 
contribute to an understanding of developmental models of psychopathology (Rutter & 
Sroufe 2000; Hudziak et al. 2007) relevant to intellectual disabilities. For example, age 
has been proposed as a key factor to study in relation to developing valid models of the 
development of anti-social problem behaviours (Lahey et al. 1999). 
 
5.2.3 Level of intellectual disabilities and psychopathology 
A significant, independent association was found between level of intellectual 
disabilities and the organic, behavioural-affective and anxiety dimensions of 
psychopathology. Level of intellectual disabilities was also associated with all three of 
the overall measures of psychopathology. In all models the relationship was a direct 
relationship such that as the severity of intellectual disabilities increased the scores on 
the organic, behavioural-affective and anxiety dimensions, and the overall measures, 
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increased. However, none of the relationships were consistent across the range of 
abilities, suggesting that the relationships are non-linear. 
 
Only for the behaviour-affective dimension factor scores were the three dummy 
variables representing the full range of intellectual disabilities retained in the final 
regression model. This suggests that this is the dimension which has the most coherent 
relationship with intellectual disabilities. If there was a linear relationship we would 
expect the value of β to gradually increase, or decrease, across the mild-moderate, mild-
severe and mild-profound dummy variables. However, the standardised coefficients (β) 
in table 4.25 show that, even controlling for potential confounding effects of the other 
socio-clinical variables, the relationship is not linear. The effect is even greater for the 
behaviour-affective symptom count where the mild-severe variable drops out of the final 
model. It is difficult to be certain of the reasons for this non-linear relationship between 
level of intellectual disabilities and the dimensions of psychopathology from the PPS-
LD. Of the models that retain level of intellectual disabilities, the mild-moderate variable 
is retained as the only dummy variable for the anxiety dimension factor scores and 
symptom counts, and for all three overall measures of psychopathology. However, it is 
the mild-severe dummy variable that is retained as significant in the regression model for 
the organic dimension factor score. Therefore, there does not appear to be a consistent 
pattern of association between level of intellectual disabilities and psychopathology 
across the dimensions of psychopathology. 
 
The linearity of the relationship between level of intellectual disabilities and 
psychopathology was examined in the study by Hove & Havik (2010). Similar to the 
findings reported here, a non-linear relationship between level of intellectual disabilities 
and the measures of organic, problem behaviour, anxiety, depressive and obsessional 
psychopathology was reported. However, a linear relationship was reported for 
psychosis psychopathology, with a linear decrease in psychopathology as the severity of 
intellectual disabilities increased (Hove & Havik 2010).  
 
 315 
At a general level, these findings highlight the complexity of understanding the 
influences on psychopathology experienced by individuals with intellectual disabilities. 
Although multivariate statistics were used to control for the effects of relevant variables 
(Hove & Havik 2010), it could be that there are confounding effects from other variables 
that could explain the non-linear relationships. For example, bias from the methods used 
to assess psychopathology could have differential effects across the range of intellectual 
disabilities. An example of such a bias is similar to that described for diagnostic 
overshadowing. The study by Hove and Havik (2010) used informant ratings of 
psychopathology across the entire sample. Perhaps participating in an assessment 
relevant to mental disorders, informants attribute changes in mood, or behaviour for 
individuals with profound intellectual disabilities to a person’s intellectual disabilities, 
rather than reporting the changes as indicative of psychopathology. Alternatively, the 
items of psychopathology included in assessment instruments may not be appropriate for 
use across the full range of intellectual disabilities. 
 
Similar to this study, a direct relationship between severity of intellectual disabilities and 
problem behaviour (Jones et al. 2008; Hove & Havik 2010) and overall psychopathology 
(Cooper & Bailey 2001; Cooper et al. 2007a; Bailey 2007; Hove & Havik 2010) was 
reported in more than one population-based study. It is of note that this finding is 
consistent across studies using dimensional, continuous (Hove & Havik 2010) and 
categorical models of psychopathology (Jones et al. 2008; Cooper & Bailey 2001; 
Cooper et al. 2007a; Bailey 2007. Problem behaviour is included in the overall measure 
of psychopathology in several (Cooper et al. 2007a; Bailey 2007; Hove & Havik 2010), 
but not all studies (Cooper & Bailey 2001). This and the direct relationship between 
severity of intellectual disabilities and anxiety reported here and one other study (Hove 
& Havik 2010) suggest the association is not entirely due to psychopathology related to 
problem behaviours. 
 
No association between level of intellectual disabilities and depressive psychopathology 
was found in this thesis, or the other two studies summarised in table 1.4 that examined 
this (Cooper et al. 2007c; Hove & Havik 2010). Within the context of the tripartite 
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model of affective psychopathology suggested by the results of the EFA, it is interesting 
to discuss the possible relevance of the different relationships between severity of 
intellectual disabilities and depressive, behaviour-affective and anxiety psychopathology.  
 
Level of intellectual disabilities and age are both considered of relevance to 
developmental models of psychopathology used in intellectual disabilities (Dosen 2007)- 
younger age and more severe intellectual disabilities considered as lower developmental 
levels of functioning.   In this study, higher levels on the behaviour-affective and anxiety 
dimension were associated with younger age and increasing severity of intellectual 
disabilities. Therefore, there is a strong suggestion that behaviour-affective and anxiety 
psychopathology are associated with a lower developmental level of functioning. 
Although higher levels on the depressive dimension correlated with older age, there was 
no association with severity of intellectual disabilities. The findings on the association 
between depressive psychopathology and older age are inconsistent in section 5.2.2. 
Taken with the more consistent lack of association between depressive psychopathology 
and level of intellectual disabilities (Cooper et al. 2007c; Hove & Havik 2010), a 
tentative conclusion is that depressive psychopathology is not associated with 
developmental level of functioning. 
 
Independent depressive, behaviour-affective and anxiety dimensions, in keeping with the 
tripartite model of depression and anxiety psychopathology, were described in this thesis 
and one other multi-dimensional model of psychopathology in table 1.4 (Kellet et al. 
2004). Given that these dimensions are distinct and have different associations with 
variables relevant to development, further study of developmental aspects of the 
tripartite model should be considered. For example, of relevance to understanding 
pathophysiology studies have described phenotypic and genetic associations with the 
tripartite model in middle childhood (Hallett et al. 2009).  
 
5.2.4 Down syndrome and psychopathology 
Individuals with Down syndrome were found to have higher scores on the organic 
dimension, and lower scores on the behaviour-affective dimension of psychopathology. 
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These results are in agreement with one study, summarised in table 1.4, using categorical 
model of psychopathology for DC-LD problem behaviours (Jones et al. 2008), and the 
study using the continuous measures of organic psychopathology derived from the DC-
LD (Hove & Havik 2010). 
 
Down syndrome is known to be associated with a higher risk of dementia. Considerable 
research has been done to examine the nature of the association in the hope that it will 
further our understanding of dementia and Alzheimer’s disease more broadly. In contrast 
to the increased risk of dementia- and other disorders, including congenital heart disease, 
autoimmune disorders and haematological malignancies- individuals with Down 
syndrome are thought to be protected against other disorders, including solid tumours 
(Hasle et al. 2000) and hypertension (McIntyre et al. 1999). It is relevant to examine the 
reasons these disorders are less frequently experienced by individuals with Down 
syndrome. Problem behaviours are known to have a significant negative impact on the 
quality of life of individuals with intellectual disabilities, some of whom have Down 
syndrome (Beadle-Brown et al. 2009), their families and carers (Jenkins et al. 1997; 
Hastings 2002). Therefore, research on problem behaviours should be seen as a priority 
and could examine further the findings that individuals with Down syndrome are at 
lower risk of psychopathology related to problem behaviours. It is possible that 
identifying protective factors could inform prevention and intervention strategies for 
individuals with Down syndrome, and other persons. Understanding the factors 
protecting individuals with Down syndrome against the development of problem 
behaviours could also have relevance for broader models of aggression (Loeber & Hay 
1997; Eley et al. 2003). 
 
5.2.5 Other categorical socio-clinical variables and psychopathology 
Participants with epilepsy, mobility problems and bowel incontinence were found to 
have lower scores on the anxiety dimension of psychopathology. This seems 
counterintuitive, as it might be expected that individuals with additional health needs 
would be at greater risk of anxiety, or other forms of psychopathology (Deb et al. 2001). 
However, other population based studies in table 1.4 also found that individuals with 
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similar health problems, to those included in the analyses have lower levels of 
psychopathology. 
 
Individuals with mobility problems were less likely to be diagnosed with any mental 
disorder (Cooper et al. 2007a), persons with epilepsy were at lower risk of psychosis 
(Cooper et al. 2007b) and anxiety (Hove & Havik 2010), and having a hearing 
impairment was associated with a lower risk of an affective disorder (Cooper et al. 
2007c). However, it is noted that the more expected direction of association was also 
reported- visual impairment was directly associated with psychosis (Cooper et al; 2007b) 
and problem behaviours (Jones et al. 2008); urinary incontinence was associated with 
being diagnosed with any mental ill-health (Cooper et al. 2007a) and problem 
behaviours (Jones et al. 2008). 
 
Even in the context of similar findings from other studies, it is not easy to explain why 
individuals with epilepsy, mobility problems and incontinence would have lower levels 
of anxiety psychopathology. One possibility is that the management of a specific health 
problem has an impact on psychopathology. For example anti-epileptic drugs are known 
to have a positive effect on affective psychopathology (Muzina et al. 2005) and have 
been suggested to have a role in the management of anxiety (Mula et al. 2007). It could 
also be that individuals with additional health needs are supported by family or paid 
carers in a way that reduces the risk of experiencing anxiety. Although entirely 
speculative, if carers tend to support individuals with complex health problems in their 
own home this would reduce an individual’s risk of exposure to anxiety provoking 
triggers.  
 
These additional health needs occur with increased frequency in persons with more 
severe intellectual disabilities. Therefore, informant report is more likely to form the 
basis of any assessment of psychopathology in individuals with these needs. Perhaps the 
reduced levels of anxiety are an artifact related to informant reporting of 
psychopathology in individuals with more severe intellectual disabilities. This is unlikely 
as we would expect reduced anxiety to be reported universally across all the health needs 
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included in the analyses. Nonetheless, this does raise the issue of the reliability of the 
assessment of psychopathology, using self-report and informant/ proxy report across the 
full range of intellectual disabilities (Bramston & Fogarty 2000; Ross & Oliver 2003).  
 
Compared to most other socio-clinical variables, there have been more studies published 
specifically examining the relationship between epilepsy and psychopathology. 
However, no studies using an empirically defined dimensional model of 
psychopathology were identified. Most studies used a categorical model to compare 
psychopathology in individuals with epilepsy against individuals who do not have 
epilepsy. Although one study reported an increased risk in individuals who do not have 
epilepsy (Deb & Hunter 1991), studies have tended to report no between group 
differences in the risk of psychopathology (Espie et al. 1989; Gillies et al. 1989; Deb & 
Hunter 1991; Matson et al. 1999; Chung & Cassidy 2001). However, analyses including 
more detailed seizure- related data suggest that greater seizure intensity and frequency 
(Gillies, Espie & Montgomery, 1989; Espie et al. 2003) and treatment-resistance of 
seizures (Espie, Pashley et al. 1987) are associated with an increased risk of 
psychopathology. A meta-analysis of psychopathology in children with epilepsy 
highlights the potential value of using a dimensional model of psychopathology in future 
studies (Rodenburg et al. 2005). Children with epilepsy had higher scores on 
internalising and externalising dimensions of psychopathology, than controls (studies 
involving participants with severe intellectual disabilities were excluded from the 
analysis).  
 
Autism was not associated with psychopathology in this study. This disagrees with the 
finding of increased levels of anxiety psychopathology reported by Hove & Havik 
(2010). However, another population based study found no difference in the prevalence 
and incidence of mental disorders, or problem behaviours, between adults with autism 
and intellectual disabilities and controls with intellectual disabilities, matched for gender, 
age, level of intellectual disabilities and Down syndrome (Melville et al. 2008). These 
conflicting results suggest further research in this area is required. 
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5.2.6 Key issues on risk factors for mental disorders in intellectual disabilities 
This exploratory study of the relationships between a dimensional model of 
psychopathology identified several findings of interest: 
1. multi-dimensional models of psychopathology offer a useful adjunct to the use of 
categorical diagnostic classification systems in studying risk factors 
2. studying the complex relationships between psychopathology and socio-clinical 
variables can potentially elucidate the causes and pathophysiology of mental 
disorders.  
3. examining the associations between psychopathology and gender, age, level of 
intellectual disabilities and behavioural phenotypes are of particular relevance. 
4. psychopathology research in intellectual disabilities should aim to have a  broader 
relevance to the understanding of the pathophysiology of mental disorders. 
 
5.3 Psychopathology, socio-clinical variables and the severity of mental 
disorders 
Section 4.7 examined the independent relationships between the multi-dimensional 
model of psychopathology, socio-clinical variables and measures of the severity of 
mental disorders. This offers an insight into the contribution that psychopathology makes 
to impairment and need associated with mental disorders. Socio-clinical variables were 
included in the analyses as potential confounders but also to identify if any are 
independently associated with the severity of mental disorders. 
 
The depressive, organic and behaviour-affective dimensions of psychopathology were 
independently associated, in varying combinations, with all of the measures of the 
severity of mental disorders. However, the anxiety dimension was not correlated with 
any measure of severity. Since the association of socio-clinical variables with the 
measures of severity of disorder did not show any particular pattern, these are discussed 
individually below. 
 
It is important to discuss the relevance of the CANDID-R met needs as a measure of 
severity of mental disorders. Met needs is reported as standard in studies using the CAN 
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or CANDID. The original CAN is most often used in epidemiological studies or needs 
assessment in relation to a specific clinical service, or population. Met needs are relevant 
to these types of study, as they give an indication of what level of needs a service should 
be resourced to address. Thus, they can be helpful to strategic planning and delivery of 
clinical services. However, the total number of met needs is less useful as a measure of 
severity of disorder. A higher score is a reflection of the degree to which services are 
meeting an individual’s needs, whilst a lower score reflects that an individual has fewer 
needs that services are currently meeting. Since neither of these circumstances provide 
any relevant issue relevant to severity, the CANDID-R met needs will not be discussed 
here.  
 
The individual measures of severity were found to have different associations with the 
psychopathology and socio-clinical measures. This finding suggests that the measures of 
severity assess distinct aspects of the severity of mental disorders. Thus, they can be 
considered to be complementary and useful to include within a battery of measures of 
severity.  Not unexpectedly, the results for the two overall measures of severity, the GAF 
and CGI were similar. These were both included because of the limited evidence on their 
use, and concerns that the GAF may not be reliable in intellectual disabilities (Hurley 
2001; Shedlack et al. 2005; Hurley et al. 2007). However, the results for the HoNOS-
LD, the two global measures and the CANDID-R unmet need are quite distinct. These 
are examined in detail below, after first considering some relevant findings for the multi-
dimensional model of psychopathology. 
 
5.3.1 The multi-dimensional model of psychopathology and severity of mental 
disorders 
Greater levels of psychopathology on the depressive dimension were associated with 
increased severity measured with the HoNOS-LD, GAF and CGI. The GAF and CGI are 
global measures, with an explicit focus on psychopathology. Therefore, the association 
with HoNOS-LD could be considered of greater significance as it suggests that 
depressive psychopathology has an impact on broader aspects of the severity of mental 
disorders, such as physical health, interpersonal functioning, self-care, and occupation 
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and activities. Two previous studies (table 1.5) examined the relationship between 
depressive psychopathology and the severity of mental disorders (Lunsky & Benson 
2001; Endermann & Zimmermann 2009). However, only the study including participants 
with mild intellectual disabilities (Lunsky & Benson 2001) found a significant 
association between higher depressive psychopathology and greater severity, measured 
as a lower quality of life. These results suggest that effective management of depressive 
psychopathology could have a significant positive impact on the lives of individuals with 
intellectual disabilities.  
 
Examining the CANDID-R and HoNOS-LD in table 3.6 it is seen that there is 
considerable overlap in the items included in the two measures. Therefore, since 
depressive psychopathology was associated with severity measured on the HoNOS-LD, 
an association with unmet needs on the CANDID-R might have been expected. Although 
the scoring system across the CANDID-R and HoNOS-LD are different, if this explained 
why depressive psychopathology was not significantly related to unmet need, the 
association with organic and behaviour-affective psychopathology to both measures of 
severity would not have been found. Therefore, it is not clear why depressive 
psychopathology was associated with all the measures of severity apart from the level of 
unmet need on the CANDID-R. 
 
The organic and behaviour-affective dimensions of psychopathology, within the multi-
dimensional model, were significantly associated with all four measures of disease 
severity. None of the studies summarised in table 1.5 examined the relationship between 
organic psychopathology and disease severity. Therefore, the impact on severity 
highlights the importance of including items relevant to organic psychopathology in 
research studies - which was also only done in a minority of the previous studies of 
multi-dimensional models of psychopathology in the table 1.2. Combined with the 
increased prevalence of dementia in adults with intellectual disabilities (Strydom et al. 
2007), the strong relationship with severity of mental disorders, suggests that organic 
psychopathology should be a priority for research and clinical services (Janicki & Dalton 
2000).  
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An association of the behaviour-affective dimension with severity of mental disorder 
offers some validation of the novel dimension, hypothesized to fit within a tripartite 
model of depression and anxiety psychopathology (Clark & Watson 1991).  Since this 
dimension is correlated with all measures of severity, it appears to be of potential 
significance to the lives of adults with intellectual disabilities. Some support for this is 
provided by the previous study that reported an association of problem behaviours with 
severity of mental disorders (Beadle-Brown et al. 2009).  
 
Given the link to severity, one area of relevance to consider is how comorbid affective 
and problem behaviour psychopathology could be effectively managed. There is some 
evidence on the separate assessment and management of affective psychopathology 
(Masi et al. 1997; McCabe et al. 2006) and problem behaviours (Tyrer et al. 2009; 
Harvey et al. 2009) experienced by individuals with intellectual disabilities. However, 
research on the co-morbidity of the two forms of psychopathology is more limited- 
largely focused on examining problem behaviours as equivalent criteria for the diagnosis 
of depressive disorders (Lowry & Sovner 1992; Charlot et al. 1993; Marston et al. 1997; 
Moss et al. 2000; Holden & Gitlesen 2003; Tsiouris et al. 2003; Cain et al. 2003; Rojahn 
et al. 2004; Kishore et al. 2005; Tyrer et al. 2006; Hurley 2008). Interestingly, research 
is beginning to consider the effectiveness of interventions based on the tripartite model 
(Barlow et al. 2004; Diefenbach & Goethe 2006). If the model is confirmed as valid in 
future studies it may offer novel treatment strategies for problem behaviours.  
 
One previous study reported a correlation between neuroticism (as a proxy measure of 
anxiety) and severity of mental disorders (Endermann & Zimmermann 2009). However, 
the anxiety dimension of psychopathology was not significantly correlated with any 
measure of severity in this thesis. Given that the other dimensions are correlated to 
severity, it is not clear why the findings for the anxiety dimension are quite different. 
One possibility is that the measures of severity are not sensitive to the impact of anxiety 
psychopathology. However, the GAF and CGI are designed to be used across any form 
of mental disorder and the items included in the HoNOS-LD and CANDID-R, shown in 
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table 3.4, would appear to be relevant. That said, only 8% of participants in the HoNOS-
LD pilot study had an ICD-10 neurotic disorder and there were no participants with 
neurotic/ anxiety disorders in the CANDID-R pilot study. Therefore, the psychometric 
properties of these measures when used by individuals with anxiety psychopathology 
would benefit from clarification. 
 
5.3.2 Socio-clinical variables associated with the severity of mental disorders 
The only socio-clinical variable independently associated across more than one measure 
of the severity of mental disorders was the level of intellectual disabilities. This finding 
is consistent with the previously described direct relationship between severity of 
intellectual disabilities and severity of mental disorder, rated as lower quality of life 
(Beadle-Brown et al. 2009). Compared to the mild intellectual disabilities reference 
category - moderate, severe and profound intellectual disabilities were associated with 
higher levels of unmet needs on the CANDID-R, and profound intellectual disabilities 
was associated with greater severity on the HoNOS-LD. Since the findings reported here 
are independent of the impact of psychopathology, and other variables, it suggests that 
either: 
• the impact of psychopathology increases as the severity of intellectual disabilities 
increases 
• interventions and services provided to individuals with mental disorders are less 
effective with increasing severity of intellectual disabilities. 
 
One explanation that could account for both of these effects is the challenge inherent in 
identifying psychopathology as the level of intellectual disabilities of individuals’ 
increases. Verbal communication and methods of self-report are central to the reliable 
identification and assessment of psychopathology. As the severity of intellectual 
disabilities increases, the level of functioning in the verbal communication domain is 
reduced. As a consequence, the assessment of psychopathology is increasingly 
dependent on informant report and observation. However, informants have been found to 
be less likely to identify psychopathology, and recognise the need for treatment, in adults 
with more severe intellectual disabilities (Edelstein & Glenwick 2001). Furthermore, it 
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has been found that there is poor agreement in the items of psychopathology reported by 
individuals with intellectual disabilities and informants (Moss et al. 1996). Therefore, 
this dependence on informant report has been recognised as a potential barrier to the 
recognition of psychopathology (Ruddick 2005) and other health problems (NHS Health 
Scotland 2004). These issues surrounding informant report could therefore lead to the 
delayed identification and assessment of psychopathology in persons with more severe 
intellectual disabilities.  
 
Intellectual disabilities research on the impact of the delayed presentation of 
psychopathology is limited. However, such delayed presentation has been shown to be 
associated with increased severity of mental disorders in children (Keller et al. 1992) and 
adults who do not have intellectual disabilities (Coryell et al. 1995; Scully et al. 1997). 
Potential solutions to improve informant recognition and report of psychopathology are 
proactive screening for psychopathology (Cooper et al. 2006; Baxter et al. 2006), 
training programs for carers (Costello et al. 2006; Woodwards & Halls 2009) and the use 
of reliable and valid informant-report measures of psychopathology (Cuthill et al. 2003).  
 
Despite this possible effect associated with informant report of psychopathology, the 
positive impact of support from carers is supported by the lower level of unmet needs, 
and higher met needs, for individuals living with family or paid carers- compared to 
individuals living independent of support. This was not examined in previous studies 
(Lunsky & Benson 2001; Beadle-Brown et al. 2009; Endermann & Zimmermann 2009). 
However, the key role that carers have in supporting the health and social needs of adults 
with intellectual disabilities is widely recognised (McGrother et al. 1996; McConkey et 
al. 2006). 
 
Younger age was found to be independently associated with severity of mental disorders, 
indicated by higher levels of unmet needs. Once again, none of the previous studies 
examining correlates with severity included age in the analysis (Lunsky & Benson 2001; 
Beadle-Brown et al. 2009; Endermann & Zimmermann 2009). Although younger age 
was found to be associated with higher levels of psychopathology in the behaviour-
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affective and anxiety dimensions, the association of younger age with severity is 
independent of the effects of psychopathology. It is not certain why this might be but one 
possibility could be that younger individuals are more likely to be presenting to services 
for the first time, or are at an earlier stage of contact with services. Therefore, unmet 
needs which have been addressed through previous, or longer, contact with services in 
older people have not yet been addressed for younger people.  
 
Generally, researchers have highlighted the health needs of older people with intellectual 
disabilities (Janicki et al. 1999; Evenhuis et al. 2000; Janicki et al. 2002). Perhaps the 
finding reported here serves as a reminder that mental disorders starting in childhood and 
adolescence can continue to have an impact into adulthood in individuals with 
intellectual disabilities (Maughan et al. 1999; Beadle-Brown et al. 2008). Furthermore, 
the transition period into adulthood is recognised as a period of increased risk for the 
development of mental disorders (NHS Health Scotland 2004). 
 
 5.3.3. Key issues on psychopathology, socio-clinical and severity of mental 
disorders 
1. the multi-dimensional model of psychopathology is related to severity of mental 
disorders measured with a battery of measures that include the impact of 
psychopathology on physical health, interpersonal functioning, self-care and 
occupation and activities. 
2. increased severity of intellectual disabilities is associated with greater severity of 
mental disorders, even after controlling for the effects of psychopathology and other 
potential confounding variables.  
 
5.4 Psychopathology as a predictor of the longitudinal outcome of 
mental disorders 
A key criticism of the prevailing categorical model of psychopathology is that it lacks 
predictive validity; that is to say, categorical models of psychopathology are poorly 
correlated with longitudinal outcome and thus provide little information on an 
individual’s prognosis. Therefore, the examination of psychopathology and longitudinal 
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outcome is an important aspect of understanding psychopathology experienced by 
persons with intellectual disabilities. 
 
5.4.1 Psychopathology and longitudinal outcome 
The finding that the depressive and behaviour-affective dimensions of psychopathology 
are related to positive longitudinal outcome is similar to some previously published 
studies (tables 1.6 and 1.7). Follow up studies of adults with intellectual disabilities have 
reported that problem behaviours (van Minnen et al. 1997) and affective/ neurotic 
psychopathology (Spiller et al. 2007) are correlated to outcome. Only one previous study 
found an association between childhood psychopathology and outcome in adulthood 
(McCarthy 2008). These three studies used only a single measure of outcome (van 
Minnen et al. 1997; Spiller et al. 2007; McCarthy  2008). The one study that included a 
battery of measures of outcome, including the GAF used in this thesis, did not find any 
significant correlation between psychopathology and outcome (Xenitidis et al. 2004). 
 
The organic dimension symptom count was negatively correlated with the change in the 
HoNOS-LD over time. This is in keeping with the progressive nature of most types of 
dementia. Although there is some suggested efficacy of cognitive-enhancers in adults 
with Down syndrome (Lott et al. 2002; Prasher et al. 2002) this research is at an early 
stage and there is less evidence on the use of cognitive enhancers in adults with 
intellectual disabilities not associated with Down syndrome. Furthermore, with the four-
five year follow-up, it would be expected that progression of the dementia would have 
occurred even if an individual had received cognitive enhancers.  The limited evidence 
base on non-pharmacological management of organic psychopathology experienced by 
individuals with intellectual disabilities has also been recognized (Courtenay et al. 
2010). 
  
Of equal relevance is the finding that the anxiety dimension of psychopathology was not 
related to longitudinal outcome. Since there was no significant change in this dimension 
over time (table 4.70), this could be attributed to the lack of effectiveness of 
interventions and services on this dimension of psychopathology. Although adults with 
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intellectual disabilities experience high rates of anxiety psychopathology, there is little 
evidence on the effectiveness of pharmacological and psychosocial interventions 
(Dagnan & Jahoda 2006; Davis et al. 2008) for anxiety psychopathology. 
 
Give the strong association between psychopathology and longitudinal outcome, 
research on the assessment and management of psychopathology should be a priority.  
Based on these findings, developing effective interventions and services and may  
improve outcomes and quality of life of adults with intellectual disabilities and mental 
disorders.  
 
5.4.2 Level of intellectual disabilities and the longitudinal outcome of mental 
disorders 
Independent of psychopathology and the effects of other variables, outcome is better for 
individuals with moderate, severe and profound intellectual disabilities compared to 
persons with mild intellectual disabilities. This contrasts with findings from one study 
(van Minnen et al. 1997) that reported poorer outcomes for individuals with lower levels 
of social competence, whilst another found no significant association between 
intellectual disabilities and outcome (Spiller et al. 2007). The use of social competence 
as a proxy measure of level of intellectual disabilities, and a composite measure of 
psychopathology as the sole measure of outcome could partly explain the different 
finding from the study by van Minnen et al. (1997). Clearly, in light of limited evidence 
on the influence of level of intellectual disabilities on the outcome of mental disorders, 
further research would be desirable.  
 
Although living circumstances were not independently associated with outcome, it could 
be that the improved outcome for adults with more severe intellectual disabilities is 
related to support arrangements. Since individuals with more severe intellectual 
disabilities will receive increased support from carers, this could influence outcomes. For 
example, perhaps individuals living with support from family or paid carers have 
improved compliance with pharmacological and psychosocial interventions for mental 
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disorders. This again highlights the positive impact that carers can maybe have on the 
outcome of mental disorders. 
 
5.4.3 Other socio-clinical variables associated with outcome 
The finding that individuals with poorly controlled seizures have poorer outcomes 
highlights the relevance of epilepsy to the management of mental disorders in 
individuals with intellectual disabilities.  This is in keeping with the finding that 
individuals with intellectual disabilities and poorly controlled seizures are more likely to 
report psychopathology (Espie et al. 2003; Ring et al. 2007). Previous studies have 
rarely examined the influence of epilepsy on the outcomes of mental disorders 
experienced by adults with intellectual disabilities. However, potential barriers to the 
effective management of mental disorders (Barry et al. 2008) and the interaction 
between seizures and the efficacy of interventions (Kanner 2004) have been recognized 
in non-intellectual disabilities research. The poorer outcome of individuals with 
psychopathology and seizures supports the suggested need for specialist intellectual 
disabilities services for individuals with comorbid mental disorders and epilepsy 
(McGrother et al. 2006; Fitzgerald & Ring 2009). 
 
Individuals with hearing impairment were found to have poorer outcomes on the GAF 
and CGI. It is difficult to understand why this would be the case. Hearing impairment 
was included in the analysis on the basis that a previous study showed that individuals 
with intellectual disabilities and a hearing impairment were less likely to be diagnosed 
with an affective disorder (Cooper et al. 2007c). More generally, individuals with 
hearing impairments are described as being at increased risk of mental disorders (Carvill 
2008). The poorer outcome for individuals with hearing impairment can perhaps be 
needs to be understoodin the context of the complex physical and mental health needs of 
adults with intellectual disabilities. 
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5.4.4 Key issues on psychopathology, socio-clinical variables and the outcome of 
mental disorders 
1. the multi-dimensional model of psychopathology is useful to developing an 
understanding of the longitudinal outcome of mental disorders 
2. further research is required to examine if the efficacy of interventions and services 
for individuals with mental disorders varies with level of intellectual disabilities  
3. the complex physical health needs of adults with intellectual disabilities could impact 
on the longitudinal outcome of mental disorders. 
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5.5 Comparisons of dimensional and categorical models of 
psychopathology 
The categorical model of psychopathology was independently associated with severity of 
mental disorder on the HoNOS-LD, and longitudinal outcome on the GAF and CGI. 
However, the multi-dimensional model of psychopathology was associated with all four 
measures of severity, and longitudinal outcome on the HoNOS-LD, GAF and CGI. 
Further, the categorical model was no longer associated with any measure of severity or 
longitudinal outcome, when both models of psychopathology were included in the 
regression analysis. Therefore, the categorical model does not provide any additional 
contribution to the variance in measures of severity & outcome, over and above the 
dimensional model of psychopathology. It is concluded that the multi-dimension model 
is a better representation of psychopathology when considering the severity, and 
longitudinal outcome, of mental disorders. This finding strongly suggests that 
dimensional models of psychopathology are of relevance to future research on 
psychopathology experienced by individuals with intellectual disabilities, and may be of 
value to the strategic planning and provision of clinical services. 
 
No intellectual disabilities studies have compared dimensional and categorical models of 
psychopathology. Although one study of psychosis found that dimensional and 
categorical models of psychopathology were equally relevant to predicting longitudinal 
outcome (Dikeos et al. 1996), the finding that the multi-dimensional model is more 
strongly associated with severity of disorder (van Os et al. 1999a; Prisciandro & Roberts 
2009) and outcome (van Os et al. 1996; van Os et al. 1999b) is in keeping with most 
studies examining dimensions of psychosis. The potential relevance of the finding that 
dimensional models of psychopathology are more closely associated with severity, and 
outcome, of mental disorders is worth considering. 
 
This thesis used similar methods to the general research comparing the association of 
dimensional and categorical models with severity and outcome of psychosis (van Os et 
al. 1996; van Os et al. 1999b; van Os et al. 1999a Dikeos et al. 2006) and affective 
disorders (Prisciandro & Roberts 2009). It has been suggested that the methodology 
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examines the predictive validity of different models of psychopathology (Prisciandro & 
Roberts 2009). However, before accepting that there there is a need to consider some 
aspects of the methodology.  
 
The strength of dimensional models of psychopathology over categorical models has 
been attributed to the retention of greater information describing the person to person 
variability in psychopathology (Kraemer 2007). Examining the requirements for a good 
classification system for mental disorders in section 1.2.1, this suggests that a 
dimensional model has better face validity than a categorical model of psychopathology. 
The improved face validity of dimensional models is also supported by the findings that 
psychopathology has a continuous rather than bimodal distribution (section 1.5.1), which 
is better represented by a dimensional model of psychopathology. The retention of 
greater information relevant to the psychopathology an individual is experiencing within 
the dimensional model, which can be used to derive continuous measures, is also 
recognised to improve the sensitivity to change, compared to a categorical model of 
psychopathology (Hemingway et al. 1997; Haslam 2003). It could be that the improved 
face validity and sensitivity of a dimensional model of psychopathology, at least in part, 
explains the stronger relationships with severity and longitudinal outcome, compared to 
a categorical model. However, the research is at an early stage and further work 
examining the advantages and disadvantages of both models of psychopathology is 
required. 
 
The severity of an individual’s mental disorder is closely tied to decisions by clinician’s 
about need for treatment. This is a complex process, which at some level will always 
involve clinicians making a categorical decision (Pickles & Angold 2003).  However, the 
validity of using categorical models of psychopathology within the decision making 
process has been questioned.  Decisions on the need for treatment of mental disorders 
are, at least in part, influenced by whether the psychopathology an individual is 
experiencing meets the criteria for a disorder, defined within a categorical diagnostic 
classification system (Kraemer et al. 2004). Certain systems of health care operate a 
policy where the costs for treatment will only be met by health insurance in 
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circumstances where the diagnostic criteria are met. In these circumstances categorical 
models of psychopathology act as barriers to care for some individuals. Clinical decision 
making processes based on a categorical model of psychopathology, run the risk of 
viewing all individuals who meet the diagnostic criteria as identical (Widiger & Samuel 
2005) and excluding individuals from care who have significant impairments and would 
benefit from treatment (Angst et al. 1997; Wagner et al. 2000; Cuijpers et al. 2004; 
Chuan et al. 2008). Overall, this represents a loss of relevant data to inform the decision 
making process. The multi-dimensional model of psychopathology was more closely 
related to severity than the DC-LD categorical model in this thesis, and previous studies 
of psychosis (van Os et al. 1999a). This suggests that incorporating dimensional models 
into assessments could have advantages for clinical decision-making processes based on 
the severity of mental disorders.  
 
In this thesis, the multi-dimensional model of psychopathology was also more strongly 
associated with the outcome of mental disorders than the categorical model. This 
suggests that dimensional models may hold advantages in monitoring response to 
treatment in clinical services and intervention studies, and understanding change in 
psychopathology in longitudinal studies. Of course, continuous measures of 
psychopathology are often used as outcome measures in intervention studies. 
Instruments have been developed for the assessment of depressive (Cuthill et al. 2003), 
anxiety (Mindham & Espie 2003; Charlot et al. 2007) and problem behaviour (Rojahn et 
al. 2009) psychopathology in adults with intellectual disabilities. Examining multi-
dimensional models of psychopathology derived through EFA, and other multivariate 
methods, can help to ensure the validity of these measures. For example, further work 
examining the relationship between affective and problem behaviour psychopathology 
could lead to the development of new assessment instruments. 
 
What is likely to be more challenging is the incorporation of dimensional models of 
psychopathology into routine clinical practice. Even with robust instruments to assess 
and monitor dimensions of psychopathology, changing clinical practice to routinely 
monitor psychopathology or outcomes has been shown to be problematic. The reasons 
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for this are likely to be complex but one possibility is that the categorical model of 
psychopathology already meets the needs of clinicians (Kendell & Jablensky 2003; 
Mellsop et al. 2007; Bell et al. 2008).  
 
In fact, although multi-dimensional models appear to be more closely related to severity 
and outcome of mental disorders, there is no suggestion that they should replace 
categorical models of psychopathology. As described in section 1.4.1, categorical 
models have several strengths- particularly when used in clinical practice. Rather, 
current proposals explore means by which dimensional and categorical models can be 
used side-by-side, to complement one another (Achenbach et al. 2005; Kraemer 2007). 
This will capture the strengths of both approaches to understanding psychopathology and 
hopefully take forward the study and management of mental disorders. It will be 
interesting to see if dimensional models of psychopathology are incorporated into ICD-
11 and DSM-V, due for publication in the near future.  
 
5.6 Strengths and limitations 
This study followed best practice guidelines on EFA to identify a multi-dimensional 
model of psychopathology experienced by adults with intellectual disabilities. A review 
highlighted the methodological weaknesses in studies that use EFA in the field of 
developmental disabilities (Norris & Lecavalier 2010). The EFA reported in this thesis 
meets the criteria set out in the review paper and current best-practice guidelines 
(Costello & Osborne 2005). None of the previous studies, summarised in table 1.2, that 
describe a dimensional model of psychopathology meet these criteria, with specific 
methodological limitations related to sample size and a case: item ratio of less than 5:1 
(Tabachnik & Fidell 2001; Matson et al. 1984; Linaker 1991; Gustafsson & Sonnander 
2005; Watson et al. 1988; Sturmey et al. 1996; Sturmey et al. 2003; Tsiouris et al. 
2003), the sole use of eigenvalues to decide the number of factors extracted in models 
(Matson et al. 1984; Linaker 1991; Balboni et al. 2000; Gustafsson & Sonnander 2005; 
Watson et al. 1988; Moss et al. 1998; Hatton & Taylor 2008; Hove & Havik 2008; 
Kellet et al. 2004), acceptance of factors with less than three items loading significantly 
(Moss et al. 1998; Hatton & Taylor 2008; Hove & Havik 2008) and cross-loading of 
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items across factors (Moss et al. 1998; Sturmey et al. 2005; Sturmey et al. 1996; Kellet 
et al. 2004). 
 
A further strength of the EFA described here is the use of a method of factor analysis 
appropriate to the analysis of categorical data (Wood et al. 2003). Most psychopathology 
assessment instruments collect data that is categorical, usually either ordinal or binary in 
nature. Common factor and principal components analysis are designed for use with 
continuous variables (Linting et al. 2007). Comparative analyses have shown that the use 
of these methods with categorical data produces models with poor reliability and 
stability, compared to non-linear methods of analysis (Woods 2002). In this EFA, a 
specific form of non-linear analysis better suited to the binary PPS-LD data was used.  
The method of analysis used is based on inter-item tetrachoric correlations (du Toit 
2003), carried out with TESTFACT software. As is common in published 
psychopathology research, all the studies in table 1.2 use the principal components 
method to analyse categorical data. Clearly, further studies of intellectual disabilities of 
psychopathology using appropriate and reliable multivariate methods of analysis are 
required. 
 
The use of an appropriate method to assess psychopathology in this study will have 
impacted positively on the data used for the EFA. PPS-LD is a psychopathology 
assessment instrument specifically developed for use with adults with intellectual 
disabilities. Inclusion of items of psychopathology from the SCAN, with additional items 
relevant to mental disorders experienced by persons with intellectual disabilities, ensured 
appropriate psychopathology was included in the analysis. Although items related to 
psychosis and mania/ hypomania were not included in the analysis, the results represent 
a broad, multi-dimensional model of commonly experienced psychopathology. 
Previously described multi-dimensional models are limited by the range of items of 
psychopathology included in the assessment instruments, e.g. the PAS-ADD checklist 
(Moss et al. 1998; Sturmey et al. 2004; Hatton & Taylor, 2008) or the CBCPID (Tsiouris 
et al. 2003). The inclusion of an extensive range of items of psychopathology also makes 
it more likely that the reported model of psychopathology is potentially valid.   
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Despite the comprehensive nature of the PPS-LD, as discussed in section 5.1, there are 
items of psychopathology of potential relevance to the behaviour-affective and anxiety 
dimensions that could not be included in the EFA. To improve the coverage of items of 
psychopathology in the PPS-LD for future studies, consideration should be given to 
extending the items assessing problem behaviours, and separating out items on free-
floating anxiety, autonomic overarousal and avoidance that are currently incorporated in 
composite items. 
 
Although the use of the PPS-LD can be considered a strength of this thesis, it is relevant 
to consider the strengths and limitations of other available instruments. 
 
At the start of the period of study relevant to this thesis, the only comprehensive 
instrument for the assessment of psychopathology in adults with intellectual disabilities 
that was available was the PAS-ADD (Moss et. al 1993). The PAS-ADD is a semi-
structured interview schedule based on the Psychiatric Assessment Schedule (PAS: Gask 
1988). Since the items of psychopathology in the PAS were included in order to be able 
to diagnoses depression, generalised anxiety, dysythymia, panic disorder and 
agoraphobia, additional items for the assessment of psychopathology relevant to 
psychoses and autism were included in the PAS-ADD.  
 
The researchers who developed the PAS-ADD found it to be a reliable and valid 
instrument for the assessment of psychopathology in adults with intellectual disabilities 
(Moss et al. 1993; Moss et al. 1997). Furthermore, the semi-structured format of the 
PAS-ADD interview included several innovations designed to maximise its utility in the 
identification of psychopathology experienced by adults with intellectual disabilities. 
These innovations included parallel participant and informant interviews and the use of 
an anchor event to improve recall.  
 
Despite these strengths, certain limitations in the range of items of psychopathology 
included in the PAS-ADD limited its suitability for use in the EFA to examine the 
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dimensional structure of psychopathology experienced by adults with intellectual 
disabilities. In particular, the PAS-ADD does not include items of psychopathology 
relevant to problem behaviour and obsessional psychopathology. Since problem 
behaviours are the most commonly experienced form of psychopathology experienced by 
adults with intellectual disabilities the absence of these in the PAS-ADD was considered 
to limit its use to examine research hypothesis one, in this thesis. 
 
As the PPS-LD includes a broader range of items of psychopathology than the PAS-
ADD, and crucially includes items relevant to problem behaviours it was used in this 
thesis. Another instrument for the assessment of a broad range of psychopathology in 
adults with intellectual disabilities has been published since the start of the work 
described in this thesis- the Developmental Behaviour Checklist for Adults (DBC-A; 
Mohr et al. 2005). The DBC-A was developed from an established checklist of 
psychopathology for completion by carers of children with intellectual disabilities called 
the DBC (Einfeld & Tonge, 1992). To decide on the items of psychopathology for 
inclusion in the DBC-A, the items of psychopathology described in the clinical notes of 
six hundred and five adults with intellectual disabilities seen at a specialist centre in 
Victoria, Australia were compared against the 94 items of psychopathology included in 
the DBC.  Twelve items of psychopathology were added to those in the DBC. The 
resultant 106 items of psychopathology in the DBC-A were reported to have satisfactory 
inter-rater reliability, and concurrent validity compared to the PAS-ADD. 
 
Since the development of the DBC-A was informed by a “bottom up process” that 
examined psychopathology recorded in a large sample of case notes it is likely that it 
assesses a comprehensive range of psychopathology However, the researchers that 
developed the DBC-A note that the clinical assessments were unstructured and are thus 
dependant on the training and clinical practice of professionals working in the specialist 
centre (Mohr et al. 2005). Nonetheless, like the PPS-LD, the DBC-A includes items of 
psychopathology commonly experienced by adults with intellectual disabilities that are 
not included in generic psychopathology assessments e.g. problem behaviours. Therefore, 
the breadth and relevance of items of psychopathology in the DBC-A suggest it may be 
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suitable for use in an EFA to examine the dimensional structure of psychopathology 
experienced by adults with intellectual disabilities.  
 
A second checklist of psychopathology published recently is the P-AID (Hove & Havik 
2008) used in the EFA described in table 1.2. The P-AID comprises 260 items of 
psychopathology based on diagnostic criteria in DC-LD (Royal College of Psychiatrists 
2001), including problem behaviours. Although the 260 items of psychopathology are 
organised into 18 separate checklists that correspond to DC-LD categorical diagnoses, as 
described in section 5.1.1, use of the 260 items of psychopathology in an EFA could be 
done to examine the dimensional structure of psychopathology.  
 
The PPS-LD (Cooper 1997), DBC-A (Mohr et al. 2005) and P-AID (Hove & Havik 
2008) all include a comprehensive range of psychopathology relevant to mental disorders 
experienced by adults with intellectual disabilities, and use a similar checklist format to 
rate items of psychopathology. Therefore, future research should consider comparing the 
multi-dimensional model of psychopathology extracted from the three instruments. 
 
Since the items of psychopathology included in the EFA can be identified by self and 
informant report, the model is applicable to individuals across the range of mild-
profound intellectual disabilities. Although the model from the BSI (Kellett et al. 2004) 
is similar, the design of the assessment instrument and the sample used mean the results 
are not generalisable beyond individuals with mild intellectual disabilities. Adults with 
intellectual disabilities are heterogeneous across many variables, and using inclusion 
criteria to define samples more tightly could be advantageous for some types of 
psychopathology research. For example, studies of psychosis psychopathology could 
limit the samples to individuals with mild intellectual disabilities.  However, one aspect 
of the thesis was comparing a dimensional model of psychopathology to the categorical 
models in diagnostic classification systems. Since systems such as DC-LD and DM-ID 
are designed for use across mild-profound intellectual disabilities it was necessary to 
include participants across a similar range of abilities. The use of a sample that includes 
individuals with severe-profound intellectual disabilities meant that psychopathology 
 339 
relevant to problem behaviours was more likely to be included in the EFA. This 
contributed to finding a potentially important model to explain the relationship of 
problem behaviours to other commonly experienced psychopathology. Finally, a broad 
sample makes the findings more likely to be of relevance to professionals working in the 
field of intellectual disabilities and clinical services.  
 
All the psychopathology assessments were done by psychiatrists trained by the 
intellectual disabilities psychiatrist who originally developed the PPS-LD (Cooper 
1997). This ensures the consistent use of the PPS-LD. The collection of psychopathology 
data was done in the context of the standardised UCEDD clinical assessment. Since this 
includes a full clinical history and examination, consideration is given to changes 
attributable to physical health problems or side-effects of medication and avoids falsely 
rating long-standing traits as psychopathology associated with a mental disorder. This 
standardised process will, therefore, have improved the reliability of the 
psychopathology data used in the EFA.  
 
Further to the use of the PPS-LD, the use of standardised methods to assess level of 
intellectual disabilities and outcome is a further strength of this study. Level of 
intellectual disabilities was assessed by psychiatrists trained in the use of the Vineland’s 
adaptive behaviour scales (Sparrow et al. 1984). The Vineland’s adaptive behaviour 
scales have been endorsed for use in the assessment of functioning by the World Health 
Organisation (World Health Organisation 1994) and the Royal College of Psychiatrists 
(2001). Furthermore, they were used in the process to examine the standardization of the 
Weschler Adult Intelligence Scale-Third Edition (Weschler 1997), which is commonly 
used to measure IQ. A field trial to test the psychometric properties of the Vineland’s 
adaptive behavior scales and derive population norms for adults with intellectual 
disabilities living in institutional and community settings was used as part of the process 
to develop the Vineland’s adaptive behavior scales (Sparrow et al. 1984). This 
established the Vineland’s as reliable and valid for the assessment of level of functioning 
in adults with intellectual disabilities. Despite these strengths, some specific weaknesses 
of the Vineland’s scales when compared to other measures of ability have been 
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highlighted (Beail 2003). The version of the Vineland’s used in this thesis has been 
replaced by an updated version which addresses criticisms that the previous version, 
piloted in 1984, was outdated. To complete the Vineland’s adaptive behaviour scales a 
trained interviewer administers the scale with an informant who knows the person with 
intellectual disabilities, covering a broad range of functioning. It has been suggested that 
more direct assessments of an individual’s functioning would improve the reliability and 
validity of the Vineland’s adaptive behaviour scales (Beail 2003). Whilst this is the case, 
and more comprehensive batteries of assessments are available, these require 
considerable more time and resource. One advantage of the Vineland’s adaptive 
behaviour scales is that a trained interviewer can complete it in 20-30 minutes. It is 
therefore useful as a standardised way to assess level of functioning in circumstances 
where a more comprehensive battery of assessments is not feasible, such as large-scale 
research studies, or in busy clinical services.  
 
This study uses four measures of outcome designed to be complementary and provide a 
battery of assessments relevant of mental disorders experienced by adults with 
intellectual disabilities. HoNOS-LD (Roy et al. 2002) and the CANDID-R (Xenitidis et 
al. 2000) were developed specifically for use with adults with intellectual disabilities. 
Although they have only been used in a limited number of published research studies, 
both include items of relevance to the lives of adults with intellectual disabilities and 
have been shown to be reliable, valid and sensitive to change. In keeping with 
recommendations on the use of different forms of outcome measures, the HoNOS-LD 
and CANDID-R are designed to measure different aspects of outcome. HoNOS-LD, like 
the generic HoNOS, aims to measure a person’s health and social functioning, against a 
theoretical “optimal functional autonomy” (Wing et al. 1998). The CANDID-R 
measures need across the 25 domains (Xenitidis et al. 2000). A strength of these two 
measures is that they cover a broad range of domains that could be impacted upon by 
psychopathology associated with mental disorders. Thus they avoid the criticism aimed 
at other measures of outcome that they are limited in scope and place too much emphasis 
on measuring symptoms.   
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Two global outcome measures were also used. The GAF and CGI are the two most 
commonly used global measures in psychopathology research. Since they were not 
developed for specific use in intellectual disabilities, and the psychometric properties 
have not been studied it was decided to use both measures. Researchers have raised 
concerns that GAF scores in intellectual disabilities may be scored down due to the 
influence of a person’s intellectual disabilities on functioning. However, in contrast to 
previous studies (Oliver et al. 2003; Shedlack et al. 2005; Hall et al. 2006) this study 
used the recommended modified scoring method (Hurley 2001) which rates the GAF 
purely on the impact of psychopathology. 
 
Although this thesis used several measures of outcome, there are some available forms 
of outcome measure that were not used. In a review of different measures of outcome 
used in non-intellectual disabilities mental disorder research seven relevant categories of 
outcome measure were identified (Slade  2002): 
• well-being e.g. quality of life 
• cognition/ emotion- symptom or psychopathology 
• behavior- psychopathology and functioning 
• physical health 
• interpersonal functioning- social functioning and relationships  
• society- carer burden, employment and welfare benefits 
• services- service use, satisfaction with services and health economics. 
 
Despite certain gaps, overall the measures of outcome used in this thesis provide an 
assessment relevant to the majority of these categories of outcome. The HoNOS-LD and 
CANDID-R include items of relevance to cognition/ emotion, behavior, physical health, 
interpersonal functioning and society. The battery of measures of outcome could have 
been made more comprehensive by the inclusion of a measure relevant to the categories 
of well-being and services. Quality of life research is well established in intellectual 
disabilities research, and several specific quality of life measures have been developed 
and validated for use. Therefore, future studies would benefit from inclusion of a 
measure of well-being; for example using the QoLQ (Schalock & Keith 1993) or LSS 
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(Harner & Heal 1993), used in two of the studies summarised in table 1.5. No measures 
of service use or satisfaction with services have been developed for use in the field of 
intellectual disabilities. The use of generic instruments in studies with adults with 
intellectual disabilities as participants could be considered following research to 
establish the utility, reliability and validity of such measures.  
 
Perhaps the most significant limitation in the study is the low rate of participation in the 
follow up research interviews. Of 150 individuals assessed in the UCEDD clinical 
services 40 (26.7%) consented to participate in the interviews. However, since there 
were no significant differences in the socio-clinical characteristics of sample 2 and 
sample 3 the follow up sample is representative. What is less certain is whether a latent 
difference between participants in sample 2 and individuals who chose not to participate 
could have biased the results. For example, if individuals were more likely to take part in 
the follow-up interviews if there had been an improvement from baseline in the 
psychopathology they experience this could introduce a systematic bias to the findings. 
Alternatively, individuals may be more likely to participate if they are still using 
specialist intellectual disabilities services which could mean they continue to experience 
significant levels of psychopathology. Although it is difficult to be certain of the 
influence of the attrition rate on the findings, perhaps of greater relevance is giving 
consideration as to how to improve recruitment rates in future follow up studies. 
 
One methodological change that may improve follow-up would be to reduce the duration 
of time between interviews. For example, in a recent two-year incidence study of mental 
disorders the follow-up rate was 70% (Smiley et al. 2007). Even if the aim of the study is 
to follow up participants over a longer period, perhaps contacting participants more 
frequently would help to improve retention. Serial follow-up research interviews would 
also give valuable detail on changes in psychopathology over time, and could address the 
research questions, discussed in section 5.2, about the relationship between 
psychopathology and age, and developmental aspects of the proposed tripartite model. 
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5.7 Implications for clinical practice 
The findings in this thesis raise several issues of relevance to clinical practice, and the 
delivery of services, for individuals with intellectual disabilities and mental disorders. 
Identification of a mixed behaviour-affective dimension in the EFA highlights the 
importance of comprehensive assessments of psychopathology, whenever an individual 
presents to services. From this thesis, and other epidemiological studies, it appears that 
as severity of intellectual disabilities increases the risk and severity of psychopathology 
also increases. This suggests that mental health promotion interventions should be 
targeted at individuals with more severe intellectual disabilities. Finally, the follow-up 
study emphasizes the potential usefulness of incorporating outcome measures into 
routine clinical practice.  
 
In clinical services, individuals presenting with problem behaviours are often referred to 
psychologists and psychiatrists see individuals with other forms of psychopathology. 
This model of service provision could encourage an unhelpful focus on a restricted range 
of psychopathology when assessing individuals at the time of presentation.  The finding 
that affective and problem behaviour items of psychopathology loaded significantly to a 
single dimension reinforces the need to assess the full range of psychopathology, 
regardless of the primary presenting complaint. To achieve this, structured assessments 
of psychopathology should be used in clinical practice.  
 
The prevention of mental disorders, and mental health promotion, have received 
increasing attention in national mental health strategies and clinical guidelines. 
Resources have been provided to educational and clinical interventions to support 
children and young people to develop resilience, and parenting interventions to improve 
outcomes for at risk children. Since individuals with more severe intellectual disabilities 
appear to be at greater risk of mental disorders, consideration should be given to how 
best to reduce the risk. Some aspects of generic resilience models may be of use. 
However, it is likely that prevention and mental health promotion interventions for 
persons with intellectual disabilities will have a broader focus beyond an individual. A 
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social model of disability would suggest that interventions with parents and families, 
schools and communities should be considered as well as work with individuals. 
 
Although routine monitoring of outcome in clinical practice is often advocated, it is 
seldom achieved. Several different outcome measures were used in this study, all of 
which are appropriate for use in clinical settings. It is unlikely that clinicians would 
move from not using any measure, to using four. Therefore, it is more realistic to invite 
clinicians to incorporate one measure of outcome into clinical practice. Although 
concerns over the use of the GAF in intellectual disabilities have been raised, the revised 
scoring method (Hurley 2001) described in DM-ID appeared to produce similar results 
to the other outcomes- including the HoNOS-LD and CANDID-R designed for use in 
intellectual disabilities. Therefore, since the GAF is linked to the DM-ID, appears to be 
valid, likely to be familiar to clinicians and takes the minimum time to complete- it may 
be appropriate to introduce first. Of course, the GAF is limited in scope compared to 
other measures and it would be hoped that clinicians may use other measures once the 
value of using the GAF routinely is recognized. Since the GAF is a continuous measure 
of outcome, its use alongside the prevailing categorical models of psychopathology may 
be the first step towards incorporating dimensional models in routine clinical practice. 
 
5.8 Future research 
This thesis described the first multi-dimensional model of psychopathology experienced 
by adults with intellectual disabilities; derived using data collected using the PPS-LD. 
The value of intellectual disabilities psychopathology research has been demonstrated 
and suggests possible directions of future research. One obvious stream of future 
research is to further examine the reliability and stability of the dimensional model of 
psychopathology. Given that problem behaviours have a negative impact on the lives of 
persons with intellectual disabilities, the finding that problem behaviours was extracted 
within a behaviour-affective dimension of psychopathology merits further study. Finally, 
a common theme running throughout the thesis is the challenge of reliably identifying 
psychopathology experienced by persons with intellectual disabilities. Thus, returning to 
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a basic level of research to improve methods of self, and informant, report of 
psychopathology should be considered. 
 
Possible methods to study the reliability and validity of the multi-dimensional model of 
psychopathology are repeating the EFA described here using a different sample, and the 
use of confirmatory factor analysis. The only two psychopathology assessment 
instruments for which more than one EFA has been published are the PIMRA (Matson et 
al. 1984) and the PAS-ADD checklist (Moss et al. 1998; Sturmey et al. 2004; Hatton & 
Taylor 2008). Inclusion of items of psychopathology in the PIMRA of questionable 
validity, the limited range of items in the PAS-ADD checklist and the broader limitations 
of the methods of EFA used in these studies have been described previously. Therefore, 
replicating any multi-dimensional model of psychopathology would add significantly to 
the evidence-base. If possible, using a larger population-based sample, or a random sub-
sample of such a sample would maximize the reliability and validity of the multi-
dimensional model.  
 
Confirmatory factor analysis (CFA) can be used to examine whether a multi-dimensional 
model of psychopathology derived using EFA is verified in a separate sample. Although 
none of the models from previous intellectual disabilities studies have been tested with 
CFA, it has been used previously to verify the dimensional model of psychopathology in 
psychosis (Dollfus & Everitt 1998), ADHD in children (Gomez et al. 2003) and autism 
(Frazier et al. 2008). Various different methods can be used for CFA but most 
commonly structural equation modeling is used. Thus the methods of CFA are quite 
separate from those used in EFA, which might partly explain why few EFA studies in 
intellectual disabilities have lead on to research with CFA.  Either through replicating the 
EFA or using CFA, examining further the PPS-LD could develop the understanding of 
the relationship between a putative tripartite model of depression and anxiety 
psychopathology and problem behaviours. 
 
Another future study of value to understanding the multi-dimensional model of 
psychopathology would improve the coverage of items of psychopathology included in 
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the analysis. In particular, including additional items of psychopathology relevant to the 
presentation of anxiety, and inclusion of problem behaviours in addition to physical and 
verbal aggression, and self-injurious behaviour in PPS-LD could be considered. As well 
as potentially improving the validity of any resultant model, this could potentially reveal 
additional dimensions of psychopathology or higher order dimensions.  
 
Examining the existing research literature, it appears that the relationship between 
problem behaviours and other forms of psychopathology is of interest to researchers and 
clinicians alike. This thesis has shown that EFA offers one method to examine this area 
in more detail. One hypothesis that arises is that problem behaviours are associated with 
a general distress dimension, within a tripartite model of depression and anxiety 
psychopathology. As well as future research involving EFA and CFA, methodologies to 
examine this area could include: 
• longitudinal studies involving detailed and frequent assessments of affective 
psychopathology in individuals with clinically significant problem behaviours. This 
would inform an understanding of the relationship in time between changes in affect 
and behaviour  
• follow up studies of individuals receiving interventions for the management of 
disorders presenting with mixed affective psychopathology and problem behaviours. 
If these two forms of psychopathology are part of a single dimension, and possibly 
share an underlying pathophysiology, it would be predicted that effective 
interventions would lead to improvements in both. 
 
Such studies offer an opportunity for close working between intellectual disabilities 
psychiatrists and psychologists. Both professions have important, and complementary, 
contributions to make to the study of psychopathology. Bringing together the distinct 
areas of expertise could potentially lead to new models and management approaches for 
problem behaviours and other psychopathology. 
 
The inclusion of affective items of psychopathology across the depressive, behaviour-
affective and anxiety dimensions suggests examining the relevance of global affective 
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models of psychopathology. Findings from this thesis support studying models of affect 
regulation, affective arousal and valence models of affect in relation to psychopathology 
experienced by persons with intellectual disabilities.  
 
 A potential use for dimensional models of psychopathology is in the study of the 
pathophysiology of mental disorders. Genetic and neurobiological research has already 
evidenced the relevance of dimensions of psychopathology and endophenotypes to 
pathophysiology. In the field of intellectual disabilities, this is most likely to be of value 
in behavioural phenotype research. The use of categorical models of psychopathology 
has produced potentially important findings in understanding psychopathology 
experienced by individuals with Prader-Willi syndrome (Soni et al. 2008) and Williams 
syndrome (Einfeld et al. 1997; Dodd et al. 2009). However, the insights offered by 
moving beyond categorical models of autism spectrum disorders in individuals with 
fragile X syndrome (Kaufmann et al. 2004; Hagerman 2006), is a useful example of the 
potential offered by the study of dimensions and endophenotypes. The sample sizes 
required for EFA may be larger than those in many published behaviour phenotype 
studies. However, initiative to promote collaboration between researchers working on 
phenotype, such as the European Prader- Willi syndrome Clinical Research Database 
(Holland et al. 2009), offer an opportunity to examine the relevance of dimensional 
models of psychopathology to behaviour phenotypes. 
 
5.9 Conclusions 
The findings presented in this thesis highlight the value of research on psychopathology 
experienced by individual with intellectual disabilities. Psychopathology research in the 
field of intellectual disabilities is at an earlier stage compared to the evidence from 
studies involving children, adolescents and adults who do not have intellectual 
disabilities. However, research using categorical and dimensional models of 
psychopathology can further our understanding of mental disorders experienced by 
individuals with intellectual disabilities. 
 
 348 
Categorical models of psychopathology are integral to existing classification systems for 
mental disorders. With the improved utility and reliability of categorical diagnostic 
classification systems it is likely that they will continue to be used for clinical and 
research purposes. The findings of this thesis suggest that the use of multivariate 
statistical methods to identify dimensional models of psychopathology can contribute to 
research examining the validity of categorical diagnostic classification systems. For 
example, the validity of including  “tearfulness” and “reduced verbal communication” in 
the DC-LD criteria for a depressive episode is supported by item loadings to the 
depressive dimensions. However, since “increased irritability” did not load to the 
depressive dimension. Therefore, including irritable mood as an alternative to depressed 
mood in the DC-LD criteria for a depressive episode needs further study and validation. 
 
One potential advantage of dimensional models of psychopathology compared to 
categorical models is improved validity. The results of this thesis are in agreement with 
previous research suggesting that dimensional models of psychopathology have stronger 
associations with the severity and outcome of mental disorders, and therefore greater 
predictive validity. Further research is needed to examine the validity of both categorical 
models, which are central to diagnostic classification systems, and dimensional models. 
However, perhaps exploring ways to combine the utility and reliability of categorical 
models with the advantages for validity of dimensional models offers an opportunity to 
develop classification systems.  
 
On the basis of the increased prevalence and negative impact on the lives of adults with 
intellectual disabilities, psychopathology associated with problem behaviors is a priority 
area for research. This study highlights the relevance of examining problem behaviours 
within broader models of psychopathology. The findings in this thesis support new 
research hypotheses on psychopathology experienced by adults with intellectual 
disabilities. A dimensional model with similarities to the tripartite model of depression 
and anxiety psychopathology was defined by the exploratory factor analysis. Items 
representing problem behaviour psychopathology were extracted within the dimension 
similar to the general distress, rather than the depressive, dimension of the tripartite 
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model. Few intellectual disabilities studies have studied the relevance of the tripartite 
model of depression and affective psychopathology. Therefore, further research is 
required to examine hypotheses that: 
• affective psychopathology experienced by adults with intellectual disabilities is best 
represented by a tripartite model of depressive, anxiety and general distress 
dimensions. 
• problem behaviours are associated with a general distress dimension of 
psychopathology. 
 
Psychopathology research offers opportunities to develop an understanding of mental 
disorders experienced by adults with intellectual disabilities. There are advantages to 
considering novel models, methods and hypotheses alongside those derived from the 
prevailing categorical model of psychopathology. 
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Appendix I Information sheets 
 
          
  
 
 
SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS 
 
PARTICIPANT INFORMATION SHEET 
 
We would like to invite you to take part in a research study. The 
information sheet tells you about the study. Please read the information 
sheet, or ask someone to read it with you. This information sheet is for 
you to keep. It is also available on a tape.  
 
You can talk to your family and friends about the study. Ask them what 
they think about it.  
 
What will the research study find out? 
This research study will find out how mental health problems affect 
people with learning disabilities.  
 
Why do you want me to take part? 
We would like to invite you to take part because you used the Learning 
Disabilities Psychiatry Service.  Your name was given to us by the 
psychiatrist you met with to talk about your mental health. We would 
like to speak to people who used the Learning Disabilities Psychiatry 
Service four to five years ago.  
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What will the study involve? 
A researcher will contact you and ask to visit you.  You do not have to 
meet the researcher. Please let us know if you do not want to see the 
researcher. 
 
You can ask the researcher questions about the study.  The researcher 
will invite you to decide if you want to take part in the research study.  If 
you say yes, you will be asked to sign a form.  You can keep a copy of 
the consent form.  
 
If you take part, the researcher will arrange to meet you, at a place that is 
suitable for you.  The meeting will last about one hour.  If this seems too 
long for you, you can choose to have two shorter meetings instead. 
 
The researcher will ask you questions about:  
 The things you do in your life, and yourself 
 Any symptoms of mental ill-health you still have 
 The problems caused by mental ill-health 
 
We would like to speak to someone who knows you well like a relative, 
or carer.  We would also like to look at your Learning Disabilities 
Psychiatry casenotes.  This will provide us with information about the 
time when you first started using the Learning Disabilities Psychiatry 
Service. 
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If you have a mental illness which is not being treated we will discuss 
this.  We will offer to arrange an appointment with a psychiatrist from 
the health service.  Your GP could be involved in getting you help for 
your mental illness. 
 
If you are harmed by taking part in this research project, there are no 
special compensation arrangements.  If you are harmed due to 
someone’s negligence, then you may have grounds for a legal action but 
you may have to pay for it.  Regardless of this if you wish to complain 
about any aspect of the way you have been treated during the course of 
this study, the normal National Health Service complaints mechanism 
will be available to you. 
 
Has ethical approval been granted for this study? 
This study has been granted ethical approval by the MREC for Scotland, 
Committee A, and the local research ethics committee for the Primary 
Care Division of NHS Greater Glasgow. 
 
Will taking part in the study help me? 
If you decide to take part, it won’t benefit you now.  It may help people 
with learning disabilities in the future.  This study will also help people 
who plan services. 
 
What will happen if I decide not to take part in the study? 
You do not have to take part in this research study.  It is OK to say no.  
If you don’t want to take part, this will not affect the care and support 
you receive. 
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What if I change my mind and do not want to take part during the 
study? 
You can change your mind about taking part, or stop, at any time.  You 
do not have to give a reason.  If you change your mind this will not 
affect the care and support you receive.  
 
Where would the interviews take place? 
If it is OK with you, the researcher will arrange to see you at your home.  
If you want the researcher can arrange to see you somewhere else.  
 
What will happen to the information the researcher collects? 
All the information about you is kept safe. It will be treated with strict 
confidence. It will be kept secret. They will not tell 
anyone your name. The information will be kept very safely on a 
computer. The Data Protection Act will be followed at all times. 
 
What will happen to the results of the study? 
When the research study is finished, the research team will write to you 
about the research findings. They will also write reports about the 
research. Your name will not be used in the reports. No one will be able 
to tell from the reports if you took part in the research. 
 
Who is organising the research? 
This study is organised by the Learning Disabilities Research Group, at 
the University of Glasgow.  
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How can I find out more about the study? 
You can ask the researcher questions about the study.  The name and 
telephone number of the researcher are shown below.  The names of the 
members of the research team are below. You can contact them at any 
time to ask questions. 
 
If you would like to take part please complete the reply slip below.  
After two weeks we will phone to ask if you would like to take part. 
 
Thank you for taking the time to read this information sheet. 
 
 
Researcher  
Dr Craig Melville 
Section of Psychological Medicine, Division of Community Based 
Sciences, Academic Centre, Gartnavel Royal Hospital, 1055 Great 
Western Road, Glasgow, G12 0XH. 
Telephone: 0141 211 0693 
 
 
 390 
Research Team 
 
Professor Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.   
Telephone: 0141 211 0690 
 
Dr. Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.   
Telephone: 0141 211 0693 
 
……………………………………………………………………………………… 
 
 
Name ………………………………………………… 
 
 
Address ………………………………………………. 
 
……………………………………………………….. 
 
……………………………………………………….. 
 
Telephone Number ………………………………….. 
 
I would like to find out more about the study    Yes  
 
           No  
Please return this form to: 
 
Dr Craig Melville 
Section of Psychological Medicine 
University of Glasgow 
Academic Centre 
Gartnavel Royal Hospital 
1055 Great Western Road 
GLASGOW 
G12 0XH 
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SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS 
RELATIVE, WELFARE GUARDIAN INFORMATION SHEET 
 
We would like to invite the person with learning disabilities whom you support to 
take part in a research study.  We do not think that this person has the capacity to 
consent to participate in research.  However, under the provisions of the Adults with 
Incapacity (Scotland) Act you are able to provide consent.  Before you make your 
decision about whether to give consent for them to participate in this study, it is 
important that you understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it 
with the person with learning disabilities whom you support, and others if you wish.  
Ask us if there is anything that is not clear or if you would like more information.  
Please keep this information sheet, which is also available on cassette tape. Thank 
you for reading this information sheet. 
 
What will the research study find out? 
 
This research study wants to examine the impact and outcomes of mental ill-health 
on adults with learning disabilities.  We would like to find out if the person you 
support still experiences symptoms of mental ill-health, and learn about any 
changes, or problems that have come about as a consequence of the mental ill-health 
they have experienced.  No one has ever looked carefully at this before.  If we know 
how mental ill-health affects people with learning disabilities, this will help us to 
plan the services that might be needed.  The study will not be of immediate benefit 
for the person you support, or you, but it may help people with learning disabilities 
in the future. 
 
Why do you want the person I support to take part? 
 
The person with learning disabilities whom you support has been invited to take part 
in the study as he/she has used the Learning Disabilities Psychiatry Service.  We 
were given the name of the person with learning disabilities you support by the 
psychiatrist, who helped the person you support with their mental ill-health.  We 
would like to speak to as many people as possible, who were assessed by the 
Learning Disabilities Psychiatry Service between January 2000 and August 2002.  
We are interested to find out what has happened in the life of the person you support 
since that time.  In addition, we want to look at whether their mental ill-health has 
improved, and the impact that it has had on their life. 
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What will the study involve? 
 
The study involves a researcher meeting with the person with learning disabilities 
whom you support, and a carer where appropriate.  This meeting will take 
approximately one hour.  However, if this seems too long, the meeting can be 
divided into two or more shorter meetings.  At this meeting, the researcher will ask 
questions about the life of person with learning disabilities whom you support, 
including things they enjoy doing, questions about health and the support they 
receive, and questions about symptoms of mental ill-health that they still experience. 
 
We would also like to examine the learning disabilities psychiatric casenotes 
belonging to the person with learning disabilities whom you support. This will 
provide us with information about the time when the person you support first started 
using the service, and the way in which they have used the service since then.  You 
will be asked separately to decide whether to give consent to the researcher 
examining the casenotes of the person with learning disabilities whom you support. 
 
If the information we gather suggests that the person you support has a mental 
illness which is not being managed we will discuss this with you.  The GP of the 
person you support may be able to help with the problem.  We will offer to arrange 
for an assessment to be carried out by a psychiatrist working for the Glasgow 
Learning Disability Partnership. 
 
If the person you support is harmed by taking part in this research project, there are 
no special compensation arrangements.  If the person you support is harmed due to 
someone’s negligence, then he/she may have grounds for a legal action but he/she 
may have to pay for it.  Regardless of this if the person you support wishes to 
complain about any aspect of the way he/she has been treated during the course of 
this study, the normal National Health Service complaints mechanism will be 
available to him/her. 
  
Will taking part in the study help me, or the person I support? 
 
If you decide to take part, there will be no direct benefits for you, or the person you 
support.  However, the information we gather from the study may help the people 
who plan services for people with learning disabilities who experience mental ill-
health to provide better services in the future. 
 
What will happen if I decide to give consent to the person I support 
participating in the study? 
 
If you decide to give consent for the participation of the person you support in this 
research study, you will be asked to sign a written consent form.  You will be given 
a copy of the consent form to keep.  The researcher will then arrange to meet with 
the person with learning disabilities, and a carer where appropriate.   
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What will happen if I decide not to give consent to the person I support 
participating in the study? 
 
You do not have to give consent for the participation of the person you support in 
this research study.  It is OK to say ‘no’.  If you decide you do not want the person 
you support to take part in the study this will not affect the care that they receive 
from the psychiatrist, or from anybody else who provides care or support to that 
person.  
 
 
 
What if I change my mind about the person I support taking part during the 
study? 
 
You can change your mind about the person you support taking part, at any time.  
You do not have to give a reason for changing your mind.  If you change your mind 
this will not affect the care the person you support receives from the psychiatrist, or 
anyone else who provides care to that person. 
 
Where would the interview take place? 
 
The researcher will arrange to meet with the person with learning disabilities at a 
place that is convenient for them.  You may like to help the person with learning 
disabilities choose where they want to meet the researcher.  The researcher could 
meet the person at the home.  If this is not suitable, the researcher will arrange to 
meet with the person with learning disabilities somewhere that is suitable for them. 
 
What will happen to the information the research team collect? 
 
The research team will keep all the information you provide in strict confidence.  No 
one outside of the research team will have access to the information you provide.  
The information will be kept very safely on a computer database.  The Data 
Protection Act will be adhered to at all times. 
 
Who is organising and funding the research? 
 
This research study is organised by members of the Learning Disability Research 
Group at the University of Glasgow.  The study was funded by the Baily Thomas 
Charitable Trust. 
 
Has ethical approval been granted for this study? 
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This study has been granted ethical approval by the MREC for Scotland Committee 
A and the local Research Ethics Committee for the Primary Care Division of NHS 
Greater Glasgow. 
 
 
What will happen to the results of the study? 
 
We will post out information about the findings of this research study to everyone 
who takes part, after the study is finished.  Findings of this study will also be given 
to managers of learning disabilities health and social work services.  The research 
findings will be written into reports which will be published.  It will not be possible 
to identify any of the individuals who take part in the study from the reports, as all 
the information will be anonymised, with information from many individuals 
grouped together. 
 
 
 
How can I find out more about this study? 
 
If you would like to discuss any aspect of this study, or wish to ask any questions 
please ask the researcher, or contact any of the research team, at any stage of the 
study. 
 
Thank you for taking the time to read this information sheet. 
 
 
Researcher         
Dr Craig Melville 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Tel. 0141 211 3878 
 
Research Team  
Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.  Tel. 0141 211 0690 
 
Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Tel. 0141 211 3878 
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SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC  
DISORDERS 
 
CARER INFORMATION SHEET 
 
We would like to invite the person with learning disabilities whom you support to 
take part in a research study.  Please keep this information sheet, which is also 
available on CD.  Before you decide it is important to understand why the research is 
being done and what it will involve.  Please take time to read the following 
information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part.  Thank you for reading this. 
 
What will the research study find out? 
 
This research study wants to examine the impact and outcomes of mental ill-health 
on adults with learning disabilities.  We would like to find out if the person you 
support still experiences symptoms of mental ill-health, and learn about any 
changes, or problems that have come about as a consequence of the mental ill-health 
they have experienced.  No one has ever looked carefully at this before.  If we know 
how mental ill-health affects people with learning disabilities, this will help us to 
plan the services that might be needed.  The study will not be of immediate benefit 
for the person you support, or you, but it may help people with learning disabilities 
in the future. 
 
Why do you want the person I support to take part? 
 
The person with learning disabilities whom you support has been invited to take part 
in the study as he/she has used the Learning Disabilities Psychiatry Service.  We 
were given the name of the person with learning disabilities you support by the 
psychiatrist, who helped the person you support with their mental ill-health.  We 
would like to speak to as many people as possible, who were assessed previously by 
the Learning Disabilities Psychiatry Service.  We are interested to find out what has 
happened in the life of the person you support since that time.  In addition, we want 
to look at whether their mental ill-health has improved, and the impact that it has had 
on their life. 
 
What will the study involve? 
 
If the person you support wants to find out more, a researcher will contact them to 
arrange a time to meet.  This meeting would be to discuss the study, and answer any 
questions about the study.  If the person you support does not wish to meet the 
researcher, please let us know. 
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The researcher will explain the study to the person you support, and answer any 
questions.  If the person you support chooses to take part in the research project 
there will be a consent form to sign.  He/she will be given a copy of the consent 
form to keep.  The person you support does not have to take part in the project it is 
OK to say ‘no’ and this will not affect the care that the person you support receives 
from the Learning Disabilities Psychiatry Service.  Some people with learning 
disabilities are unable to consent to participation in research.  If this is the case, 
under the procedures of the Adults with Incapacity (Scotland) Act a relative, or 
welfare guardian will be asked to consider providing consent to participation. 
 
If the person you support chooses to take part in the study, the researcher would like 
to meet for about one hour.  If this seems too long, you can choose to have two or 
more shorter meetings.  At this meeting, the researcher would like to ask questions 
about aspects of the life of the person you support, including things they enjoy 
doing, questions about their health and the support they receive, and questions about 
symptoms of mental ill-health that they still experience. 
 
After meeting the person you support, we would like to examine the learning 
disabilities psychiatric casenotes belonging to the person that you support.  This will 
provide us with information about the time when the person you support first started 
using the service, and the way in which they have used the service since then.   
 
If the information we gather suggests that the person you support has a mental 
illness which is not being managed we will discuss this with you.  The GP of the 
person you support may be able to help with the problem.  We will offer to arrange 
for an assessment to be carried out by a psychiatrist working for the Glasgow 
Learning Disability Partnership. 
 
If the person you support is harmed by taking part in this research project, there are 
no special compensation arrangements.  If the person you support is harmed due to 
someone’s negligence, then he/she may have grounds for a legal action but he/she 
may have to pay for it.  Regardless of this if the person you support wishes to 
complain about any aspect of the way he/she has been treated during the course of 
this study, the normal National Health Service complaints mechanism will be 
available to him/her. 
  
Will taking part in the study help me, or the person I support? 
 
If the person you support decides to take part, there will be no direct benefits for the 
person you support.  However, the information we gather from the study may help 
the people who plan services for people with learning disabilities who experience 
mental ill-health to provide better services in the future. 
 
What will happen if the person I support decides not to take part in the study? 
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The person with learning disabilities whom you support does not have to take part in 
this research study.  It is OK to say ‘no’.  If he/she decides not to take part in the 
study this will not affect the care that the person you support receives from the 
psychiatrist, or from anybody else who provides care or support to that person.  
 
 
What if the person I support changes his/her mind about taking part during the 
study? 
 
The person you support can change his/her mind about taking part, or stop, at any 
time.  He/she does not have to give a reason for changing their mind.  If he/she 
changes their mind about taking part in the study this will not affect the care the 
person you support receives from the psychiatrist, or anyone else who provides care 
to that person. 
 
Where would the interview take place? 
 
The researcher will arrange to meet with the person with learning disabilities at a 
place that is convenient for them.  He/she can choose where they want to meet with 
the researcher.  The researcher could meet at the home of the person you support.  If 
this is not suitable, the researcher will arrange to meet somewhere that is suitable for 
the person you support.  The person you support will be invited to choose whether 
they would like a friend, family member or carer to be present during the interview. 
 
What will happen to the information the research team collect? 
 
The research team will keep all the information you provide in strict confidence.  No 
one outside of the research team will have access to the information you provide.  
The information will be kept very safely on a computer database.  The Data 
Protection Act will be adhered to at all times. 
 
Who is organising the research? 
 
This research study is organised by members of the Learning Disability Research 
Group at the University of Glasgow.   
 
Has ethical approval been granted for this study? 
 
This study has been granted ethical approval by the MREC for Scotland, Committee 
A, and the local Research Ethics Committee for the Primary Care Division of NHS 
Greater Glasgow. 
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What will happen to the results of the study? 
 
We will post out information about the findings of this research study to everyone 
who takes part, after the study is finished.  Findings of this study will also be given 
to managers of learning disabilities health and social work services.  The research 
findings will be written into reports which will be published.  It will not be possible 
to identify any of the individuals who take part in the study from the reports, as all 
the information will be anonymised, with information from many individuals 
grouped together. 
 
 
How can I find out more about this study? 
 
If you would like to discuss any aspect of this study, or wish to ask any questions 
please ask the researcher, or contact any of the research team, at any stage of the 
study. 
 
Thank you for taking the time to read this information sheet. 
 
Researcher                                                                                      
Dr Craig Melville 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Tel. 0141 211 0693 
 
Research Team  
Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.  Tel. 0141 211 0690 
 
Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Tel. 0141 211 0693 
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Appendix II Consent forms 
 
 
 
    
 
SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS 
 
PARTICIPANT CONSENT FORM 
 
This form asks if I will take part in a research study. 
A researcher will ask me questions about mental ill-health. 
The researchers will keep my information confidential (secret) and safe. 
Taking part in the research study won’t immediately help me. 
Please tick the box if you agree with what it says. 
 
I have been given an information sheet about the study. Yes 
  
⁭ 
   
I have asked all the questions I want to. Yes 
  
⁭ 
   
I have been given enough answers to my questions. Yes 
  
⁭ 
   
I know it is OK to say ‘No’ to taking part in the study.   
I don’t have to take part.  I don’t have to say why. 
Yes ⁭ 
 
  
 
  
Saying ‘No’will not affect my future health care or support 
in any way.  I know I can change my mind and say ‘No’ 
later on. 
Yes ⁭ 
 
  
 
  
I know the research team will write about the study 
results.  I know the results will not include my name.  No 
one will be able to identify me from the results. 
Yes ⁭ 
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Signed 
…………………………………………………………………………………………
. 
Name 
……………………………………………………………………………………… 
Date 
……………………………………………………………………………………… 
 
Reviewing your casenotes 
We would like to look at your Learning Disabilities Psychiatry casenotes.  This will 
provide information about your use of the clinical service.  Only members of the 
research team will have access to your casenotes. This information will be kept 
confidential (secret) and safe.  If you do not want us to look at your casenotes it is 
OK. 
 
I am happy for you to look at my Learning Disabilities 
Psychiatry casenotes. 
Yes ⁭ 
 
Signed  
………………………………………………………………………………….. 
Name  
………………………………………………………………………………… 
Date  
……………………………………………………………………………………. 
 
 
 
Researcher  
            
Dr Craig Melville 
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Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Telephone: 0141 211 0693 
Fax: 0141 357 4899 
 
Research Team  
    
Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.  Tel. 0141 211 0690 
 
Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Tel. 0141 211 0693 
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SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS  
RELATIVE, WELFARE GUARDIAN CONSENT FORM 
 
This form asks if I will consent to my relative, or the person I support 
taking part in a study. 
 
I have been asked to do this as my relative, or the person I support, does not have the 
capacity to consent to participation in research.  I understand that under the 
provisions of the Adults with Incapacity (Scotland) Act 2000, I can provide consent 
to the person participating in the research study. 
 
If I provide consent to my relative, or the person I support, participating in the study, 
a researcher will ask questions about health and the learning disabilities services. 
  
The researchers will keep all the information confidential. Only members of the 
research team will have access to the information I discuss. 
 
I understand that if I provide consent, participation in the study won’t directly help 
me, or the person with learning disabilities whom I support. 
 
I am completing this form as the nearest relative/welfare guardian. (Delete as 
appropriate) 
 
My relationship to the participant is ………………………………………………  
 
As the nearest relative, I confirm that there is no welfare 
guardian or nearer relative. 
Yes ⁭ 
   
   
I have been given an information sheet about the study. Yes 
  
⁭ 
   
I have asked all the questions I want to. Yes 
  
⁭ 
   
I am satisfied that my questions have been thoroughly 
answered. 
Yes ⁭ 
 
  
 
  
I know it is OK to say ‘no’ to taking part in the study.  I 
don’t have to take part.  I don’t have to say why.  
Yes ⁭ 
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If I say ‘no’, I know it will not affect the future health care, 
or support, that the person I support receives. 
Yes ⁭ 
 
  
 
  
If I decide to take part in the study, I know I can still 
change my mind and say ‘no’ later on. 
Yes ⁭ 
 
  
 
  
I know the research team will write about the study 
results.  However, the results will not include my name, or 
the name of the person I support. No one will be able to 
identify me, or the person with learning disabilities I 
support, from the results. 
Yes ⁭ 
 
  
 
  
I agree to my relative, or the person I support taking part 
in the research study. 
Yes ⁭ 
 
 
 
 
Reviewing the casenotes of your relative/the person you support 
We would like to look at the Learning Disabilities Psychiatry casenotes of your 
relative/the person you support.  This will provide information about his/her use of 
the clinical service.  Only members of the research team will have access to the 
casenotes.  This information will be kept confidential and safe.  If you do not want 
us to look at the casenotes of your relative/the person you support, it is OK. 
 
 
 
I am happy for you to look at the Learning Disabilities 
Psychiatry casenotes of my relative/the person I support. 
Yes ⁭ 
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Signed  
 
………………………………………………………………………………………… 
Name  
………………………………………………………………………………………… 
Date 
………………………………………………………………………………………… 
 
Researcher  
            
Dr Craig Melville 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Telephone: 0141 211 0693 
Fax: 0141 357 4899    
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